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Abstract 
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Abstract 
The fundamental substrate class of α,β-unsaturated esters offers extraordinary synthetic 
potential for carbon-carbon bond forming reactions, such as cycloadditions and conjugate 
additions, however is rarely applied in asymmetric catalysis due to its relatively low 
reactivity. By expanding the concept of silylium-ACDC to non-silicon transfer reactions 
(catalytic in silicon), the introduction of chiral C–H acids into asymmetric catalysis and the 
identification of two distinct families of imidodiphosphorimidates (IDPi) catalysts, we could 
report unprecedented highly enantio- and diastereoselective Diels–Alder and Mukaiyama–
Michael reactions of simple α,β-unsaturated methyl esters. The developed extremely active 
chiral Lewis acids represent the most efficient catalysts for asymmetric Diels–Alder reactions 
of α,β-unsaturated esters to date while tolerating a very broad scope on a variable scale with 
catalyst loadings as low as 0.1 mol%. 
Kurzzusammenfassung 
Die grundlegende Substratklasse der α,β-ungesättigten Ester bietet herausragendes 
synthetisches Potential für Kohlenstoff-Kohlenstoff Bindungsknüpfungsreaktionen wie 
Cycloadditionen und konjugierte Additionen, wird jedoch in der asymmetrischen Katalyse 
aufgrund ihrer relativ niedrigen Reaktivität kaum angewendet. Durch die Erweiterung des 
Konzept der asymmetrischen Gegenanion-vermittelten Katalyse mit Silylium-Equivalenten 
(silylium-ACDC) hin zu Reaktionen mit katalytischen Mengen Silizium, die Einführung von 
chiralen C–H Säuren in die asymmetrische Katalyse und die Identifizierung von zwei 
separaten Familien an Imidodiphosphorimidat-Katalysatoren, konnten bisher beispiellose 
hoch enantio- und diastereoselektive Diels–Alder und Mukaiyama–Michael Reaktionen 
beschrieben werden. Die entwickelten chiralen Lewis Säuren stellen die bis dato 
effizientesten Katalysatoren für asymmetrische Diels–Alder Reaktionen von α,β-
ungesättigten Estern dar und tolerieren trotzdem ein sehr breites Substratspektrum auf 
verschiedenen Reaktionsmaßstäben mit sehr niedrigen Katalysatorbeladungen von bis zu 
0.1 mol%. 
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1 Introduction & Objective 
1.1 Background 
In asymmetric catalysis, the majority of reactions proceed through partially charged or 
completely ionic intermediates. When anionic intermediates are involved such as negatively 
charged nucleophiles, chiral enantiopure countercations can render subsequent 
transformations enantioselective upon sufﬁcient association of the ion pair (Scheme 1.1). 
This principle has widely been applied in enantioselective phase-transfer catalysis (PTC).1 
Asymmetric induction upon ion-pair formation may also proceed with a crucial anionic 
partner. In the concept of asymmetric counteranion-directed catalysis (ACDC), a cationic 
species, such as a protonated intermediate, forms an ion pair with a chiral anion, which 
directs enantiotopos/-face-differentiation or enantiomer-differentiation.2,3 
 
Scheme 1.1 Schematic representation of ion pairs in enantioselective catalysis: phase-
transfer catalysis with chiral countercations (PTC) and asymmetric counteranion-directed 
catalysis (ACDC) with chiral counteranions. P = product; S = substrate; X = anion; NR4
- = chiral 
ammonium ion; cat. = cation (H+). 
A general deﬁnition of ACDC is given as: “Asymmetric counteranion-directed catalysis refers 
to the induction of enantioselectivity in a reaction proceeding through a cationic 
intermediate by means of ion pairing with a chiral, enantiomerically pure anion provided by 
the catalyst.”2 The term ion pair is further deﬁned according to Anslyn and Dougherty: “An 
ion pair is deﬁned to exist when a cation and anion are close enough in space that the 
energy associated with their electrostatic attraction is larger than the thermal energy (RT) 
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available to separate them.”4 Further attractive interactions, in addition to the Coulomb 
attraction, between cation and anion may be involved in the context of ACDC.2 The term ion-
pair catalysis is understood in a broader sense merging the concepts of phase-transfer-
catalysis and asymmetric counteranion-directed catalysis.5 Thus, catalyzed reactions 
proceeding through ion pairs in general are categorized into this class of catalytic processes. 
A proof-of-principle on the feasibility of ACDC as a powerful strategy for asymmetric 
catalysis beyond Brønsted acid catalysis was delivered by List and coworkers in 2006 for the 
highly enantioselective transfer hydrogenations of enals using a Hantzsch ester as the 
reductant (Scheme 1.2).6 The morpholinium salt of TRIP phosphoric acid (1) forms a chiral 
ion pair upon condensation with the enal substrate. The chiral anion directs the approach of 
the hydride source to the reactive iminium intermediate by enantiofacial steric shielding. 
The chiral ion pair intermediate as being present in the enantiodetermining step renders this 
reaction a clear showcase of ACDC. The high potential of this concept was rapidly realized 
and let to many applications in enantioselective organocatalysis but also in transition-metal 
catalysis featuring chiral enantiopure anions.2-5-7  
 
Scheme 1.2 Proof-of-principle for asymmetric counteranion-directed catalysis (ACDC): The 
catalytic asymmetric transfer hydrogenation of enals with the salt of morpholine and TRIP 
phosphoric acid. 
While enantioselective Brønsted acid catalysis is particularly successful for relatively 
electrophilic and/or basic substrates, such as imines, Brønsted acidic activation of substrates 
such as aldehydes, ketones, unsaturated carboxylic acid derivatives and oleﬁns is profoundly 
more challenging. Thus, the focus shifted towards organic Lewis acids as potential catalysts 
for activating such substrates. In the presence of silylating agents, Brønsted acids such as 
triﬂic acid (TfOH) and triﬂimide (Tf2NH) can be converted into their silylated analogues, 
which are very potent Lewis acids.8-9 As indicated by trends in pKa values, triﬂimide  
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(pKa = –11.9 in DCE; pKa = 0.3 in MeCN)
10 is turned into a much stronger Lewis acid upon 
silylation then triﬂic acid (pKa = –11.4 in DCE; pKa = 0.7 in MeCN) rendering TMS-NTf2 a 
promising motif for chiral organic Lewis acids.11 For previously reported metal-based Lewis 
acid-catalyzed asymmetric transformations, such as Mukaiyama–Aldol reactions, a major 
issue was competition between the desired enantioselective Lewis acid catalysis and a non-
enantioselective pathway catalyzed by silylium ions.12-13 By taking advantage of silylium 
ions/equivalents as potent Lewis acid, it was envisioned that a combination with a suitable 
chiral anion may render this pathway enantioselective through ACDC. In 2009, List and 
coworkers reported the ﬁrst realization of this concept featuring chiral disulfonimide (DSI) 
catalysts in Mukaiyama–Aldol reactions of aromatic aldehydes with silyl ketene acetals to 
give excellent yields and enantioselectivities.14 Disulfonimides as Brønsted-acidic pre-
catalysts are silylated to form the active species (Scheme 1.3). Residual water in the reaction 
mixture is transformed into TMS2O via catalyst hydrolysis and re-silylation by the silylated 
reagent, which is present in excess. In the dormant phase of the reaction, this process is 
continued until all water is consumed into TMS2O.
15 The highly relevant ability of catalyst 
regeneration after hydrolysis under silylating conditions is referred as self-healing or self-
regeneration. Aldehyde substrates are activated through complexation of the silyl group 
forming a chiral ion pair which allows effective enantiofacial differentiation. Upon 
nucleophilic attack of the silyl ketene acetal, the primary reaction product collapses to give 
the product and to regenerate the silylated catalyst. 
 
Scheme 1.3 General catalytic cycle for asymmetric Lewis acid catalysis with silylium ion 
equivalents and chiral counteranions.  
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The existence of underlying Lewis acid catalysis was supported by experiments in the 
presence of 2,6-di-tert-butyl-4-methyl pyridine as a Brønsted acid scavenger, which did not 
suppress the reaction. The shown catalytic cycle is considered to be general for the 
activation of aldehydes in reactions with silylated nucleophiles. This concept and the novel 
class of chiral Brønsted acids led to a renaissance of asymmetric Lewis acid catalysis for 
transformations of carbon electrophiles, such as aldehydes and imines, with silylated 
nucleophiles (Scheme 1.4).16-17 Aromatic aldehydes and imines are preferred substrates for 
silylated DSI catalysts and have subsequently been used for a series of other transformations 
with various silylated nucleophiles resulting in consistently high enantioselectivities. In 
analogy to the common Mukaiyama–Aldol reaction with silyl ketene acetals, a vinylogous, a 
bis-vinylogous18 and an alkynylogous19 variant have been developed. Combination with 
Danishefsky-type dienes gave hetero-Diels–Alder products after cyclization with 
triﬂuoroacetic acid (TFA),20 while treatment with (2-methylallyl)trimethylsilanes (N = 4.41)21 
afforded the corresponding methallylation products.22 
 
Scheme 1.4 Overview on applications of DSI catalysts in enantioselective Lewis acid-
catalyzed reactions of aromatic aldehydes and imines. 
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The corresponding Hosomi–Sakurai reaction employing allyltrimethylsilane as a very simple 
allylating reagent proved to be challenging due to its very low nucleophilicity (N = 1.68)23 and 
required higher reaction temperatures, resulting in only moderate enantioselectivity. 
However, if in situ generated N-ﬂuorenylmethoxycarbonyl (Fmoc) imines were used as 
electrophiles, the allylation with allyltrimethylsilane proceeds with excellent 
enantioselectivity in all examined cases.24 Aliphatic aldehydes, which gave only low to 
moderate enantioselectivities in previous transformations, could be employed as well 
without loss of selectivity. With N-butyloxycarbonyl (Boc) imines formed in situ from N-Boc 
amino sulfone precursors, an asymmetric Mukaiyama–Mannich reaction with silyl ketene 
acetal nucleophiles has been developed.25 Consuming one equivalent of SKA, the imine 
substrate is generated and Mannich products were afforded after the subsequent step with 
excellent yields and enantioselectivities. A vinylogous variant yielding versatile δ-amino-β-
ketoesters could be achieved using silyloxydienes.26 With TMS-CN, the cyanosilylation of 
aldehydes has been possible with catalyst loadings as low as 0.005 mol% (50 ppm),15 while 
the asymmetric catalytic Abramov reaction with silylated phosphites gave access to highly 
enantioenriched α-hydroxy phosphonates.27   
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1.2 Objective 
While aldehydes and aldimines as reactive substrates became routinely accessible with 
silylated DSI catalysts, more challenging electrophiles, such as ketones and unsaturated 
carboxylic acid derivatives, became attractive targets. In particular, α,β-unsaturated esters 
represent an underdeveloped substrate class for asymmetric catalysis despite their 
prominent role as dienophiles for Diels–Alder reactions and as versatile Michael acceptors. 
α,β-Unsaturated esters, and cinnamates in particular, have recently been ranked among the 
very least electrophilic Michael acceptors via quantitative measurements by Mayr and 
coworkers.28 Also for Diels–Alder reactions, α,β-unsaturated esters have been determined to 
be a relatively unreactive class of dienophiles through empirical observations in asymmetric 
catalysis and by computational studies.29-30 Thus, the main objectives of the doctoral studies 
presented herein were: 
1. Proof-of-principle for the activation of α,β-unsaturated esters with chiral silylium 
Lewis acids and the development of enantioselective methodology. 
2. Broadening the concept of silylium-ACDC by introducing transformations catalytic in 
silicon. 
3. Overcoming current limitations of catalytic asymmetric Diels–Alder reactions of 
simple α,β-unsaturated esters in scope and scale. 
 
Scheme 1.5 Enantioselective access to Diels–Alder and Mukaiyama–Michael products. 
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Preliminary results on the activation and application of α,β-unsaturated esters for 
enantioselective Diels–Alder and Mukaiyama–Michael reactions have been obtained in my 
Master thesis conducted in the List laboratory.31 By further exploration of catalyst structures 
and the optimization of reaction conditions, we aimed for very high enantioselectivities over 
a broad substrate scope for these transformations. 
As described in the previous chapter, enantioselective catalysis with chiral disulfonimides 
was applicable to a variety of silylated reagents acting as both activators for the catalyst and 
as nucleophiles in the reactions with aldehydes and aldimines (Scheme 1.4). In these silicon-
transfer reactions, the silyl group of the nucleophiles is always attached to the primary 
reaction product, while cleaved off in some cases by the workup or treatment with 
appropriate reagents. In contrast, no example for a reaction employing a non-silylated 
nucleophile or reactant has been described in silylium-ACDC. The use of only catalytic 
amounts of a silylating reagent, solely for the activation of the catalyst, would lead to a 
significant broadening of this concept, allowing for example its application in pericyclic 
reactions, such as the Diels–Alder reaction. 
Asymmetric catalytic Diels–Alder reactions have been developed for many activated α,β-
unsaturated carboxylic acid derivatives, such as N-acyl oxazolidinones32-39 and N-acyl 
pyrazoles.40-42 These ester surrogates, however, exhibit the inherent disadvantage of 
featuring a stereocontrolling and electrophilicity enhancing group that has to be attached 
and subsequently be cleaved off the molecule of interest. For simple α,β-unsaturated esters 
as highly desirable dienophiles only a limited number of examples have been reported. 
Evans et al. described the highly enantioselective Diels–Alder reactions of tert-butyl acrylate 
with cyclopentadiene with a bis(oxazolinyl)pyridine copper complex.34 Using a chiral 
alkyldichloroborane Lewis acid, Hawkins and coworkers obtained very good results in Diels–
Alder reactions of methyl acrylate and crotonate with cyclopentadiene.43-45 The broadest 
scope for α,β-unsaturated esters and different dienes to date was achieved with cationic 
oxazaborolidines introduced by Corey et al..30,46-50 For most transformations, however, more 
reactive trifluoroethyl ester substrates were used and a diene scope was only reported for 
readily reactive trifluoroethyl acrylate. In addition to the severe limitations in scope, catalyst 
loadings for all applicable chiral Lewis acids are generally high (5–20 mol%), while catalyst 
recycling or regeneration has never been demonstrated. Such a high demand of chiral 
catalyst currently prevents the use of asymmetric catalysis of the Diels–Alder reaction on a 
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larger scale as the authors of a recent review on the industrial application of the Diels–Alder 
reaction stated: “To our knowledge, no example of a catalytic asymmetric DA reaction 
carried out on a large scale has so far appeared in the literature.”51 For asymmetric synthesis 
of Diels–Alder products, the chiral auxiliary approach is currently the method of choice, e.g. 
for the large-scale synthesis of adenosine receptor agonist naxifylline52-54 or LY235959,55 a 
potential agent for the treatment of neurodegenerative disorders. We therefore aimed for 
the development of new highly enantioselective methodology applying simple α,β-
unsaturated methyl esters and various dienes with only very low catalyst loadings (≤1 mol%), 
potentially also enabling future application of asymmetric catalysis for the Diels–Alder 
reaction on an industrial scale. 
 
Scheme 1.6 Current limitations in asymmetric Diels–Alder chemistry. 
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Asymmetric Lewis acid
organocatalysis of the Diels–Alder
reaction by a silylated C–H acid
Tim Gatzenmeier,* Manuel van Gemmeren,* Youwei Xie, Denis Höfler,
Markus Leutzsch, Benjamin List†
Silylium ion equivalents have shown promise as Lewis acid catalysts for a range of
important C–C bond-forming reactions. Here we describe chiral C–H acids that upon in
situ silylation, generate silylium-carbanion pairs, which are extremely active Lewis acid
catalysts for enantioselective Diels–Alder reactions of cinnamates with cyclopentadiene.
Enantiomeric ratios of up to 97:3 and diastereomeric ratios of more than 20:1 are observed
across a diverse set of substitution patterns with 1 mole percent (mol %) of C–H acid
catalyst and 10 mol % of a silylating reagent. The results show promise for broad applications
of such C–H acid–derived silylium ion equivalents in asymmetric Lewis acid catalysis.
L
ewis acid catalysis enables key reactions in
chemical synthesis, such as the Diels–Alder,
Friedel–Crafts, and various aldol, Mannich,
and Michael reactions. Consequently, sub-
stantial efforts have been directed toward
enantiopure Lewis acids, which have enabled im-
portant asymmetric variations of such reactions
(1, 2). Despite the plethora of elegant catalysts
and methodologies developed in this context, a
key limitation of enantioselective Lewis acid ca-
talysis is the frequent need for relatively high
catalyst loadings, which result from issues such
as insufficient Lewis acidity (keeping some sub-
strate classes completely out of reach), product
inhibition, hydrolytic instability, and the compe-
tition with nonenantioselective background ca-
talysis (3, 4). With respect to these issues, we are
now envisioning an alternative approach to asym-
metric Lewis acid catalysis (Fig. 1). Conventional
chiral Lewis acids typically consist of a metal
(loid) complex with chiral ligands or substituents
(5–9). Their activity can often be increased by
rendering the complexes cationic and combining
them with weakly coordinating, achiral counter-
anions. By inverting the chiral entities within
the ion pair, a conceptually different strategy
results.
We have recently developed in situ silylated
disulfonimide Lewis acid organocatalysts for
highly enantioselective Mukaiyama-type reactions
involving silylated nucleophiles with catalyst
loadings as low as 10 parts per million (ppm)
(10–15). As an example of asymmetric counteranion-
directed catalysis (ACDC) (16–19), these reactions
proceed via silylation of an electrophile, generat-
ing a cationic reactive species that ion pairs with
an enantiopure counteranion and reacts with a
silylated nucleophile. We became interested in ex-
panding this silylium ion–ACDC to, in principle,
all types of Lewis acid–catalyzed reactions, in-
cluding those that do not involve stoichiometric
amounts of silylated reagents. We hypothesized
that the use of a suitable enantiopure precata-
lyst and a catalytic amount of a silylating reagent
should effect the formation of a catalytically
competent silylium ion equivalent. If successful,
silylium ion–ACDC, catalytic in silicon, would
provide an efficient approach to alleviating chal-
lenges in modern asymmetric Lewis acid catal-
ysis. Here we report the realization of this idea.
We have developed chiral C–H acids that, upon in
situ silylation, become extremely active Lewis acid
catalysts for highly enantioselective Diels–Alder
reactions of cinnamates with cyclopentadiene.
Enantioselective Diels–Alder reactions of a,b-
unsaturated ester dienophiles are generally chal-
lenging, and only a few have been reported. For
example, Ghosez applied chiral silylium ion equiv-
alents in combination with triflimide as achiral
counteranion to catalyze Diels–Alder reactions of
a,b-unsaturated esters with moderate enantio-
selectivity (6, 7). Corey has reported that triflimide-
activated chiral oxazaborolidine Lewis acids (8, 9)
give excellent results with acrylates and crotonates
as dienophiles. Cinnamates, with their highly con-
jugated p-electron system, represent an evenmore
challenging substrate class for asymmetric Diels–
Alder reactions, and in a reported example, ac-
tivated trifluoroethyl cinnamate required 20 mole
percent (mol %) of the protonated oxazaboroli-
dine catalyst to react (9, 20).
Given the superb reactivity observed in silylium
ion–ACDC in Mukaiyama-type reactions (10, 13),
we were curious to explore if our strategy would
also be suitable for the activation of cinnamates
in enantioselectiveDiels–Alder reactions.Weantic-
ipated that a highly Brønsted-acidic precatalyst
SCIENCE sciencemag.org 26 FEBRUARY 2016 • VOL 351 ISSUE 6276 949
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would be activated in situ with a catalytic amount
of a silylating reagent such as a silyl ketene acetal.
The resulting silylium ion equivalent would then
activate the cinnamate, while he chiral counter-
anion would induce the enantioselectivity.
We began our studies by exploring various pre-
viously developed chiral disulfonimide precatalysts
in the reaction of cinnamate 1a with cyclopenta-
diene2 (Fig. 2A). Disappointingly, their observed
high activity was insufficient toward this substrate
class, indicating that catalysts of evenhigher Lewis
acidity would be required (see table S3 for fur-
ther details). Inspired by the activity trends known
for achiral silylium ion equivalents in solution
(Fig. 2B), which indicate that the use of a carbon-
centered counteranion leads to higher Lewis acid-
ities (21), we became interested in developing
chiral, enantiopure C–H acids as precatalysts.
After considerable synthetic efforts, we accessed
compounds of sufficient C–H acidity and could
identify binaphthyl-allyl-tetrasulfones (BALTs)
as promising candidates for the enantioselective
catalysis of our target reaction (Fig. 2C). These
catalysts were designed based on the notion
that the Lewis acidity of the silylium ion equiva-
lent should increase on rendering the catalyst-
derived counteranion less Lewis basic. This goal
was achieved by exploiting the principle of vinyl-
ogy: In BALT anions, the negative charge is highly
delocalized (onto eight oxygen atoms and two
carbon atoms), leading to a low charge density
and thus Lewis basicity on every position of the
anionic substructure, and therefore to the excel-
lent catalytic activities observed with this cata-
lyst class.
The optimized reaction conditions involve the
use of a 9-fluoroenylmethyl cinnamate ester, which
enables higher stereoselectivities but is not re-
quired for catalytic activity; 9-phenanthryl groups
as 3,3′-substituents on the catalyst; and the use of
only 1mol% of catalyst6b, alongside 10mol% of
silyl ketene acetal 4b to effect the initial catalyst
silylation. The Brønsted acidic catalyst 6b itself
was found to be inactive for this transformation
(see table S9 for further details). Under the op-
timal conditions, our model reaction proceeded
smoothly, giving the desired product 3a in 94%
yield and an enantiomeric ratio (e.r.) of 97:3
(Fig. 3). Using these conditions, we proceeded
to explore the scope of the reaction. We found
that the transformation proceeds smoothly in
the presence of both strongly electron-donating
substituents (3b: 93%; e.r. = 95:5), as well as
strongly electron-withdrawing groups (3c: 90%;
e.r. = 95:5). Halide substituents were well tol-
erated, and the corresponding products 3d–3g
were all obtained in high to excellent yields and
with excellent stereocontrol. We proceeded to as-
sess the influence of regioisomeric substitution
on the cinnamate substrate and found thatmethyl
substituents in para, meta, and ortho position are
tolerated, and the corresponding products 3h–j
were obtained with yields ≥90% and enantiomeric
950 26 FEBRUARY 2016 • VOL 351 ISSUE 6276 sciencemag.org SCIENCE
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Fig. 2. Initial catalyst screening and optimization. (A) Model reaction of an unactivated cinnamate ester 1a with cyclopentadiene 2. (B) Trends of Lewis and
Brønsted acidities in solution for silylium ion equivalents bearing CF3SO2 (Tf)–substituted O-, N-, and C-centered counteranions and the corresponding Brønsted
acids (21). (C) Precatalysts: disulfonimides (DSI) and chiral C–H acids (BALTs).
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ratios ≥95.5:4.5. To further demonstrate the
tolerance of substituents in various positions of
the aryl-ring, the meta-nitro-substituted product
3kwas prepared in 91% yield and with an e.r. of
97:3, a result that compares very well to the one
obtained for the para-substituted analog 3c. Fur-
thermore, we studied substrates with extended
p-surfaces, and the corresponding 1- and 2-naphthyl–
substituted products (3l and 3m) were obtained
with excellent results. Finally, we synthesized the
2-furyl– and 2-thiophenyl–substituted products 3n
and 3o, which were both obtained in good yields
andwithhigh stereoselectivities, thus revealing that
ourmethodology can be applied to hetero-aromatic
substrates. All Diels–Alder adducts described in
this work were obtained with excellent endo-
diastereoselectivities (d.r. >25:1 in virtually all cases).
Having studied the scope of our reaction, we
were interested in probing the mode of action
proposed at the outset of our studies. To do so,
we applied 1H nuclearmagnetic resonance (NMR)
spectroscopy to monitor the in situ activation of
the BALT catalyst, using the 3,3′-unsubstituted
variant 6d and silyl ketene acetal 4a as model
compounds (Fig. 4A). We found that over a pe-
riod of ~70 min, the signals corresponding to
the precatalyst disappeared, and a new species
emerged lacking the signal corresponding to the
acidic proton (H-1). In comparison to the pre-
catalyst (two diastereotopic naphthyl groups with
sharp 1HNMR signals), the newly formed species
showed relatively broad signals at room temper-
ature. Increasing the temperature to 55°C allowed
us to observe pseudohomotopic naphthyl groups
in the activated species, an observation in good
agreement with expectations for the formation
of a silylium BALT–anion pair such as 7d. The
anionic character of the BALT motif in this ac-
tivated species was corroborated by the spectral
similarities to the features observed for a BALT-
derived tetraalkyl ammonium salt (see fig. S6 for
further details).
On the basis of these observations and pre-
vious studies (22–25), we propose a catalytic cycle
(Fig. 4B), which involves ionic species and thus
represents a case of asymmetric counteranion-
directed catalysis.
After the initial catalyst activation, achieved
via protodesilylation of a catalytic amount of
silyl ketene acetal4, the resulting silyliumBALT–
anion pair 7 could exchange the Lewis base, thus
forming species 9, which is activated by lowering
of the lowest unoccupied molecular orbital
(LUMO-lowering). Traces of water that may be
present in the reaction mixture will presum-
ably immediately hydrolyze ion pair 7, fur-
nishing C–H acid 6, which in turn is reactivated
by silyl ketene acetal 4. The Diels–Alder reaction
of9with cyclopentadiene (2), proceeding through
a transition state such asA≠, would then result in
SCIENCE sciencemag.org 26 FEBRUARY 2016 • VOL 351 ISSUE 6276 951
Fig. 3. Scope of the Diels–Alder reaction
(Tf: SO2CF3; Fm: fluorenylmethyl; TBS:
tert-butyldimethylsilyl). All yields are isolated.
Enantiomeric ratios (e.r.) were determined via
high-performance liquid chromatography
(HPLC). Diastereomeric ratios (d.r.) were
determined by 1H-NMR. *Using 3 instead of
1 mol % of catalyst loading gave full conversion
after 3 days with identical enantiomeric and
diastereomeric ratios.
Et2O (0.2 M), –20 °C, 
1–6 days
Ar
O
OAr
O
O
(S)-6b
O
OFm
O
OFm
OMe
O
OFm
NO2
O
OFm
F
O
OFm
Cl
O
OFm
Br
O
OFm
I
O
OFm
Me
O
OFm
Me
O
OFm
Me
O
OFm
NO2
O
OFm
O
OFm
O
OFm
O
O
OFm
S
3a, 94% (15 h)
e.r. 97:3
d.r. >25:1
3b, 93% (6 days in CHCl3)a
e.r. 95:5
d.r. >25:1
3c, 90% (2 days in CHCl3)
e.r. 95:5
d.r. >25:1
3d, 91% (3 days)
e.r. 95:5
d.r. >25:1
3f, 97% (4 days)
e.r. 96:4
d.r. >25:1
3e, 94% (0 °C, 10 h)
e.r. 95:5
d.r. >20:1
3g, 89% (3 days)
e.r. 95.5:4.5
d.r. >25:1
3h, 96% (24 h)
e.r. 95.5:4.5
d.r. >25:1
3i, 92% (10 h)
e.r. 95.5:4.5
d.r. >25:1
3j, 90% (3 days)
e.r. 96:4
d.r. >25:1
3k, 91% (36 h)
e.r. 97:3
d.r. >25:1
3l, 93% (24 h)
e.r. 96:4
d.r. >25:1
3m, 93% (2 days)
e.r. 96.5:3.5
d.r. >25:1
3n, 91% (3 days)
e.r. 95.5:4.5
d.r. >25:1
3o, 88% (0 °C, 3 days)
e.r. 92.5:7.5
d.r. >25:1
+ SO2
SO2
Tf
Tf
1
2
3
(S)-6b  (1 mol%)
OTBS
OMe
(10 mol%)
4b
≡
3o (x-ray structure)
RESEARCH | REPORTS
o
n
 July 10, 2018
 
http://science.sciencem
ag.org/
D
ow
nloaded from
 
a product complex 10. The asymmetric induc-
tion in transition state A≠ would result largely
from the stereochemical communication between
the achiral cationic moiety and the enantiopure
BALTanion.After the enantio-determining step, the
final product 3 could be liberated by direct Lewis
base exchange with anothermolecule of substrate
1, or via the intermediate formation of the acti-
vated complex 7with 8, in both cases resulting in
the concomitant closing of the catalytic cycle.
An important andunique feature of our silylium
ion–ACDC approach arises from the possibility
of a repair pathway upon hydrolytic deactiva-
tion of the Lewis acid catalyst, enabled by simply
adjusting the amount of the silylating reagent.
The valuable source of chirality is hydrolytically
stable and can only switch between the anionic
state (active Lewis acid) and the Brønsted acidic
state, thus allowing very low catalyst loadings.
Our findings immediately suggest widespread
applications of this activation mode to other re-
actions susceptible to Lewis acid catalysis. Further-
more, our studies constitute a proof of principle
for the feasibility of enantioselective C–H acid ca-
talysis and likely pave the way for the application
of such catalysts in enantioselective Brønsted acid
catalysis. We believe that our C–H acid-based
catalyst design may furnish solutions for ad-
dressing limitations remainingwith current O–H–
and N–H–based organocatalysts, and in ACDC
in general.
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Fig. 4. Proposed catalytic cycle and mechanistic considerations. (A) In situ NMR spectroscopic study of catalyst activation. 3,3′-Unsubstituted BALT
catalyst 6dwas treated with an excess of silyl ketene acetal 4a to give the silylium BALT–anion pair 7d. (Right) 1H-NMR spectra of the startingmaterial and of the
product at different temperatures. (B) Catalyst activation and proposed catalytic cycle.
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General Information 
Unless otherwise stated, all reagents were purchased from commercial suppliers and used 
without further purification. Unless otherwise stated, solvents were used without prior 
degassing or drying. Freshly cracked 1,3-cyclopentadiene was stored in a Schlenk flask under 
Argon at -78 °C. Reactions were monitored by thin layer chromatography (TLC) on silica gel 
pre-coated plastic sheets (0.2 mm, Macherey-Nagel). Visualization was accomplished by 
irradiation with UV light at 254 nm and/or phosphomolybdic acid (PMA) stain and/or Cerium 
Ammonium Molybdate (CAM) stain and/or permanganate stain. Column chromatography 
was performed on Merck silica gel (60, particle size 0.040-0.063 mm). Optical rotations were 
measured on an Autopol IV automatic polarimeter (Rudolph Research Analytical) at 589 nm, 
25°C. Data are reported as: [α]D
t
, concentration (c in g/100 mL), and solvent. The absolute 
configurations were determined by comparing the optical rotations with reported values when 
such values were available in literature and by x-ray crystallography– all other products were 
assigned by analogy. Proton and carbon NMR spectra were recorded on Bruker Avance III 
500 MHz spectrometer in deuterated solvents. Proton chemical shifts are reported in ppm (δ) 
relative to tetramethylsilane (TMS) with the solvent resonance employed as the internal 
standard (CD2Cl2, δ = 5.32 ppm; CDCl3 δ = 7.26 ppm, DMSO δ = 2.50 ppm). Data are 
reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, triplet = t, q = 
quartet, m = multiplet, b = broad), coupling constants (Hz) and integration. 
13
C chemical 
shifts are reported in ppm (δ) from tetramethylsilane (TMS) with the solvent resonance as the 
internal standard (CD2Cl2, δ = 53.8 ppm; CDCl3, δ = 77.16 ppm, DMSO δ = 39.52 ppm). 
High resolution mass spectra were determined on a Bruker APEX III FTMS (7 T magnet). 
The enantiomeric ratios were determined by HPLC analysis employing a chiral stationary 
phase column specified in the individual experiment (HPLC traces analysis), by comparing 
the samples with the appropriate racemic mixtures. Unless otherwise stated, diastereomeric 
ratios were determined by 
1
H-NMR. 
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Substrate Synthesis & Characterization 
All ester substrates have been prepared from commercially available cinnamic acids 
purchased from Sigma-Aldrich, Alfa Aesar, Acros Organics, AK Scientific, Apollo Scientific, 
Key Organics and Aronis. 
General procedure A: Preparation of 9-fluorenylmethyl cinnamates: 
A literature procedure reported by Trost et al. was applied with slight modifications.(26) 
A mixture of 9-fluorenylmethanol (2.16 g, 11 mmol, 1.1 equiv.), the appropriate cinnamic 
acid (10 mmol), pTSA (172 mg, 1 mmol, 10 mol%) in toluene (50 mL) was heated to reflux 
in a Dean-Stark trap and the reaction progress was controlled by TLC. After full conversion 
(typically after 1-2d), the reaction mixture was allowed to cool to room temperature, diluted 
with MTBE or diethylether (100 mL), washed with saturated NaHCO3 (50 mL) and brine (50 
mL), dried over MgSO4, and concentrated under reduced pressure. Purification by flash 
column chromatography on silica gel followed by recrystallization gave the corresponding 
esters as solid, crystalline compound. 
(E)-(9H-Fluoren-9-yl)methyl cinnamate (1a) 
To a solution of cinnamic acid (1.63g, 11.0 mmol) under argon in dry 
CH2Cl2 (100 mL) at r.t., 9-fluorenylmethanol (2.38 g, 12.1 mmol, 1.1 
equiv.), EDC hydrochloride (2.11 g, 12.1 mmol, 1.1 equiv.) and DMAP 
(134 mg, 1.1 mmol, 10 mol%) were added in this order. The reaction mixture was stirred at 
r.t. overnight, subsequently transferred to a separation funnel and washed with diluted HCl 
solution (10%, 50 mL), water (50 mL) and brine (50 mL). The organic phase was dried over 
MgSO4 and concentrated under reduced pressure. The crude product was puriﬁed by ﬂash 
column chromatography (eluent hexane/EtOAc 40:1 → 20:1) affording 1a as a colorless, 
crystalline solid (2.14 g, 66%). 
1
H‐NMR (300 MHz, CDCl3): δ = 4.33 (t, J = 7.2 Hz, 1H), 4.53 (d, J = 7.2 Hz, 2H), 6.54 (d, J 
= 16.0 Hz, 1H), 7.30–7.38 (m, 2H), 7.39–7.47 (m, 5H), 7.53–7.62 (m, 2H), 7.63–7.69 (m, 
2H), 7.71–7.84 (m, 3H) ppm. 
13
C NMR (75 MHz, CDCl3): δ = 47.1, 66.7, 118.0, 120.2, 125.3, 127.3, 128.0, 128.3, 129.1, 
130.6, 134.5, 141.5, 144.1, 145.4, 167.0 ppm. 
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MS (EI) m/z (%):178 (100%), 131 (29%). 
HRMS (ESIpos) m/z  calculated for C2H18NaO2
+
 : 349.1199; found 349.1198. 
 
(E)-(9H-Fluoren-9-yl)methyl-p-methoxycinnamate (1b) 
The product was synthesized according to the general procedure A 
employing p-methoxycinnamic acid (1.78g, 10 mmol) as starting 
material. The crude product was puriﬁed by ﬂash column 
chromatography (eluent hexane/EtOAc 98:2 → 90:10) to give a solid (2.60 g, 73%), which 
was further purified by precipitation from toluene by addition of hexanes, affording 1b as a 
colorless, powder. 
1
H NMR (501 MHz, CDCl3): δ = 3.85 (s, 3H), 4.34 (t, J = 7.3 Hz, 1H), 4.53 (d, J = 7.3 Hz, 
2H), 6.43 (d, J = 15.9 Hz, 1H), 6.90 – 6.97 (m, 2H), 7.36 (td, J = 7.4, 1.0 Hz, 2H), 7.44 (t, J = 
7.4 Hz, 2H), 7.50 – 7.55 (m, 2H), 7.65 – 7.70 (m, 2H), 7.74 (d, J = 15.9 Hz, 1H), 7.78 – 7.83 
(m, 2H). 
13
C NMR (126 MHz, CDCl3): δ = 47.0, 55.5, 66.5, 114.4, 115.3, 120.1, 125.2, 127.1, 127.2, 
127.8, 129.9, 141.4, 144.0, 145.0, 161.6, 167.3. 
HRMS (ESIpos) m/z  calculated for C24H20NaO3
+
 : 379.1305; found 379.1305 
 
(E)-(9H-Fluoren-9-yl)methyl-p-nitrocinnamate (1c) 
The product was synthesized according to the general procedure A 
employing p-nitrocinnamic acid (1.93g, 10 mmol) as starting material. 
The crude product was puriﬁed by ﬂash column chromatography 
(eluent hexane/CH2Cl2 90:10 → 40:60) to give a solid (3.57 g, 96%), which was further 
purified by recrystallization from EtOAc/hexanes (5:3), affording 1c as a pale brownish 
powder. 
1
H NMR (501 MHz, CDCl3): δ = 4.31 (t, J = 7.0 Hz, 1H), 4.56 (d, J = 7.1 Hz, 2H), 6.62 (d, J 
= 16.0 Hz, 1H), 7.35 (td, J = 7.5, 0.9 Hz, 2H), 7.43 (t, J = 7.5 Hz, 2H), 7.64 (d, J = 7.5 Hz, 
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2H), 7.66 – 7.70 (m, 2H), 7.73 (d, J = 16.1 Hz, 1H), 7.80 (d, J = 7.6 Hz, 2H), 8.22 – 8.28 (m, 
2H) ppm.
 
13
C NMR (126 MHz, CDCl3) δ 46.9, 66.9, 120.2, 122.1, 124.3, 125.1, 127.3, 128.0, 128.9, 
140.5, 141.4, 142.4, 143.7, 148.6, 166.0 ppm. 
HRMS (ESIpos) m/z  calculated for C23H17NNaO4
+
 : 394.1050; found 394.1050. 
 
(E)-(9H-Fluoren-9-yl)methyl-p-fluorocinnamate (1d) 
The product was synthesized according to the general procedure A 
employing p-fluorocinnamic acid (1.66, 10 mmol) as starting material. 
The crude product was puriﬁed by ﬂash column chromatography (eluent 
hexane/EtOAc 99:1 → 95:5) to give a solid (3.23 g, 94%), which was further purified by 
recrystallization from hexanes/EtOAc (5:1), affording 1d as a colorless solid. 
1
H NMR (501 MHz, CDCl3): δ = 4.34 (t, J = 7.2 Hz, 1H), 4.55 (d, J = 7.2 Hz, 2H), 6.47 (d, J 
= 15.9 Hz, 1H), 7.10 (t, J = 8.6 Hz, 2H), 7.37 (td, J = 7.4, 1.1 Hz, 2H), 7.45 (tm, J = 7.3 Hz, 
2H), 7.51 – 7.58 (m, 2H), 7.68 (dq, J = 7.6, 1.0 Hz, 2H), 7.73 (d, J = 16.0 Hz, 1H), 7.82 (dm, 
J = 7.6 Hz, 2H) ppm. 
13
C NMR (126 MHz, CDCl3): δ = 46.9, 66.6, 116.0, 116.2, 117.6, 117.6, 120.1, 125.1, 127.2, 
127.9, 130.1, 130.2, 130.6, 130.6, 141.4, 143.9, 144.0, 163.0, 165.0, 166.8 ppm. 
HRMS (ESIpos) m/z  calculated for C23H17FNaO2
+
 : 367.1105; found 367.1105. 
 
(E)-(9H-Fluoren-9-yl)methyl-p-chlorocinnamate (1e) 
The product was synthesized according to the general procedure A 
employing p-chlorocinnamic acid (1.83, 10 mmol) as starting material. 
The crude product was puriﬁed by ﬂash column chromatography (eluent 
hexane/EtOAc 99:1 → 96:4) to give a solid (3.61 g, >99%), which was further purified by 
recrystallization from hexanes/EtOAc (5:1), affording 1e as a colorless, crystalline solid. 
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1
H NMR (501 MHz, CDCl3): δ = 4.33 (t, J = 7.2 Hz, 1H), 4.55 (d, J = 7.2 Hz, 2H), 6.51 (d, J 
= 16.0 Hz, 1H), 7.33 – 7.40 (m, 4H), 7.41 – 7.51 (m, 4H), 7.64 – 7.74 (m, 3H), 7.81 (dm, J = 
7.6 Hz, 2H) ppm. 
13
C NMR (126 MHz, CDCl3): δ = 46.9, 66.6, 118.4, 120.2, 125.1, 127.2, 127.9, 129.2, 129.4, 
132.8, 136.4, 141.4, 143.9, 166.7 ppm. 
HRMS (ESIpos) m/z  calculated for C23H17ClNaO2
+
 : 383.0809; found 383.0809. 
 
(E)-(9H-Fluoren-9-yl)methyl-p-bromocinnamate (1f) 
The product was synthesized according to the general procedure A 
employing p-bromocinnamic acid (2.27, 10 mmol) as starting material. 
The crude product was puriﬁed by ﬂash column chromatography (eluent 
hexane/EtOAc 99:1 → 90:10) to give a solid (4.05 g, 99%), which was further purified by 
recrystallization from hexanes/EtOAc (5:1), affording 1f as a colorless, crystalline solid. 
1
H NMR (501 MHz, CDCl3): δ = 4.32 (t, J = 7.2 Hz, 1H), 4.53 (d, J = 7.2 Hz, 2H), 6.52 (d, J 
= 16.0 Hz, 1H), 7.35 (td, J = 7.5, 1.1 Hz, 2H), 7.38 – 7.47 (m, 4H), 7.52 – 7.56 (m, 2H), 7.63 
– 7.70 (m, 3H), 7.80 (dm, J = 7.5 Hz, 2H) ppm. 
13
C NMR (126 MHz, CDCl3): δ = 46.9, 66.7, 118.5, 120.2, 124.8, 125.2, 127.2, 127.9, 129.6, 
132.2, 133.3, 141.4, 143.9, 144.0, 166.7 ppm. 
HRMS (ESIpos) m/z  calculated for C23H17BrNaO2
+
 : 427.0304; found 427.0304. 
 
(E)-(9H-Fluoren-9-yl)methyl-p-iodocinnamate (1g) 
The product was synthesized according to the general procedure A 
employing p-iodocinnamic acid (822 mg, 3 mmol) as starting material. 
The crude product was puriﬁed by ﬂash column chromatography (eluent 
hexane/EtOAc 99:1 → 94:6) to give a solid (1.14 g, 84%), which was further purified by 
recrystallization from hexanes/EtOAc (5:1), affording 1g as a colorless powder. 
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1
H NMR (501 MHz, CDCl3): δ = 4.34 (t, J = 7.2 Hz, 1H), 4.56 (d, J = 7.2 Hz, 2H), 6.55 (d, J 
= 16.0 Hz, 1H), 7.29 (dm, J = 8.4 Hz, 2H), 7.38 (td, J = 7.4, 1.0 Hz, 2H), 7.46 (t, J = 7.4 Hz, 
2H), 7.65 – 7.70 (m, 3H), 7.76 (dm, J = 8.4 Hz, 2H), 7.83 (d, J = 7.5 Hz, 2H) ppm. 
13
C NMR (126 MHz, CDCl3): δ = 46.9, 66.7, 96.8, 118.6, 120.2, 125.1, 127.2, 127.9, 129.7, 
133.8, 138.2, 141.4, 143.9, 144.1, 166.6 ppm. 
HRMS (ESIpos) m/z  calculated for C23H17INaO2
+
 : 475.0165; found 475.0165. 
 
(E)-(9H-Fluoren-9-yl)methyl-p-methylcinnamate (1h) 
The product was synthesized according to the general procedure A 
employing p-methylcinnamic acid (1.62 g, 10 mmol) as starting material. 
The crude product was puriﬁed by ﬂash column chromatography (eluent 
hexane/EtOAc 99:1 → 96:4) to give a solid (3.30 g, 97%), which was further purified by 
recrystallization from hexanes/EtOAc (5:1), affording 1h as a colorless, crystalline solid. 
1
H NMR (501 MHz, CDCl3): δ = 2.40 (s, 3H), 4.33 (t, J = 7.2 Hz, 1H), 4.52 (d, J = 7.3 Hz, 
2H), 6.52 (d, J = 15.9 Hz, 1H), 7.23 (d, J = 7.8 Hz, 2H), 7.35 (t, J = 7.6 Hz, 2H), 7.44 (t, J = 
7.4 Hz, 2H), 7.48 (d, J = 7.8 Hz, 2H), 7.67 (d, J = 7.4 Hz, 2H), 7.75 (d, J = 16.0 Hz, 1H), 7.81 
(d, J = 7.5 Hz, 2H) ppm. 
13
C NMR (126 MHz, CDCl3): δ = 21.6, 47.0, 66.6, 116.8, 120.2, 125.2, 127.2, 127.9, 128.3, 
129.8, 131.7, 141.0, 141.4, 144.0, 145.4, 167.2 ppm. 
HRMS (ESIpos) m/z  calculated for C24H20NaO2
+
 : 363.1356; found 363.1355. 
 
(E)-(9H-Fluoren-9-yl)methyl-m-methylcinnamate (1i) 
The product was synthesized according to the general procedure A 
employing m-methylcinnamic acid (1.62 g, 10 mmol) as starting 
material. The crude product was puriﬁed by ﬂash column 
chromatography (eluent hexane/EtOAc 99:1 → 96:4) affording 1i as a colorless, crystalline 
solid (3.33 g, 98%). 
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1
H NMR (501 MHz, CDCl3): δ 2.46 (s, 3H), 4.42 (t, J = 6.3 Hz, 1H), 4.65 (d, J = 6.6 Hz, 
2H), 6.66 (d, J = 16.0 Hz, 1H), 7.24 – 7.40 (m, 2H), 7.40 – 7.59 (m, 6H), 7.79 (d, J = 6.9 Hz, 
2H), 7.84 – 7.94 (m, 3H) ppm. 
13
C NMR (126 MHz, CDCl3): δ = 21.2, 46.8, 66.3, 117.4, 120.0, 125.0, 125.3, 127.0, 127.7, 
128.7, 128.7, 131.2, 134.1, 138.4, 141.2, 143.8, 145.3, 166.7 ppm. 
HRMS (ESIpos) m/z  calculated for C24H20NaO2
+
 : 363.1356; found 363.1355. 
 
(E)-(9H-Fluoren-9-yl)methyl-o-methylcinnamate (1j) 
The product was synthesized according to the general procedure A 
employing o-methylcinnamic acid (1.62 g, 10 mmol) as starting material. 
The crude product was puriﬁed by ﬂash column chromatography (eluent 
hexane/EtOAc 99:1 → 95:5) to give a solid (3.37 g, 99%), which was further purified by 
recrystallization from hexanes/EtOAc (5:1), affording 1j as a colorless, crystalline solid. 
1
H NMR (501 MHz, CDCl3): δ = 2.50 (s, 3H), 4.37 (t, J = 7.2 Hz, 1H), 4.59 (d, J = 7.2 Hz, 
2H), 6.50 (d, J = 15.9 Hz, 1H), 7.24 – 7.32 (m, 2H), 7.35 (td, J = 7.4, 1.4 Hz, 1H), 7.39 (td, J 
= 7.4, 1.2 Hz, 2H), 7.47 (tm, J = 7.4 Hz, 2H), 7.65 (d, J = 7.8 Hz, 1H), 7.70 – 7.74 (m, 2H), 
7.84 (d, J = 7.5 Hz, 2H), 8.08 (d, J = 15.9 Hz, 1H) ppm. 
13
C NMR (126 MHz, CDCl3): δ = 19.9, 47.0, 66.5, 118.8, 120.2, 125.2, 126.5, 127.2, 127.9, 
130.3, 130.9, 133.3, 137.8, 141.4, 143.0, 144.0, 166.9 ppm. 
HRMS (ESIpos) m/z  calculated for C24H20NaO2
+
 : 363.1356; found 363.1355. 
 
(E)-(9H-Fluoren-9-yl)methyl-m-nitrocinnamate (1k) 
The product was synthesized according to the general procedure A 
employing m-nitrocinnamic acid (1.93g, 10 mmol) as starting material. 
The crude product was puriﬁed by ﬂash column chromatography 
(eluent hexane/CH2Cl2 90:10 → 40:60), affording 1k as a colorless powder (3.53 g, 95%). 
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1
H NMR (501 MHz, CDCl3): δ = 4.28 (t, J = 6.8 Hz, 1H), 4.53 (d, J = 7.0 Hz, 2H), 6.59 (d, J 
= 16.0 Hz, 1H), 7.35 (t, J = 7.4 Hz, 2H), 7.42 (t, J = 7.5 Hz, 2H), 7.49 (t, J = 7.9 Hz, 1H), 
7.60 – 7.83 (m, 6H), 8.17 (d, J = 7.7 Hz, 1H), 8.33 (s, 1H). 
13
C NMR (126 MHz, CDCl3): δ = 46.7, 66.6, 120.0, 120.7, 122.3, 124.5, 124.9, 127.1, 127.8, 
129.8, 133.6, 135.8, 141.2, 142.2, 143.6, 148.4, 165.9 ppm. 
HRMS (ESIpos) m/z  calculated for C23H17NNaO4
+
 : 394.1050; found 349.1050. 
 
(E)-(9H-Fluoren-9-yl)methyl-3-(1-naphthalenyl)acrylate (1l) 
The product was synthesized according to the general procedure A 
employing 3-(1-naphthalenyl)acrylic acid (1.98 g, 10 mmol) as starting 
material. The crude product was puriﬁed by ﬂash column 
chromatography (eluent hexane/CH2Cl2 90:10 → 40:60) to give a solid (3.50 g, 93%), which 
was further purified by recrystallization from hexanes/EtOAc (5:1), affording 1l as a 
colorless, crystalline solid. 
1
H NMR (501 MHz, Chloroform-d): δ = 4.37 (t, J = 7.1 Hz, 1H), 4.60 (d, J = 7.1 Hz, 2H), 
6.62 (d, J = 15.8 Hz, 1H), 7.36 (tm, J = 7.5 Hz, 2H), 7.44 (t, J = 7.4 Hz, 2H), 7.52 (t, J = 7.7 
Hz, 1H), 7.56 (ddd, J = 8.0, 6.8, 1.2 Hz, 1H), 7.62 (ddd, J = 8.4, 6.7, 1.4 Hz, 1H), 7.70 (d, J = 
7.4 Hz, 2H), 7.81 (d, J = 7.4 Hz, 3H), 7.90 (d, J = 8.2 Hz, 1H) , 7.93 (d, J = 8.2 Hz, 1H), 8.18 
(d, J = 8.4 Hz, 1H), 8.57 (d, J = 15.7 Hz, 1H) ppm. 
13
C NMR (126 MHz, CDCl3): δ = 47.1, 66.7, 120.2, 120.5, 123.4, 125.2, 125.2, 125.6, 126.4, 
127.1, 127.3, 127.9, 128.9, 130.8, 131.5, 131.7, 133.8, 141.5, 142.3, 144.0, 166.8 ppm. 
HRMS (ESIpos) m/z  calculated for C27H20NaO2
+
 : 399.1356; found 399.1355. 
 
(E)-(9H-Fluoren-9-yl)methyl-3-(2-naphthalenyl)acrylate (1m) 
The product was synthesized according to the general procedure A 
employing 3-(2-naphthalenyl)acrylic acid (1.98 g, 10 mmol) as starting 
material. The crude product was puriﬁed by ﬂash column 
chromatography (eluent hexane/CH2Cl2 90:10 → 40:60) followed by to give a solid (3.61 g, 
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96%), which was further purified from hexanes/EtOAc (2:1), affording 1m as a colorless, 
crystalline solid. 
1
H NMR (501 MHz, CDCl3): δ = 4.37 (t, J = 7.2 Hz, 1H), 4.59 (d, J = 7.3 Hz, 2H), 6.68 (d, J 
= 16.0 Hz, 1H), 7.39 (td, J = 7.5, 1.2 Hz, 2H), 7.47 (t, J = 7.3 Hz, 2H), 7.52 – 7.58 (m, 2H), 
7.72 (dt, J = 8.4, 1.4 Hz, 3H), 7.81 – 7.91 (m, 5H), 7.95 (d, J = 16.0 Hz, 2H) ppm. 
13
C NMR (126 MHz, CDCl3): δ = 47.0, 66.6, 118.0, 120.2, 123.6, 125.2, 126.8, 127.2, 127.4, 
127.9, 127.9, 128.7, 128.8, 130.2, 131.9, 133.3, 134.4, 141.4, 144.0, 145.4, 167.0 ppm. 
HRMS (ESIpos) m/z  calculated for C27H20NaO2
+
 : 399.1356; found 399.1356. 
 
(E)-(9H-Fluoren-9-yl)methyl-3-(2-furanyl)acrylate (1n) 
The product was synthesized according to the general procedure A 
employing 3-(2-furanyl)acrylic acid (1.38, 10 mmol) as starting material. 
The crude product was puriﬁed by ﬂash column chromatography (eluent 
hexane/EtOAc 99:1 → 95:5), affording 1n as a colorless powder (1.04g, 33%). 
1
H NMR (501 MHz, CDCl3): δ = 4.31 (t, J = 7.4 Hz, 1H), 4.49 (d, J = 7.4 Hz, 2H), 6.44 (d, J 
= 15.7 Hz, 1H), 6.50 (dd, J = 3.5, 1.8 Hz, 1H), 6.66 (d, J = 3.5 Hz, 1H), 7.31 – 7.37 (m, 2H), 
7.43 (t, J = 7.5 Hz, 2H), 7.50 (d, J = 15.8 Hz, 2H), 7.65 (d, J = 7.4 Hz, 2H), 7.79 (d, J = 7.5 
Hz, 2H) ppm. 
13
C NMR (126 MHz, CDCl3): δ = 47.0, 66.7, 112.5, 115.3, 115.5, 120.2, 125.3, 127.2, 127.9, 
131.6, 141.4, 144.0, 145.0, 151.0, 167.1 ppm. 
HRMS (ESIpos) m/z  calculated for C21H16NaO3
+
 : 339.0992; found 339.0992. 
 
(E)-(9H-Fluoren-9-yl)methyl-3-(2-thiophenyl)acrylate (1o) 
The product was synthesized according to the general procedure A 
employing 3-(2-thiophenyl)acrylic acid (1.54, 10 mmol) as starting 
material. The crude product was puriﬁed by ﬂash column chromatography 
(eluent hexane/EtOAc 98:2 → 92:8) to give a solid (3.12 g, 94%), which was further purified 
by recrystallization from hexanes/EtOAc (15:1), affording 1o as a pale yellow powder. 
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1
H NMR (501 MHz, Chloroform-d): δ = 4.33 (t, J = 7.3 Hz, 1H), 4.54 (d, J = 7.3 Hz, 2H), 
6.37 (d, J = 15.7 Hz, 1H), 7.08 (dd, J = 5.1, 3.6 Hz, 1H), 7.30 (d, J = 3.6 Hz, 1H), 7.37 (td, J 
= 7.4, 1.1 Hz, 2H), 7.41 (dm, J = 5.1 Hz, 1H), 7.45 (tm, J = 7.3 Hz, 2H), 7.68 (dm, J = 7.5 
Hz, 2H), 7.82 (dm, J = 7.5 Hz, 2H), 7.88 (dm, J = 15.7 Hz, 1H) ppm. 
13
C NMR (126 MHz, CDCl3): δ = 46.9, 66.6, 116.5, 120.1, 125.2, 127.2, 127.9, 128.2, 128.7, 
131.3, 137.7, 139.5, 141.4, 143.9, 166.8 ppm. 
HRMS (ESIpos) m/z  calculated for C21H16NaO2S
+
 : 355.0763; found 355.0763. 
 
Synthesis of Chiral C-H Acids 
 
Fig. S1. Synthetic route to chiral C–H acids. 
Synthesis of Disulfones from BINOLs 
 (S)-3,3′-Bis(3,5-bis(trifluoromethyl)phenyl)-[1,1′-binaphthalene]-2,2′-dithiol (S3a): 
To a flame dried flask under Ar, (S)-(3,3′-Bis(3,5-
bis(trifluoromethyl)phenyl)-[1,1′-binaphthalene]- 2,2′diyl-S,S′-bis(N,N-
dimethylthiocarbamate)(10) (10.4 g, 11.7 mmol) and KOH (9.8 g, 
0.18 mol, 15 equiv.) were added and the solids were set under Ar by 3 
cycles of evacuation and Ar-flushing. Degassed (30 min Ar bubbling) 
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EtOH (120 mL) was added and the reaction mixture was stirred at 70 °C for 36 h. After 
cooling to room temperature the reaction mixture was partitioned between degassed aq. HCl 
sol. (10%, 400 mL) and CH2Cl2 (400 mL). The organic layer was separated, dried over 
Na2SO4 and concentrated under reduced pressure. The obtained crude product was purified by 
column chromatography (5% EtOAc in hexanes) giving the title compound (9.1 g, >99%) as a 
yellow powder. 
1
H-NMR (CDCl3, 500 MHz): δ = 3.26 (s, 2H), 7.07 (d, J = 8.5 Hz, 2H), 7.40 (dd, J = 8.5 Hz, 
6.8 Hz, 2H), 7.52 (dd, J = 8.3 Hz, 6.8 Hz, 2H), 7.91 (s, 2H), 7.94 (d, J = 8.3 Hz, 2H), 7.98 (br 
s, 2H), 8.08 (s, 4H) ppm. 
13
C-NMR (CDCl3, 125 MHz): δ = 122 (m), 124.3, 125.0, 126.6, 128.5, 128.6, 130.0, 130.3, 
130.8, 131.6, 131.7, 132.1, 133.2, 136.2, 142.4 ppm. 
MS (ESIneg) m/z: 741 (M–H). 
HRMS (ESIneg) m/z: calculated (M–H = C36H17F12S2) 741.0586, found 741.0589. 
 
(S)-2,6-Bis(3,5-bis(trifluoromethyl)phenyl)dinaphtho[2,1-d:1′,2′-f][1,3]dithiepine (S4a): 
(S)-3,3′-Bis(3,5-bis(trifluoromethyl)phenyl)- [1,1′-binaphthalene]-2,2′-
dithiol S3a (4.4 g, 5.9 mmol) was placed in a flame dried flask under 
Ar and dissolved in CH2Cl2 (30 mL). H2C(OMe)2 (0.52 mL, 5.9 mmol, 
1.0 equiv.) was added, followed by BF3•OEt2 (0.75 mL, 5.9 mmol, 
1.0 equiv.). The resulting mixture was stirred for 24 h, after which 
identical quantities of both reagents were added. After another 24 h the 
reaction was quenched by addition to aq. KOH sol. (2%, 100 mL) and 
diluted with further CH2Cl2 (100 mL). The organic phase was washed with aq. KOH sol. (2%, 
50 mL) and brine (50 mL), dried over MgSO4 and concentrated under reduced pressure. After 
purification by column chromatography (2% EtOAc in hexanes), the title compound (4.1 g, 
92%) was obtained as a yellow powder. 
1
H-NMR (CDCl3, 500 MHz): δ = 3.90 (s, 2H), 7.19 (d, J = 8.5 Hz, 2H), 7.37 (ddd, J = 8.5 
Hz, 6.9 Hz, 1.3 Hz 2H), 7.61 (ddd, J = 8.2 Hz, 6.9 Hz, 1.0 Hz, 2H), 7.96 (s, 2H), 8.01 (s, 4H), 
8.04 (d, J = 8.2 Hz, 2H), 8.11 (s, 2H) ppm. 
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13
C-NMR (CDCl3, 100 MHz): δ = 48.2, 121.4 (sept., JC–F = 3.5 Hz), 123.5 (q, JC–F = 273.0 
Hz), 127.5, 127.6, 127.9, 128.6, 130.3, 130.4 (m), 131.2 (q, JC–F = 32.8 Hz), 132.1, 133.7, 
140.4, 143.1, 144.7 ppm. (Not all C-signals could be detected, presumably due to overlap of 
several signals in the designated multipletts.)
 19
F-NMR (CDCl3, 376 MHz): δ = –62.6 ppm. 
MS (EI) m/z: 754 (21%), 740 (22%), 721 (61%), 708 (100%), 494 (18%). 
HRMS (ESIpos) m/z: calculated (M+Na = C37H18F12S2Na) 777.0551, found 777.0554. 
 
(S)-2,6-Bis(3,5-bis(trifluoromethyl)phenyl)-4H-dinaphtho[2,1-d:1′,2′-f][1,3]dithiepine 
3,3,5,5-tetraoxide (S5a): 
(S)-2,6-Bis(3,5-bis(trifluoromethyl)phenyl)dinaphtho [2,1-d:1′,2′-
f][1,3]dithiepine S4a (5.4 g, 7.1 mmol) was placed in a flame dried flask 
under Ar and dissolved in CHCl3 (70 mL). mCPBA (9.8 g, 57 mmol, 
8.0 equiv.) was added at 0 °C. The resulting mixture was stirred at 
40 °C for 36 h. The reaction mixture was diluted with CH2Cl2 (400 mL) 
and washed with aq. KOH sol. (2%, 3 × 80 mL), H2O (20 mL) and 
brine (20 mL). The organic phase was dried over MgSO4 and 
concentrated under reduced pressure. After purification by column chromatography (20–80% 
gradient of CH2Cl2 in hexanes), the title compound (6.4 g, 75%) was obtained as light orange 
foam. 
 
1
H-NMR (CDCl3, 400 MHz): δ = 4.59 (s, 2H), 7.17 (d, J = 8.5 Hz, 2H), 7.53 (ddd, J = 8.5 
Hz, 7.0 Hz, 1.2 Hz, 2H), 7.80 (ddd, J = 8.2 Hz, 7.0 Hz, 1.0, 2H), 7.91 (s, 2H), 7.96 (s, 2H), 
7.98 (s, 2H), 8.09 (s, 2H), 8.09 (d, J = 8.2 Hz, 2H) ppm. 
13
C-NMR (CDCl3, 100 MHz): δ = 84.2, 121.9 (sept, JC-F = 3.8 Hz), 123.3 
(q, JC-F = 273.0 Hz), 123.4 (q, JC-F = 273.0 Hz), 127.9, 128.1 (m), 128.7, 129.5, 130.1, 130.5 
(sept, JC-F = 33.6 Hz), 130.9, 131.4 (m), 130.5 (sept, JC-F = 33.8 Hz), 132.7, 134.4, 134.8, 
135.0, 141.0, 141.2 ppm. 
19
F-NMR (CDCl3, 376 MHz): δ = –62.5, –62.6 ppm. 
MS (ESIpos) m/z: 841 (M+Na). 
HRMS (ESIpos) m/z: calculated (M+Na = C37H18O4F12S2Na) 841.0347, found 841.0339. 
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(S)-(3,3′-Bis(9-phenanthryl)-[1,1′-binaphthalene]-2,2′-diyl)-O,O′-bis(N,N-
dimethylthiocarbamate) (S1b): 
The title compound was prepared following the procedure previously 
described by our group.(10) 
(S)-(3,3′-Bis(9-phenanthryl)-[1,1′-binaphthalene]-2,2′-diol (16.5 g, 
25.8 mmol)(27) was placed in a flame dried flask under Ar and 
dissolved in DMF (150 mL). The solution was cooled to 0 °C and NaH 
(60% dispersion in oil, 4.10 g, 103 mmol, 4.0 equiv.) was added 
portionwise. The cooling bath was removed and the reaction was 
stirred at room temperature for 5 min. N,N-dimethyl thiocarbamoylchloride (16.0 g, 
130 mmol, 5.0 equiv.) was added and the resulting mixture was stirred at 85 °C for 36 h. The 
reaction mixture was allowed to cool to 40 °C and aq. KOH sol. (2%, 300 mL) was added. 
The resulting precipitate was separated by filtration, washed with aq. KOH sol. (2%, 200 mL) 
and taken up in CH2Cl2 (500 mL). The solution was washed with H2O (1 × 100 mL) and brine 
(1 × 50 mL), dried over MgSO4 and concentrated under reduced pressure. The resulting crude 
product was subjected to column chromatography (gradient from 20% to 50% of CH2Cl2 in 
hexanes) giving partially purified compound and revealing an instability of the title compound 
upon prolonged exposure to silica, which was further confirmed by 2D-TLC. A second 
purification step was thus conducted, which was optimized for short contact to silica 
(hexanes/CH2Cl2 = 3/2) giving the title compound (7.97 g, 38%) as yellow foam. 
Due to the presence of rotamers of the thiocarbamate groups and the 9-phenanthryl 
substituents, several signal sets could be observed for the title compound. NMR-
characterization of the major conformer, amounting to approx. 43% of the overall compound 
is given below: 
1
H-NMR (CDCl3, 400 MHz): δ = 2.07 (s, 6H), 2.71 (s, 6H), 7. (dd, J = 7.0 Hz, 1.1 Hz, 1H), 
7.23 (dd, J = 6.8 Hz, 1.0 Hz, 1H), 7.36 (ddd, J = 8.4 Hz, 6.8 Hz, 1.2 Hz, 2H), 7.49 (ddd, J = 
8.2 Hz, 7.0 Hz, 1.0 Hz, 2H), 7.52–7.57 (m, 3H), 7.62–7.73 (m, 5H), 7.50 (d, J = 8.6 Hz, 2H), 
7.91 (d, J = 7.8 Hz, 2H), 7.98 (dd, J = 7.8 Hz, 1.2 Hz, 2H), 8.05 (s, 2H), 8.12 (s, 2H), 8.70–
8.76 (m, 4H) ppm. 
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13
C-NMR (CDCl3, 100 MHz): δ = 37.5, 42.6, 122.4, 122.9, 125.9, 126.05, 126.1, 126.2, 
126.9, 127.0, 127.7, 129.2, 129.4, 129.9, 130.1, 130.5, 131.4, 131.6, 132.0, 132.1, 133.1, 
133.7, 133.8, 148.8, 186.6 ppm. (The list of 
13
C-signals is incomplete, as only those signals 
clearly corresponding to the major conformer as judged by signal intensity were included.) 
MS (ESIpos) m/z: 835 (M+Na) 
HRMS (ESIpos) m/z: calculated (M+H = C54H41N2O2S2) 813.2604, found 813.2600. 
 
(S)-(3,3′-Bis(9-phenanthryl)-[1,1′-binaphthalene]-2,2′diyl-S,S′-bis(N,N-
dimethylthiocarbamate) (S2b): 
The title compound was prepared following a modified form of the 
procedure previously described by our group.(10) 
(S)-(3,3′-Bis(9-phenanthryl)- [1,1′-binaphthalene]-2,2′-diyl)- O,O′-
bis(N,N-dimethylthiocarbamate) S1a (7.95 g, 6.10 mmol) was split into 5 
approximately equal batches, which were placed in Ar-flushed dram glass 
vials equipped with a magnetic stirring bar. The vials were placed in a 
preheated (250 °C) stirring plate equipped with an aluminum heating block and stirred at this 
temperature for 120 min. The vials were removed from the heating block and allowed to reach 
room temperature. The obtained crude products were taken up in CH2Cl2 (20 mL for each 
vial), combined and concentrated onto silica. Analysis of the crude product by 2D-TLC 
revealed the presence of rotamers, which were partially stable on the chromatography time 
scale but equilibrated upon storage in solid state or solution. On a small scale one of the two 
rotamers could be separated by column chromatography (CH2Cl2) and analyzed by 
1
H-NMR 
spectroscopy. 
After storage of this sample for 3d, a 
1
H-NMR spectrum was again recorded and found to be 
identical to the spectrum obtained for the unseparated rotamers. Likewise both rotamers could 
be detected again by TLC. 
A comparison of the aromatic region of spectra obtained for the purified least polar symmetric 
rotamer (top), the remaining rotamer(s) (middle) and the spectrum obtained for both samples 
after 3 d (bottom) is shown below. 
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Fig. S2. Comparison of NMR spectra of the different rotamers. 
Thus no attempt to separate these rotamers on a large scale was undertaken. The crude 
product was purified by column chromatography (CH2Cl2), giving the mixture of rotamers of 
the title compound (6.69 g, 84%) as a yellow foam. 
1
H-NMR (CDCl3, 400 MHz): δ = 2.25 (br s, 12H), 7.27–7.30 (m, 1H), 7.34–7.46 (m, 3H), 
7.50–7.70 (m, 12H), 7.82–7.98 (m, 5H), 8.00–8.02 (m, 1H), 8.06–8.10 (m, 2H), 8.72–8.78 (m, 
4H) ppm. (Due to the overlap of signals belonging to different rotamers, the integrations are 
non-integer and have been rounded to best account for the overall number of protons.) 
13
C-NMR (CDCl3, 101 MHz): δ = 165.5, 144.5, 144.1, 142.8, 142.6, 142.3, 137.6, 137.5, 
133.9, 133.87, 133.5, 133.4, 132.7, 132.66, 132.3, 132.1, 132.0, 131.6, 131.4, 130.5, 130.3, 
130.2, 130.1, 130.0, 129.9, 129.7, 129.0, 128.8, 128.7, 127.9, 127.6, 127.5, 127.3, 127.26, 
127.2, 127.14, 127.0, 126.7, 126.6, 126.57, 126.5, 126.48, 126.4, 126.3, 126.2, 126.0, 125.95, 
122.6, 122.5, 122.43, 122.40, 36.6 ppm. 
MS (ESIpos) m/z: 835 (M+Na). 
HRMS (ESIpos) m/z: calculated (M+Na = C54H40N2O2S2Na) 835.2423, found 835.22425. 
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(S)-3,3′-Bis(9-phenanthryl)-[1,1′-binaphthalene]-2,2′-dithiol (S3b): 
In a flame dried flask under Ar, (S)-(3,3′-bis(9-phenanthryl)-[1,1′-
binaphthalene]-2,2′diyl-S,S′-bis(N,N-dimethylthiocarbamate) S2b 
(6.6 g, 8.1 mmol) was dissolved in THF (80 mL) and LiAlH4 (1.54 g, 
40.6 mol, 5.0 equiv.) was added. The reaction mixture was stirred at 
65 °C overnight. After cooling to room temperature, degassed aq. HCl 
sol. (10%, 50 mL) was added and the aqueous phase was extracted with 
CH2Cl2 (3 × 80 mL). The combined organic phases were separated, 
dried over Na2SO4 and concentrated under reduced pressure. The obtained crude product 
(5.5 g, >99%) was analyzed and used in the next step without further purification. As 
expected from the preceding experiments, the title compound was obtained as a mixture of 
rotamers.  
1
H-NMR (CDCl3, 500 MHz): δ = 3.28 + 3.30 + 3.34 + 3.36 (4 × s, 2H), 7.31 (t, J = 8.4 Hz, 
1H), 7.38 (t, J = 8.0 Hz, 1H), 7.41–7.46 (mAr, 2H), 7.46–7.55 (mAr, 3H), 7.59–7.76 (mAr, 8H), 
7.78 (d, J = 8.3 Hz, 1H), 7.87–7.97 (mAr, 5H), 7.98–8.02 (mAr, 1H), 8.03–8.06 (mAr, 2H), 
8.76–8.85 (mAr, 4H) ppm. (Due to the overlap of signals belonging to different rotamers, the 
integrations are non-integer and have been rounded to best account for the overall number of 
protons.) 
13
C-NMR (CDCl3, 125 MHz): δ = 122.7, 122.8, 123.0, 123.1, 124.9, 125.2, 125.9, 125.95, 
126.0, 126.8, 126.9, 126.95, 127.0, 127.05 (3C), 127.1, 127.15 (3C), 127.2, 127.6, 127.65 
(2C), 127.7, 128.4,128.45, 128.5, 128.6, 128.8, 129.0 (2C), 129.05, 129.1, 130.4, 130.5, 
130.55 (2C), 130.6 (2C), 130.8, 131.1, 131.6, 131.7, 131.75, 131.8, 132.15, 132.2, 132.4, 
132.8, 132.85, 133.7, 133.9 (2C), 136.8, 136.85, 137.1, 137.5, 137.7 ppm. 
MS (EI) m/z: 670 (21%), 636 (100%), 459 (21%), 334 (12%), 318 (12%), 302 (12%). 
HRMS (ESIpos) m/z: calculated (M+Na = C48H30S2Na) 693.1681, found 693.1685. 
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(S)-2,6-Bis(9-phenanthryl)dinaphtho[2,1-d:1′,2′-f][1,3]dithiepine (S4b): 
In a flame dried flask under Ar, (S)-3,3′-bis(9-phenanthryl)-[1,1′-
binaphthalene]-2,2′-dithiol S3b (5.5 g, 8.1 mmol) was dissolved in 
CH2Cl2 (40 mL). Dimethoxymethane (820 µL, 705 mg, 9.30 mmol, 
1.1 equiv.) and BF3•OEt2 (2.84 mL, 2.47 g, 17.4 mmol, 2.1 equiv.) 
were added and the reaction mixture was stirred at room temperature 
overnight. The reaction mixture was diluted with CH2Cl2 (200 mL) and 
washed with aq. KOH sol. (2%, 4 × 50 mL). The organic phase was 
dried over MgSO4 and concentrated under reduced pressure. The crude product was purified 
by column chromatography (gradient form 30% to 40% of CH2Cl2 in hexanes) giving the title 
compound (4.38 g, 79%) as a mixture of interconverting rotamers. 
1
H-NMR (CDCl3, 500 MHz): δ = 3.62, 3.65 + 3.68 + 3.70 + 3.72 (5 × s, 2H), 7.21–7.25 (mAr, 
4H), 7.45–7.50 (mAr, 2H), 7.51–7.74 (mAr, 10H), 7.80–7.87 (mAr, 2H), 7.91–7.92 (mAr, 1H), 
7.96–7.99 (mAr, 1H), 8.00–8.06 (mAr, 2H), 8.16–8.18 (mAr, 1H), 8.20–8.24 (mAr, 1H), 8.74–
8.85 (mAr, 4H) ppm. (Due to the overlap of signals belonging to different rotamers, the 
integrations are non-integer and have been rounded to best account for the overall number of 
protons. Based on the experience from previous steps, no 
13
C-NMR was recorded, as the 
assignment of signals had generally proven impossible in the obtained mixtures of rotamers.) 
MS (EI) m/z: 682 (38%), 649, (97%), 636 (100%), 458 (9%). 
HRMS (ESIpos) m/z: calculated (M+Na = C49H30S2Na) 705.1681, found 705.1678. 
 
(S)-2,6-Bis(9-phenanthryl)-4H-dinaphtho[2,1-d:1′,2′-f][1,3]dithiepine 3,3,5,5-tetraoxide 
(S5b): 
(S)-2,6-Bis(3,5-bis(9-phenanthryl) dinaphtho [2,1-d:1′,2′-f] [1,3] 
dithiepine S4b (4.5 g, 6.4 mmol) was placed in a flame dried flask under 
Ar and dissolved in CH2Cl2 (250 mL). mCPBA (70%, 8.8 g, 51 mmol, 
8.0 equiv.) was added at 0 °C. The resulting mixture was stirred at room 
temperature for 36 h. The reaction mixture was diluted with CH2Cl2 
(500 mL) and washed with aq. KOH sol. (2%, 3×250 mL) and brine 
(100 mL). The organic phase was dried over MgSO4 and concentrated 
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under reduced pressure. Column chromatography (hexanes/CH2Cl2 = 4/6 to pure CH2Cl2) 
gave a yellowish powder (3.14 g, 66%) as a mixture of three different rotamers.  
Separation of 1.5 g of this rotamer mixture was achieved with column chromatography (pure 
toluene). The least polar rotamer was obtained as a yellow powder, which could be 
precipitated from CH2Cl2/hexanes to give a colorless powder (0.4 g). 
1
H-NMR (CD2Cl2, 500 MHz): δ = 4.46 (s, 2H), 7.31 (dm, J = 8.7 Hz, 2H), 7.51 (ddd, J = 8.2, 
6.1, 1.2 Hz, 6H), 7.65 (ddd, J = 8.3, 6.1, 2.2 Hz, 2H), 7.69 (ddd, J = 7.8, 7.0, 1.2 Hz, 2H), 
7.74 (ddd, J = 8.3, 7.0, 1.5 Hz, 2H), 7.79 (ddd, J = 8.2, 6.9, 1.1 Hz, 2H), 7.92 (s, 2H), 7.98 
(dd, J = 7.8, 1.5 Hz, 2H),f 8.07 (d, J = 8.2 Hz, 2H), 8.22 (d, J = 0.8 Hz, 2H), 8.78 (d, J = 8.3 
Hz, 2H), 8.81 (d, J = 8.3 Hz, 2H) ppm. 
13
C NMR (CD2Cl2, 126 MHz): δ = 82.2, 123.1, 123.6, 126.7, 126.9, 127.3, 127.5, 127.5, 
128.5, 128.6, 128.7z.8, 129.0, 130.3, 130.5, 130.7, 131.6, 132.5, 132.9, 132.9, 134.7, 135.7, 
136.0, 136.7, 140.0 ppm. 
MS (EI) m/z: 746 (100%), 708 (11%), 615 (14%), 439 (20%), 373 (17%), 315 (43%). 
HRMS (ESIpos) m/z: calculated (M+Na = C49H30O4S2Na) 769.1478, found 769.1474. 
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Table S1. Overview of NMR chemical shifts of all atoms of S5b and the correspoinding 2D 
correlations used for assignment. 
Atom 
Chemical Shift 
[ppm] 
J [Hz] 
Cross-peaks 
COSY HSQC HMBC NOESY 
1  C 140.01    4, 10  
1'  C       
2  C 132.47    25, 4  
2'  C       
3  C 136.68    4, 24  
3'  C       
4  C 134.69   4 4, 7, 24  
H 8.22 0.80(10) 10 4 2, 1, 3, 11, 
5, 4, 6, 7 
13, 24, 7 
4'  C       
H       
5  C 135.68    4, 7, 8, 10  
5'  C       
6  C 132.89    9, 7, 4  
6'  C       
7  C 128.84   7 4, 9  
H 8.07 8.20(8), 1.20(9) 8 7 5, 4, 6, 9 4, 8 
7'  C       
H       
8  C 130.65   8 10  
H 7.79 8.20(7), 1.10(10), 
6.90(9) 
7, 9 8 5, 10 9, 7 
8'  C       
H       
9  C 128.73 162.00(9H)  9 7  
H 7.52 1.20(7), 6.90(8), 
162.00(9C), 8.70(10) 
8, 10 9 6, 7 8, 10 
9'  C       
H       
10  C 128.55   10 8  
H 7.31 0.80(4), 1.10(8), 
8.70(9) 
9, 4 10 1, 5, 8 9 
10'  C       
H       
11  C 136.04    4, 24, 13  
11'  C       
12  C 132.88    16, 24, 15, 
14 
 
12'  C       
13  C 126.71 159.00(13H)  13 15  
H 7.53 159.00(13C), 
8.20(14), 2.20(15) 
 13 11, 17, 15 25, 4 
13'  C       
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H       
14  C 127.51   14 16, 15, 14  
H 7.5 1.20(16), 6.10(15), 
8.20(13) 
15 14 12, 14, 16 15 
14'  C       
H       
15  C 126.95   15 15, 13  
H 7.65 6.10(14), 8.30(16), 
2.20(13) 
16, 14 15 12, 17, 14, 
15, 13 
16, 14 
15'  C       
H       
16  C 123.6   16 16, 14  
H 8.81 1.20(14), 8.30(15) 15 16 12, 18, 14, 
16 
19, 15 
16'  C       
H       
17  C 130.31    19, 15, 13  
17'  C       
18  C 130.45    16, 22, 24, 
20 
 
18'  C       
19  C 123.06   19 19, 21  
H 8.78 1.20(21), 8.30(20) 20 19 23, 17, 21, 
19 
16, 20 
19'  C       
H       
20  C 127.33   20 22  
H 7.74 8.30(19), 7.00(21), 
1.50(22) 
19 20 18, 22 19 
20'  C       
H       
21  C 127.5   21 19  
H 7.69 1.20(19), 7.80(22), 
7.00(20) 
22 21 23, 19 22 
21'  C       
H       
22  C 129.01   22 24, 20  
H 7.98 7.80(21), 1.50(20) 21 22 18, 24, 20 21, 24 
22'  C       
H       
23  C 131.62    19, 21, 24  
23'  C       
24  C 128.52   24 22  
H 7.92   24 3, 11, 4, 12, 
23, 18, 22 
4, 22 
24'  C       
H       
25  C 82.25 146.00(25H)  25   
H2 4.46 146.00(25C)  25 2 13 
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(S)-(3,3′-Bis(2,4,6-triisopropylphenyl)-[1,1′-binaphthalene]-2,2′-diyl)-O,O′-bis(N,N-
dimethylthiocarbamate) (S1d): 
(S)-(3,3′-Bis(2,4,6-triisopropylphenyl)-[1,1′-binaphthalene]-2,2′-
diol(28) (1.44 g, 2.00 mmol) was placed in a flame dried flask under Ar 
and dissolved in DMF (8 mL). The solution was cooled to 0 °C and 
NaH (60% dispersion in oil, 320 mg, 8.00 mmol, 4.0 equiv.) was added 
portionwise. The cooling bath was removed and the reaction was stirred 
at room temperature for 5 min. A solution of N,N-dimethyl 
thiocarbamoylchloride (1.23 g, 10.0 mmol, 5.0 equiv.) in DMF (1.4 mL) was added and the 
resulting mixture was heated to 85 °C for 2 d. The reaction mixture was allowed to cool to 
40 °C and aq. KOH sol. (2%, 50 mL) was added. The resulting precipitate was separated by 
filtration, washed with aq. KOH sol. (2%, 50 mL) and taken up in CH2Cl2 (200 mL). The 
solution was washed with H2O (10 mL) and brine (10 mL), dried over MgSO4 and 
concentrated under reduced pressure. The resulting crude product was purified by column 
chromatography (1% to 5% EtOAc in hexanes) giving the title compound (1.22 g, 71%) as 
yellow foam. 
Due to the presence of rotamers of the thiocarbamate groups, several signal sets could be 
observed for the title compound. NMR-characterization of the major rotamer is given below: 
1
H-NMR (CDCl3, 400 MHz): δ = 1.10 (d, J = 7.1 Hz, 6H), 1.12 (d, J = 6.9 Hz, 6H), 1.16 (d, J 
= 6.8 Hz, 6H), 1.27 (d, J = 7.0 Hz, 18H), 2.39 (s, 6H), 2.87 (s, 6H) superimposed with 2.85–
2.97 (m, 4H), 3.00–3.10 (m, 2H), 6.98 (d, J = 1.7 Hz, 2H), 7.07 (d, J = 1.7 Hz, 2H), 7.23 (ddd, 
J = 8.3 Hz, 6.8 Hz, 1.4 Hz, 2H), 7.40 (ddd, J = 8.1 Hz, 7.0 Hz, 1.1 Hz, 2H), 7.64 (d, J = 8.7 
Hz, 2H), 7.75 (s, 2H) overlays one part of 7.77 (d, J = 7.6 Hz, 2H) ppm. 
13
C-NMR (CDCl3, 100 MHz): δ = 22.9, 23.9, 24.2, 24.4, 25.3, 26.8, 30.5, 30.8, 34.5, 37.8, 
42.6, 119.7, 121.1, 124.9, 125.5, 127.3, 127.9, 130.5, 131.1, 131.8, 132.3, 133.0, 134.0, 147.0, 
148.4, 148.5, 148.6, 185.5 ppm. 
MS (EI) m/z: 864 (26%), 792 (48%), 760 (18%), 677 (22%), 88 (100%), 72 (58%). 
HRMS (ESIpos) m/z: calculated (M+Na = C56H68S2O2Na) 887.4614, found 887.4608. 
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(S)-(3,3′-Bis(2,4,6-triisopropylphenyl)-[1,1′-binaphthalene]-2,2′diyl-S,S′-bis(N,N-
dimethylthiocarbamate) (S2d): 
(S)-(3,3′-Bis(2,4,6-triisopropylphenyl)-[1,1′-binaphthalene]-2,2′-diyl)-
O,O′-bis(N,N-dimethylthiocarbamate) S1d (1.22 g, 1.41 mmol) was 
placed in an Ar-flushed dram glass vial equipped with a magnetic 
stirring bar. The vial was placed on a preheated (250 °C) stirring plate 
equipped with an aluminum heating block and stirred at this 
temperature for 120 min. The vial was removed from the heating block and allowed to reach 
room temperature. The obtained crude product was taken up in CH2Cl2 (20 mL) and 
concentrated onto silica. The crude product from six separate experiments was combined and 
purified by column chromatography (5% to 10% EtOAc in hexanes), giving the title 
compound (894 mg, 73%) as a yellow foam. 
1
H-NMR (CDCl3, 400 MHz): δ = 0.85 (d, J = 6.8 Hz, 6H), 1.09 (d, J = 6.7 Hz, 6H), 1.18 (d, J 
= 6.8 Hz, 6H), 1.21 (d, J = 6.8 Hz, 6H), 1.28 (d, J = 6.9 Hz, 12H), 2.28 (s, 12H), 2.73 (sept, J 
= 6.9 Hz, 2H), 2.92 (sept, J = 6.8 Hz, 2H), 3.03 (sept, J = 6.8 Hz, 2H), 6.99 (d, J = 1.7 Hz, 
2H), 7.06 (d, J = 1.7 Hz, 2H), 7.30 (ddd, J = 8.3 Hz, 6.8 Hz, 1.1 Hz, 2H), 7.40 (ddd, J = 8.0 
Hz, 6.9 Hz, 1.1 Hz, 2H), 7.55 (d, J = 8.4 Hz, 2H), 7.80 (d, J = 8.2 Hz, 2H), 7.83 (s, 2H) ppm. 
(The symmetry of the aliphatic H-signals and the number of aliphatic C-atoms detected 
indicate that the two CH3-parts of the ortho-i Pr substituents are magnetically non-equivalent, 
while the two CH3-parts of the para-i Pr substituents are magnetically equivalent.) 
13
C-NMR (CDCl3, 100 MHz):
a
 δ = 23.3, 23.8, 24.2, 24.3, 25.6, 26.6, 30.5, 34.3, 36.6, 120.1, 
120.9, 125.5, 126.9, 127.2, 129.6, 129.7, 129.8, 132.3, 133.5, 135.9, 142.8, 145.6, 147.1, 
147.7, 147.8, 165.0 ppm. 
MS (EI) m/z:
 
864 (16%), 792 (36%), 760 (11%), 677 (13%), 72 (100%). 
HRMS (ESIpos) m/z: calculated (M+H = C56H69S2O2) 865.4795, found 865.4800. 
  
                                                          
a
   
S24 
 
(S)-3,3′-Bis(2,4,6-triisopropylphenyl)-[1,1′-binaphthalene]-2,2′-dithiol (S3d): 
In a flame dried flask under Ar, (S)-(3,3′-bis(3,5-bis(2,4,6-
triisopropylphenyl)- [1,1′-binaphthalene]-2,2′diyl- S,S′-bis(N,N-
dimethylthiocarbamate) S2d (894 mg, 1.04 mmol) was dissolved in 
THF (13 mL) and LiAlH4 (280 mg, 7.38 mol, 7.0 equiv.) was added. 
The reaction mixture was heated to 65 °C overnight. After cooling to 
room temperature, degassed aq. HCl sol. (10%, 10 mL) was added and 
the aqueous phase was extracted with CH2Cl2 (3 × 20 mL). The combined organic phases 
were separated, dried over Na2SO4 and concentrated under reduced pressure. The obtained 
crude product (732 mg, 98%) was found to be of sufficient purity without further purification. 
1
H-NMR (CDCl3, 500 MHz): δ = 1.05 (d, J = 6.8 Hz, 6H), 1.16 (d, J = 6.8 Hz, 6H), 1.20 (d, J 
= 6.8 Hz, 12H), 1.34 (d, J = 6.9 Hz, 12H), 2.66 (sept, J = 6.8 Hz, 2H), 2.79 (sept, J = 6.8 Hz, 
2H), 2.98 (sept, J = 6.9 Hz, 2H), 3.17 (s, 2H), 7.12–7.19 (mAr, 6H), 7.34 (ddd, J = 8.3 Hz, 6.9 
Hz, 1.2 Hz, 2H), 7.45 (ddd, J = 8.0 Hz, 6.9 Hz, 1.2 Hz, 2H), 7.78 (s, 2H), 7.88 (d, J = 8.1 Hz, 
2H) ppm. 
13
C-NMR (CDCl3, 125 MHz): δ = 23.7, 23.8, 24.1, 24.2, 24.9, 27.1, 30.8, 31.1, 34.4, 121.2, 
121.4, 124.8, 125.5, 127.0, 128.3, 129.3, 131.6, 131.8, 132.1, 134.8, 135.4, 137.4, 147.0, 
147.5, 149.2 ppm. 
MS (EI) m/z: 722 (100%), 637 (9%), 595 (10%), 520 (6%). 
HRMS (ESIneg) m/z: calculated (M–H = C50H57S2) 721.3907, found 721.3909. 
 
(S)-2,6-Bis(2,4,6-triisopropylphenyl)dinaphtho[2,1-d:1′,2′-f][1,3]dithiepine (S4d): 
In a flame dried flask under Ar, (S)-3,3′-bis(2,4,6-triisopropylphenyl)-
[1,1′-binaphthalene]-2,2′-dithiol S3d (196 mg, 0.270 mmol) was 
dissolved in CH2Cl2 (0.8 mL). Dimethoxymethane (21 mg, 0.27 mmol, 
1.0 equiv.) and BF3•OEt2 (40 µL, 44 mg, 0.27 mmol, 1.0 equiv.) were 
added and the reaction mixture was stirred at room temperature for 6 h. 
The reaction mixture was diluted with CH2Cl2 (10 mL) and washed 
with aq. KOH sol. (2%, 4 × 3 mL). The organic phase was dried over MgSO4 and 
concentrated under reduced pressure. The crude product (185 mg, 93%) was found to be of 
sufficient purity to be used without further purification.
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1
H-NMR (CDCl3, 300 MHz): δ = 1.10–1.25 (m, 24H), 1.38 (d, J = 6.8 Hz, 12H), 
2.63 (apparent octet, presumably superimposition of 2 × sept, J = 6.8 Hz, 4H), 
3.02 (sept, J = 6.9 Hz, 2H), 4.02 (s, 2H), 7.10–7.20 (mAr, 6H), 
7.31 (dd, J = 8.1 Hz, 6.9 Hz, 2H), 7.54 (dd, J = 8.0 Hz, 7.0 Hz, 2H), 7.93 (s, 2H) overlays 
with one part of 7.95 (d, J approx. 8 Hz, 2H), ppm. 
13
C-NMR (CDCl3, 76 MHz):
 δ = 23.3, 23.8, 24.1, 24.9, 25.9, 30.7, 31.1, 34.3, 47.2, 120.6, 
120.7, 126.2, 126.8, 127.4, 128.2, 129.9, 130.5, 131.9, 133.7, 135.7, 141.7, 143.3, 146.2, 
147.1, 148.2 ppm. (The number of aliphatic C-atoms detected indicates that the two CH3-parts 
of the ortho-i-Pr substituents are magnetically non-equivalent, while the two CH3-parts of the 
para-i-Pr substituents are magnetically equivalent.) 
MS (EI) m/z: 734 (100%), 701 (28%), 691 (98%), 649 (35%), 373 (36%). 
HRMS (ESIpos) m/z: calculated (M+Na = C51H58S2Na) 757.3872, found 757.3877. 
 
(S)-2,6-Bis(2,4,6-triisopropylphenyl)-4H-dinaphtho[2,1-d:1′,2′-f][1,3]dithiepine 3,3,5,5-
tetraoxide (S5d): 
(S)-2,6-Bis(3,5-bis(2,4,6-triisopropylphenyl) dinaphtho[2,1-d:1′,2′-
f][1,3]dithiepine S4d (185 mg, 0.250 mmol) was placed in a flame 
dried flask under Ar and dissolved in CHCl3 (3 mL). mCPBA (70%, 
350 mg, 2.02 mmol, 5.6 equiv) was added at 0 °C. The resulting 
mixture was stirred at room temperature for 6 h. The reaction mixture 
was diluted with CH2Cl2 (10 mL) and washed with aq. KOH sol. (2%, 
3 × 4 mL) and brine (2 mL). The organic phase was dried over MgSO4 and concentrated 
under reduced pressure. After several purification steps by column chromatography (20% to 
80% gradient of CH2Cl2 in hexanes), the title compound (107 mg, 54%) was obtained as 
yellowish powder. 
1
H-NMR (CDCl3, 500 MHz): δ = 1.16 (d, J = 6.9 Hz, 6H), 1.19 (d, J = 6.8 Hz, 12H), 1.25 (d, 
J = 6.9 Hz, 6H), 1.35 (d, J = 6.9 Hz, 12H), 2.67 (sept, J = 6.9 Hz, 4H), 3.00 (sept, J = 6.9 Hz, 
2H), 4.56 (s, 2H), 7.06 (d. J = 8.6 Hz, 2H), 7.09–7.13 (mAr, 4H), 7.41 (ddd, J = 8.4 Hz, 6.9 
Hz, 1.1 Hz, 2H), 7.68 (ddd, J = 8.0 Hz, 6.9 Hz, 0.9 Hz, 2H), 7.96 (d, J = 8.0 Hz, 2H), 7.97 (s, 
2H) ppm. 
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13
C-NMR (CDCl3, 125 MHz): δ = 23.5, 23.53, 24.15, 24.2, 24.6, 25.3, 31.4, 34.3, 83.0, 
120.5, 120.6, 127.7, 128.1, 128.3, 129.9, 132.1, 132.4, 133.38, 133.4, 135.2, 136.5, 139.5, 
145.6, 146.6, 148.6 ppm. 
MS (EI) m/z: 798 (100%), 783 (7%), 649 (8%), 587 (4%). 
HRMS (ESIneg) m/z: calculated (M–H = C51H58 O4S2) 798.3777, found 798.3781. 
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Synthesis of C-H Acid Catalysts 
 
2-Ethoxy-1,1-bis((trifluoromethyl)sulfonyl)ethane (S6): 
Bis(trifuluoromethanesulfonyl)methane (0.60 g, 2.1 mmol) and triethyl 
orthoformate (0.39 mL, 0.35 g, 2.4 mmol, 1.1 equiv.) were placed in a flame 
dried flask under argon and dissolved in Ac2O (7.5 mL). The solution was stirred at room 
temperature for 1 h and then heated to 60 °C for 6 h. The reaction mixture was allowed to 
cool below 40 °C and subsequently concentrated under reduced pressure. Complete removal 
of all volatiles was achieved by dissolving in dry CH2Cl2 (3 × 3 mL) and subsequent 
evaporation to dryness. The title compound was obtained as a yellow powder (689 mg, 98%). 
1
H-NMR (CDCl3, 300 MHz): δ = 1.55 (t, J = 7.2 Hz, 3H), 4.70 (q, J = 7.2 Hz, 2H), 8.42 (s, 
1H) ppm. 
13
C-NMR (CDCl3, 75.5 MHz): δ = 15.1, 80.1, 107.2 (m), 119.4 (q, JC–F = 325.3 Hz), 119.6 
(q, JC–F = 326.3 Hz), 180.0 ppm. 
19
F-NMR (CDCl3, 282 MHz): δ = –76.4, –77.7 ppm. 
MS (EI) m/z: 267 (41%), 239 (75%), 127 (16%), 69 (66%), 29 (100%). 
HRMS (ESIpos) m/z: calculated (M+H = C6H7O5F6S2) 336.9634, found 336.9635. 
 
(S)-4-(2,2-Bis((trifluoromethyl)sulfonyl)vinyl)-2,6-bis(3,5-bis(trifluoromethyl)phenyl)-
4H-dinaphtho[2,1-d:1′,2′-f][1,3]dithiepine-3,3,5,5-tetraoxide (6a): 
(S)-2,6-Bis(3,5-bis(trifluoromethyl)phenyl)- 4H-dinaphtho[2,1-
d:1′,2′-f][1,3]dithiepine-3,3,5,5-tetraoxide S5a (0.20 g, 0.25 mmol) 
and 2-ethoxy-1,1-bis((trifluoromethyl)sulfonyl) ethane S6 (0.12 g, 
0.38 mmol, 1.5 equiv.) were placed in a flame dried flask under Ar 
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and dissolved in Et2O (1.5 mL). The resulting solution was cooled to 0 °C and 
TMPMgBr•LiCl (1M sol. in toluene, 0.75 mL, 0.75 mmol, 3.0 equiv.) was added dropwise. 
The reaction mixture was allowed to slowly reach room temperature and stirred overnight. 6 
mL of a saturated NH4Cl solution and CH2Cl2 (20 mL) were added subsequently. The reaction 
mixture was washed three times with a 6 M aq. HCl solution. The organic phase was dried 
over MgSO4 and concentrated under reduced pressure. After purification by column 
chromatography (0.5% to 4% gradient of MeOH in CH2Cl2 and 1% of AcOH), and 
acidification (shaking of CH2Cl2 solution with 6M aq. HCl) the title compound (165 mg, 
60%, 69% brsm) was obtained as off-white powder. A significant amount of starting material 
could also be re-isolated, the yields varying between 25% and 50% in different experiments. 
 
1
H-NMR (CDCl3, 500 MHz): δ = 6.37 (d, J = 12.2 Hz, 1H), 7.24 (d, J = 8.6 Hz, 2H), 7.54 (d, 
J = 12.2 Hz, 1H), 7.57–7.62 (m, 2H), 7.79 (s, 1H), 7.85–7.90 (m, 3H), 7.95 (d, J = 10.0 Hz, 
2H), 7.97 (s, 1H), 8.07 (s, 1H), 8.12 (d, J = 8.3 Hz, 1H), 8.14 (d, J = 8.3 Hz, 1H), 8.16 (s, 2H) 
ppm. 
13
C-NMR (CDCl3, 125 MHz): δ = 90.6, 118.8 (q, JC–F = 329 Hz), 119.0 (q, JC–F = 328 Hz), 
122.2 (m), 123.2 (q, JC–F = 273 Hz), 123.3 (q, JC–F = 272 Hz), 123.5, 127.3, 127.95, 127.98, 
128.0, 128.3 (m), 128.9, 129.0, 129.3, 130.0, 130.4 (m), 130.7, 130.8, 131.1, 131.6, 131.8, 
131.9, 132.1, 132.4, 142.5, 132.6, 134.8, 135.3, 135.35, 135.4, 135.7, 140.4, 140.9, 141.7 (m), 
152.4 ppm. (Not all C-signals could be detected, presumably due to overlap of several signals 
in the designated multiplets.) 
19
F-NMR (CDCl3, 282 MHz): δ = –62.7, –62.8, –62.9, –72.8, –73.0 ppm. 
MS (EI) m/z: 1108 (22%), 740 (100%), 676 (59%), 606 (13%), 126 (29%). 
MS (ESIneg) m/z: 1107 (M–H). 
HRMS (ESIneg) m/z: calculated (M–H = C41H18O8F18S4) 1106.9524, found 1106.9529. 
Elemental analysis (CHS): 
Element: C H S 
Calculated 44.91 1.729 11.18 
Found 44.91 1.725 11.39 
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(S)-4-(2,2-Bis((trifluoromethyl)sulfonyl)vinyl)-2,6-bis(9-phenanthryl)-4H-dinaphtho[2,1-
d:1′,2′-f][1,3]dithiepine-3,3,5,5-tetraoxide (6b): 
(S)-2,6-bis(9-phenanthryl)-4H-dinaphtho[2,1-d:1′,2′-f][1,3]dithiepine 
3,3,5,5-tetraoxide (220 mg, 0.29 mmol) and 2-ethoxy-1,1-
bis((trifluoromethyl) sulfonyl)ethene S6 (190 mg, 0.55 mmol, 
1.9 equiv.) were placed in a three times flame dried 50 mL Schlenk 
flask under Ar and dissolved in Et2O (4.6 mL). The resulting solution 
was cooled to –5°C and TMPMgCl•LiCl (1M sol. in toluene, 1.0 mL, 
1.0 mmol, 3.4 equiv.) was added dropwise. The reaction mixture was 
allowed to slowly reach room temperature and was stirred overnight. 6 mL of a saturated 
NH4Cl solution and CH2Cl2 (20 mL) were added subsequently. The reaction mixture was 
washed three times with a 6 M aq. HCl solution. The organic phase was dried over MgSO4, 
concentrated under reduced pressure, and was purified via flash chromatography (SiO2, 
stepwise gradient from 0.5% MeOH, 0.5% AcOH in DCM to 4% MeOH, 1% AcOH in 
DCM). The desired fractions were acidified (washing of a methyl tert-butyl ether solution 
with 6 M HCl) and the desired compound was obtained as an orange to red solid (104 mg, 
34%). 
1
H NMR (CD2Cl2, 600 MHz): δ = 6.35 (d, J = 12.6 Hz, 1H), 7.24 (d, J = 8.6 Hz, 1H), 7.29 (d, 
J = 8.7 Hz, 1H), 7.47 (d, J = 8.0 Hz, 1H), 7.53 – 7.59 (m, 3H), 7.61 (d, J = 12.6 Hz, 1H), 7.63 
– 7.70 (m, 5H), 7.71 – 7.76 (m, 3H), 7.77 (d, J = 8.2 Hz, 1H), 7.81 – 7.88 (m, 2H), 7.90 (d, J 
= 8.7 Hz, 1H), 7.91 (s, 1H), 7.96 (d, J = 7.7 Hz, 1H), 8.08 (d, J = 8.2 Hz, 1H), 8.13 (d, J = 8.3 
Hz, 1H), 8.26 (s, 1H), 8.31 (s, 1H), 8.78 (d, J = 8.6 Hz, 3H), 8.81 (d, J = 9.3 Hz, 1H) ppm. 
13
C NMR (CD2Cl2, 151 MHz): δ = 90.6, 118.2, 118.5, 122.8, 122.9, 123.3, 123.4, 125.8, 
126.1, 127.0, 127.0, 127.3, 127.4, 127.4, 127.4, 128.1, 128.2, 128.2, 128.4, 128.5, 128.8, 
128.8, 128.9, 128.9, 129.2, 129.3, 130.1, 130.2, 130.3, 130.3, 130.5, 130.5, 130.9, 131.1, 
131.1, 131.3, 131.5, 132.4, 132.5, 132.6, 134.2, 134.8, 135.2, 135.4, 135.9, 136.0, 136.4, 
136.6, 140.0, 140.6, 140.9, 153.4 ppm. 
19
F NMR (CD2Cl2, 282 MHz): δ = -74.8, -72.4. 
MS (ESIneg) m/z: 1035 (M–H) 
HRMS (ESIneg) m/z: calculated (M–H = C53H29O8F6S4) 1035.0655, found 1035.0663. 
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Table S2. Overview of NMR chemical shifts of all atoms of 6b and the correspoinding 2D 
correlations used for assignment.  
Atom 
Chemical Shift 
[ppm] 
J [Hz] 
Cross-peaks 
COSY HSQC HMBC NOESY 
1  C 139.97    4, 10  
1'  C 140.65    4', 10'  
2  C 131.06    4, 25  
2'  C 130.46    4', 25  
3  C 136.43    4, 24  
3'  C 136.56    4', 24'  
4  C 135.37   4 4, 7, 24  
H 8.31  10, 7 4 1, 3, 5, 4, 
11, 6, 2, 7 
24, 7, 13 
4'  C 135.91   4' 4', 7', 24'  
H 8.26  10', 7' 4' 1', 3', 4', 5', 
11', 6', 2', 7' 
24', 7', 13' 
5  C 136.01    4, 7, 8, 10  
5'  C 135.22    7', 4', 8', 10'  
6  C 132.62    4, 7, 9  
6'  C 132.49    4', 7', 9'  
7  C 128.89   7 9, 4, 7  
H 8.13 8.30(8), 1.20(9) 4, 9, 8 7 5, 4, 6, 7, 9 4, 8 
7'  C 128.77   7' 9', 4', 7'  
H 8.08  4', 8', 9' 7' 4', 5', 6', 7', 
9' 
4', 8' 
8  C 131.48   8 10  
H 7.87 8.30(7), 1.00(10), 
7.00(9) 
10, 7, 9 8 5, 10 7, 9 
8'  C 131.27   8' 10'  
H 7.83  9', 10', 7' 8' 5', 10' 7', 9' 
9  C 129.30   9 7  
H 7.58 1.20(7), 7.00(8), 
8.70(10) 
10, 7, 8 9 6, 7 8, 10 
9'  C 129.17   9' 7'  
H 7.57  8', 10', 7' 9' 6', 7' 10', 8' 
10  C 128.20   10 8, 10  
H 7.24 1.00(8), 8.70(9) 4, 9, 8 10 1, 5, 8, 10 9, 10' 
10'  C 128.14   10' 8', 10'  
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H 7.29  4', 9', 8' 10' 1', 5', 8', 10' 9', 10 
11  C 134.77    4, 24, 13  
11'  C 134.18    4', 13', 24'  
12  C 132.36    16, 14, 24  
12'  C 131.27    16', 14', 24'  
13  C 125.82   13 13, 14, 15  
H 7.47 8.20(14) 15, 14 13 11, 17, 14, 
13, 15 
25, 4 
13'  C 126.13   13' 13', 14', 15'  
H 7.77  15', 14' 13' 11', 17', 14', 
13', 15' 
4', 14', 26 
14  C 128.22   14 16, 13, 14  
H 7.55 8.20(13), 7.00(15), 
1.10(16) 
13, 15, 16 14 12, 14, 13, 
16 
25 
14'  C 128.39   14' 16', 13', 14', 15' 
H 7.63  13', 15', 16' 14' 12', 14', 13', 
16' 
13' 
15  C 126.99   15 13  
H 7.65 8.30(16), 7.00(14) 13, 14, 16 15 17, 13 16 
15'  C 127.05   15' 13'  
H 7.69  13', 14', 16' 15' 17', 14', 13' 16' 
16  C 123.41   16 14, 16  
H 8.80 8.30(15), 1.10(14) 15, 14 16 12, 18, 14, 
16 
15, 19 
16'  C 123.34   16' 14', 16'  
H 8.82  15', 14' 16' 12', 18', 14', 
16' 
15', 19' 
17  C 130.08    13, 15, 19  
17'  C 130.54    13', 15', 19'  
18  C 130.31    22, 20, 24, 16 
18'  C 130.20    20', 22', 24', 16' 
19  C 122.94   19 21, 19  
H 8.78 8.30(20), 1.20(21) 24, 20, 21 19 23, 17, 21, 
19 
16, 20 
19'  C 122.83   19' 21', 19'  
H 8.78  24', 20', 21' 19' 23', 17', 21', 
19' 
16', 21 
20  C 127.32   20 22  
H 7.74 8.30(19), 1.30(22), 
6.30(21) 
22, 21, 19 20 18, 22 19 
20'  C 127.37   20' 22'  
H 7.73  22', 21', 19' 20' 18'  
21  C 127.38   21 19  
H 7.68 1.20(19), 6.30(20), 
8.00(22) 
22, 20, 19 21 23, 19 22, 19' 
21'  C 127.36   21' 19'  
H 7.65  22', 20', 19' 21' 23', 19' 22' 
22  C 128.83   22 20, 24  
H 7.96 1.30(20), 8.00(21) 21, 20 22 18, 24, 20 24, 21 
22'  C 128.87   22' 22', 24'  
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H 7.90  21', 20' 22' 24', 18', 22', 
20' 
24', 21' 
23  C 131.11    19, 24, 21  
23'  C 130.92    19', 24', 21'  
24  C 128.54   24 22  
H 7.91  19 24 3, 4, 11, 12, 
23, 18, 22 
4, 22 
24'  C 130.27   24' 22'  
H 7.74  19' 24' 3', 4', 11', 
12', 23', 18', 
22' 
4', 22' 
25  C 90.59 154.00(25H)  25 25, 26  
H 6.35 12.50(26), 
154.00(25C) 
26 25 25, 26, 27, 
2, 2' 
26, 14, 13 
26  C 153.43 171.00(26H)  26 25, 26  
H 7.61 12.50(25), 
171.00(26C) 
25 26 25, 26, 27, 
29 
25, 13' 
27  C 140.93    25, 26  
28  C 118.15 328.00(?)*     
29  C 118.48 328.00(?)*   26  
 
*could not be unambiguously assigned 
 
(S)-4-(2,2-Bis((trifluoromethyl)sulfonyl)vinyl)-2,6-bis(2,4,6-triisopropylphenyl)-4H-
dinaphtho[2,1-d:1′,2′-f][1,3]dithiepine-3,3,5,5-tetraoxide (6c): 
(S)-2,6-Bis(2,4,6-triisopropylphenyl)- 4H-dinaphtho[2,1-d:1′,2′-
f][1,3]dithiepine 3,3,5,5-tetraoxide S5d (107 mg, 0.130 mmol) and 
2-ethoxy-1,1-bis((trifluoromethyl)sulfonyl)ethene S6 (45 mg, 
0.13 mmol, 1.0 equiv.) were placed in a flame dried flask under Ar 
and dissolved in Et2O (0.4 mL). The resulting solution was cooled 
to –78 °C and TMPMgCl•LiCl (1M sol. in toluene, 0.4 mL, 3.0 
equiv.) was added dropwise. The reaction mixture was slowly allowed to reach room 
temperature and stirred overnight. The reaction mixture was diluted with CH2Cl2 (5 mL) and 
washed with aq. HCl sol. (10%, 2 mL). The organic phase was dried over MgSO4 and 
concentrated under reduced pressure. After several purification steps by column 
chromatography (2.5% of MeOH in CH2Cl2) and acidification (shaking of CH2Cl2 solution 
with 6M aq. HCl), the title compound (67 mg, 48%) was obtained as brownish powder. An 
unquantified amount of starting material was isolated as the only other major component of 
the reaction mixture. 
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1
H-NMR (CDCl3, 500 MHz): δ = 0.97 (d, J = 6.7 Hz, 3H), 1.00 (d, J = 6.7 Hz, 3H), 1.04 (d, J 
= 6.8 Hz, 3H), 1.05 (d, J = 6.8 Hz, 3H), 1.08 (d, J = 6.6 Hz, 3H), 1.13 (d, J = 6.8 Hz, 3H), 
1.14 (d, J = 6.9 Hz, 3H), 1.16 (d, J = 7.0 Hz, 3H), 1.27–1.32 (m, 12H), 2.49 (sept, J = 6.9 Hz, 
1H), 2.60 (apparent oct, presumably 2 × sept, J = 6.9 Hz, 2H), 2.70 (sept, J = 7.0 Hz, 1H), 
2.87–3.00 (m, 2H), 6.83 (d, J = 8.6 Hz, 1H), 6.99 (m, 2H) 7.01 (d, J = 1.6 Hz, 1H), 7.05 (d, J 
= 1.6 Hz, 1H), 7.15–7.20 (m, 1H), 7.26–7.31 (m, 2H), 7.38 (ddd, J = 8.5 Hz, 6.8 Hz, 0.6 Hz, 
1H), 7.54–7.62 (m, 2H), 7.70 (s, 1H), 7.82–7.91 (m, 4H) ppm. 
13
C-NMR (CDCl3, 125 MHz): δ = 23.4, 23.5, 23.6, 23.7, 24.0, 24.1, 24.25, 24.3, 24.6, 25.0, 
25.3, 25.5, 31.0, 31.1, 31.4, 31.8, 34.1, 34.6, 119.6, 120.3, 120.6, 120.8, 120.5 (q, JC–F = 331.2 
Hz), 123.7 (q, JC–F = 323.9 Hz), 127.4, 127.45, 127.5, 128.0, 128.28, 128.3, 128.5, 129.0, 
129.1, 130.5 (m), 132.1, 132.6, 133.6, 134.1, 134.2, 134.3, 134.7, 135.8, 136.0, 136.3, 136.6, 
138.1, 138.8, 139.3, 145.3, 145.6, 146.4, 146.5, 147.9, 148.1, 186.3 ppm. 
19
F-NMR (CDCl3, 282 MHz): δ = –66.6, –74.6 ppm. 
MS (ESIneg) m/z: 1087 (M–H). 
HRMS (ESIneg) m/z: calculated (M–H = C55H57F6O8S4) 1087.2846, found 1087.2849. 
 
(S)-4-(2,2-Bis((trifluoromethyl)sulfonyl)vinyl)-4H-dinaphtho[2,1-d:1′,2′-f][1,3]dithiepine 
3,3,5,5-tetraoxide (6d): 
(S)-4H-Dinaphtho[2,1-d:1′,2′-f][1,3]dithiepine 3,3,5,5-tetraoxide 
S5c (197 mg, 0.500 mmol) and 2-ethoxy-1,1-
bis((trifluoromethyl)sulfonyl)ethene S6 (168 mg, 0.600 mmol, 
1.0 equiv.) were placed in a flame dried flask under Ar and 
dissolved in Et2O (1.5 mL). The resulting solution was cooled to –78 °C and TMPMgBr•LiCl 
(1M sol. in toluene, 1.5 mL, 1.5 mmol, 3.0 equiv.) was added dropwise. The reaction mixture 
was allowed to slowly reach room temperature and stirred overnight. The reaction mixture 
was diluted with CH2Cl2 (20 mL) and washed with aq. HCl sol. (10%, 5 mL). The organic 
phase was dried over MgSO4 and concentrated under reduced pressure. After several 
purification steps by column chromatography (0% to 5% gradient of MeOH in CH2Cl2) and 
acidification (shaking of CH2Cl2 solution with 6M aq. HCl), the title compound (110 mg, 
0.16 mmol, 32%) was obtained as a brownish foam. 
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1
H-NMR (CDCl3, 300 MHz): δ = 6.66 (d, J = 12.4 Hz, 1H), 7.19–7.28 (mAr, 2H), 7.40–7.52 
(mAr, 2H), 7.72–7.82 (mAr, 2H), 7.93 (d, J = 12.4 Hz, 1H), 8.07–8.17 (mAr, 3H), 8.26–8.37 
(mAr, 3H) ppm. 
13
C-NMR (CDCl3, 76 MHz): δ = 91.0, 124.0, 124.8, 128.0, 128.95, 129.0, 129.1, 130.7, 
131.1, 131.4, 131.7, 132.3, 132.5, 136.7, 136.9, 137.15, 137.2, 154.5 ppm. (The signals 
corresponding to the CF3 groups could not be detected, presumably due to the low signal 
intensity caused by coupling. The number of aromatic C-atoms detected is between the one 
expected for a C2-symmetric backbone and the one expected for an non-symmetric backbone. 
As the signals in the 
1
H-spectrum indicate a non-symmetric structure, this can be rationalized 
by the superimposition of signals or the low signal intensity for some C-atoms.) 
19
F-NMR (CDCl3, 282 MHz): δ = –72.8, –73.6 ppm. 
MS (EI) m/z: 684 (37%), 556 (8%), 316 (100%), 289 (28%), 252 (32%). 
HRMS (EI) m/z: calculated (M = C25H14O8F6S4) 683.9476, found 683.9477. 
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Reaction Development & Screening of Reaction Conditions 
Table S3. Catalyst screening.
 
 
catalyst conversion
*
 d.r. 
†
 e.r.
‡
 
5a traces / / 
6a full 13 : 1 56 : 44 
6a full (-40°C) 18 : 1 65 : 35 
6b full 18 : 1 86.5 : 13.5 
6c full 13 : 1  56.5 : 43.5 
* conversions were determined by 1H-NMR 
† diastereomeric ratios were determined by HPLC 
‡ enantiomeric ratios were determined by HPLC with a chiral stationary phase 
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Table S4. Screening of silyl ketene acetals. 
 
SKA (R =) conversion d.r. e.r. 
TMS (4a) full 18:1 86.5 : 13.5 
TBS (4b) full 16:1 89.5 : 10.5 
 
TES (4c) full 13:1 87.5 : 12.5 
TIPS (4d) full 6:1 87.5 : 12.5 
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Table S5. Solvent screening. 
 
solvent conversion d.r. e.r. solvent conversion d.r. e.r. 
Et2O full 17:1 94 : 6 Benzene full 16:1 89 : 11 
MTBE full 14:1 93.5 : 6.5 Toluene full 16:1 89.5 : 10.5 
Dioxane full 15:1 91.5 : 8.5 o-Xylene full 18:1 90 : 10 
TMS2O >95% 11:1 81.5 : 18.5 m-Xylene full 19:1 90 : 10 
CHCl3 >95% 16:1 91.5 : 8.5 p-Xylene full 18:1 89.5 : 10.5 
CCl4 >95% 14:1 90 : 10 Mesitylene full 18:1 90 : 10 
EtOAc full 18:1 93.5 : 6.5 n-Hexane full 11:1 79.5 : 20.5 
MeCN no product / / Cyclohexane full 14:1 87 : 13 
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Table S6. Temperature screening. 
 
solvent temp. conversion d.r. e.r. 
Et2O 0°C full 31:1 95.5 : 4.5 
-20°C >95% 39:1 96 : 4 
MTBE 0°C >95% 28:1 95.5 : 4.5 
-20°C full 30:1 94 : 6 
CHCl3 0°C >95% 24:1 93.5 : 6.5 
-20°C >95% 31:1 95 : 5 
EtOAc 0°C >75% 31:1 95.5 : 4.5 
-20°C 40% 36:1 97 : 3 
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Table S7. Concentration screening. 
 
concentration conversion d.r. e.r. 
1M full 30:1 91 : 9 
0.5M full 32:1 91 : 9 
0.2M full 32:1 91.5 : 8.5 
0.1M >95% 31:1 92 : 8 
0.05M >95% 33:1 92 : 8 
0.025M >95% 33:1 92.5 : 7.5 
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Table S8. Catalyst loading and screening of reagents. 
 
catalyst loading 
(x) 
equiv. of Cp (y) loading silyl 
ketene acetal (z) 
conversion d.r. e.r. 
5 mol% 10 50 mol% full (in GC-vial 
under Ar) 
33 : 1 96 : 4 
1 mol% 10 50 mol% full (in GC-vial 
under Ar) 
35 : 1 97 : 3 
1 mol% 5 50 mol% >95% (in GC-
vial under Ar) 
36 : 1 97 : 3 
1 mol% 5 20 mol% 92% (in GC-vial 
under Ar) 
27 : 1 97 : 3 
1 mol% 5 10 mol% 0 % (in GC-vial 
under Ar) 
/ / 
1 mol% 5 10 mol% full (15h, in 
Schlenk under 
Ar); 94% 
isolated yield 
>25 : 1 96.75 : 
3.25 
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Table S9. Control experiments. 
 
conditions time conversion d.r. e.r. 
no catalyst, no silyl ketene acetal 5d 3%  / / 
no catalyst 5d 1% / / 
no silyl ketene acetal 5d 5% / / 
with catalyst and silyl ketene acetal 18h full 16:1 89.5 : 10.5 
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General Procedure for the Catalytic, Asymmetric Diels-Alder Reaction: 
A flame-dried Schlenk flask was charged with unsaturated ester (0.1 mmol), catalyst (S)-6b 
(0.001 mmol, 1.04 mg) and a magnetic stir bar under Argon and further dried under high 
vacuum overnight. After addition of Et2O and cyclopentadiene (0.05 mmol, 42 µL), the 
reaction mixture was cooled to -20 °C. Methyl tert-butyldimethylsilyl dimethylketene acetal 
4b (0.01 mmol, 2.5 µL) was added and the reaction mixture was stirred at -20 °C for 1-6 d. 
After complete conversion was detected by TLC analysis, the reaction was quenched with 
NEt3 (one drop) and concentrated under reduced pressure. The crude product was puriﬁed by 
ﬂash column chromatography (SiO2, stepwise gradient from 1% to 5% ethyl acetate in 
hexanes) affording Diels-Alder cycloadducts. 
 
General Procedure for the Preparation of Racemic Products: 
A GC-vial was charged with the appropriate unsaturated ester (0.04 mmol) and 
cyclopentadiene (30 equiv., 0.1 mL) in toluene (0.1 mL). The reaction mixture was heated to 
120 °C overnight. A racemic mixture of the endo- and exo-product was obtained after 
purification of the crude material by preparative TLC. Under these conditions, the exo-
cycloadduct is typically the main product. 
Racemic 3j was obtained by applying the general procedure for the catalytic Diels-Alder 
reaction at room temperature using the R/S mixture of 6b. 
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Characterization of Diels-Alder Products 
(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-phenylbicyclo[2.2.1]hept-5-ene-2-carboxylate 
(3a) 
The product was synthesized according to the general procedure employing 
substrate 1a (15h). 3a was obtained as a yellow powder (36.9 mg, 94%, d.r. 
>25:1). 
1
H-NMR (300 MHz, CDCl3) δ = 1.52-1.59 (m, 1H), 1.74-1.80 (m, 1H), 2.94-2.98 (m, 3H), 
3.21 (br. s, 1H), 4.19 (t, J = 6.3 Hz, 1H), 4.49 (d, J = 6.3 Hz, 2H), 5.92 (dd, J = 5.6, 2.8 Hz, 
1H), 6.34 (dd, J = 5.6, 3.2 Hz, 1H), 7.15-7.33 (m, 7H), 7.38-7.45 (m, 2H), 7.56 (d, J = 7.6 Hz, 
2H), 7.77 (d, J = 7.6 Hz, 2H) ppm. 
13
C-NMR (75 MHz, CDCl3) δ = 46.4, 47.26, 47.3, 47.7, 48.5, 52.4, 53.6, 66.1, 120.2, 120.25, 
125.09, 125.1, 126.3, 127.29, 127.3, 127.7, 127.9, 128.0 128.7, 134.7, 139.2, 141.6, 141.63, 
144.0, 144.1, 144.3, 174.4 ppm. 
MS (EI) m/z: 178 (100%), 66 (2%), 327 (2%). 
HRMS (ESIpos) m/z: calculated for C28H24NaO2
+
: 415.1668; found 415.1671. 
[α]D
25
: +82.6° (c=0.78, CH2Cl2). 
Optical rotation for the corresponding carboxylic acid obtained by basic deprotection: 
[α]D
25
: +186° (c=0.3, CH2Cl2). 
Literature value: [α]D
25
: +126.0° (c=1.0, CH2Cl2).(29) 
HPLC: Daicel Chiralcel OD-3R, acetonitrile:water = 80:20, ﬂow: 1 mL/min, 25°C, absorption 
at 220 nm, tR (endo-Diels Alder product) = 17.6 min (major) and 40.4 min (minor); tR (exo-
Diels Alder product) = 23.5 min and 27.4 min. e.r = 97:3 
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(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(4-methoxyphenyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (3b) 
The product was synthesized according to the general procedure employing 
substrate 1b in CHCl3 for 6d. 3b was obtained as a colorless solid (39.3 mg, 
93%, d.r. >25:1). 
 
1
H-NMR (500 MHz, CDCl3) δ = 1.54 (dm, J = 8.8 Hz, 1H), 1.75 (d, J = 8.7 Hz, 1H), 2.94-
2.98 (m, 3H), 3.19 (br. s, 1H), 3.80 (s, 3H), 4.19 (t, J = 6.2 Hz, 1H), 4.48 (d, J = 6.4 Hz, 2H), 
5.90 (dd, J = 5.6, 2.7 Hz, 1H), 6.32 (dd, J = 5.6, 3.2 Hz, 1H), 6.80-6.85 (m, 2H), 7.13-7.18 
(m, 2H), 7.30 (dddd, J = 7.5, 7.5, 3.4, 1.1 Hz, 2H), 7.41 (ddd, J = 7.5, 7.5, 2.6 Hz, 2H), 7.56 
(d, J = 7.5 Hz, 2H), 7.77 (d, J = 7.5 Hz, 2H) ppm. 
13
C-NMR (125 MHz, CDCl3) δ = 46.1, 46.9, 47.06, 47.1, 48.6, 52.4, 55.3, 65.8, 113.9, 120.0, 
120.1, 124.9, 124.95, 127.1, 127.1,4, 127.75, 127.8, 128.4, 134.5, 136.2, 139.1, 141.4, 141.45, 
143.85, 143.9, 157.9, 174.3 ppm. 
HRMS (ESIpos) m/z: calculated for C29H26NaO3
+
: 445.1774; found 445.1777. 
[α]D
25
: +82.1° (c=0.98, CH2Cl2). 
HPLC: Daicel Chiralcel OD-3R, acetonitrile:water = 70:30, ﬂow: 1 mL/min, 25°C, absorption 
at 220 nm, tR (endo-Diels Alder product) = 43.9 min (major) and 86.6 min (minor); tR (exo-
Diels Alder product) = 58.2 min and 60.2 min. e.r = 95:5 
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(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(4-nitrophenyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (3c) 
The product was synthesized according to the general procedure employing 
substrate 1c for 2d in CHCl3. 3c was obtained as a colorless solid (39.4 mg, 
90%, d.r. >25:1). 
1
H-NMR (500 MHz, CDCl3) δ = 1.57 (dm, J = 8.9 Hz, 1H), 1.64 (d, J = 8.9 Hz, 1H), 2.83 
(dd, J = 5.1, 3.7 Hz, 1H), 2.92 (dm, J = 5.1 Hz, 1H), 2.98-3.01 (m, 1H), 3.18 (br. s, 1H), 4.19 
(t, J = 5.5 Hz, 1H), 4.59 (dd, J = 11.0, 5.5 Hz, 1H), 4.61 (dd, J = 11.0, 5.7 Hz, 1H), 5.88 (dd, J 
= 5.7, 2.8 Hz, 1H), 6.27 (dd, J = 5.7, 3.2 Hz, 1H), 7.26-7.29 (m, 2H), 7.33 (dddd, J = 7.5, 7.5, 
4.4, 1.1 Hz, 2H), 7.42 (dddm, J = 7.5, 7.5, 4.2 Hz, 2H), 7.56 (dm, J = 7.6 Hz, 2H), 7.77 (dm, J 
= 7.6 Hz, 2H), 8.06-8.10 (m, 2H) ppm. 
13
C-NMR (125 MHz, CDCl3) δ 46.1, 47.1, 47.15, 47.5, 47.7, 52.7, 65.6, 120.07, 120.1, 123.6, 
124.7, 124.72, 127.17, 127.2, 127.8, 127.9, 128.2, 135.1, 138.6, 141.5, 141.5, 143.7, 143.71, 
146.3, 152.1, 173.5 ppm. 
HRMS (ESIpos) m/z: calculated for C28H23NNaO4
+
: 460.1519; found 460.1522. 
[α]D
25
: +107.5° (c=0.96, CH2Cl2). 
HPLC: Kromasil Cellucoat RP, acetonitrile:water = 80:20, ﬂow: 1 mL/min, 25°C, absorption 
at 220 nm, tR (endo-Diels Alder product) = 21.8 min (minor) and 39.0 min (major); tR (exo-
Diels Alder product) = 19.7 min and 28.7 min. e.r = 95:5 
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(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(4-fluorophenyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (3d) 
The product was synthesized according to the general procedure employing 
substrate 1d (3d). 3d was obtained as a colorless solid (37.4 mg, 91%, d.r. 
>25:1). 
1
H-NMR (500 MHz, CDCl3) δ = 1.55 (dm, J = 8.7 Hz, 1H), 1.71 (d, J = 8.7 Hz, 1H), 2.89 
(dd, J = 5.0, 3.5 Hz, 1H), 2.92 (dm, J = 5.0 Hz, 1H), 2.94-2.97 (m, 1H), 3.19 (br. s, 1H), 4.19 
(t, J = 6.1 Hz, 1H), 4.53 (d, J = 6.1 Hz, 2H), 5.90 (dd, J = 5.6, 2.8 Hz, 1H), 6.31 (dd, J = 5.6, 
3.2 Hz, 1H), 6.92-7.00 (m, 2H), 7.13-7.19 (m, 2H), 7.32 (dddd, J = 7.5, 7.5, 2.8, 1.1 Hz, 2H), 
7.42 (dddm, J = 7.5, 7.5, 3.2 Hz, 2H), 7.56 (dm, J = 7.6 Hz, 2H), 7.78 (dm, J = 7.6 Hz, 2H) 
ppm. 
13
C-NMR (125 MHz, CDCl3) δ 46.2, 46.9, 47.1, 47.2, 48.3, 52.6, 65.8, 115.1, 115.3, 120.1, 
120.11, 124.85, 124.9, 127.15, 127.2, 127.8, 127.85, 128.8, 128.9, 134.7, 139.0, 139.85, 
139.9, 141.5, 141.52, 143.8, 143.9, 160.3, 162.3, 174.1 ppm. 
HRMS (ESIpos) m/z: calculated for C28H23FNaO2
+
: 433.1574; found 433.1572. 
[α]D
25
: +73.9° (c=0.71, CH2Cl2). 
HPLC: Kromasil Cellucoat RP, acetonitrile:water = 70:30, ﬂow: 1 mL/min, 25°C, absorption 
at 220 nm, tR (endo-Diels Alder product) = 35.1 min (major) and 56.2 min (minor); tR (exo-
Diels Alder product) = 41.9 min and 44.2 min. e.r = 95:5 
 
  
S47 
 
(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(4-chlorophenyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (3e) 
The product was synthesized according to the general procedure employing 
substrate 1e (0 °C, 10h). 3e was obtained as a pale yellow, crystalline solid 
(40.0 mg, 94%, d.r. >25:1). 
1
H-NMR (500 MHz, CDCl3) δ = 1.55 (dm, J = 8.9 Hz, 1H), 1.70 (d, J = 8.9 Hz, 1H), 2.89 
(dd, J = 5.0, 3.4 Hz, 1H), 2.90 (dm, J = 5.1 Hz, 1H), 2.94-2.97 (m, 1H), 3.19 (br. s, 1H), 4.19 
(t, J = 6.1 Hz, 1H), 4.53 (d, J = 6.0 Hz, 2H), 5.90 (dd, J = 5.6, 2.7 Hz, 1H), 6.30 (dd, J = 5.6, 
3.3 Hz, 1H), 7.11-7.15 (m, 2H), 7.21-7.26 (m, 2H), 7.32 (dddd, J = 7.5, 7.5, 2.9, 0.8 Hz, 2H), 
7.42 (dddm, J = 7.5, 7.5, 3.9 Hz, 2H), 7.56 (dm, J = 7.5 Hz, 2H), 7.78 (dm, J = 7.5 Hz, 2H) 
ppm. 
13
C-NMR (125 MHz, CDCl3) δ 46.1, 47.0, 47.1, 47.15, 48.1, 52.5, 65.8, 120.07, 120.1, 124.8, 
124.9, 127.1, 127.2, 127.8, 127.85, 128.5, 128.8, 131.8, 134.7, 138.9, 141.46, 141.5, 142.7, 
143.8, 174.0 ppm. 
HRMS (ESIpos) m/z: calculated for C28H23ClNaO2
+
: 449.1279; found 449.1280. 
[α]D
25
: +82.3° (c=1.0, CH2Cl2). 
HPLC: Daicel Chiralcel OD-3R, acetonitrile:water = 80:20, ﬂow: 1 mL/min, 25°C, absorption 
at 220 nm, tR (endo-Diels Alder product) = 29.3 min (major) and 42.4 min (minor); tR (exo-
Diels Alder product) = 31.8 min and 35.1 min. e.r = 95:5 
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(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(4-bromophenyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (3f) 
The product was synthesized according to the general procedure employing 
substrate 1f (4d). 3f was obtained as a yellowish syrup (45.7 mg, 97%, d.r. 
>25:1). 
1
H-NMR (500 MHz, CDCl3) δ = 1.54 (dm, J = 8.7 Hz, 1H), 1.68 (d, J = 8.7 Hz, 1H), 2.86-
2.90 (m, 2H), 2.92-2.96 (m, 1H), 3.18 (br. s, 1H), 4.18 (t, J = 6.0 Hz, 1H), 4.52 (d, J = 6.0 Hz, 
2H), 5.89 (dd, J = 5.7, 2.9 Hz, 1H), 6.29 (dd, J = 5.7, 3.3 Hz, 1H), 7.04-7.10 (m, 2H), 7.32 
(dddd, J = 7.5, 7.5, 4.2, 3.1 Hz, 2H), 7.36-7.40 (m, 2H), 7.42 (dddm, J = 7.5, 7.5, 4.1 Hz, 2H), 
7.56 (dm, J = 7.6 Hz, 2H), 7.77 (dm, J = 7.6 Hz, 2H) ppm. 
13
C-NMR (125 MHz, CDCl3) δ 46.1, 47.1, 47.15, 48.1, 52.4, 65.8, 119.8, 120.1, 120.12, 
124.8, 124.9, 127.15, 127.2, 127.8, 127.9, 129.2, 131.5, 134.8, 138.9, 141.47, 141.5, 143.2, 
143.8, 174.0 ppm. 
HRMS (ESIpos) m/z: calculated for C28H23BrNaO2
+
: 493.0774; found 493.0775. 
[α]D
25
: +76.3° (c=0.92, CH2Cl2). 
HPLC: Kromasil Cellucoat RP, acetonitrile:water = 70:30, ﬂow: 1 mL/min, 25°C, absorption 
at 220 nm, tR (endo-Diels Alder product) = 61.9 min (major) and 89.6 min (minor); tR (exo-
Diels Alder product) = 64.4 min and 75.0 min. e.r = 96:4 
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(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(4-iodophenyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (3g) 
The product was synthesized according to the general procedure employing 
substrate 1g (3d). The crude product was puriﬁed by ﬂash column 
chromatography affording 3g as a colorless solid (46.1 mg, 89%, d.r. >25:1). 
1
H-NMR (500 MHz, CDCl3) δ = 1.54 (dm, J = 8.9 Hz, 1H), 1.67 (d, J = 8.9 Hz, 1H), 2.84-
2.90 (m, 2H), 2.92-2.96 (m, 1H), 3.18 (br. s, 1H), 4.18 (t, J = 6.1 Hz, 1H), 4.52 (dm, J = 6.1 
Hz, 2H), 5.89 (dd, J = 5.6, 2.8 Hz, 1H), 6.29 (dd, J = 5.6, 3.2 Hz, 1H), 6.93-6.97 (m, 2H), 
7.32 (dddd, J = 7.5, 7.5, 3.0, 1.1 Hz, 2H), 7.42 (dddm, J = 7.5, 7.5, 4.1 Hz, 2H), 7.56 (dm, J = 
7.5 Hz, 2H), 7.56-7.60 (m, 2H), 7.77 (dm, J = 7.5 Hz, 2H) ppm.  
13
C-NMR (125 MHz, CDCl3) δ 46.1, 47.1, 47.15, 47.2, 48.1, 52.4, 65.8, 91.2, 120.0, 120.1, 
124.8, 124.9, 127.15, 127.2, 127.8, 127.9, 129.6, 134.7, 137.5, 138.9, 141.47, 141.5, 143.8, 
143.9, 173.9 ppm. 
HRMS (ESIpos) m/z: calculated for C28H23INaO2
+
: 541.0635; found 541.0637. 
[α]D
25
: +68.4° (c=0.92, CH2Cl2). 
HPLC:  
Diastereomer separation: 
YMC Triart ExRS, acetonitrile:water = 85:15, ﬂow: 0.5 mL/min, 25°C, absorption at 220 nm, 
tR (endo-Diels Alder product) = 5.56 min; tR (exo-Diels Alder product) = 5.78 min 
Enantiomer separation: 
Kromasil Cellucoat RP, acetonitrile:methanol = 5:95, ﬂow: 1 mL/min, 25°C, absorption at 
220 nm, tR (endo-Diels Alder product) = 33.7 min (major) and 34.7 min (minor). e.r = 
95.5:4.5 
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(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(p-tolyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate 
(3h) 
The product was synthesized according to the general procedure employing 
substrate 1h (1d). 3h was obtained as a yellowish syrup (39.0 mg, 96%, d.r. 
>25:1). 
1
H-NMR (500 MHz, CDCl3) δ = 1.55 (dm, J = 8.7 Hz, 1H), 1.78 (d, J = 8.7 Hz, 1H), 2.35 (s, 
3H), 2.94-3.03 (m, 3H), 3.22 (br. s, 1H), 4.20 (t, J = 6.3 Hz, 1H), 4.48 (dm, J = 6.3 Hz, 2H), 
5.90-5.95 (m, 1H), 6.33-6.37 (m, 1H), 7.12 (d, J = 7.9 Hz, 2H), 7.16 (d, J = 7.9 Hz, 2H), 7.29-
7.35 (m, 2H), 7.39-7.45 (m, 2H), 7.58 (d, J = 7.5 Hz, 2H), 7.78 (d, J = 7.5 Hz, 2H) ppm.  
13
C-NMR (125 MHz, CDCl3) δ 21.0, 46.2, 47.1, 47.3, 48.6, 52.2, 65.9, 120.0, 120.1, 124.95, 
125.0, 127.1, 127.14, 127.4, 127.75, 127.8, 129.2, 134.5, 135.6, 139.1, 141.1, 141.4, 141.5, 
143.9, 143.95, 174.3 ppm. 
HRMS (ESIpos) m/z: calculated for C29H26NaO2
+
: 429.1825; found 429.1828. 
[α]D
25
: +83.8° (c=0.78, CH2Cl2). 
HPLC: Kromasil Cellucoat RP, acetonitrile:water = 80:20, ﬂow: 1 mL/min, 25°C, absorption 
at 220 nm, tR (endo-Diels Alder product) = 15.1 min (major) and 30.9 min (minor); tR (exo-
Diels Alder product) = 20.3 min and 22.2 min. e.r = 95.5:4.5 
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(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(m-tolyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate 
(3i) 
The product was synthesized according to the general procedure employing 
substrate 1i (10h). 3i was obtained as a colorless powder (37.4 mg, 92%, d.r. 
>25:1). 
1
H-NMR (500 MHz, CDCl3) δ = 1.57 (dm, J = 8.8 Hz, 1H), 1.80 (d, J = 8.8 Hz, 1H), 2.36 (s, 
3H), 3.00-3.07 (m, 3H), 3.23 (br. s, 1H), 4.21 (t, J = 6.4 Hz, 1H), 4.49 (d, J = 6.4 Hz, 2H), 
5.93 (dd, J = 5.7, 2.8 Hz, 1H), 6.36 (dd, J = 5.7, 3.2 Hz, 1H), 7.05 (d, J = 7.6 Hz, 1H), 7.09 (d, 
J = 7.6 Hz, 1H), 7.12 (s, 1H), 7.21 (dd, J = 7.6, 7.6 Hz, 2H), 7.32 (dddd, J = 7.5, 7.5, 2.6, 1.1 
Hz, 2H), 7.43 (ddm, J = 7.5, 7.5 Hz, 2H), 7.59 (dm, J = 7.5 Hz, 2H), 7.79 (dm, J = 7.5 Hz, 
2H) ppm.  
13
C-NMR (125 MHz, CDCl3) δ 21.6, 46.3, 47.1, 47.2, 47.5, 48.6, 53.1, 67.0, 120.0, 120.1, 
124.5, 124.95, 125.0, 126.9, 127.1, 127.2, 127.8, 127.81, 128.4, 128.43, 134.5, 138.1, 139.2, 
141.4, 141.5, 143.9, 144.0, 144.1, 174.3 ppm. 
HRMS (ESIpos) m/z: calculated for C29H26NaO2
+
: 429.1825; found 429.1827. 
[α]D
25
: +88.1° (c=0.90, CH2Cl2). 
HPLC: Kromasil Cellucoat RP, acetonitrile:water = 80:20, ﬂow: 1 mL/min, 25°C, absorption 
at 220 nm, tR (endo-Diels Alder product) = 12.8 min (major) and 31.2 min (minor); tR (exo-
Diels Alder product) = 17.9 min and 20.6 min. e.r = 95.5:4.5 
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(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(o-tolyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate 
(3j) 
The product was synthesized according to the general procedure employing 
substrate 1j (3d). 3j was obtained as a colorless solid (36.6 mg, 90%, d.r. 
>25:1). 
1
H-NMR (500 MHz, CDCl3) δ = 1.53 (dm, J = 8.8 Hz, 1H), 1.84 (d, J = 8.8 Hz, 1H), 2.28 (s, 
3H), 2.82 (br.s, 1H), 3.14-3.20 (m, 2H), 3.22 (br. s, 1H), 4.17 (t, J = 6.5 Hz, 1H), 4.42 (dd, J = 
10.9, 6.4 Hz, 1H), 4.47 (dd, J = 10.9, 6.7 Hz, 1H), 5.88-5.92 (m, 1H), 6.37-6.41 (m, 1H), 
7.14-7.25 (m, 3H), 7.27-7.33 (m, 3H), 7.42 (dd, J = 7.5, 7.5 Hz, 2H), 7.53 (dd, J = 7.6 Hz, 
2H), 7.78 (d, J = 7.6 Hz, 2H) ppm.  
13
C-NMR (125 MHz, CDCl3) δ 20.3, 44.5, 46.7, 46.9, 47.0, 49.5, 49.55, 65.9, 120.0, 124.9,, 
125.0, 125.4, 126.0, 126.2, 127.1, 127.14, 127.76, 127.8, 130.7, 134.2, 137.2, 138.9, 141.4, 
141.45, 141.7, 143.8, 144.0, 174.4 ppm. 
HRMS (ESIpos) m/z: calculated for C29H26NaO2
+
: 429.1825; found 429.1825. 
[α]D
25
: +106.4° (c=0.91, CH2Cl2). 
HPLC: Kromasil Cellucoat RP, acetonitrile:water = 70:30, ﬂow: 1 mL/min, 25°C, absorption 
at 220 nm, tR (endo-Diels Alder product) = 30.6 min (major) and 60.4 min (minor); tR (exo-
Diels Alder product) = 42.5 min and 50.8 min. e.r = 96:4 
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(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(3-nitrophenyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (3k) 
The product was synthesized according to the general procedure employing 
substrate 1k (36h). 3k was obtained as a colorless solid (39.8 mg, 91%, d.r. 
>25:1). 
1
H-NMR (500 MHz, CDCl3) δ = 1.59 (dm, J = 9.0 Hz, 1H), 1.68 (d, J = 9.0 Hz, 1H), 2.90 
(dd, J = 5.0, 3.6 Hz, 1H), 2.97 (dm, J = 5.0 Hz, 1H), 2.99-3.02 (m, 1H), 3.20 (br. s, 1H), 4.19 
(t, J = 5.8 Hz, 1H), 4.57 (d, J = 5.8 Hz, 2H), 5.88 (dd, J = 5.8, 2.9 Hz, 1H), 6.29 (dd, J = 5.7, 
3.2 Hz, 1H), 7.32 (ddd, J = 7.5, 7.5, 0.8 Hz, 2H), 7.38-7.43 (m, 3H), 7.48 (dm, J = 7.7 Hz, 
1H), 7.57 (dm, J = 7.6 Hz, 2H), 7.76 (d, J = 7.6 Hz, 2H) 8.04 (dm, J = 8.2 Hz, 1H), 8.08-8.12 
(m, 2H) ppm.  
13
C-NMR (125 MHz, CDCl3) δ 46.1, 47.0, 47.2, 47.3, 48.0, 52.4, 65.8, 120.06, 120.1, 121.3, 
121.7, 124.7, 124.8, 127.17, 127.2, 127.8, 127.9, 129.3, 134.4, 135.0, 138.6, 141.5, 141.52, 
143.7, 143.8, 146.4, 148.5, 173.5 ppm. 
HRMS (ESIpos) m/z: calculated for C28H23NNaO4
+
: 460.1519; found 460.1520. 
[α]D
25
: +85.4° (c=0.99, CH2Cl2). 
HPLC: Kromasil Cellucoat RP, acetonitrile:water = 60:40, ﬂow: 1 mL/min, 25°C, absorption 
at 220 nm, tR (endo-Diels Alder product) = 113.3 min (major) and 143.0 min (minor); tR (exo-
Diels Alder product) = 100.3 min and 105.7 min. e.r = 97:3 
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(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(1-naphthalenyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (3l) 
The product was synthesized according to the general procedure employing 
substrate 1l (24h). 3l was obtained as a colorless, crystalline solid (41.2 mg, 
93%, d.r. >25:1). 
1
H-NMR (500 MHz, CDCl3) δ = 1.61 (dm, J = 8.8 Hz, 1H), 1.86 (d, J = 8.8 
Hz, 1H), 3.04-3.07 (m, 1H), 3.25-3.29 (m, 1H), 3.31 (dd, J = 5.0, 3.7 Hz, 1H), 3.78 (dm, J = 
5.0 Hz, 1H), 4.16 (t, J = 6.5 Hz, 1H), 4.43 (dd, J = 10.8, 6.4 Hz, 1H), 4.52 (dd, J = 10.8, 6.7 
Hz, 1H), 6.00 (dd, J = 5.6, 2.6 Hz, 1H), 6.54 (dd, J = 5.6, 3.1 Hz, 1H), 7.24 (ddd, J = 7.5, 7.5, 
1.1 Hz, 1H), 7.16 (ddd, J = 7.5, 7.5, 0.8 Hz, 1H), 7.38 (dd, J = 7.5, 7.5 Hz, 1H), 7.45-7.51 (m, 
4H), 7.50-7.56 (m, 2H), 7.75 (d, J = 7.5 Hz, 2H), 7.78 (dd, J = 7.2, 1.6 Hz, 1H) 7.88-7.92 (m, 
1H), 8.12-8.18 (m, 1H) ppm.  
13
C-NMR (125 MHz, CDCl3) δ 44.0, 46.7, 47.0, 47.6, 49.7, 49.73, 66.1, 120.0, 122.7, 124.0, 
125.0, 125.3, 125.7, 126.2, 127.0, 127.09, 127.1, 127.7, 127.73, 128.9, 132.6, 134.0, 134.6, 
138.7, 139.5, 141.4, 143.8, 143.9, 174.5 ppm. 
HRMS (ESIpos) m/z: calculated for C32H26NaO2
+
: 465.1825; found 465.1825. 
[α]D
25
: +66.9° (c=0.82, CH2Cl2). 
HPLC: Kromasil Cellucoat RP, acetonitrile:water = 80:20, ﬂow: 1 mL/min, 25°C, absorption 
at 220 nm, tR (endo-Diels Alder product) = 23.1 min (major) and 43.7 min (minor); tR (exo-
Diels Alder product) = 35.0 min and 36.7 min. e.r 96:4 
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(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(2-naphthalenyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (3m) 
The product was synthesized according to the general procedure employing 
substrate 1m (2d). 3m was obtained as a colorless solid (41.2 mg, 93%, d.r. 
>25:1). 
1
H-NMR (500 MHz, CDCl3) δ = 1.63 (dm, J = 8.7 Hz, 1H), 1.87 (d, J = 8.7 Hz, 1H), 3.12-
3.17 (m, 2H), 3.21 (d, J = 4.8 Hz, 1H), 3.28 (br s, 1H), 4.22 (t, J = 6.3 Hz, 1H), 4.54 (dm, J = 
6.4 Hz, 1H), 5.98 (dd, J = 5.7, 2.8 Hz, 1H), 6.42 (dd, J = 5.7, 3.2 Hz, 1H), 7.27-7.33 (m, 2H), 
7.39-7.45 (m, 3H), 7.45-7.52 (m, 2H), 7.60 (d, J = 7.6 Hz, 2H), 7.71 (br s, 1H) 7.78 (d, J = 7.5 
Hz, 2H), 7.79 (d, J = 8.5 Hz, 1H), 7.80-7.86 (m, 2H) ppm.  
13
C-NMR (125 MHz, CDCl3) δ 46.4, 47.1, 47.2, 47.8, 48.4, 52.1, 66.0,120.0, 120.1, 124.8, 
124.9, 125.0, 125.5, 126.1, 127.1, 127.13, 127.15, 127.6, 127.77, 127.8, 128.1, 132.1, 133.6, 
134.7, 139.1, 141.4, 141.5, 141.7, 143.85, 143.9 174.2 ppm. 
HRMS (ESIpos) m/z: calculated for C32H26NaO2
+
: 465.1825; found 465.1826. 
[α]D
25
: +109.6° (c=0.81, CH2Cl2). 
HPLC: Kromasil Cellucoat RP, acetonitrile:water = 80:20, ﬂow: 1 mL/min, 25°C, absorption 
at 220 nm, tR (endo-Diels Alder product) = 23.0 min (major) and 57.0 min (minor); tR (exo-
Diels Alder product) = 32.0 min and 33.8 min. e.r = 96.5:3.5 
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(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(2-furanyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (3n) 
The product was synthesized according to the general procedure employing 
substrate 1n (3d). 3n was obtained as a yellowish syrup (34.8 mg, 91%, d.r. 
>25:1). 
1
H-NMR (500 MHz, CDCl3) δ = 1.51 (dm, J = 8.7 Hz, 1H), 1.75 (d, J = 8.7 Hz, 1H), 2.97-
3.00 (m, 1H), 3.02 (d, J = 4.6 Hz, 1H), 3.15 (dd, J = 4.8, 3.8 Hz, 1H), 3.20 (br s, 1H), 4.19 (t, 
J = 6.5 Hz, 1H), 4.42 (dd, J = 10.8, 6.4 Hz, 1H), ), 4.46 (dd, J = 10.8, 6.8 Hz, 1H), 5.90 (dd, J 
= 5.6, 2.8 Hz, 1H), 6.05 (dm, J = 3.2 Hz, 1H), 6.30 (dd, J = 5.6, 3.2 Hz, 1H), 6.32 (dd, J = 3.1, 
1.9 Hz, 1H), 7.29-7.35 (m, 3H), 7.42 (dd, J = 7.5,7.5 Hz, 2H), 7.59 (dd, J = 8.9,7.5 Hz, 2H), 
7.78 (d, J = 7.6 Hz, 1H) ppm.  
13
C-NMR (125 MHz, CDCl3) δ 41.9, 45.8, 47.5, 48.5, 49.9, 66.1, 105.1, 110.2, 120.1, 125.0, 
125.05, 127.15, 127.2, 127.8, 127.82, 134.4, 138.1, 141.3, 141.4, 141.5, 143.8, 144.0, 157.6, 
173.7 ppm. 
HRMS (ESIpos) m/z: calculated for C26H22NaO3
+
: 405.1461; found 405.1463. 
[α]D
25
: +104.4° (c=0.86, CH2Cl2). 
HPLC: Kromasil Cellucoat RP, acetonitrile:water = 80:20, ﬂow: 1 mL/min, 25°C, absorption 
at 265 nm, tR (endo-Diels Alder product) = 10.1 min (major) and 23.6 min (minor); tR (exo-
Diels Alder product) = 12.9 min and 14.3 min. e.r = 95.5:4.5 
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(9H-fluoren-9-yl)methyl (1R,2S,3S,4S)-3-(2-thiophenyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (3o) 
The product was synthesized according to the general procedure employing 
substrate 1o (0 °C, 3d). 3o was obtained as a colorless powder (35.1 mg, 88%, 
d.r. >25:1). 
1
H-NMR (500 MHz, CDCl3) δ = 1.59 (dm, J = 8.9 Hz, 1H), 1.82 (d, J = 8.9 Hz, 1H), 2.97-
3.01 (m, 1H), 3.08 (dd, J = 4.7, 3.8 Hz, 1H), 3.19-3.23 (m, 2H), 4.20 (t, J = 6.4 Hz, 1H), 4.47 
(dd, J = 10.8, 6.3 Hz, 1H), ), 4.50 (dd, J = 10.8, 6.6 Hz, 1H), 5.92 (dd, J = 5.6, 2.7 Hz, 1H), 
6.31 (dd, J = 5.6, 3.1 Hz, 1H), 6.83 (dm, J = 3.5 Hz, 1H), 6.94 (dd, J = 5.1, 3.5 Hz, 1H), 7.16 
(dd, J = 5.2, 1.2 Hz, 1H), 7.32 (dd, J = 7.5,7.5 Hz, 2H), 7.42 (dd, J = 7.5, 7.5 Hz, 2H), 7.58 
(dd, J = 7.5, 3.8 Hz, 2H), 7.78 (d, J = 7.5 Hz, 2H) ppm.  
13
C-NMR (125 MHz, CDCl3) δ 43.8, 46.0, 47.1, 47.5, 50.6, 53.7, 66.0, 120.05, 120.1, 123.2, 
123.9, 124.96, 125.0, 126.8, 127.15, 127.2, 127.8, 127.82, 134.4, 138.3, 141.4, 141.5, 143.8, 
143.9, 148.5, 173.6 ppm. 
HRMS (ESIpos) m/z: calculated for C26H22NaO2S
+
: 421.1233; found 421.1233. 
[α]D
25
: +86.1° (c=0.84, CH2Cl2). 
HPLC: Kromasil Cellucoat RP, acetonitrile:water = 80:20, ﬂow: 1 mL/min, 25°C, absorption 
at 220 nm, tR (endo-Diels Alder product) = 13.0 min (major) and 34.3 min (minor); tR (exo-
Diels Alder product) = 16.9 min and 19.8 min. e.r = 92.5:7.5 
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Mechanistic NMR Studies 
Kinetic Studies of C–H Acid Catalyst Activation 
To investigate the activation of catalyst 6d, we studied the disappearance of the protonated BALT 6d 
in the presence of an excess of silyl ketene acetal 4a (Fig S3). Catalyst 6d and the SiMe3-derived silyl 
ketene acetal 4a were chosen in order to facilitate the analysis of the mixtures obtained during the 
activation process. 
Accordingly, C-H acid 6d (0.8 mg, 12 µmol) was dissolved in 0.5 mL dry CDCl3 under an argon 
atmosphere in a 5mm NMR tube. The sample was analyzed by 
1
H-NMR spectroscopy to obtain the 
point t = 0s. Then, (1-methoxy-2-methyl-1-propenyloxy)trimethylsilane 4a (10 µL, 49 µmol) was 
added under argon and the sample was, after shaking, transferred back to the NMR instrument. Every 
10 min, a 
1
H-NMR spectrum was acquired and the obtained kinetic NMR data was analyzed with the 
reaction monitoring module of MNova 10.0.2 (Mestrelab Research, Santiago de Compostela, Spain) 
(Fig. S4). 
 
 
Fig. S3. 
1
H-NMR spectroscopic analysis of reaction kinetics. The integration regions that 
were used to obtain the plot  are shown in Fig. S4 (green fields). 
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Fig. S4. Stack plot of different 
1
H-NMR spectra which were measured at different time points 
in the course of the reaction. 
 
Characterization of C–H Acid-Derived Ion Pairs 
The sample obtained from the previous measurements was used to analyze the activated 
catalyst by 
1
H and 
19
F NMR spectroscopy at several temperatures (Fig S5). At high 
temperatures, the 
1
H-NMR signals of the two naphthalene rings are pseudo homotopic. This 
observation can be explained with the anionic nature of the compound. At lower temperatures 
at least two different species could be detected in the 
1
H and the 
19
F-NMR spectra. 
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Fig. S5. (a) 
1
H- and (b) 
19
F-NMR spectra of 7d at various temperatures. 
In order to further support the identification of the detected species as the catalyst-derived 
anion, we compared the obtained NMR spectra to those of the tetraethyl-ammonium-salt of 
BALT 6d. The NMR sample of this salt was prepared by dissolving 6d in a (NEt4)2CO3-
solution (10 mM in CH2Cl2). After removing of the solvent under reduced pressure, the 
residue was dissolved in CDCl3 (0.5 mL). 
The direct comparison of the 
19
F- and 
1
H-NMR spectra (Fig. S6) reveals the involvement of 
very similar species, as well as similar temperature dependent behaviors, thus underscoring 
the largely anionic character of the BALT-derived activated species formed under the reaction 
conditions. 
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Fig. S6. Comparison of the 
1
H- and 
19
F-NMR spectra of NEt4-BALT and Si-BALT 7d at 
various temperatures.  
The temperature dependence of the NMR signals can likely be explained by the exchange 
between different conformers or isomers of the allyl anion, which is probably non-planar due 
to the steric demand of the SO2-groups.(30) 
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X-Ray data 
 
Fig. S7. X-Ray structural analysis parameter for 3o. 
Table S10. Crystal data and structure refinement of 3o. 
Identification code  9782 
Empirical formula  C26 H22 O2 S 
Color  colourless 
Formula weight  398.49 g·mol-1  
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P 21, (no. 4)  
Unit cell dimensions a = 8.6044(3) Å = 90°. 
 b = 7.9270(7) Å = 102.446(3)°. 
 c = 14.7952(7) Å  = 90°. 
Volume 985.42(11) Å3 
Z 2 
Density (calculated) 1.343 Mg·m-3 
Absorption coefficient 0.185 mm-1 
F(000) 420 e 
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Crystal size 0.16 x 0.10 x 0.07 mm3 
range for data collection 4.953 to 33.168°. 
Index ranges -13  h  13, -12  k  12, -22  l  22 
Reflections collected 35604 
Independent reflections 7482 [Rint = 0.0467] 
Reflections with I>2 (I) 7156 
Completeness to  = 25.242° 98.9 %  
Absorption correction Gaussian 
Max. and min. transmission 0.98903 and 0.97287 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7482 / 1 / 269 
Goodness-of-fit on F2 1.042 
Final R indices [I>2 (I)] R1 = 0.0337 wR
2 = 0.0883 
R indices (all data) R1 = 0.0361 wR
2 = 0.0904 
Absolute structure parameter -0.05(3) 
Extinction coefficient 0 
Largest diff. peak and hole 0.325 and -0.322 e·Å-3 
 
Table S11. Atomic coordinates and equivalent isotropic displacement parameters (Å2). 
Ueq is defined as one third of the trace of the orthogonalized Uij tensor. 
____________________________________________________________________ 
 x y z Ueq 
____________________________________________________________________ 
C(1) 0.2163(2) 0.6744(2) 0.2009(1) 0.015(1) 
C(2) 0.0501(2) 0.6054(2) 0.1963(1) 0.015(1) 
C(3) -0.0434(2) 0.6145(2) 0.2619(1) 0.018(1) 
C(4) -0.1913(2) 0.5337(2) 0.2435(1) 0.021(1) 
C(5) -0.2454(2) 0.4479(2) 0.1601(1) 0.022(1) 
C(6) -0.1539(2) 0.4426(2) 0.0928(1) 0.020(1) 
C(7) -0.0058(2) 0.5218(2) 0.1120(1) 0.016(1) 
C(8) 0.1169(2) 0.5313(2) 0.0567(1) 0.017(1) 
C(9) 0.1220(2) 0.4631(2) -0.0294(1) 0.022(1) 
C(10) 0.2604(2) 0.4835(2) -0.0629(1) 0.026(1) 
C(11) 0.3906(2) 0.5712(3) -0.0118(1) 0.027(1) 
C(12) 0.3849(2) 0.6422(2) 0.0737(1) 0.021(1) 
C(13) 0.2474(2) 0.6214(2) 0.1078(1) 0.017(1) 
C(14) 0.3449(2) 0.5962(2) 0.2766(1) 0.016(1) 
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C(15) 0.4189(2) 0.5792(2) 0.4389(1) 0.013(1) 
C(16) 0.3731(2) 0.6170(2) 0.5296(1) 0.014(1) 
C(17) 0.1903(2) 0.6140(2) 0.5267(1) 0.018(1) 
C(18) 0.1329(2) 0.4392(2) 0.4931(1) 0.020(1) 
C(19) 0.1936(2) 0.3300(2) 0.5605(1) 0.020(1) 
C(20) 0.2908(2) 0.4304(2) 0.6407(1) 0.017(1) 
C(21) 0.4437(2) 0.4865(2) 0.6071(1) 0.014(1) 
C(22) 0.1952(2) 0.5968(2) 0.6311(1) 0.021(1) 
C(23) 0.5749(2) 0.5560(2) 0.6819(1) 0.016(1) 
O(1) 0.3086(1) 0.6329(1) 0.3656(1) 0.015(1) 
O(2) 0.5425(1) 0.5129(1) 0.4313(1) 0.017(1) 
S(1A) 0.7577(1) 0.5935(1) 0.6622(1) 0.019(1) 
C(24A) 0.8301(4) 0.6579(4) 0.7748(2) 0.022(1) 
C(25A) 0.7187(4) 0.6506(3) 0.8270(2) 0.020(1) 
C(26A) 0.5702(6) 0.5914(7) 0.7740(3) 0.023(1) 
S(1B) 0.5619(2) 0.5907(3) 0.7905(2) 0.020(1) 
C(24B) 0.7579(7) 0.6545(6) 0.8236(3) 0.016(1) 
C(25B) 0.8383(6) 0.6527(6) 0.7549(4) 0.015(1) 
C(26B) 0.7320(11) 0.5927(16) 0.6697(8) 0.024(2) 
____________________________________________________________________
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Table S12. Bond lengths [Å] and angles [°]. 
______________________________________________________________________ 
C(1)-C(13) 1.5181(19) C(1)-C(2) 1.5187(19)
C(1)-C(14) 1.5264(19) C(2)-C(3) 1.3903(18)
C(2)-C(7) 1.4025(18) C(3)-C(4) 1.398(2)
C(4)-C(5) 1.397(2) C(5)-C(6) 1.397(2)
C(6)-C(7) 1.394(2) C(7)-C(8) 1.470(2)
C(8)-C(9) 1.3944(19) C(8)-C(13) 1.406(2)
C(9)-C(10) 1.394(2) C(10)-C(11) 1.394(3)
C(11)-C(12) 1.395(2) C(12)-C(13) 1.392(2)
C(14)-O(1) 1.4475(16) C(15)-O(2) 1.2131(16)
C(15)-O(1) 1.3468(15) C(15)-C(16) 1.5077(17)
C(16)-C(17) 1.5645(18) C(16)-C(21) 1.5664(18)
C(17)-C(18) 1.519(2) C(17)-C(22) 1.542(2)
C(18)-C(19) 1.338(2) C(19)-C(20) 1.522(2)
C(20)-C(22) 1.545(2) C(20)-C(21) 1.5675(19)
C(21)-C(23) 1.5048(19) C(23)-C(26A) 1.400(4)
C(23)-C(26B) 1.432(9) C(23)-S(1B) 1.658(3)
C(23)-S(1A) 1.6873(18) S(1A)-C(24A) 1.725(3)
C(24A)-C(25A) 1.355(4) C(25A)-C(26A) 1.427(6)
S(1B)-C(24B) 1.728(6) C(24B)-C(25B) 1.348(7)
C(25B)-C(26B) 1.468(12) 
 
C(13)-C(1)-C(2) 102.01(11) C(13)-C(1)-C(14) 108.18(11)
C(2)-C(1)-C(14) 114.42(11) C(3)-C(2)-C(7) 120.45(12)
C(3)-C(2)-C(1) 129.11(12) C(7)-C(2)-C(1) 110.43(11)
C(2)-C(3)-C(4) 118.61(13) C(5)-C(4)-C(3) 120.79(13)
C(6)-C(5)-C(4) 120.78(14) C(7)-C(6)-C(5) 118.21(13)
C(6)-C(7)-C(2) 121.12(13) C(6)-C(7)-C(8) 130.15(13)
C(2)-C(7)-C(8) 108.70(12) C(9)-C(8)-C(13) 120.62(14)
C(9)-C(8)-C(7) 131.04(14) C(13)-C(8)-C(7) 108.29(12)
C(10)-C(9)-C(8) 118.49(15) C(11)-C(10)-C(9) 120.91(14)
C(10)-C(11)-C(12) 120.76(15) C(13)-C(12)-C(11) 118.63(15)
C(12)-C(13)-C(8) 120.57(13) C(12)-C(13)-C(1) 128.73(13)
C(8)-C(13)-C(1) 110.56(12) O(1)-C(14)-C(1) 108.78(11)
O(2)-C(15)-O(1) 122.84(12) O(2)-C(15)-C(16) 124.81(12)
O(1)-C(15)-C(16) 112.31(11) C(15)-C(16)-C(17) 115.24(10)
C(15)-C(16)-C(21) 112.67(10) C(17)-C(16)-C(21) 103.81(10)
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C(18)-C(17)-C(22) 100.61(12) C(18)-C(17)-C(16) 106.10(11)
C(22)-C(17)-C(16) 99.45(10) C(19)-C(18)-C(17) 107.41(13)
C(18)-C(19)-C(20) 107.64(13) C(19)-C(20)-C(22) 100.53(12)
C(19)-C(20)-C(21) 104.98(11) C(22)-C(20)-C(21) 101.30(11)
C(23)-C(21)-C(16) 114.05(11) C(23)-C(21)-C(20) 114.70(11)
C(16)-C(21)-C(20) 101.54(10) C(17)-C(22)-C(20) 93.80(10)
C(26A)-C(23)-C(21) 128.0(2) C(26B)-C(23)-C(21) 124.1(5)
C(26B)-C(23)-S(1B) 110.6(5) C(21)-C(23)-S(1B) 125.26(12)
C(26A)-C(23)-S(1A) 110.8(2) C(21)-C(23)-S(1A) 121.14(10)
C(15)-O(1)-C(14) 114.58(10) C(23)-S(1A)-C(24A) 92.37(13)
C(25A)-C(24A)-S(1A) 112.6(2) C(24A)-C(25A)-C(26A) 111.1(3)
C(23)-C(26A)-C(25A) 113.0(4) C(23)-S(1B)-C(24B) 93.3(2)
C(25B)-C(24B)-S(1B) 114.3(4) C(24B)-C(25B)-C(26B) 109.0(5)
C(23)-C(26B)-C(25B) 112.8(7)  
______________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
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Table S13. Anisotropic displacement parameters (Å2). 
The anisotropic displacement factor exponent takes the form:  
-22[ h2a*2U11 + ... + 2 h k a* b* U12 ]. 
___________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
___________________________________________________________________ 
C(1) 0.016(1)  0.016(1) 0.014(1)  0.000(1) 0.001(1)  0.000(1) 
C(2) 0.015(1)  0.014(1) 0.014(1)  0.000(1) 0.001(1)  0.001(1) 
C(3) 0.017(1)  0.020(1) 0.016(1)  -0.001(1) 0.003(1)  0.002(1) 
C(4) 0.016(1)  0.023(1) 0.023(1)  0.001(1) 0.004(1)  0.002(1) 
C(5) 0.016(1)  0.021(1) 0.026(1)  0.000(1) 0.001(1)  -0.002(1) 
C(6) 0.019(1)  0.019(1) 0.020(1)  -0.001(1) -0.002(1)  -0.002(1) 
C(7) 0.017(1)  0.014(1) 0.013(1)  0.000(1) 0.000(1)  0.001(1) 
C(8) 0.020(1)  0.017(1) 0.013(1)  0.001(1) 0.000(1)  0.003(1) 
C(9) 0.026(1)  0.024(1) 0.014(1)  -0.002(1) 0.001(1)  0.004(1) 
C(10) 0.029(1)  0.035(1) 0.015(1)  0.000(1) 0.005(1)  0.008(1) 
C(11) 0.024(1)  0.039(1) 0.017(1)  0.004(1) 0.007(1)  0.006(1) 
C(12) 0.019(1)  0.029(1) 0.016(1)  0.005(1) 0.002(1)  0.002(1) 
C(13) 0.018(1)  0.018(1) 0.013(1)  0.002(1) 0.001(1)  0.002(1) 
C(14) 0.016(1)  0.018(1) 0.013(1)  -0.001(1) 0.002(1)  -0.001(1) 
C(15) 0.014(1)  0.012(1) 0.014(1)  0.000(1) 0.001(1)  -0.002(1) 
C(16) 0.014(1)  0.013(1) 0.014(1)  0.000(1) 0.001(1)  0.001(1) 
C(17) 0.014(1)  0.020(1) 0.019(1)  -0.001(1) 0.002(1)  0.004(1) 
C(18) 0.015(1)  0.024(1) 0.019(1)  -0.002(1) 0.003(1)  -0.003(1) 
C(19) 0.017(1)  0.022(1) 0.021(1)  0.000(1) 0.004(1)  -0.005(1) 
C(20) 0.016(1)  0.020(1) 0.015(1)  0.000(1) 0.004(1)  -0.002(1) 
C(21) 0.014(1)  0.013(1) 0.014(1)  0.001(1) 0.002(1)  0.001(1) 
C(22) 0.018(1)  0.028(1) 0.020(1)  -0.003(1) 0.006(1)  0.004(1) 
C(23) 0.016(1)  0.015(1) 0.014(1)  0.001(1) 0.001(1)  0.001(1) 
O(1) 0.015(1)  0.018(1) 0.011(1)  0.000(1) 0.000(1)  0.001(1) 
O(2) 0.016(1)  0.019(1) 0.016(1)  0.002(1) 0.003(1)  0.002(1) 
S(1A) 0.014(1)  0.023(1) 0.018(1)  0.002(1) 0.002(1)  -0.004(1) 
S(1B) 0.020(1)  0.025(1) 0.015(1)  -0.004(1) 0.004(1)  -0.001(1) 
___________________________________________________________________
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Table S14. Hydrogen coordinates and isotropic displacement parameters (Å2). 
_________________________________________________________________ 
 x  y  z  Ueq 
_________________________________________________________________ 
 
H(1) 0.2171 0.8001 0.2065 0.019 
H(3) -0.0075 0.6744 0.3182 0.022 
H(4) -0.2557 0.5371 0.2881 0.025 
H(5) -0.3457 0.3926 0.1491 0.026 
H(6) -0.1916 0.3866 0.0355 0.024 
H(9) 0.0331 0.4040 -0.0646 0.026 
H(10) 0.2661 0.4371 -0.1213 0.031 
H(11) 0.4842 0.5828 -0.0355 0.032 
H(12) 0.4730 0.7035 0.1080 0.026 
H(14A) 0.3485 0.4727 0.2676 0.019 
H(14B) 0.4502 0.6436 0.2738 0.019 
H(16) 0.4149 0.7314 0.5507 0.017 
H(17) 0.1273 0.7109 0.4945 0.021 
H(18) 0.0661 0.4123 0.4350 0.023 
H(19) 0.1787 0.2112 0.5585 0.024 
H(20) 0.3094 0.3748 0.7028 0.021 
H(21) 0.4857 0.3875 0.5779 0.017 
H(22A) 0.0882 0.5835 0.6449 0.026 
H(22B) 0.2534 0.6901 0.6682 0.026 
H(24A) 0.9365 0.6945 0.7978 0.026 
H(25A) 0.7371 0.6810 0.8905 0.024 
H(26A) 0.4778 0.5774 0.7986 0.027 
H(24B) 0.8051 0.6879 0.8851 0.019 
H(25B) 0.9463 0.6850 0.7606 0.018 
H(26B) 0.7641 0.5797 0.6125 0.029 
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Abstract: a,b-Unsaturated esters are readily available but
challenging substrates to activate in asymmetric catalysis. We
now describe an efficient, general, and highly enantioselective
Mukaiyama–Michael reaction of silyl ketene acetals with a,b-
unsaturated methyl esters that is catalyzed by a silylium
imidodiphosphorimidate (IDPi) Lewis acid.
Michael additions of enolate equivalents to a,b-unsatu-
rated carbonyl compounds are widely applied carbon–carbon
bond-forming reactions, and the development of catalytic
asymmetric variants has been the subject of intensive research
over the past decades.[1] Whereas a,b-unsaturated aldehydes
and ketones readily engage in various catalytic enantioselec-
tive Michael additions by iminium ion, Brønsted acid, or
Lewis acid catalysis,[2–4] a,b-unsaturated esters—the original
substrates in MichaelQs seminal study from 1887[5]—have
proven to be particularly challenging substrates for such
reactions. Very recently, Mayr and co-workers provided an
explanation for their low reactivity by systematically quanti-
fying the electrophilicity of a wide range of common Michael
acceptors.[6] Indeed, a,b-unsaturated esters in general, and
cinnamates in particular, rank among the very least electro-
philic substrates (Figure 1A). However, because a,b-unsatu-
rated esters are naturally abundant, industrially relevant, and
inexpensive or readily available, they are highly attractive
substrates for Michael additions. Herein, we show that
a silylium imidodiphosphorimidate (IDPi) Lewis acid cata-
lyzes a highly enantioselective catalytic Mukaiyama–Michael
addition of silyl ketene acetals to a range of simple a,b-
unsaturated methyl esters.
In contrast to the desired Michael additions of enolate
equivalents, elegant and useful catalytic asymmetric conju-
gate additions to a,b-unsaturated esters have previously been
developed. Examples include FeringaQs copper phosphorami-
dite catalyzed conjugate additions of Grignard reagents,[7]
HayashiQs rhodium-catalyzed 1,4-additions of boronic
acids,[8] and PfaltzQ cobalt-catalyzed conjugate reductions.[9]
Organocatalytic enantioselective Stetter reactions with a,b-
unsaturated esters have also been described.[10] Furthermore,
to circumvent the poor reactivity of a,b-unsaturated esters,
more electrophilic a,b-unsaturated N-acyl oxazolidinones, N-
acyl imides, N-acyl imidazolides, thioamides, a-ketophosph-
onates, alkylidene malonates, or perfluorinated esters[11] have
been suggested as ester surrogates in Michael-type additions,
but such reagents are inherently less atom- and step-
economic. To activate a,b-unsaturated esters themselves,
only few Lewis acidic catalysts have been reported, including
CoreyQs oxazaborolidines or bifunctional hydrogen-bonding
catalysts.[12,13]
Within our research program of exploring the potential of
asymmetric counteranion-directed silylium Lewis acid catal-
ysis (silylium-ACDC),[14, 15] we recently focused our attention
on the activation of a,b-unsaturated esters in catalytic
asymmetric Diels–Alder reactions with cyclopentadiene.[16]
While these studies suggested sufficient reactivity of our
silylium Lewis acid catalysts, high enantioselectivities were
only obtained with 9-fluorenylmethyl esters. These substrates
are electronically non-activated, but prone to strong disper-
sion interactions.[17] Striving to make the simplest and most
readily available methyl esters accessible as substrates, we
became highly interested in exploring their utility in silylium-
ACDC and specifically in the asymmetric Mukaiyama–
Michael reaction (Figure 1B).
We began our study with the asymmetric conjugate
addition reaction of methyl trans-cinnamate (1a) with com-
mercial silyl ketene acetal (SKA) 2a (Table 1).[18] In prelimi-
nary studies of this model reaction, we found that Lewis acids
derived from our chiral disulfonimides (DSIs),[15] or
binaphthyl allyl tetrasulfone (BALT) C@H acids,[16] were
either insufficiently reactive as catalysts or gave very low
Figure 1. Asymmetric catalysis of the Michael reaction.
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enantioselectivities (see the Supporting Information for
further details). In contrast, encouraging results were
obtained with our recently developed IDPi acids[19] 4a–
e (Table 1, entries 1–5). This catalyst motif combines very
high acidity with a confined three-dimensional structure, and
generates a C2-symmetric anion upon deprotonation.
Of the investigated IDPi acids, 4e was identified as the
best catalyst (entry 5). Further optimization resulted in very
high enantioselectivity but only moderate conversion
(entry 8). A remarkable enhancement in reactivity was
observed when freshly synthesized and purified reagent was
used instead of commercially available SKA 2a.[20] This
allowed us to obtain full conversion with only 1 mol% of
catalyst at 0 8C after 12 h (entry 11). With the commercial
reagent, the conversion was only 52% at room temperature
with 3 mol% of the catalyst after a reaction time of 24 h
(entry 8). We attribute this effect to trace impurities of
diisopropylamine in the commercially available SKA, which
potentially deactivate the catalyst.
With optimized reaction conditions in hand, we next
investigated the scope of the reaction by employing a variety
of 3-aryl and 3-alkyl methyl trans-acrylates (Table 2). With
model substrate 1a, the catalyst loading could even be
lowered to 0.25 mol% (entries 1–3), giving consistently
excellent yields of product 3a with prolonged reaction
times. Differently substituted arenes (3b–d, 3h) as well as
halogenated substrates (3e–g) gave the desired products in
excellent yields and enantioselectivities. Furthermore, both
electron-rich (3 i, 3 l) and electron-deficient substrates (3j,
3k) were well tolerated under slightly modified conditions.
Heterocyclic product 3m could also be obtained with good
results. As linear 3-alkyl trans-acrylates are generally more
reactive than cinnamates,[6, 12b] it was necessary to decrease the
Table 1: Reaction development.[a]
Entry Cat. Solvent Temp. Conv. [%][b] e.r.[c]
1 4a toluene RT full 73.5:26.5
2 4b toluene RT full 54.5:45.5
3 4c toluene RT full 14:86
4 4d toluene RT full 83:17
5 4e toluene RT full 93:7
6 4e Et2O RT 43 92:8
7 4e CHCl3 RT 80 77:23
8 4e cyclohexane RT 52 95.5:4.5
9[d,e] 4e cyclohexane RT full 95.5: 4.5
10[d,e] 4e cyclohexane 10 8C full 96.5:3.5
11[d,e,f ] 4e cyclohexane 0 8C full 97:3
[a] Reactions were performed on 0.02 mmol scale. [b] Determined by
1H NMR analysis. [c] Determined by HPLC analysis on a chiral stationary
phase. [d] Freshly prepared and purified SKA 2a was used. [e] With
1 mol% of the catalyst. [f ] 12 h reaction time.
Table 2: Ester scope.[a]
Entry R= Product Time Yield [%][b] e.r.[c]
1 3a 14 h 97 (1 mol%) 97:3
2 3a 5 d 98 (0.5 mol%) 97:3
3 3a 5 d 98 (0.25 mol%) 96.5:3.5
4 3b 14 h 95 97:3
5 3c 14 h 95 98:2
6 3d 5 d 92 96.5:3.5
7 3e 14 h 99 97.5:2.5
8 3 f 14 h 97 97.5:2.5
9 3g 14 h 98 98:2
10 3h 2 d 92 94.5:5.5
11 3 i 24 h 95 95.5:4.5
12[d] 3 j 14 h 89 97.5:2.5
13[e] 3k 4 d 76 95:5
14[f ] 3 l 3 d 84 97:3
15 3m 14 h 94 94.5:5.5
16[g] 3n 24 h 92 97:3
17[g] 3o 2 d 94 95:5
18[h] 3p 24 h 27% conv.[i] 84.5:15.5
19[h] 3q 24 h no reaction –
[a] Reactions were performed on 0.2 mmol scale with 3.0 equiv of SKA 2a
for the specified period of time. [b] Yield of isolated product. [c] Deter-
mined by HPLC analysis on a chiral stationary phase. [d] In p-xylene.
[e] In toluene/1,4-dioxane (3:1) at RT. [f ] In m-xylene. [g] In methyl-
cyclohexane at @40 8C. [h] With 5 mol% of the catalyst at 40 8C.
[i] Determined by 1H NMR analysis.
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reaction temperature to obtain the desired products with high
enantiocontrol (3n, 3o). g-Branched substrates (entries 18
and 19) were found to be very unreactive, and only very low
or no conversion was detected even at increased catalyst
loadings and temperatures.
We also studied other cinnamates, including the corre-
sponding ethyl and benzyl esters, free cinnamic acid, cinna-
moyl chloride, and methyl cis-cinnamate. Interestingly, ethyl
trans-cinnamate gave strongly diminished enantioselectivity
(e.r. 77.5:22.5) and reactivity (89% yield, 3 d reaction time).
When methyl cis-cinnamate (Z/E> 99:1) was used, only very
low conversion (55% yield) was detected after 5 days, and the
opposite enantiomer was enriched (e.r. 62.5:37.5). All other
tested substrates gave no conversion. These results are
consistent with a scenario in which catalyst 4e exhibits an
ideally shaped chiral pocket to accommodate the geometry of
trimethylsilylated a,b-unsaturated trans-methyl esters. While
modifications of the 3-position are well-tolerated, distortion
of this geometry would result in either decelerated or
complete shutdown of catalysis.
The scope with respect to the silyl ketene acetals was
explored next (Table 3). With cyclic SKA nucleophiles (2b–
d), the corresponding products were obtained with high yields
and enantioselectivities. With a-monosubstituted silyl ketene
acetals, the reaction outcome was found to significantly
depend on the type of SKA employed. The two isomeric
SKAs (E)-2e (E/Z 4:1) and (Z)-2e (E/Z 1:19) both gave
excellent enantioselectivities (e.r. + 98.5:1.5) while favoring
opposite diastereomers: (E)-2e afforded syn product 5d (d.r.
12:1) whereas (Z)-2e predominantly gave the corresponding
anti product 5e (d.r. 1.6:1). Intriguingly, the reaction failed to
provide any increased diastereoselectivity with all SKA
variants when triflimide (HNTf2) was used as an achiral
catalyst, highlighting an additional benefit of the confined
reaction environment beyond enantiocontrol (see the Sup-
porting Information for further details). The isopropyl-sub-
stituted SKA (E)-2g was found to provide product 5 f with
excellent diastereoselectivity and enantioselectivity (entry 7).
The observed preference for the syn or anti diastereomer in
relation to the E or Z enolate geometry is in agreement with
that observed by Evans and co-workers in their Mukaiyama–
Michael reactions of a,b-unsaturated N-acyl oxazolidi-
nones.[21]
Towards understanding the reaction mechanism, we
became interested in the nature of the initial reaction product
before methanolysis. Aside from the previously reported
[2+2] or [4+2] intermediates[22,21a]with ketene acetals, we also
anticipated an open-chain intermediate as proposed in other
silylium Lewis acid catalyzed reactions.[18c,23] Indeed, by
monitoring the reaction by NMR spectroscopy, we were
able to identify and characterize silyl ketene acetal D
(Figure 2) as the initial reaction product. Interestingly, the
Z/E ratio of product D was determined to be > 99:1, which is
consistent with an s-cis conformation for the reacting a,b-
unsaturated ester in the carbon–carbon bond-forming tran-
sition state. Accordingly, a tentative catalytic cycle is sug-
gested, which is initiated by the protonation of the SKAwith
the IDPi precatalyst, furnishing silylated ester A. Silicon
transfer to the substrate then leads to the activated chiral ion
pair B, which reacts with the nucleophile to provide the
doubly silylated intermediate C. Silylation of the next
substrate molecule could then occur either directly or via
other esters of the generic type A. As intermediate D is
a potential nucleophile itself, we tested whether reduced
amounts of the starting SKA 2awould cause oligomerizations
Table 3: Silyl ketene acetal (SKA) scope.[a]
Entry SKA Product Yield
[%][b]
e.r.
(d.r.)[c]
1 97 97:3
2[d] 95 98:2
3 97 96:4
4 99 96.5:3.5
5 98
99:1
(12:1)
6[e] 96
98.5:1.5
(1.6:1)
7 98
99.5:0.5
(24:1)
[a] Reactions were performed on 0.2 mmol scale with 3.0 equiv of the
SKA. [b] Yield of isolated product. [c] e.r. and d.r. determined by HPLC
analysis on a chiral stationary phase. [d] With 2 mol% of the catalyst.
[e] With 5 mol% of the catalyst. Figure 2. Proposed reaction mechanism.
Angewandte
ChemieCommunications
2466 www.angewandte.org T 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2018, 57, 2464 –2468
by subsequent Michael addition of intermediate D to
unsaturated ester 1a. However, we found that even only
1.1 equivalents of SKA 2a gave a clean reaction profile and
the same yield after prolonged reaction time. Also sub-
stoichiometric amounts of 2a did not result in any significant
side product formation even after prolonged reaction times at
room temperature. Increased steric hindrance at silyl ketene
acetal D, and as a consequence lower reactivity, may account
for this observation. Generally, the yield of isolated product
correlated well with the employed amount of SKA (see the
Supporting Information for further details), and the self-
healing features of silylium Lewis acid catalysis[15b,16] also
allowed us to conduct the reaction in non-dried solvent and
without an inert gas atmosphere. Product 3a was isolated in
identical yield and enantioselectivity under these conditions.
As differentiation of the two product ester groups would
be highly attractive for further transformations, we inves-
tigated possibilities for selective derivatization (Figure 3).
Gratifyingly, we found that simple saponification with aque-
ous NaOH provided a very high degree of selectivity for the
less sterically hindered ester group. Thus both products 3a
and 5d were converted smoothly into the corresponding
mono-carboxylic acids 6 and 7 in quantitative yield and, in the
case of product 5d, without epimerization. An alternative and
complementary approach for differentiating the two ester
groups of our products would involve the direct utilization of
silyl ketene acetal intermediate D. Indeed, we found that
adding LAH instead of methanol to the reaction mixture
selectively gave lactol 8. Reduction of product 3a with LAH
gave the corresponding diol, which cyclizes under acidic
conditions to furnish tetrahydropyran 9.
In summary, we have developed the first asymmetric
Mukaiyama–Michael reaction of a,b-unsaturated methyl
esters. This reaction is enabled by the use of chiral silylium
ion based Lewis acids and delivers high enantio- and
diastereoselectivity with a broad scope of different substrates.
Without catalysis, the reaction half-life of our model reaction
would instead exceed 35 million years.[24] Future work will
focus on further applications of this catalytic system and its
reaction intermediates for asymmetric synthesis.
Acknowledgements
Funding from the Max-Planck-Society, the European
Research Council (Advanced Grant CHAOS), and the
DFG (Leibniz Award to B.L.) is gratefully acknowledged.
This work is part of the Cluster of Excellence RESOLV (EXC
1069) funded by the DFG. We thank Sunggi Lee and
Francesca Mandrelli for helpful discussions and sharing of
reagents. We also thank the technicians of our group and the
analytical departments of our institute for their excellent
service.
Conflict of interest
The authors declare no conflict of interest.
Keywords: Brønsted acids · cinnamates · Mukaiyama–
Michael reaction · organocatalysis · silyl ketene acetals
How to cite: Angew. Chem. Int. Ed. 2018, 57, 2464–2468
Angew. Chem. 2018, 130, 2489–2493
[1] a) E. M. Carreira, L. Kvaerno, Classics in Stereoselective Syn-
thesis, Wiley, Hoboken, 2009 ; b) Y. Zhang, W. Wang, Catal. Sci.
Technol. 2012, 2, 42 – 53; c) C. Hui, F. Pu, J. Xu, Chem. Eur. J.
2017, 23, 4023 – 4036.
[2] a) S. P. Brown, N. C. Goodwin, D. W. C. MacMillan, J. Am.
Chem. Soc. 2003, 125, 1192 – 1194; b) Y. K. Chen, M. Yoshida,
D. W. C. MacMillan, J. Am. Chem. Soc. 2006, 128, 9328 – 9329;
c) S. Bertelsen, P. Diner, R. L. Johansen, K. A. Jørgensen, J. Am.
Chem. Soc. 2007, 129, 1536 – 1537; d) A. Erkkil-, I. Majander,
P. M. Pihko, Chem. Rev. 2007, 107, 5416 – 5470; e) S. G. Ouellet,
A. M. Walji, D. W. C. Macmillan, Acc. Chem. Res. 2007, 40,
1327 – 1339; f) C. Appayee, S. E. Brenner-Moyer, Org. Lett.
2010, 12, 3356 – 3359.
[3] a) D. Nakashima, H. Yamamoto, J. Am. Chem. Soc. 2006, 128,
9626 – 9627; b) T. Sakamoto, J. Itoh, K. Mori, T. Akiyama, Org.
Biomol. Chem. 2010, 8, 5448 – 5454; c) B.-M. Yang, P.-J. Cai, Y.-
Q. Tu, Z.-X. Yu, Z.-M. Chen, S.-H. Wang, S.-H. Wang, F.-M.
Zhang, J. Am. Chem. Soc. 2015, 137, 8344 – 8347; d) N.
Momiyama, K. Funayama, H. Noda, M. Yamanaka, N. Akasaka,
S. Ishida, T. Iwamoto, M. Terada, ACS Catal. 2016, 6, 949 – 956.
[4] a) K. Hermann, H. Wynberg, J. Org. Chem. 1979, 44, 2238 –
2244; b) M. Sawamura, H. Hamashima, Y. Ito, J. Am. Chem.
Soc. 1992, 114, 8295 – 8296; c) M. Sawamura, H. Hamashima, Y.
Ito, Tetrahedron 1994, 50, 4439 – 4454; d) T. Arai, H. Sasai, K.-i.
Aoe, K. Okamura, T. Date, M. Shibasaki,Angew. Chem. Int. Ed.
Engl. 1996, 35, 104 – 106; Angew. Chem. 1996, 108, 103 – 105;
e) Y. Hamashima, D. Hotta, M. Sodeoka, J. Am. Chem. Soc.
2002, 124, 11240 – 11241.
[5] a) A. Michael, J. Prakt. Chem. 1887, 35, 349 – 356; b) T.
Tokoroyama, Eur. J. Org. Chem. 2010, 2009 – 2016.
[6] D. S. Allg-uer, H. Jangra, H. Asahara, Z. Li, Q. Chen, H. Zipse,
A. R. Ofial, H. Mayr, J. Am. Chem. Soc. 2017, 139, 13318 –
13329.
[7] a) S. R. Harutyunyan, F. Lopez, W. R. Browne, A. Correa, D.
PeÇa, R. Badorrey, A. Meetsma, A. J. Minnaard, B. L. Feringa, J.
Am. Chem. Soc. 2006, 128, 9103 – 9118; b) S.-Y. Wang, S.-J. Ji, T.-
P. Loh, J. Am. Chem. Soc. 2007, 129, 276 – 277; c) S. R.
Harutyunyan, T. den Hartog, K. Geurts, A. J. Minnaard, B. L.
Feringa, Chem. Rev. 2008, 108, 2824 – 2852.
[8] a) Y. Takaya, T. Senda, H. Kurushima, M. Ogasawara, T.
Hayashi, Tetrahedron: Asymmetry 1999, 10, 4047 – 4056; b) S.
Figure 3. Selective product derivatizations. Reagents and conditions:
a) aq. NaOH (5 equiv), MeOH/THF (2:1), 0 8C to RT, 1 h, quant.;
b) LAH (1.5 equiv), THF, 0 8C to RT, 3 h, quant.; c) TsOH (20 mol%),
MgSO4, toluene, 120 8C, 16 h, 97%; d) LAH (1.5 equiv), 0 8C, 3 h, 75%.
Angewandte
ChemieCommunications
2467Angew. Chem. Int. Ed. 2018, 57, 2464 –2468 T 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
Sakuma, M. Sakai, R. Itooka, N. Miyaura, J. Org. Chem. 2000,
65, 5951 – 5955; c) T. Hayashi, K. Yamasaki, Chem. Rev. 2003,
103, 2829 – 2844.
[9] a) A. Pfaltz, Acc. Chem. Res. 1993, 26, 339 – 345; b) U. Leute-
negger, A. Madin, A. Pfaltz, Angew. Chem. Int. Ed. Engl. 1989,
28, 60 – 61; Angew. Chem. 1989, 101, 61 – 62.
[10] a) M. S. Kerr, T. Rovis, J. Am. Chem. Soc. 2004, 126, 8876 – 8877;
b) J. R. de Alaniz, T. Rovis, J. Am. Chem. Soc. 2005, 127, 6284 –
6289; c) J. R. de Alaniz, T. Rovis, Synlett 2009, 2009, 1189 – 1207;
d) N. E. Wurz, C. G. Daniliuc, F. Glorius, Chem. Eur. J. 2012, 18,
16297 – 16301.
[11] a) G. Desimoni, G. Faita, P. Quadrelli, Chem. Rev. 2015, 115,
9922 – 9980; b) N. Kumagai,M. Shibasaki,Chem. Eur. J. 2016, 22,
15192 – 15200; c) D. Monge, H. Jiang, Y. Alvarez-Casao, Chem.
Eur. J. 2015, 21, 4494 – 4504.
[12] a) E. Canales, E. J. Corey, J. Am. Chem. Soc. 2007, 129, 12686 –
12687; b) E. J. Corey, Angew. Chem. Int. Ed. 2009, 48, 2100 –
2117;Angew. Chem. 2009, 121, 2134 – 2151; c) B. K. Senapati, G.-
S. Hwang, S. Lee, D. H. Ryu, Angew. Chem. Int. Ed. 2009, 48,
4398 – 4401; Angew. Chem. 2009, 121, 4462 – 4465.
[13] a) J. Yang, A. J. M. Farley, D. J. Dixon, Chem. Sci. 2017, 8, 606 –
610; b) A. J. M. Farley, C. Sandford, D. J. Dixon, J. Am. Chem.
Soc. 2015, 137, 15992 – 15995; c) Y. Kobayashi, Y. Taniguchi, N.
Hayama, T. Inokuma, Y. Takemoto,Angew. Chem. Int. Ed. 2013,
52, 11114 – 11118; Angew. Chem. 2013, 125, 11320 – 11324;
d) J. Y. Kang, R. G. Carter, Org. Lett. 2012, 14, 3178 – 3181.
[14] a) S. Mayer, B. List,Angew. Chem. Int. Ed. 2006, 45, 4193 – 4195;
Angew. Chem. 2006, 118, 4299 – 4301; b) M. Mahlau, B. List,
Angew. Chem. Int. Ed. 2013, 52, 518 – 533; Angew. Chem. 2013,
125, 540 – 556.
[15] a) T. James, M. van Gemmeren, B. List, Chem. Rev. 2015, 115,
9388 – 9409; b) Z. Zhang, H. Y. Bae, J. Guin, C. Rabalakos, M.
van Gemmeren, M. Leutzsch, M. Klussmann, B. List, Nat.
Commun. 2016, 7, 12478.
[16] T. Gatzenmeier, M. van Gemmeren, Y. Xie, D. Hçfler, M.
Leutzsch, B. List, Science 2016, 351, 949 – 952.
[17] T. J. Seguin, S. E. Wheeler, Angew. Chem. Int. Ed. 2016, 55,
15889 – 15893; Angew. Chem. 2016, 128, 16121 – 16125.
[18] a) N. Minowa, T. Mukaiyama, Chem. Lett. 1987, 16, 1719 – 1722;
b) J. Otera, Y. Fujita, S. Fukuzumi, Tetrahedron 1996, 52, 9409 –
9418; c) H. Yanai, O. Kobayashi, K. Takada, T. Isono, T. Satoh, T.
Matsumoto, Chem. Commun. 2016, 52, 3280 – 3283.
[19] a) P. S. J. Kaib, L. Schreyer, S. Lee, R. Properzi, B. List, Angew.
Chem. Int. Ed. 2016, 55, 13200 – 13203; Angew. Chem. 2016, 128,
13394 – 13397; b) Y. Xie, G.-J. Cheng, S. Lee, P. S. J. Kaib, W.
Thiel, B. List, J. Am. Chem. Soc. 2016, 138, 14538 – 14541; c) S.
Lee, P. S. J. Kaib, B. List, J. Am. Chem. Soc. 2017, 139, 2156 –
2159.
[20] A. G. Wenzel, E. N. Jacobsen, J. Am. Chem. Soc. 2002, 124,
12964 – 12965.
[21] a) D. A. Evans, M. C. Willis, J. N. Johnston, Org. Lett. 1999, 1,
865 – 868; b) J. S. Johnson, D. A. Evans, Acc. Chem. Res. 2000,
33, 325 – 335.
[22] a) S. Ahmad, Tetrahedron Lett. 1991, 32, 6997 – 7000; b) K.
Narasaka, Y. Hayashi, H. Shimadzu, S. Niihata, J. Am. Chem.
Soc. 1992, 114, 8869 – 8885.
[23] a) M. B. Boxer, H. Yamamoto, Org. Lett. 2005, 7, 3127 – 3129;
b) K. Takasu, N. Hosokawa, K. Inanaga, M. Ihara, Tetrahedron
Lett. 2006, 47, 6053 – 6056; c) Y. Zhang, F. Lay, P. Garc&a-Garc&a,
B. List, E. Y. X. Chen, Chem. Eur. J. 2010, 16, 10462 – 10473.
[24] Calculated by applying formulas: logk20 8C= sN(N+E), and t1=2 =
ln(2)/k20 8C. E (ethyl cinnamate)=@24.52 (Ref. [6]); N (SKA
2a)= 9.00; sN (SKA 2a)= 0.98 (Mayr’s Database Of Reactivity
Parameters).
Manuscript received: November 24, 2017
Accepted manuscript online: December 12, 2017
Version of record online: January 26, 2018
Angewandte
ChemieCommunications
2468 www.angewandte.org T 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2018, 57, 2464 –2468
Supporting Information
The Catalytic Asymmetric Mukaiyama–Michael Reaction of Silyl
Ketene Acetals with a,b-Unsaturated Methyl Esters
Tim Gatzenmeier, Philip S. J. Kaib, Julia B. Lingnau, Richard Goddard, and Benjamin List*
anie_201712088_sm_miscellaneous_information.pdf
S-1 
 
Supporting Information 
The Catalytic Asymmetric Mukaiyama–Michael Reaction of Silyl Ketene Acetals with  
α,β-Unsaturated Methyl Esters 
Tim Gatzenmeier, Philip S. J. Kaib, Julia B. Lingnau, Richard Goddard and Benjamin List* 
Max-Planck-Institut für Kohlenforschung, Kaiser-Wilhelm-Platz 1, 45470 Mülheim an der Ruhr, 
Germany. 
*
Email: list@kofo.mpg.de 
Contents 
General Information and Instrumentation ............................................................................ 2 
Synthesis and Characterization of Substrates ....................................................................... 3 
Synthesis and Characterization of Silyl Ketene Acetals ....................................................... 8 
Synthesis and Characterization of Catalysts ....................................................................... 11 
Reaction Development & Optimization ................................................................................ 14 
Characterization of Products ................................................................................................ 18 
Product Derivatizations & Assignment of Absolute and Relative Stereochemistry ........ 27 
X-ray Crystallography Data .................................................................................................. 33 
Mechanistic NMR Studies ..................................................................................................... 44 
References................................................................................................................................ 48 
NMR Spectra .......................................................................................................................... 49 
HPLC Traces ........................................................................................................................ 130 
GC Traces .............................................................................................................................. 153 
 
S-2 
 
General Information and Instrumentation 
Unless otherwise stated, all reagents were purchased from commercial suppliers and used without 
further purification. For all reactions under argon, dried and degassed solvents were used. Dry 
argon was purchased from Air Liquide with >99.5% purity. All reported yields, unless otherwise 
specified, refer to spectroscopically and chromatographically pure compounds. Nomenclature 
follows the suggestions proposed by the computer program ChemBioDraw of CBD/Cambridgesoft. 
The enantiomeric ratios were determined by HPLC analysis employing a chiral stationary phase 
column specified in the individual experiment (HPLC traces analysis), by comparing the samples 
with the appropriate racemic mixtures. Diastereoselectivities were determined by HPLC analysis of 
the combined diastereomeric mixture after purification. 
 
Thin-layer chromatography (TLC) was performed using silica gel pre-coated plastic sheets 
(Polygram SIL G/UV254, 0.2 mm, with fluorescent indicator; Macherey-Nagel), which were 
visualized with a UV lamp (254 or 366 nm) and/or phosphomolybdic acid (PMA) stain and/or 
KMnO4 stain. Preparative thin-layer chromatography (PrepTLC) was performed on silica gel pre-
coated glass plates SIL G-25 UV254 and SIL G-100 UV254 with 0.25 mm and 1.0 mm SiO2 layers 
(Macherey-Nagel). Flash column chromatography was performed on Merck silica gel (60, particle 
size 0.040–0.063 mm). 1H, 13C, 19F, 31P nuclear magnetic resonance (NMR) spectra were recorded 
on a Bruker AV-500, AV-400 or DPX-300 spectrometer in a suitable deuterated solvent. The 
solvents employed and respective measuring frequencies are indicated for each experiment. The 
resonance multiplicity is described as s (singlet), d (doublet), t (triplet), q (quadruplet), p (pentet), 
hept (heptet), m (multiplet), and br (broad). All spectra were recorded at 298 K unless otherwise 
noted, processed with Bruker TOPSPIN or MestReNova suits of programs, and coupling constants 
are reported as observed. The residual deuterated solvent signal relative to tetramethylsilane was 
used as the internal reference in 
1
H NMR spectra (e.g. CDCl3 = 7.26 ppm), and are reported as 
follows: chemical shift δ in ppm (multiplicity, coupling constant J in Hz, number of protons). 13C, 
19
F, 
31
P NMR spectra were referenced according to Ξ-values (IUPAC recommendations 2008)[1] 
relative to the internal references set in 
1
H NMR spectra (e.g. 
13
C: Me4Si, 
19
F: CCl3F, 
31
P: H3PO4 
each 0.00 ppm). All spectra are broadband decoupled unless otherwise noted. Electron impact (EI) 
mass spectrometry (MS) was performed on a Finnigan MAT 8200 (70 eV) or MAT 8400 (70 eV) 
spectrometer. Electrospray ionization (ESI) mass spectrometry was conducted on a Bruker ESQ 
3000 spectrometer. High resolution mass spectrometry (HRMS) was performed on a Finnigan 
MAT 95 (EI) or Bruker APEX III FTMS (7 T magnet, ESI). The ionization method and mode of 
detection employed is indicated for the respective experiment. High performance liquid 
chromatography (HPLC) was performed on a Shimadzu LC-20AD liquid chromatograph (SIL-
20AC auto sampler, CMB-20A communication bus module, DGU-20A5 degasser, CTO-20AC 
column oven, SPD-M20A diode array detector), Shimadzu LC-20AB liquid chromatograph (SIL-
20ACHT auto sampler, DGU-20A5 degasser, CTO-20AC column oven, SPD-M20A diode array 
detector), or Shimadzu LC-20AB liquid chromatograph (reversed phase, SIL-20ACHT auto 
sampler, CTOS3 20AC column oven, SPD-M20A diode array detector) using Daicel columns with 
a chiral stationary phase. All solvents used were commercial HPLC-grade quality. The column 
employed and the respective solvent mixture is indicated for each experiment. Optical rotations 
were measured on an Autopol IV automatic polarimeter (Rudolph Research Analytical) at 589 nm 
(sodium D line), 25 °C. Data are reported as: [α]D
t
, concentration (c in g/100 mL), and in the 
corresponding solvent. 
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Synthesis and Characterization of Substrates 
Commercially available α,β-unsaturated carboxylic acids were purchased from Sigma-Aldrich, 
Alfa Aesar, Acros Organics, AK Scientific, Apollo Scientific, Key Organics and Aronis. E/Z ratios 
were >99:1, unless stated otherwise. p-Tolylsulfonylmethylnitrosamide (Diazald
®
) was purchased 
from Sigma-Aldrich. 
 
General Procedure A: Methylation with Diazomethane 
 
 
 
An ethereal solution of diazomethane was prepared from p-tolylsulfonylmethylnitrosamide 
(Diazald
®
) following a reported procedure.
[2]
 A stirring solution/suspension of the appropriate α,β-
unsaturated carboxylic acid (2.0 mmol) in MeOH (10 mL) was treated portionwise with an ethereal 
solution of diazomethane (~0.1 M) at room temperature using a graduated pipette (vigorous gas 
development) until the light green color of the diazomethane persisted in the reaction solution. The 
reaction mixture was stirred for additional 15 min, then quenched by dropwise addition of AcOH 
until disappearance of the light green color and concentrated in vacuo. Filtration of the crude 
material through a plug of silica gel with DCM gave the corresponding esters. 
 
General Procedure B: Methylation with H2SO4/Methanol 
 
 
 
Following a typical protocol,
[3]
 a solution/suspension of α,β-unsaturated carboxylic acid (2.0 mmol) 
in MeOH (10 mL) was treated with conc. H2SO4 (0.4 mL, 7.5 mmol, 3.8 equiv.), stirred at room 
temperature for 24 h and then concentrated in vacuo. Filtration of the crude material through a plug 
of silica gel with DCM gave the corresponding esters. 
 
General Procedure C: Masamune-Roush Olefination 
 
 
 
Following a typical protocol,
[4]
 to a solution of anhydrous LiCl (305 mg, 7.2 mmol, 1.2 equiv.) in 
MeCN (72 mL) under argon methyl diethylphosphonoacetate (1.33 mL, 7.2 mmol, 1.2 equiv.) was 
added, followed by 1,8-diazabicyclo[5.4.0]undec-7-en (DBU; 0.90 mL, 6.0 mmol, 1.0 equiv.) and 
appropriate aldehyde (6.0 mmol, 1.0 equiv.), and the mixture was stirred at room temperature for 
3 d. The reaction mixture was diluted EtOAc, washed with water and brine, dried over MgSO4 and 
concentrated in vacuo. The crude product was purified by column chromatography on silica gel. 
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General Procedure D: Still-Gennari Olefination 
 
 
 
Following a typical protocol,
[5]
 a solution of methyl P,P-bis(2,2,2-trifluoroethyl)phosphonoacetate 
(1.78 mL, 8.4 mmol, 1.40 equiv.) and 18-crown-6 (3.96 g, 15 mmol, 2.50 equiv.) in THF (120 mL) 
under argon was treated with KHMDS (0.5 M in toluene, 16.8 mL, 8.4 mmol, 1.40 equiv.) at –
78 °C and was stirred for 30 min at this temperature. To this suspension, a solution of appropriate 
aldehyde (6 mmol, 1.0 equiv.) in THF (2 mL) was added dropwise, and the reaction mixture was 
stirred at –78 °C until full consumption of starting material was indicated by TLC (typically 2 . The 
reaction was quenched with sat. NH4Cl solution and the organic phase was washed with water and 
brine, dried over MgSO4 and concentrated in vacuo. The crude product was purified by column 
chromatography on silica gel. 
 
(E)-methyl 3-(p-tolyl)acrylate (1b): Prepared according to general procedure A from (E)-3-(p-
tolyl)acrylic acid (324 mg, 2.0 mmol) and obtained as a colorless solid 
(318 mg, 1.81 mmol, 90%, E/Z >99:1); 
1
H NMR (500 MHz, CDCl3) δ 
7.67 (d, J = 16.0 Hz, 1H), 7.47 – 7.38 (m, 2H), 7.19 (d, J = 7.8 Hz, 2H), 
6.40 (d, J = 16.0 Hz, 1H), 3.80 (s, 3H), 2.37 (s, 3H);
 13
C NMR (126 
MHz, CDCl3) δ 167.8, 145.0, 140.9, 131.8, 129.8, 128.2, 116.8, 51.8, 
21.6; HRMS (ESI) calculated for C11H12O2Na
+
 [M+Na]
+
: 199.0729; 
found 199.0727. 
 
(E)-methyl 3-(m-tolyl)acrylate (1c): Prepared according to general procedure A from (E)-3-(m-
tolyl)acrylic acid (324 mg, 2.0 mmol) and obtained as a colorless liquid 
(331 mg, 1.88 mmol, 94%, E/Z >99:1); 
1
H NMR (500 MHz, CDCl3) δ 
7.67 (d, J = 16.0 Hz, 1H), 7.33 (d, J = 6.4 Hz, 2H), 7.30 – 7.25 (m, 1H), 
7.20 (d, J = 7.7 Hz, 1H), 6.43 (d, J = 16.0 Hz, 1H), 3.81 (s, 3H), 2.37 (s, 
3H);
 13
C NMR (126 MHz, CDCl3) δ 167.6, 145.2, 138.7, 134.5, 131.3, 
128.9, 128.9, 125.4, 117.7, 51.8, 21.5; HRMS (ESI) calculated for 
C11H12O2Na
+
 [M+Na]
+
: 199.0729; found 199.0727. 
 
(E)-methyl 3-(o-tolyl)acrylate (1d): Prepared according to general procedure A from (E)-3-(o-
tolyl)acrylic acid (324 mg, 2.0 mmol) and obtained as a colorless liquid (344 
mg, 1.95 mmol, 97%, E/Z >99:1); 
1
H NMR (500 MHz, CDCl3) δ 7.99 (d, J = 
15.9 Hz, 1H), 7.59 – 7.50 (m, 1H), 7.30 – 7.25 (m, 1H), 7.21 (t, J = 7.2 Hz, 
2H), 6.36 (d, J = 15.9 Hz, 1H), 3.81 (s, 3H), 2.44 (s, 3H);
 13
C NMR (126 
MHz, CDCl3) δ 167.6, 142.7, 137.8, 133.5, 130.9, 130.2, 126.5, 126.5, 119.0, 
51.8, 19.9; HRMS (ESI) calculated for C11H12O2Na
+
 [M+Na]
+
: 199.0729; 
found 199.0727. 
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(E)-methyl 3-(4-fluorophenyl)acrylate (1e): Prepared according to general procedure A from (E)-
3-(4-fluorophenyl)acrylic acid (332 mg, 2.0 mmol) and obtained as a 
colorless solid (325 mg, 1.80 mmol, 90%, E/Z >99:1); 
1
H NMR (500 
MHz, CDCl3) δ 7.66 (d, J = 16.1 Hz, 1H), 7.55 – 7.47 (m, 2H), 7.16 – 7.02 
(m, 2H), 6.36 (d, J = 16.0 Hz, 1H), 3.81 (s, 3H);
 13
C NMR (126 MHz, 
CDCl3) δ 167.3, 164.9, 162.9, 143.6, 130.6 (d, J = 3.3 Hz), 129.9 (d, J = 
8.6 Hz), 117.6 (d, J = 2.3 Hz), 116.0 (d, J = 22.0 Hz), 51.7; 
19
F NMR (471 
MHz, CDCl3) δ –109.6; HRMS (ESI) calculated for C10H9O2FNa
+
 
[M+Na]
+
: 203.0479; found 203.0476. 
 
(E)-methyl 3-(4-chlorophenyl)acrylate (1f): Prepared according to general procedure A from (E)-
3-(4-chlorophenyl)acrylic acid (365 mg, 2.0 mmol) and obtained as a 
colorless solid (387 mg, 1.97 mmol, 98%, E/Z >99:1); 
1
H NMR (500 
MHz, CDCl3) δ 7.64 (d, J = 16.0 Hz, 1H), 7.52 – 7.42 (m, 2H), 7.41 – 
7.32 (m, 2H), 6.41 (d, J = 16.0 Hz, 1H), 3.81 (s, 3H);
 13
C NMR (126 
MHz, CDCl3) δ 167.3, 143.6, 136.4, 133.0, 129.4, 129.3, 118.5, 51.9; 
HRMS (EI) calculated for C10H9O2Cl: 196.0291; found 196.0292. 
 
 
(E)-methyl 3-(4-bromophenyl)acrylate (1g): Prepared according to general procedure A from 
(E)-3-(4-bromophenyl)acrylic acid (473 mg, 2.1 mmol) and obtained as a 
colorless solid (460 mg, 1.91 mmol, 92%, E/Z >99:1); 
1
H NMR (500 
MHz, CDCl3) δ 7.61 (d, J = 16.0 Hz, 1H), 7.51 (d, J = 8.5 Hz, 2H), 7.37 
(d, J = 8.4 Hz, 2H), 6.42 (d, J = 16.0 Hz, 1H), 3.80 (s, 3H);
 13
C NMR 
(126 MHz, CDCl3) δ 167.2, 143.5, 133.4, 132.2, 129.5, 124.6, 118.6, 
51.9; HRMS (ESI) calculated for C10H9BrO2Na
+
 [M+Na]
+
: 262.9678; 
found 262.9679. 
 
(E)-methyl 3-(naphthalen-1-yl)acrylate (1h): Prepared according to general procedure A from 
(E)-3-(naphthalen-1-yl)acrylic acid (396 mg, 2.0 mmol) and obtained as a 
pale yellow, viscous oil (372 mg, 1.75 mmol, 88%, E/Z 98:2); 
1
H NMR 
(500 MHz, CDCl3) δ 8.54 (d, J = 15.8 Hz, 1H), 8.20 (d, J = 7.9 Hz, 1H), 
7.89 (t, J = 8.7 Hz, 2H), 7.76 (d, J = 7.2 Hz, 1H), 7.58 (ddd, J = 8.4, 6.8, 
1.5 Hz, 1H), 7.54 (ddd, J = 8.0, 6.9, 1.2 Hz, 1H), 7.51 – 7.47 (m, 1H), 6.54 
(d, J = 15.8 Hz, 1H), 3.86 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 167.5, 
142.1, 133.8, 131.9, 131.5, 130.7, 128.9, 127.0, 126.4, 125.6, 125.2, 123.5, 120.6, 51.9; HRMS 
(ESI) calculated for C14H12O2Na
+
 [M+Na]
+
: 235.0729; found 235.0726. 
 
(E)-methyl 3-(4-methoxyphenyl)acrylate (1i): Prepared according to general procedure A from 
(E)-3-(4-methoxyphenyl)acrylic acid (356 mg, 2.0 mmol) and obtained 
as a colorless solid (371 mg, 1.93 mmol, 96%, E/Z >99:1); 
1
H NMR 
(500 MHz, CDCl3) δ 7.65 (d, J = 15.9 Hz, 1H), 7.58 – 7.40 (m, 2H), 
6.98 – 6.82 (m, 2H), 6.31 (d, J = 16.0 Hz, 1H), 3.84 (s, 3H), 3.79 (s, 
3H);
 13
C NMR (126 MHz, CDCl3) δ 167.8, 161.4, 144.5, 129.7, 127.1, 
115.3, 114.3, 55.38, 51.6; HRMS (ESI) calculated for C11H12O3Na
+
 
[M+Na]
+
: 215.0679; found 215.0675. 
 
(E)-methyl 3-(4-cyanophenyl)acrylate (1j): Prepared according to general procedure B from (E)-
3-(4-cyanophenyl)acrylic acid (346 mg, 2.0 mmol) and obtained as a 
colorless solid (300 mg, 1.60 mmol, 80%, E/Z >99:1); 
1
H NMR (300 
MHz, CDCl3) δ 7.77 – 7.54 (m, 5H), 6.51 (d, J = 16.1 Hz, 1H), 3.82 (s, 
3H);
 13
C NMR (75 MHz, CDCl3) δ 166.7, 142.5, 138.8, 132.8, 128.5, 
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121.5, 118.4, 113.6, 52.1; HRMS (ESI) calculated for C11H9NO2Na
+
 [M+Na]
+
: 210.0525; found 
210.0524. 
 
(E)-methyl 3-(4-nitrophenyl)acrylate (1k): Prepared according to general procedure B from (E)- 
4-nitrocinnamic acid (368 mg, 2.0 mmol) and obtained as a pale yellow 
solid (389 mg, 1.88 mmol, 94%, E/Z 99:1); 
1
H NMR (300 MHz, 
CDCl3) δ 8.32 – 8.17 (m, 2H), 7.72 (d, J = 16.2 Hz, 1H), 7.69 – 7.64 
(m, 2H), 6.56 (d, J = 16.0 Hz, 1H), 3.84 (s, 3H);
 13
C NMR (126 MHz, 
CDCl3) δ 166.6, 148.7, 142.0, 140.6, 128.8, 124.3, 122.2, 52.2; HRMS 
(EI) calculated for C10H9NO4: 207.0532; found 207.0532. 
 
 
(E)-methyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate (1l): Prepared according to general procedure A 
from (E)-3-(benzo[d][1,3]dioxol-5-yl)acrylic acid (384 mg, 2.0 mmol) 
and obtained as a colorless solid (411 mg, 1.99 mmol, 99%, E/Z >99:1); 
1
H NMR (500 MHz, CDCl3) δ 7.59 (d, J = 15.9 Hz, 1H), 7.02 (d, J = 1.7 
Hz, 1H), 6.99 (dd, J = 8.0, 1.7 Hz, 1H), 6.80 (d, J = 8.0 Hz, 1H), 6.26 (d, 
J = 15.9 Hz, 1H), 6.00 (s, 2H), 3.78 (s, 3H);
 13
C NMR (126 MHz, 
CDCl3) δ 167.7, 149.7, 148.5, 144.7, 128.9, 124.5, 115.9, 108.7, 106.6, 
101.7, 51.8; HRMS (ESI) calculated for C11H10O4Na
+
 [M+Na]
+
: 229.0471; found 229.0469. 
 
(E)-methyl 3-(furan-2-yl)acrylate (1m): Prepared according to general procedure A from (E)-3-
(furan-2-yl)acrylic acid (276 mg, 2.0 mmol) and obtained as an acid labile, 
colorless liquid (277 mg, 1.82 mmol, 91%, E/Z >99:1); 
1
H NMR (500 MHz, 
CDCl3) δ 7.49 – 7.46 (m, 1H), 7.43 (d, J = 15.8 Hz, 1H), 6.60 (d, J = 3.4 Hz, 
1H), 6.46 (dd, J = 3.4, 1.8 Hz, 1H), 6.31 (d, J = 15.7 Hz, 1H), 3.78 (s, 3H);
 13
C 
NMR (126 MHz, CDCl3) δ 167.6, 151.0, 144.9, 131.3, 115.6, 114.9, 112.4, 
51.8; HRMS (EI) calculated for C8H8O3: 152.0473; found 152.0472. 
 
NOTE: Co-evaporation with reagent grade CHCl3 to remove solvent impurities, resulted in an 
orange decomposition product. 
 
(E)-methyl 5-phenylpent-2-enoate (1n): Prepared according to general procedure C from 3-
phenylpropionaldehyde (0.79 mL, 6.0 mmol) and obtained after column 
chromatography (hexane/Et2O 15:1) as a colorless oil (704 mg, 3.70 mmol, 
62%, E/Z >99:1); 
1
H NMR (500 MHz, CDCl3) δ 7.29 (t, J = 7.5 Hz, 2H), 
7.23 – 7.16 (m, 3H), 7.01 (dt, J = 15.7, 6.9 Hz, 1H), 5.85 (dt, J = 15.8, 1.6 
Hz, 1H), 3.72 (s, 3H), 2.78 (t, J = 7.7 Hz, 2H), 2.59 – 2.47 (m, 2H); 13C 
NMR (126 MHz, CDCl3) δ 167.1, 148.5, 140.9, 128.6, 128.5, 126.3, 121.6, 
51.6, 34.5, 34.0; HRMS (ESI) calculated for C12H14O2Na
+
 [M+Na]
+
: 
213.0886; found 213.0882. 
 
(E)-methyl dec-2-enoate (1o): Prepared according to general procedure C from octanal (0.73 mL, 
6.0 mmol) and obtained after column chromatography (hexane/Et2O 15:1) 
as a colorless oil (597 mg, 3.24 mmol, 54%, E/Z 98:2); 
1
H NMR (500 
MHz, CDCl3) δ 6.97 (dt, J = 15.7, 7.0 Hz, 1H), 5.81 (dt, J = 15.6, 1.6 Hz, 
1H), 3.72 (s, 3H), 2.19 (qd, J = 7.2, 1.6 Hz, 2H), 1.49 – 1.40 (m, 2H), 1.32 
– 1.23 (m, 8H), 0.90 – 0.85 (m, 3H); 13C NMR (126 MHz, CDCl3) δ 167.6, 
150.2, 121.2, 51.8, 32.6, 32.1, 29.5, 29.5, 28.4, 23.0, 14.5; HRMS (ESI) 
calculated for C11H20O2Na
+
 [M+Na]
+
: 207.1355; found 207.1357. 
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(E)-methyl 4,4-dimethylpent-2-enoate (1q): Prepared according to general procedure C from 
pivaldehyde (0.65 mL, 6.0 mmol) and obtained after column chromatography 
(pentane/Et2O 20:1) as colorless oil (383 mg, 2.69 mmol, 45%, E/Z >99:1); 
1
H NMR (500 MHz, CDCl3) δ 6.98 (d, J = 15.9 Hz, 1H), 5.74 (d, J = 15.9 Hz, 
1H), 3.73 (s, 3H), 1.08 (s, 9H);
 13
C NMR (126 MHz, CDCl3) δ 167.9, 159.5, 
116.4, 51.6, 33.9, 28.8; HRMS (ESI) calculated for C8H14O2Na
+
 [M+Na]
+
: 
165.0886; found 165.0884. 
 
(Z)-methyl 3-phenylacrylate: Prepared according to general procedure D from benzaldehyde 
(0.61 mL, 6.0 mmol) and obtained after column chromatography (eluent 
hexane/EtOAc 90:10) as colorless oil (962 mg, 5.93 mmol, 98%, Z/E >99:1); 
1
H NMR 
(500 MHz, CDCl3) δ 7.63 – 7.54 (m, 2H), 7.42 – 7.30 (m, 3H), 6.96 (dd, J = 12.6, 0.8 
Hz, 1H), 5.96 (d, J = 12.6 Hz, 1H), 3.72 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 166.7, 
143.5, 134.9, 129.8, 129.2, 128.2, 119.4, 51.5; HRMS (ESI) calculated for 
C10H10O2Na
+
 [M+Na]
+
: 185.0573; found 185.0570. 
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Synthesis and Characterization of Silyl Ketene Acetals 
General Procedure A: 
 
To a stirring solution of freshly distilled 2,2,6,6-tetramethylpiperidine (TMP; 6.0 mL, 36 mmol, 
1.2 equiv.) in THF (35 mL) under argon cooled to 0 °C with an ice bath, n-BuLi (2.45 M solution 
in hexane, 13.5 mL, 33 mmol, 1.1 equiv.) was added dropwise and the reaction mixture was stirred 
for 15 min. Then, a solution of ester (30 mmol, 1.0 equiv.) and Me3SiCl (4.6 mL, 33 mmol, 
1.2 equiv.) in THF (12 mL) under argon was added at 0 °C. The ice bath was removed after 
complete addition and the reaction solution was stirred overnight at room temperature. The reaction 
mixture was concentrated in vacuo to remove THF. Hexane (50 mL) and sat. NaHCO3 solution 
(50 mL) were added to the residue and the organic layer was further washed with water (50 mL), 
sat. CuSO4 solution (3 × 50 mL), water (50 mL) and brine (50 mL) in this order. After drying over 
MgSO4 and concentration, the crude product was purified by distillation under reduced pressure to 
afford the silyl ketene acetals as colorless liquids, which were stored in Schlenk flasks under argon. 
 
General Procedure B: 
 
Following a reported protocol,
[6]
 to a stirring solution of freshly distilled i-Pr2NH (4.2 mL, 
30 mmol, 1.2 equiv.) in THF (30 mL) under argon cooled to 0 °C, n-BuLi (2.5 M solution in 
hexane, 11 mL, 28mmol, 1.1 equiv.) was added dropwise and the reaction mixture was stirred at 
0 °C for 15 mins. The reaction was subsequently cooled to –78 ºC and neat methyl isobutyrate 
(2.9 mL, 25 mmol, 1.0 equiv.) was added dropwise. The reaction mixture was stirred for 30 min at 
–78 ºC, followed by the addition of 1,3-dimethyl-3,4,5,6,-tetrahydro-2(1H)-pyrimidinone (DMPU; 
6.0 mL, 50 mmol, 2.0 equiv.) and the corresponding silyl chloride (30 mmol, 1.2 equiv.; added neat 
if liquid, or in 15 mL THF if solid). The reaction was allowed to warm up to room temperature 
(removal of dry-ice bath) and stirred overnight. The reaction mixture was then concentrated in 
vacuo (NOTE: The pressure on the rotavap was reduced to <50 mbar at 40 °C water bath 
temperature to remove the majority of solvent and i-Pr2NH). Further workup and purification 
identical to procedure A was applied. 
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((1-methoxy-2-methylprop-1-en-1-yl)oxy)trimethylsilane (2a): Prepared according to general 
procedure A from methyl isobutyrate (11.5 mL, 100 mmol) and obtained after 
distillation (bp 35 °C at 10 mbar) as a colorless liquid (11.1 g, 64.0 mmol, 64%); 
1
H NMR (500 MHz, CDCl3) δ 3.50 (s, 3H), 1.57 (s, 3H), 1.52 (s, 3H), 0.20 (s, 9H);
 
13
C NMR (126 MHz, CDCl3) δ 149.5, 91.0, 56.7, 17.0, 16.3, 0.2; HRMS (GC-EI) 
calculated for C8H18O2Si: 174.1071; found 174.1071. 
 
(cyclohexylidene(methoxy)methoxy)trimethylsilane (2b): Prepared according to general 
procedure A from methyl cyclohexanecarboxylate (4.29 mL, 30.0 mmol) and 
obtained after distillation (bp 40 °C at 0.3 mbar) as a colorless liquid (5.58 g, 
22.6 mmol, 87%); 
1
H NMR (500 MHz, CDCl3) δ 3.50 (s, 3H), 2.14 – 2.06 (m, 
2H), 2.06 – 1.99 (m, 2H), 1.52 – 1.40 (m, 6H), 0.20 (s, 9H); 13C NMR (126 
MHz, CDCl3) δ 147.3, 99.6, 57.1, 27.9, 27.4, 27.2, 27.0, 26.8, 0.1; HRMS (GC-
EI) calculated for C11H22O2Si: 214.1384; found 214.1381. 
 
(cyclopentylidene(methoxy)methoxy)trimethylsilane (2c): Prepared according to general 
procedure A from methyl cyclopentanecarboxylate (3.90 mL, 30.0 mmol) and 
obtained after distillation (bp 34 °C at 0.5 mbar) as a colorless liquid (4.84 g, 19.4 
mmol, 80%); 
1
H NMR (500 MHz, CDCl3) δ 3.52 (s, 3H), 2.23 – 2.15 (m, 2H), 
2.16 – 2.08 (m, 2H), 1.64 – 1.55 (m, 4H), 0.21 (s, 9H); 13C NMR (126 MHz, 
CDCl3) δ 147.2, 100.8, 56.1, 28.5, 27.5, 27.2, 27.0, 0.3; HRMS (GC-EI) calculated for C10H20O2Si: 
200.1227; found 200.1226. 
 
(cyclobutylidene(methoxy)methoxy)trimethylsilane (2d): Prepared according to general 
procedure A from methyl cyclobutanecarboxylate (3.31 mL, 30.0 mmol) and 
obtained after distillation (bp 30 °C at 0.5 mbar) as a colorless liquid (2.52 g, 
6.12 mmol, 45%); 
1
H NMR (500 MHz, CDCl3) δ 3.55 (s, 3H), 2.79 – 2.69 (m, 
2H), 2.61 – 2.55 (m, 2H), 1.97 – 1.87 (m, 2H), 0.19 (s, 9H); 13C NMR (126 MHz, 
CDCl3) δ 147.9, 92.8, 56.2, 26.9, 26.6, 17.8, 0.4; HRMS (GC-EI) calculated for C9H18O2Si: 
186.1071; found 186.1068. 
 
NOTE: Obtained as a mixture of 82% silyl ketene acetal and 18% α-C-silylated methyl ester. 
 
Silyl ketene acetals (E)-2e and (Z)-2e were prepared according to a reported protocol
[7]
 and were 
obtained as E/Z mixtures of 80:20 and 5:95, respectively. 
 
 
 
 
 
 
 
 
2,2,6,6-tetramethyl-4-(2-phenylethylidene)-3,5-dioxa-2,6-disilaheptane (2f): 
 
 
 
To a solution of hydrocinnamic acid (5.0 g, 33.3 mmol) and TMS-Cl (9.70 mL, 76.6 mmol, 
2.3 equiv.) in THF (40 mL) under argon at –78 ºC, a freshly prepared solution of LDA in THF 
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(76.6 mmol, 2.3 equiv.) was added via a cannula. The reaction mixture was subsequently allowed 
to warm up to room temperature and stirred for 2 h. Concentration of the reaction mixture in vacuo 
(NOTE: The pressure on the rotavap was reduced to reach <50 mbar at 40 °C water bath 
temperature to remove the majority of solvent and i-Pr2NH) and dilution of the residue with hexane 
(50 mL) gave a suspension, which was filtered through a pad of celite. After evaporation of the 
solvent, the remaining yellow oil was purified by distillation (bp 90 °C at 0.06 mbar) to afford the 
title compound in 79% purity as a colorless liquid (5.98 g, 20.3 mmol, 61%), which was stored in a 
Schlenk flask under argon. 
1
H NMR (500 MHz, CD2Cl2) δ 7.28 – 7.24 (m, 2H), 7.23 – 7.18 (m, 
2H), 7.17 – 7.12 (m, 1H), 3.78 (t, J = 7.3 Hz, 1H), 3.28 (d, J = 7.3 Hz, 2H), 0.25 (s, 9H), 0.21 (s, 
9H); 
 13
C NMR (126 MHz, CD2Cl2) δ 151.9, 143.9, 128.6, 128.6, 125.9, 82.3, 31.9, 0.7, 0.1; 
HRMS (ESI) calculated for C15H27O2Si2 [M+H]
+
: 295.1544; found 295.1545. 
 
NOTE: The obtained material contained 14% of the trimethylsilyl ester and 7% of the α-C-silylated 
trimethylsilyl ester. 
 
(E)-((1-methoxy-3-methylbut-1-en-1-yl)oxy)trimethylsilane (2g): Prepared according to general 
procedure B without DMPU from methyl isovalerate (3.96 mL, 30.0 mmol) and 
obtained after distillation (bp 47 °C at 10 mbar) as a colorless liquid (4.20 g, 22.3 
mmol, 74%, E/Z 96:4); 
1
H NMR (500 MHz, CDCl3) δ 3.56 (d, J = 8.9 Hz, 1H), 
3.51 (s, 3H), 2.51 (dp, J = 8.9, 6.7 Hz, 1H), 0.94 (s, 3H), 0.93 (s, 3H), 0.22 (s, 9H);
 
13
C NMR (126 MHz, CDCl3) δ 152.4, 93.9, 55.1, 24.8, 24.3, –0.1; HRMS (GC-EI) 
calculated for C9H20O2Si: 188.1227; found 188.1226. 
 
triethyl((1-methoxy-2-methylprop-1-en-1-yl)oxy)silane (2h): Prepared according to general 
procedure B without DMPU from methyl isobutyrate (3.44 mL, 30 mmol) and 
obtained after distillation (bp 60 °C at 2 mbar) as a colorless liquid (4.44 g, 20.5 
mmol, 68%); 
1
H NMR (500 MHz, CDCl3) δ 3.52 (s, 3H), 1.56 (s, 3H), 1.54 (s, 3H), 
0.99 (t, J = 7.9 Hz, 9H), 0.69 (q, J = 7.9 Hz, 6H);
 13
C NMR (126 MHz, CDCl3) δ 
150.0, 91.1, 57.2, 17.0, 16.3, 6.7, 5.1; HRMS (GC-EI) calculated for C11H24O2Si: 216.1540; found 
216.1539. 
 
tert-butyl((1-methoxy-2-methylprop-1-en-1-yl)oxy)dimethylsilane (2i): Prepared according to 
general procedure B from methyl isobutyrate (4.59 mL, 40 mmol) and obtained 
after distillation (bp 60 °C at 6 mbar) as a colorless liquid (6.80 g, 31.4 mmol, 
79%); 
1
H NMR (500 MHz, CDCl3) δ 3.51 (s, 3H), 1.57 (s, 3H), 1.53 (s, 3H), 0.96 
(s, 9H), 0.15 (s, 6H);
 13
C NMR (126 MHz, CDCl3) δ 149.9, 91.5, 57.2, 25.9, 18.2, 
17.0, 16.4, –4.5; HRMS (GC-EI) calculated for C11H24O2Si: 216.1540; found 216.1538. 
 
triisopropyl((1-methoxy-2-methylprop-1-en-1-yl)oxy)silane (2j): Prepared according to general 
procedure B from methyl isobutyrate (2.87 mL, 25 mmol) and obtained after 
distillation (bp 50 °C at 0.1 mbar) as a colorless liquid (5.51 g, 21.3 mmol, 85%); 
1
H NMR (500 MHz, CDCl3) δ 3.56 (s, 3H), 1.57 (s, 6H), 1.21 – 1.13 (m, 3H), 1.11 
(s, 12H), 1.09 (s, 6H);
 13
C NMR (126 MHz, CDCl3) δ 150.9, 91.2, 58.3, 18.0, 17.2, 
16.5, 12.9; HRMS (GC-EI) calculated for C14H30O2Si: 258.2010; found 258.2006. 
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Synthesis and Characterization of Catalysts 
 
Synthesis of nitrated disulfonimide catalyst (S)-DSI-B 
 
A nitrated version of (S)-DSI-A
[8]
 was synthesized according to a described protocol.
[9]
 
 
 
 
To a solution of (S)-DSI-A (478 mg, 0.58 mmol) in a mixture of CHCl3 (2.4 mL) and conc. sulfuric 
acid (6 mL) cooled to –10 °C using a cryostat, fuming nitric acid (65 μL, 1.45 mmol, 2.5 equiv.) 
was added. The reaction mixture was allowed to warm up to 0 °C and stirred at this temperature 
until TLC indicated full conversion of the starting material (typically 1 h). The reaction mixture 
was subsequently poured in ice water, slowly neutralized inside a separation funnel using a sat. 
Na2CO3 solution, and extracted with EtOAc (3 × 50 mL). The combined organic layers were dried 
over MgSO4 and concentrated to afford a mixture of product regioisomers (3 distinct spots on TLC, 
50:50 Hex/EtOAc; Rf
1
 = 0.37, Rf
2
 = 0.27, Rf
2
 = 0.25). Purification of the least polar regioisomer 
was accomplished via repeated column chromatography on silica gel (80:20→65:35→50:50 
Hex/EtOAc). The salt product was dissolved in DCM and acidified twice with aq. HCl (6 M). 
Evaporation of the organic phase and drying on high vaccum gave the acidified title compound as a 
brown solid (234 mg, 44%). 
1
H NMR (500 MHz, acetone-d6) δ 8.84 (d, J = 0.9 Hz, 2H), 8.58 (dd, 
J = 7.4, 1.2 Hz, 2H), 8.23 (s, 4H), 8.17 (s, 2H), 7.82 (dt, J = 8.7, 1.2 Hz, 2H), 7.77 (dd, J = 8.7, 7.4 
Hz, 2H); 
13
C NMR (126 MHz, acetone-d6) δ 148.1, 142.2, 139.2, 137.4, 135.3, 135.0, 134.1, 132.0 
(br), 130.5, 130.2 (br), 129.0, 128.5, 127.7, 127.0, 125.5, 123.4, 122.8 (m); 
19
F NMR (471 MHz, 
acetone-d6) δ –63.1, –63.2; HRMS (ESI) calculated for C36H14N3O8F12S2 [M–H]
-
: 908.0036; found 
908.0045. 
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Synthesis of IDPi catalyst (S,S)-4e 
(S)-A2 
To a solution of MOM-protected BINOL (S)-A1 (5.92 g, 15.8 mmol) in THF (30 mL) under argon 
at –5 °C, n-BuLi in hexane (2.45 M, 22.6 mL, 55.3 mmol, 3.5 equiv.) was added over a period of 
5 min (NOTE: The temperature was kept between –10 °C and –5 °C during the addition. The color 
changed from light yellow to deep red). The reaction was stirred between –10 °C and –5 °C for 4 h, 
during which the color changed from deep red to red-brownish. Then, the reaction mixture was 
cooled to –78 °C and a solution of ZnCl2 in THF (0.96 M, 34.7 mL, 33.2 mmol, 2.1 equiv.) was 
added over a period of 20 min. The dry-ice bath was removed and the reaction was allowed to 
warm up to r.t. and stirred for additional 45 min, during which the color changed from red-
brownish to light yellow. Then, the solvent was removed from the reaction vessel under reduced 
pressure by using a cooling trap with liquid nitrogen (NOTE: A voluminous foam is formed). Upon 
dryness, the organozinc compound was afforded as a pale yellow solid and dried on high vaccum 
overnight. A stock solution (0.29 M) in THF (54 mL) under argon was prepared and stored in a 
fridge at –20 °C. 
 
(S)-B 
In a flame-dried 2-neck flask under argon, 2-bromo-9,9-dimethyl-9H-fluorene (2.46 g, 9.0 mmol) 
and Pd(t-Bu3P)2 (77 mg, 0.15 mmol) were dissolved in THF (60 mL). Then, a solution of 
organozinc BINOL (S)-A2 in THF (0.29 M, 10.2 mL, 3.0 mmol) was added at r.t. under stirring 
and the resulting reaction mixture was refluxed under argon for 18 h. The cooled reaction mixture 
was quenched with sat. NH4Cl solution (30 mL) and extracted with MTBE (3 × 50 mL). The 
combined organic layers were washed with brine, dried over MgSO4 and concentrated in vacuo. 
The crude product was purified by column chromatography on silica (20:1→10:1 Hex/EtOAc) to 
afford the title compound as a colorless solid (1.68 g, 74%). 
1
H NMR (500 MHz, CDCl3) δ 8.03 (s, 
2H), 7.93 (d, J = 8.2 Hz, 2H), 7.84 – 7.81 (m, 4H), 7.77 (td, J = 8.0, 1.3 Hz, 4H), 7.48 (dd, J = 6.5, 
1.2 Hz, 2H), 7.44 (ddd, J = 8.1, 6.1, 1.8 Hz, 2H), 7.39 – 7.28 (m, 8H), 4.54 – 4.40 (m, 4H), 2.39 (s, 
6H), 1.60 (s, 6H), 1.55 (s, 6H);
 13
C NMR (126 MHz, CDCl3) δ 154.1, 154.0, 151.6, 139.1, 138.5, 
138.3, 136.0, 133.8, 131.0, 130.7, 128.9, 128.0, 127.4, 127.2, 126.7, 126.6, 126.4, 125.3, 124.0, 
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122.8, 120.2, 120.0, 98.7, 56.1, 47.2, 27.4, 27.3; HRMS (EI) calculated for C54H46O4: 758.3396; 
found 758.3395. 
 
(S)-C 
To a solution of MOM-protected BINOL (S)-B (1.68 g, 2.22 mmol) in MeOH (30 mL), HCl in 
MeOH (12 mL, 1.25 M, 15 mmol) was added and the reaction solution was refluxed overnight. 
After evaporation of the solvent, the crude product was purified by column chromatography on 
silica gel (20:1→10:1 Hex/EtOAc) to give the title compound as a colorless solid (1.46 g, 98%). 
1
H NMR (500 MHz, CDCl3) δ 8.10 (s, 2H), 7.96 (d, J = 8.1 Hz, 2H), 7.84 (d, J = 7.9 Hz, 2H), 7.82 
(d, J = 1.4 Hz, 2H), 7.79 – 7.76 (m, 2H), 7.73 (dd, J = 7.8, 1.6 Hz, 2H), 7.48 – 7.44 (m, 2H), 7.41 
(ddd, J = 8.1, 6.8, 1.3 Hz, 2H), 7.38 – 7.32 (m, 6H), 7.28 (d, J = 8.5 Hz, 2H), 5.47 (s, 2H), 1.55 (s, 
12H);
 13
C NMR (126 MHz, CDCl3) δ 154.1, 154.0, 150.3, 139.1, 139.0, 136.5, 133.2, 131.4, 131.2, 
129.7, 128.7, 128.6, 127.6, 127.4, 127.2, 124.5, 124.5, 124.1, 122.8, 120.3, 120.2, 112.8, 47.2, 
27.4; HRMS (ESI) calculated for C50H37O2 (M–H)
-
: 669.2799; found 669.2805. 
 
(S,S)-4e 
An reported protocol for the synthesis of imidodiphosphorimidate Brønsted acids was applied.
[10]
 In 
a flamed-dried Schlenk tube, a suspension of 3,3'-substituted BINOL (S)-9 (704 mg, 1.05 mmol) in 
toluene (2.5 mL) under argon was treated with N-triflylphosphorimidoyl trichloride (168 μL, 
298 mg, 1.05 mmol) and DIPEA (1.38 mL, 8.0 mmol). The reaction mixture was stirred for 15 min 
at r.t., until neat hexamethyldisilazane (HMDS, 104 μL, 0.5 mmol) was added dropwise. The 
reaction mixture was further stirred for 15 min at r.t.. The Schlenk tube was subsequently sealed 
and heated to 140 °C for 3 days. After cooling, aq. HCl (1 M) was added and the mixture was 
extracted with DCM. The combined organic layers were washed with water and brine, dried over 
MgSO4 and concentrated. The crude material was purified by column chromatography on silica gel 
(90:10→80:20→70:30→60:40→50:50 hexane/MTBE) to afford the desired product as a salt. The 
free acid was obtained after acidification in DCM with aq. HCl (6 M), evaporation followed by 
drying under high vacuum as a colorless solid (557 mg, 65%). 
1
H NMR (500 MHz, CD2Cl2): δ 
8.12 (s, 2H), 8.08 (dd, J = 8.3, 3.4 Hz, 4H), 7.92 – 7.84 (m, 4H), 7.73 (ddd, J = 8.3, 6.7, 1.3 Hz, 
2H), 7.64 – 7.59 (m, 4H), 7.53 (d, J = 1.6 Hz, 2H), 7.48 – 7.40 (m, 10H), 7.36 – 7.32 (m, 2H), 7.29 
(td, J = 7.4, 1.2 Hz, 2H), 7.25 – 7.21 (m, 8H), 7.09 (s, 2H), 6.79 (d, J = 8.0 Hz, 2H), 6.60 (dd, J = 
8.0, 1.6 Hz, 2H), 6.41 (d, J = 7.7 Hz, 2H), 1.50 (s, 6H), 1.42 (s, 6H), 1.25 (s, 6H), 1.17 (s, 6H); 
13
C NMR (126 MHz, CD2Cl2): δ 154.6, 154.4, 154.1, 144.4 (m), 143.3 (br), 139.7, 139.1, 139.0, 
135.4, 134.9, 134.9, 134.3, 132.7, 132.4, 132.3, 132.3, 132.2, 132.0, 129.8, 129.3, 129.3, 129.2, 
128.1, 127.7, 127.6, 127.5, 127.4, 127.3, 127.3, 127.2, 127.1, 124.3, 124.0, 123.8, 123.1, 123.0, 
122.4, 120.7, 120.2, 119.7, 119.4, 47.5, 47.4, 27.8, 27.4, 27.1, 26.8 (other signals not detected or 
observed); 
19
F NMR (282 MHz, CD2Cl2): δ −78.6; 
31
P NMR (122 MHz, CD2Cl2): δ −9.9, −17.0; 
HRMS (ESI) calculated for C102H72N3O8F6P2S2 (M–H)
-
: 1706.4146; found: 1706.4162. 
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Reaction Development & Optimization 
 
Table S1. Catalyst screening
a
 
 
entry catalyst conv. (%)b e.r.c 
1 (S)-DSI-A traces / 
2e (S)-DSI-B 60 29:71 
3f (S)-BALT-A full 50:50 
4 (S)-BALT-B full 48:52 
5 (S)-BALT-A full 50:50 
6d (S,S)-4a full 26.5:73.5 
7d (S,S)-4b full 45.5:54.5 
8d (S,S)-4c full 86:14 
9d (S,S)-4d full 17:83 
10d (S,S)-4e full 7:93 
aReactions were performed on a 0.02 mmol scale with 1.5 equiv. of commercial SKA 2a for the specified period of time 
and quenched with 5 equiv. of MeOH. bDetermined by 1H NMR analysis. cDetermined by HPLC on chiral stationary 
phase. d3 mol% of catalyst. e48 h of reaction time. fat –40 °C. 
NOTE: Silyl ketene acetal 2a was purchased from Alfa Aesar and used without further purification. 
(S)-BALT catalysts A-B have been reported previously.
[11]
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Table S2. Screening of silyl ketene acetals
a
 
 
entry SiR3 conv. (%)b e.r.c 
1 TMS (2a) 83 6:94 
2 TES (2h) full 13.25:86.75 
3 TBS (2i) 76 14.5:85.5 
4 TIPS (2j) full 34:66 
aReactions were performed on a 0.02 mmol scale with 1.5 equiv. of silyl ketene acetal for the specified period of time and 
quenched with 5 equiv. of MeOH. bDetermined by 1H NMR analysis. cDetermined by HPLC on chiral stationary phase. 
NOTE: Silyl ketene acetal 2a was purchased from Alfa Aesar and used without further purification. 
Silyl ketene acetals 2h-j were prepared and purified as described above. 
 
Table S3. Solvent screening
a
 
 
entry solvent conv. (%)b e.r.c 
1 Et2O 43 7.75:92.25 
2 MTBE 0 / 
3 1,4-dioxane 56 6.75:93.25 
4 TMS2O 98 20.5:79.5 
5 CH2Cl2 full 46:54 
6 CHCl3 80 22.75:77.25 
7 CCl4 80 4:96 
8 EtOAc 5 19.25:80.75 
9 MeCN 72 50:50 
10 MeNO2 full 49.5:50:5 
11 benzene 87 6.5:93.5 
12 toluene 91 5.75:94.25 
13 o-xylene 95 6:94 
14 m-xylene 94 5.5:94.5 
15 p-xylene 72 5.25:94.75 
16 n-hexane 30 10.25:89.75 
17 cyclohexane 52 3.75:96.25 
aReactions were performed on a 0.02 mmol scale with 3.0 equiv. of commercial SKA 2a for the specified period of time 
and quenched with 5 equiv. of MeOH. bDetermined by 1H NMR analysis. cDetermined by HPLC on chiral stationary 
phase. 
 
NOTE: Silyl ketene acetal 2a was purchased from Alfa Aesar and used without further purification. 
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Table S4. Temperature screening
a
 
 
entry temperature conv. (%)b e.r.c 
1d r.t. 52 3.75:96.25 
2e r.t. full 4.25:95.75 
3e 10 °C full 4.5:95.5 
4e 0 °C full 3:97 
5e,f 0 °C full 3:97 
aReactions were performed on a 0.02 mmol scale with 3.0 equiv. of SKA 2a for the specified period of time and 
quenched with 5 equiv. of MeOH. bDetermined by 1H NMR analysis. cDetermined by HPLC on chiral stationary phase. 
dcommercial SKA 2a was used. efreshly prepared and purified SKA 2a and 1 mol% catalyst used. f12 h reaction time. 
 
Table S5. Screening of concentration effects
a
 
 
entry concentration conv. (%)b e.r.c 
1 0.5 M full 4.5:95.5 
2 0.2 M full 4.25:95.75 
3 0.1 M 92 4:96 
4 0.05 M 0 / 
5 0.025 M 0 / 
aReactions were performed on a 0.02 mmol scale with 3.0 equiv. of freshly prepared and purified SKA 2a for the 
specified period of time and quenched with 5 equiv. of MeOH. bDetermined by 1H NMR analysis. cDetermined by HPLC 
on chiral stationary phase. 
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General Procedure for the Catalytic, Asymmetric Mukaiyama-Michael Reaction 
 
A 4 mL vial was charged with a magnetic stirrer bar, the appropriate α,β-unsaturated ester 
(0.2 mmol) and (S,S)-4e (3.4 mg, 2 μmol, 1 mol%), and the reactants were dissolved in 
cyclohexane (1 mL) under argon. The vial was cooled to 0 °C in a cryostat, at which temperature 
the reaction mixture is a half-liquid slurry. Upon addition of the appropriate silyl ketene acetal 
(0.6 mmol) and mixing, the reaction mixture becomes a homogeneous solution and was stirred at 
0 °C for the specified period of time. After complete conversion indicated by TLC, the reaction was 
quenched with MeOH (1 mmol, 40 μL). Purification by column chromatography on silica gel and 
drying in high vaccum overnight gave the pure Mukaiyama–Michael addition products. 
 
General Procedure for the Preparation of Racemic Products 
 
In a flame-dried Schlenk tube, the appropriate α,β-unsaturated ester (0.2 mmol) and the appropriate 
silyl ketene acetal (0.6 mmol) were dissolved in DCM (1 mL) under argon. A stock solution of 
HNTf2 (0.2 M in 1,2-dichloroethane, 10 μL, 2 μmol) was added at –78 °C and the reaction was 
stirred until TLC indicated full conversion (typically 10 to 20 min). The reaction was quenched by 
adding MeOH (1 mmol, 40 μL) at –78 °C. The racemic product was obtained by purification via 
preparative TLC. 
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Characterization of Products 
 
dimethyl (S)-2,2-dimethyl-3-phenylpentanedioate (3a): Prepared according to the general 
procedure using (E)-methyl cinnamate (1a, 0.20 mmol, 32 mg), 
1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of SKA 2a (0.12 mL, 
0.60 mmol) at 0 °C for 14 hours. The product was obtained after 
column chromatography on silica gel (20:1→10:1 hexane/EtOAc) as a 
colorless oil (51 mg, 97% yield), which solidified to a colorless solid 
upon cooling. The enantiomeric ratio was determined by HPLC on a 
chiral stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 7.27 (ddt, J = 7.5, 6.5, 1.1 Hz, 2H), 7.25 – 
7.20 (m, 1H), 7.19 – 7.15 (m, 2H), 3.66 (s, 3H), 3.54 (dd, J = 11.3, 4.2 Hz, 1H), 3.49 (s, 3H), 2.86 
(dd, J = 15.7, 11.3 Hz, 1H), 2.68 (dd, J = 15.7, 4.2 Hz, 1H), 1.16 (s, 3H), 1.10 (s, 3H);
 13
C NMR 
(126 MHz, CDCl3) δ 177.5, 172.6, 139.5, 129.3, 128.0, 127.1, 52.0, 51.7, 49.0, 46.2, 35.8, 24.4, 
21.7; HRMS (GC-EI) calculated for C15H20O4: 264.1356; found 264.1358; [α]D
25
 = –11.6° (c = 
0.92, CHCl3); HPLC Daicel Chiralpak OD-3, n-heptane/IPA = 98/2, 1 mL/min, 25 °C, 220 nm, tR 
(minor) = 7.7 min, tR (major) = 9.2 min; e.r. = 97:3. 
 
Reactions with lower catalyst loadings were performed using 1a and 3 equiv. of SKA 2a at 0 °C in 
cyclohexane with increasing concentrations. 
entry scale catalyst loading concentration time isolated yield (%) e.r. 
1 0.2 mmol 1 mol% 0.2 M 12 h 97 97:3 
2 0.4 mmol 0.5 mol% 0.4 M 5 d 98 97:3 
3 0.8 mmol 0.25 mol% 0.8 M 5 d 98 96.5:3.5 
 
Reactions with lower amounts of SKA 2a were performed with 1a (0.20 mmol) and 1 mol% (S,S)-
4e in 1 mL cyclohexane (0.2 M) at 0 °C. For entry 4 and 5, the reactions were run for 3 days at 
0 °C, and further stirred for 1 week at room temperature. 
entry equiv. of 2a time conv. (%)a isolated yield (%) e.r. 
1 2 24 h full 98 97:3 
2 1.5 3.5 d full 98 97:3 
3 1.1 3.5 d full 98 97:3 
4 0.5 10 d (0 °C→r.t.) 46 45 97:3 
5 0.2 10 d (0 °C→r.t.) 16 13 97:3 
aDetermined by 1H NMR analysis. 
 
For an experiment under non-dried conditions and without inert gas, 1a (0.20 mmol, 32 mg) and 
(S,S)-4e (3.4 mg, 2 μmol) were dissolved in non-dried cyclohexane in an open vial. SKA 2a 
(122 μL, 0.60 mmol) was added at room temperature. The vial was subsequently sealed and placed 
in a cryostat at 0 °C. After stirring for 3.5 days, the reaction was quenched with MeOH (40 μL, 
1 mmol, 5 equiv.). Product 3a was obtained in 96% yield after usual purification (e.r. = 97.5:2.5). 
 
The reaction with (Z)-methyl cinnamate (1s, 0.20 mmol, 32 mg) as starting material was performed 
according to the general procedure with 1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of SKA 2a 
(0.12 mL, 0.60 mmol) at 0 °C for 5 days resulting in 70% conversion as detected 
1
H NMR analysis. 
The product was obtained after usual purification in 55% yield with (R)-3a being the major 
enantiomer (e.r. 62.5:37.5). 
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dimethyl (S)-2,2-dimethyl-3-(p-tolyl)pentanedioate (3b): Prepared according to the general 
procedure using (E)-methyl 3-(p-tolyl)acrylate (1b, 0.20 mmol, 35 mg), 
1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of SKA 2a (0.12 mL, 
0.60 mmol) at 0 °C for 14 hours. The product was obtained after 
column chromatography on silica gel (20:1→10:1 hexane/EtOAc) as a 
colorless oil (53 mg, 95% yield). The enantiomeric ratio was 
determined by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, 
CDCl3) δ 7.11 – 6.99 (m, 4H), 3.65 (s, 3H), 3.49 (dd, J = 11.4, 4.3 Hz, 
1H), 3.49 (s, 3H), 2.83 (dd, J = 15.7, 11.3 Hz, 1H), 2.64 (dd, J = 15.7, 
4.1 Hz, 1H), 2.30 (s, 3H), 1.14 (s, 3H), 1.08 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 177.6, 172.7, 
136.6, 136.3, 129.2, 128.8, 51.9, 51.7, 48.6, 46.2, 35.9, 24.4, 21.7, 21.2; HRMS (GC-EI) calculated 
for C16H22O4: 278.1513; found 278.1513; [α]D
25
 = –11.8° (c = 0.51, CHCl3); HPLC Daicel 
Chiralpak OD-3, n-heptane/IPA = 98/2, 1 mL/min, 25 °C, 220 nm, tR (major) = 4.8 min, tR (minor) 
= 7.2 min; e.r. = 97.25:2.75. 
 
dimethyl (S)-2,2-dimethyl-3-(m-tolyl)pentanedioate (3c): Prepared according to the general 
procedure using (E)-methyl 3-(m-tolyl)acrylate (1c, 0.20 mmol, 
35 mg), 1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of SKA 2a 
(0.12 mL, 0.60 mmol) at 0 °C for 14 hours. The product was obtained 
after column chromatography on silica gel (20:1→10:1 hexane/EtOAc) 
as a colorless solid (53 mg, 95% yield). The enantiomeric ratio was 
determined by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, 
CDCl3) δ 7.15 (t, J = 7.6 Hz, 1H), 7.02 (d, J = 7.4 Hz, 1H), 6.95 (d, J = 
8.0 Hz, 2H), 3.65 (s, 3H), 3.49 (s, 3H), 3.49 (dd, J = 11.2, 4.2 Hz, 1H), 2.84 (dd, J = 15.8, 11.2 Hz, 
1H), 2.66 (dd, J = 15.8, 4.2 Hz, 1H), 2.31 (s, 3H), 1.14 (s, 3H), 1.09 (s, 3H);
 13
C NMR (126 MHz, 
CDCl3) δ 177.6, 172.7, 139.4, 137.4, 130.2, 127.9, 127.9, 126.3, 51.9, 51.7, 48.9, 46.2, 35.8, 24.4, 
21.7, 21.7; HRMS (GC-EI) calculated for C16H22O4: 278.1513; found 278.1515; [α]D
25
 = –15.4° (c 
= 0.26, CHCl3); HPLC Daicel Chiralpak AS-3, n-heptane/IPA = 98/2, 1 mL/min, 25 °C, 220 nm, 
tR (major) = 4.6 min, tR (minor) = 5.6 min; e.r. = 98.25:1.75. 
 
dimethyl (S)-2,2-dimethyl-3-(o-tolyl)pentanedioate (3d): Prepared according to the general 
procedure using (E)-methyl 3-(o-tolyl)acrylate (1d, 0.20 mmol, 35 mg), 
1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of SKA 2a (0.12 mL, 
0.60 mmol) at 0 °C for 5 days. The product was obtained after column 
chromatography on silica gel (20:1→10:1 hexane/EtOAc) as a 
colorless oil (51 mg, 92% yield). The enantiomeric ratio was 
determined by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, 
CDCl3) δ 7.16 – 7.06 (m, 4H), 3.90 (dd, J = 11.4, 3.9 Hz, 1H), 3.67 (s, 3H), 3.46 (s, 3H), 2.83 (dd, 
J = 15.9, 11.4 Hz, 1H), 2.69 (dd, J = 15.8, 3.9 Hz, 1H), 2.44 (s, 3H), 1.18 (s, 3H), 1.12 (s, 3H);
 13
C 
NMR (126 MHz, CDCl3) δ 177.7, 172.8, 138.5, 138.1, 130.6, 127.1, 126.7, 125.7, 52.0, 51.6, 46.8, 
42.7, 37.1, 24.7, 21.5, 20.7; HRMS (GC-EI) calculated for C16H22O4: 278.1513; found 278.1514; 
[α]D
25
 = –13.2° (c = 0.59, CHCl3); HPLC Daicel Chiralpak OD-3, n-heptane/IPA = 98/2, 
1 mL/min, 25 °C, 220 nm, tR (minor) = 7.6 min, tR (major) = 8.9 min; e.r. = 96.5:3.5. 
 
dimethyl (S)-3-(4-fluorophenyl)-2,2-dimethylpentanedioate (3e): Prepared according to the 
general procedure using (E)-methyl 3-(4-fluorophenyl)acrylate (1e, 
0.20 mmol, 36 mg), 1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of 
SKA 2a (0.12 mL, 0.60 mmol) at 0 °C for 14 hours. The product was 
obtained after column chromatography on silica gel (20:1→10:1 
hexane/EtOAc) as a colorless oil (56 mg, 99% yield). The enantiomeric 
ratio was determined by HPLC on a chiral stationary phase. 
1
H NMR 
(500 MHz, CDCl3) δ 7.18 – 7.10 (m, 2H), 7.03 – 6.91 (m, 2H), 3.64 (s, 
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3H), 3.51 (dd, J = 11.5, 4.2 Hz, 1H), 3.49 (s, 3H), 2.80 (dd, J = 15.7, 11.5 Hz, 1H), 2.66 (dd, J = 
15.7, 4.1 Hz, 1H), 1.14 (s, 3H), 1.09 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 177.3, 172.5, 163.0, 
161.0, 135.2, 135.2, 130.8, 130.7, 115.1, 114.9, 52.0, 51.7, 48.4, 46.2, 35.9, 24.2, 21.9; 
19
F NMR 
(471 MHz, CDCl3) δ –115.8; HRMS (GC-EI) calculated for C15H19O4F: 282.1262; found 
282.1262; [α]D
25
 = –14.5° (c = 0.51, CHCl3); HPLC Daicel Chiralpak OD-3, n-heptane/IPA = 98/2, 
1 mL/min, 25 °C, 220 nm, tR (major) = 4.9 min, tR (minor) = 6.9 min; e.r. = 97.5:2.5. 
 
dimethyl (S)-3-(4-chlorophenyl)-2,2-dimethylpentanedioate (3f): Prepared according to the 
general procedure using (E)-methyl 3-(4-chlorophenyl)acrylate (1f, 
0.20 mmol, 39 mg), 1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of 
SKA 2a (0.12 mL, 0.60 mmol) at 0 °C for 14 hours. The product was 
obtained after column chromatography on silica gel (20:1→10:1 
hexane/EtOAc) as a colorless oil (58 mg, 97% yield). The enantiomeric 
ratio was determined by HPLC on a chiral stationary phase. 
1
H NMR 
(500 MHz, CDCl3) δ 7.26 – 7.22 (m, 2H), 7.13 – 7.07 (m, 2H), 3.65 (s, 
3H), 3.51 (dd, J = 11.6, 4.2 Hz, 1H), 3.49 (s, 3H), 2.80 (dd, J = 15.8, 
11.5 Hz, 1H), 2.66 (dd, J = 15.9, 4.1 Hz, 1H), 1.13 (s, 3H), 1.08 (s, 3H);
 13
C NMR (126 MHz, 
CDCl3) δ 177.2, 172.4, 138.1, 133.0, 130.6, 128.3, 52.1, 51.8, 48.5, 46.1, 35.7, 24.2, 21.8; HRMS 
(GC-EI) calculated for C15H19O4Cl: 298.0966; found 298.0962; [α]D
25
 = –10.6° (c = 0.53, CHCl3); 
HPLC Daicel Chiralpak OD-3, n-heptane/IPA = 98/2, 1 mL/min, 25 °C, 220 nm, tR (major) = 5.0 
min, tR (minor) = 6.8 min; e.r. = 97.5:2.5. 
 
dimethyl (S)-3-(4-bromophenyl)-2,2-dimethylpentanedioate (3g): Prepared according to the 
general procedure using (E)-methyl 3-(4-bromophenyl)acrylate (1g, 
0.20 mmol, 48 mg), 1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of 
SKA 2a (0.12 mL, 0.60 mmol) at 0 °C for 14 hours. The product was 
obtained after column chromatography on silica gel (20:1→10:1 
hexane/EtOAc) as a colorless oil (67 mg, 98% yield). The enantiomeric 
ratio was determined by HPLC on a chiral stationary phase. 
1
H NMR 
(500 MHz, CDCl3) δ 7.42 – 7.36 (m, 2H), 7.08 – 7.01 (m, 2H), 3.65 (s, 
3H), 3.49 (s, 3H), 3.49 (dd, J = 11.4, 4.1 Hz, 1H), 2.80 (dd, J = 15.8, 
11.5 Hz, 1H), 2.66 (dd, J = 15.9, 4.1 Hz, 1H), 1.13 (s, 3H), 1.08 (s, 3H);
 13
C NMR (126 MHz, 
CDCl3) δ 177.2, 172.4, 138.6, 131.2, 131.0, 121.2, 52.1, 51.8, 48.5, 46.0, 35.6, 24.2, 21.8; HRMS 
(GC-EI) calculated for C15H19O4Br: 342.0461; found 342.0461; [α]D
25
 = –7.8° (c = 0.46, CHCl3); 
HPLC Daicel Chiralpak OD-3, n-heptane/IPA = 98/2, 1 mL/min, 25 °C, 220 nm, tR (major) = 5.4 
min, tR (minor) = 7.2 min; e.r. = 98:2. 
 
 
dimethyl (S)-2,2-dimethyl-3-(naphthalen-1-yl)pentanedioate (3h): Prepared according to the 
general procedure using (E)-methyl 3-(naphthalen-1-yl)acrylate (1h, 
0.20 mmol, 42 mg), 1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of 
SKA 2a (0.12 mL, 0.60 mmol) at 0 °C for 2 days. The product was 
obtained after column chromatography on silica gel (20:1→10:1 
hexane/EtOAc) as a colorless wax (58 mg, 92% yield), which solidified 
to a colorless solid upon cooling. The enantiomeric ratio was 
determined by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 8.36 (d, J = 8.6 
Hz, 1H), 7.82 (d, J = 8.6 Hz, 1H), 7.74 (d, J = 8.1 Hz, 1H), 7.54 (ddd, J = 8.5, 6.8, 1.4 Hz, 1H), 
7.46 (ddd, J = 7.9, 6.9, 1.0 Hz, 1H), 7.44 – 7.40 (m, 1H), 7.34 (dd, J = 7.3, 1.0 Hz, 1H), 4.67 (dd, J 
= 11.1, 4.2 Hz, 1H), 3.63 (s, 3H), 3.37 (s, 3H), 3.02 (dd, J = 15.9, 11.1 Hz, 1H), 2.85 (dd, J = 15.9, 
4.2 Hz, 1H), 1.21 (s, 3H), 1.05 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 177.7, 172.6, 136.5, 133.9, 
133.6, 128.9, 127.8, 126.1, 125.5, 125.1, 124.9, 124.2, 52.1, 51.6, 47.0, 41.0, 37.2, 25.2, 21.4; 
HRMS (GC-EI) calculated for C19H22O4: 314.1513; found 314.1512; [α]D
25
 = –74.0° (c = 0.60, 
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CHCl3); HPLC Daicel Chiralpak OD-3, n-heptane/IPA = 98/2, 1 mL/min, 25 °C, 220 nm, tR 
(minor) = 9.8 min, tR (major) = 14.8 min; e.r. = 94.5:5.5 
 
dimethyl (S)-3-(4-methoxyphenyl)-2,2-dimethylpentanedioate (3i): Prepared according to the 
general procedure using (E)-methyl 3-(4-methoxyphenyl)acrylate (1i, 
0.20 mmol, 38 mg), 1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of 
SKA 2a (0.12 mL, 0.60 mmol) at 0 °C for 24 hours. The product was 
obtained after column chromatography on silica gel (20:1→10:1 
hexane/EtOAc) as a colorless oil (59 mg, 95% yield). The enantiomeric 
ratio was determined by HPLC on a chiral stationary phase. 
1
H NMR 
(500 MHz, CDCl3) δ 7.11 – 7.03 (m, 2H), 6.84 – 6.75 (m, 2H), 3.77 (s, 
3H), 3.64 (s, 3H), 3.48 (s, 3H), 3.46 (dd, J = 11.4, 4.2 Hz, 1H), 2.80 
(dd, J = 15.6, 11.4 Hz, 1H), 2.63 (dd, J = 15.6, 4.1 Hz, 1H), 1.13 (s, 3H), 1.08 (s, 3H);
 13
C NMR 
(126 MHz, CDCl3) δ 177.6, 172.7, 158.6, 131.4, 130.3, 113.4, 55.2, 52.0, 51.7, 48.3, 46.3, 36.0, 
24.3, 21.7; HRMS (GC-EI) calculated for C16H22O5: 294.1462; found 294.1465; [α]D
25
 = –9.6° (c = 
0.50, CHCl3); HPLC Daicel Chiralpak OD-3, n-heptane/IPA = 98/2, 1 mL/min, 25 °C, 220 nm, tR 
(major) = 8.8 min, tR (minor) = 11.1 min; e.r. = 95.75:4.25 
 
dimethyl (S)-3-(4-cyanophenyl)-2,2-dimethylpentanedioate (3j): Prepared according to a 
modified general procedure (p-xylene instead of cyclohexane) using 
(E)-methyl 3-(4-cyanophenyl)acrylate (1j, 0.20 mmol, 37 mg), 1 mol% 
(S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of SKA 2a (0.12 mL, 
0.60 mmol) at 0 °C for 14 hours. The product was obtained after 
column chromatography on silica gel (10:1→5:1→3:1 hexane/EtOAc) 
as a colorless oil (58 mg, 89% yield). The enantiomeric ratio was 
determined by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, 
CDCl3) δ 7.60 – 7.55 (m, 2H), 7.31 – 7.27 (m, 2H), 3.65 (s, 3H), 3.58 
(dd, J = 11.5, 4.0 Hz, 1H), 3.49 (s, 3H), 2.84 (dd, J = 16.2, 11.5 Hz, 1H), 2.72 (dd, J = 16.1, 4.0 Hz, 
1H), 1.15 (s, 3H), 1.10 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 176.7, 172.1, 145.4, 131.9, 130.1, 
118.8, 111.2, 52.2, 51.9, 49.1, 46.1, 35.4, 24.2, 22.1; HRMS (GC-EI) calculated for C16H19NO4: 
289.1309; found 289.1310; [α]D
25
 = –10.5° (c = 0.42, CHCl3); HPLC Daicel Chiralpak OD-3, n-
heptane/IPA = 95/5, 1 mL/min, 25 °C, 220 nm, tR (major) = 9.2 min, tR (minor) = 11.0 min; e.r. = 
97.5:2.5. 
 
dimethyl (S)-3-(4-nitrophenyl)-2,2-dimethylpentanedioate (3k): Prepared according to a 
modified general procedure (toluene/1,4-dioxane 3:1 instead of 
cyclohexane) using (E)-methyl 3-(4-nitrophenyl)acrylate (1k, 
0.20 mmol, 41 mg), 1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of 
SKA 2a (0.12 mL, 0.60 mmol) at room temperature for 4 days. The 
product was obtained after column chromatography on silica gel 
(9:1→4:1→2:1 hexane/EtOAc) as an orange oil (47 mg, 76% yield). 
The enantiomeric ratio was determined by HPLC on a chiral stationary 
phase. 
1
H NMR (500 MHz, CDCl3) δ 8.18 – 8.12 (m, 2H), 7.40 – 7.31 
(m, 2H), 3.66 (s, 3H), 3.65 (dd, J = 11.5, 4.0 Hz, 1H), 3.50 (s, 3H), 2.88 (dd, J = 16.2, 11.5 Hz, 
1H), 2.75 (dd, J = 16.2, 3.9 Hz, 1H), 1.17 (s, 3H), 1.12 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 
176.7, 172.0, 147.6, 147.2, 130.2, 123.3, 52.2, 51.9, 48.9, 46.1, 35.5, 24.2, 22.2; HRMS (GC-EI) 
calculated for C15H19NO6: 309.1207; found 309.1205; [α]D
25
 = –13.5° (c = 0.64, CHCl3); HPLC 
Daicel Chiralpak OD-3, n-heptane/IPA = 95/5, 1 mL/min, 25 °C, 220 nm, tR (major) = 8.3 min, tR 
(minor) = 10.0 min; e.r. = 95.25:4.75. 
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dimethyl (S)-3-(benzo[d][1,3]dioxol-5-yl)-2,2-dimethylpentanedioate (3l): Prepared according 
to a modified general procedure (m-xylene instead of cyclohexane) 
using (E)-methyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate (1l, 0.20 mmol, 
42 mg), 1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of SKA 2a 
(0.12 mL, 0.60 mmol) at 0 °C for 3 days. The product was obtained 
after column chromatography on silica gel (10:1 hexane/EtOAc) as a 
colorless oil (52 mg, 84% yield). The enantiomeric ratio was 
determined by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, 
CDCl3) δ 6.71 (d, J = 8.0 Hz, 1H), 6.67 – 6.60 (m, 2H), 5.92 (q, J = 1.5 
Hz, 2H), 3.65 (s, 3H), 3.52 (s, 3H), 3.45 (dd, J = 11.4, 4.1 Hz, 1H), 2.76 (dd, J = 15.7, 11.4 Hz, 
1H), 2.63 (dd, J = 15.8, 4.1 Hz, 1H), 1.14 (s, 3H), 1.09 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 
177.5, 172.6, 147.4, 146.6, 133.2, 122.6, 109.5, 107.9, 101.1, 52.0, 51.7, 48.8, 46.3, 36.0, 24.3, 
21.9; HRMS (GC-EI) calculated for C16H20O6: 308.1254; found 308.1256; [α]D
25
 = –10.6° (c = 
0.49, CHCl3); HPLC Daicel Chiralpak OD-3, n-heptane/IPA = 98/2, 1 mL/min, 25 °C, 220 nm, tR 
(major) = 9.7 min, tR (minor) = 14.9 min; e.r. = 97:3. 
 
dimethyl (R)-3-(furan-2-yl)-2,2-dimethylpentanedioate (3m): Prepared according to the general 
procedure using (E)-methyl 3-(furan-2-yl)acrylate (1m, 0.20 mmol, 
30 mg), 1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of SKA 2a 
(0.12 mL, 0.60 mmol) at 0 °C for 14 hours. The product was obtained 
after column chromatography on silica gel (20:1→10:1 hexane/EtOAc) 
as a acid-labile, colorless oil (48 mg, 94% yield). The enantiomeric 
ratio was determined by HPLC on a chiral stationary phase. 
1
H NMR 
(500 MHz, CD2Cl2) δ 7.33 (dd, J = 1.9, 0.8 Hz, 1H), 6.30 (dd, J = 3.2, 1.8 Hz, 1H), 6.09 (dt, J = 
3.2, 0.7 Hz, 1H), 3.66 (s, 3H), 3.65 (dd, J = 11.4, 3.7 Hz, 1H), 3.55 (s, 3H), 2.77 (dd, J = 15.9, 11.5 
Hz, 1H), 2.53 (dd, J = 15.9, 3.6 Hz, 1H), 1.16 (s, 3H), 1.08 (s, 3H);
 13
C NMR (126 MHz, CD2Cl2) δ 
177.4, 172.7, 154.7, 142.0, 110.6, 108.2, 52.4, 52.1, 46.4, 43.1, 34.7, 24.3, 21.8; HRMS (GC-EI) 
calculated for C13H18O5: 254.1149; found 254.1147; [α]D
25
 = –4.4° (c = 0.49, CHCl3); HPLC 
Daicel Chiralpak OD-3, n-heptane/IPA = 99/1, 1 mL/min, 25 °C, 220 nm, tR (major) = 7.7 min, tR 
(minor) = 9.3 min; e.r. = 94.5:5.5. 
 
NOTE: Co-evaporation with reagent grade CHCl3 to remove solvent impurities, resulted in an 
orange decomposition product. 
 
dimethyl (R)-2,2-dimethyl-3-phenethylpentanedioate (3n): Prepared according to a modified 
general procedure using (E)-methyl 5-phenylpent-2-enoate (1n, 
0.21 mmol, 40 mg), 1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of 
SKA 2a (0.12 mL, 0.60 mmol) at –40 °C in methylcyclohexane (1 mL) 
for 24 hours. The product was obtained after chromatography on silica 
gel (20:1→10:1→5:1 hexane/EtOAc) as a colorless oil (56 mg, 92% 
yield). The enantiomeric ratio was determined by HPLC on a chiral 
stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 7.30 – 7.25 (m, 2H), 
7.20 – 7.13 (m, 3H), 3.70 (s, 3H), 3.62 (s, 3H), 2.65 (ddd, J = 13.5, 
10.9, 5.1 Hz, 1H), 2.51 (ddd, J = 13.6, 10.7, 6.3 Hz, 1H), 2.47 (dd, J = 15.6, 4.8 Hz, 1H), 2.41 – 
2.35 (m, 1H), 2.24 (dd, J = 15.6, 6.9 Hz, 1H), 1.66 (dddd, J = 13.8, 10.9, 6.3, 2.9 Hz, 1H), 1.46 
(dddd, J = 14.0, 10.6, 9.4, 5.1 Hz, 1H), 1.13 (s, 3H), 1.12 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 
177.9, 174.1, 142.2, 128.5, 128.5, 126.0, 51.9, 51.9, 46.2, 42.0, 35.9, 34.7, 34.3, 23.1, 21.7; HRMS 
(ESI) calculated for C17H24O4Na (M+Na)
+
: 315.1567; found 315.1569; [α]D
25
 = –7.4° (c=0.71, 
CHCl3); HPLC: Chiralpak OD-3, n-heptane/IPA = 99/1, 1 mL/min, 25 °C, 220 nm, tR (major) = 
8.9 min; tR (minor) = 9.8 min, e.r. = 97:3 
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dimethyl (R)-3-heptyl-2,2-dimethylpentanedioate (3o): Prepared according to the general 
procedure using (E)-methyl dec-2-enoate (1o, 0.23 mmol, 43 mg), 
(S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of SKA 2a (0.12 mL, 
0.60 mmol) at –40 °C for 48 hours. The product was obtained after 
chromatography on silica gel (20:1→10:1 hexane/EtOAc) as a colorless 
oil (66 mg, 95% yield). The enantiomeric ratio was determined by 
derivatization to the corresponding 1,5-dicarboxylic acid and GC 
analysis on a chiral stationary phase (see 3-heptyl-2,2-
dimethylpentanedioic acid). 
1
H NMR (500 MHz, CDCl3) δ 3.66 (s, 
3H), 3.65 (s, 3H), 2.37 (dd, J = 15.7, 4.9 Hz, 1H), 2.26 (ddq, J = 9.6, 
4.9, 2.6 Hz, 1H), 2.12 (dd, J = 15.6, 6.9 Hz, 1H), 1.34 – 1.16 (m, 12H), 1.12 (s, 3H), 1.10 (s, 3H), 
0.86 (t, J = 7.0 Hz, 3H);
 13
C NMR (126 MHz, CDCl3) δ 178.1, 174.3, 51.8, 51.7, 46.2, 42.2, 35.9, 
31.9, 31.9, 29.9, 29.3, 28.2, 23.2, 22.8, 21.7, 14.2; HRMS (ESI) calculated for C16H31O4 (M+H)
+
: 
287.2217; found 287.2217; [α]D
25
 = –5.9° (c=0.74, CHCl3). 
 
dimethyl (S)-3-isopropyl-2,2-dimethylpentanedioate (3p): (E)-methyl 4-methylpent-2-enoate 
(E/Z 97:3, purchased from Alfa Aesar; 0.20 mmol, 28 μL) was tested as 
substrate using a modified general procedure with 5 mol% (S,S)-4e 
(17.1 mg, 10 μmol) and 3 equiv. of SKA 2a (0.12 mL, 0.60 mmol) at 
40 °C for 16 h. A conversion of 27% was determined by 
1
H NMR 
analysis. The enantiomeric ratio was determined by GC on a chiral 
stationary phase. Rac-3p could be isolated by using HNTf2 as the catalyst. 
1
H NMR (500 MHz, 
CDCl3) δ 3.67 (s, 3H), 3.66 (s, 3H), 2.37 (dd, J = 15.3, 5.4 Hz, 1H), 2.34 – 2.29 (m, 1H), 2.26 (dd, 
J = 15.3, 5.8 Hz, 1H), 1.82 (heptd, J = 6.9, 2.6 Hz, 1H), 1.16 (s, 3H), 1.15 (s, 3H), 0.90 (d, J = 7.0 
Hz, 3H), 0.80 (d, J = 6.8 Hz, 3H).
 13
C NMR (126 MHz, CDCl3) δ 178.3, 175.0, 51.8, 47.4, 46.3, 
31.1, 28.7, 24.8, 23.9, 22.4, 18.3; HRMS (ESI) calculated for C12H22O4Na (M+Na)
+
: 253.1410; 
found 253.1412; GC column: C-DEXTRIN H G 632, 25.0 m, temperature: 230 90 62 MIN ISO 
8/MIN 170 3 MIN ISO 350, gas: 0.40 bar H2, sample size: 1.0 mL, tR (minor) = 53.58 min, tR 
(major) = 55.47 min, e.r. = 85.5:15.5. 
 
5-ethyl 1-methyl (S)-2,2-dimethyl-3-phenylpentanedioate: Prepared according to a modified 
general procedure using (E)-ethyl cinnamate (0.20 mmol, 34 μL), 
1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of SKA 2a (0.12 mL, 
0.60 mmol) at 0 °C for 5 days to reach full conversion. The 1,2-addition 
product (see below) was obtained after column chromatography on silica 
gel (20:1 hexane/EtOAc) as a colorless oil (E/Z 93:7, 4 mg, 9% yield). 
Further elusion gave the desired Mukaiyama–Michael product (title 
compound) as a colorless oil (50 mg, 89% yield). The enantiomeric ratio was determined by HPLC 
on a chiral stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 7.21 (tt, J = 6.7, 1.1 Hz, 2H), 7.18 – 
7.14 (m, 1H), 7.13 – 7.10 (m, 2H), 3.87 (qq, J = 10.8, 7.1 Hz, 2H), 3.60 (s, 3H), 3.47 (dd, J = 11.5, 
4.3 Hz, 1H), 2.79 (dd, J = 15.5, 11.5 Hz, 1H), 2.60 (dd, J = 15.5, 4.2 Hz, 1H), 1.11 (s, 3H), 1.05 (s, 
3H), 0.96 (t, J = 7.1 Hz, 3H);
 13
C NMR (126 MHz, CDCl3) δ 177.5, 172.2, 139.5, 129.5, 128.0, 
127.1, 60.4, 52.0, 49.1, 46.2, 36.0, 24.3, 21.8, 14.1; HRMS (ESI) calculated for C16H23O4 (M+H)
+
: 
279.1591; found 279.1591; HPLC Daicel Chiralpak OD-3, n-heptane/IPA = 98/2, 1 mL/min, 
25 °C, 220 nm, tR (minor) = 5.6 min, tR (major) = 6.3 min; e.r. = 77.5:22.5. [α]D
25
 = –9.5° (c=0.74, 
CHCl3). 
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methyl (E)-2,2-dimethyl-3-oxo-5-phenylpent-4-enoate: 
1
H NMR (500 MHz, CDCl3) δ 7.72 (d, J = 15.7 Hz, 1H), 7.58 – 7.52 
(m, 2H), 7.43 – 7.37 (m, 3H), 6.85 (d, J = 15.6 Hz, 1H), 3.73 (s, 3H), 
1.46 (s, 6H);
 13
C NMR (126 MHz, CDCl3) δ 196.5, 174.6, 144.2, 
134.6, 130.8, 129.1, 128.6, 120.9, 55.0, 52.7, 22.1; HRMS (ESI) 
calculated for C14H16O3Na (M+Na)
+
: 255.0992; found 255.0990.  
 
dimethyl (S)-1-(3-methoxy-3-oxo-1-phenylpropyl)cyclohexane-1-carboxylate (5a): Prepared 
according to the general procedure using (E)-methyl cinnamate (1a, 
0.20 mmol, 32 mg), 2 mol% (S,S)-4e (6.8 mg, 4 μmol) and 3 equiv. of 
SKA 2b (0.14 mL, 0.60 mmol) at 0 °C for 14 hours. The product was 
obtained after column chromatography on silica gel (20:1→10:1 
hexane/EtOAc) as a colorless oil (58 mg, 95% yield). The enantiomeric 
ratio was determined by HPLC on a chiral stationary phase. 
1
H NMR 
(500 MHz, CDCl3) δ 7.28 – 7.23 (m, 2H), 7.22 – 7.18 (m, 1H), 7.11 – 
7.06 (m, 2H), 3.63 (s, 3H), 3.46 (s, 3H), 3.28 (dd, J = 9.2, 6.3 Hz, 1H), 2.86 – 2.76 (m, 2H), 2.26 – 
2.14 (m, 1H), 2.02 – 1.91 (m, 1H), 1.67 – 1.51 (m, 3H), 1.38 – 0.98 (m, 5H); 13C NMR (126 MHz, 
CDCl3) δ 175.7, 173.0, 139.6, 129.3, 127.9, 127.1, 51.6, 51.5, 51.2, 50.7, 35.4, 33.3, 31.6, 25.6, 
23.8, 23.5; HRMS (GC-EI) calculated for C18H24O4: 304.1669; found 304.1670; [α]D
25
 = +8.9° (c = 
0.81, CHCl3); HPLC Daicel Chiralpak OD-3, n-heptane/IPA = 98/2, 1 mL/min, 25 °C, 220 nm, tR 
(major) = 9.0 min, tR (minor) = 19.4 min; e.r. = 98:2. 
 
dimethyl (S)-1-(3-methoxy-3-oxo-1-phenylpropyl)cyclopentane-1-carboxylate (5b): Prepared 
according to the general procedure using (E)-methyl cinnamate (1a, 
0.20 mmol, 32 mg), 1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of 
SKA 2c (0.13 mL, 0.60 mmol) at 0 °C for 16 hours. The product was 
obtained after column chromatography on silica gel (20:1→10:1 
hexane/EtOAc) as a colorless oil (56 mg, 97% yield). The enantiomeric 
ratio was determined by HPLC on a chiral stationary phase. 
1
H NMR 
(500 MHz, CDCl3) δ 7.28 – 7.23 (m, 2H), 7.22 – 7.18 (m, 1H), 7.15 – 
7.11 (m, 2H), 3.62 (s, 3H), 3.49 (s, 3H), 3.49 (dd, J = 11.1, 4.1 Hz, 1H), 2.91 (dd, J = 15.9, 11.2 
Hz, 1H), 2.80 (dd, J = 16.0, 4.1 Hz, 1H), 2.21 – 2.11 (m, 1H), 2.11 – 2.02 (m, 1H), 1.61 – 1.45 (m, 
6H);
 13
C NMR (126 MHz, CDCl3) δ 176.9, 172.9, 140.5, 128.8, 128.1, 127.1, 59.1, 51.9, 51.7, 
48.6, 37.1, 35.1, 33.5, 24.3, 24.2; HRMS (GC-EI) calculated for C17H22O4: 290.1513; found 
290.1514; [α]D
25
 = +24.4° (c = 0.76, CHCl3); HPLC Daicel Chiralpak OD-3, n-heptane/IPA = 
99/1, 1 mL/min, 25 °C, 220 nm, tR (major) = 11.5 min, tR (minor) = 12.9 min; e.r. = 96:4. 
 
dimethyl (S)-1-(3-methoxy-3-oxo-1-phenylpropyl)cyclobutane-1-carboxylate (5c): Prepared 
according to the general procedure using (E)-methyl cinnamate (1a, 
0.20 mmol, 32 mg), 1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of 
SKA 2d (0.15 mL, 82%, 0.60 mmol) at 0 °C for 16 hours. The product 
was obtained after column chromatography on silica gel (20:1→10:1 
hexane/EtOAc) as a colorless oil (55 mg, 99% yield). The enantiomeric 
ratio was determined by HPLC on a chiral stationary phase. 
1
H NMR 
(500 MHz, CDCl3) δ 7.30 – 7.22 (m, 2H), 7.23 – 7.19 (m, 1H), 7.17 – 
7.12 (m, 2H), 3.64 (s, 3H), 3.54 (dd, J = 10.8, 4.3 Hz, 1H), 3.51 (s, 3H), 2.88 (dd, J = 16.0, 10.8 
Hz, 1H), 2.80 (dd, J = 16.0, 4.3 Hz, 1H), 2.39 – 2.29 (m, 2H), 2.19 – 2.04 (m, 2H), 1.80 (dtt, J = 
11.5, 9.4, 7.3 Hz, 1H), 1.68 (dtt, J = 11.4, 9.4, 5.7 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 176.7, 
172.9, 139.7, 128.5, 128.3, 127.2, 52.2, 51.8, 51.7, 48.0, 35.6, 30.0, 28.4, 15.5; HRMS (ESI) 
calculated for C16H20O4Na (M+Na)
+
: 299.1254; found 299.1257; [α]D
25
 = +26.5° (c = 0.51, CHCl3); 
HPLC Daicel Chiralpak OD-3, n-heptane/IPA = 98/2, 1 mL/min, 25 °C, 220 nm, tR (minor) = 6.5 
min, tR (major) = 8.6 min; e.r. = 96.5:3.5. 
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dimethyl (2S,3R)-2-isopropyl-3-phenylpentanedioate (5f): Prepared according to the general 
procedure using (E)-methyl cinnamate (1a, 0.20 mmol, 32 mg), 
1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of SKA (E)-2g 
(0.13 mL, 0.60 mmol) at 0 °C for 20 hours. The product was obtained 
after column chromatography on silica gel (20:1→10:1 hexane/EtOAc) 
as a colorless oil (54 mg, 98% yield). The enantiomeric and 
diastereomeric ratio was determined by HPLC on a chiral stationary 
phase. The relative stereochemistry was assigned in analogy to 5d. 
1
H 
NMR (500 MHz, CDCl3) δ 7.31 – 7.27 (m, 2H), 7.24 – 7.16 (m, 3H), 3.66 (s, 3H), 3.56 – 3.49 (m, 
1H), 3.47 (s, 3H), 2.71 – 2.57 (m, 3H), 1.61 (pd, J = 6.9, 5.5 Hz, 1H), 0.89 (d, J = 6.9 Hz, 3H), 0.86 
(d, J = 6.8 Hz, 4H);
 13
C NMR (126 MHz, CDCl3) δ 174.3, 172.2, 141.4, 128.7, 128.0, 127.1, 57.1, 
51.6, 51.3, 42.0, 39.0, 28.0, 21.6, 17.7; HRMS (ESI) calculated for C16H22O4Na: 301.1410; found 
301.1410; [α]D
25
 = +19.8° (c = 0.61, CHCl3); HPLC Daicel Chiralpak OD-3, n-heptane/IPA = 
98/2, 1 mL/min, 25 °C, 220 nm, tR (minor, syn) = 5.0 min, (minor, anti) = 5.6 min, tR (major, syn) = 
6.6 min, tR (major, anti) = 7.5 min; e.r. = 99.5:0.5 (syn), e.r. 96.5:3.5 (anti), d.r. (syn/anti) = 96:4. 
 
dimethyl (2S,3R)-2-benzyl-3-phenylpentanedioate (5d): Prepared according to the general 
procedure using (E)-methyl cinnamate (1a, 0.20 mmol, 32 mg), 
1 mol% (S,S)-4e (3.4 mg, 2 μmol) and 3 equiv. of SKA (E)-2e 
(0.15 mL, 0.60 mmol) at 0 °C for 20 hours. The product was obtained 
after column chromatography on silica gel (40:1→20:1→10:1 
hexane/EtOAc) as a colorless solid (65 mg, 98%). The enantiomeric 
and diastereomeric ratios were determined by HPLC on a chiral 
stationary phase. [α]D
25
 = +0.8° (c = 0.53, CHCl3); HPLC Daicel 
Chiralpak OD-3, n-heptane/IPA = 98/2, 1 mL/min, 25 °C, 220 nm, tR 
(minor, syn) = 9.0 min, (minor, anti) = 12.1 min, tR (major, anti) = 15.2 min, tR (major, syn) = 18.3 
min; e.r. = 99:1 (syn), e.r. 94:6 (anti), d.r. (syn/anti) = 92:8. 
 
dimethyl (2R,3R)-2-benzyl-3-phenylpentanedioate (5e): Prepared according to the general 
procedure using (E)-methyl cinnamate (1a, 0.20 mmol, 32 mg), 5 mol% 
(S,S)-4e (17 mg, 10 μmol) and 1.5 equiv. of SKA (Z)-2e (80 μL, 
0.30 mmol) at 0 °C for 24 hours. The product was obtained after 
column chromatography on silica gel (40:1→20:1→10:1 
hexane/EtOAc) as a colorless solid (63 mg, 96%). The enantiomeric 
and diastereomeric ratios were determined by HPLC on a chiral 
stationary phase. [α]D
25
 = +11.9° (c = 0.51, CHCl3); HPLC Daicel 
Chiralpak OD-3, n-heptane/IPA = 98/2, 1 mL/min, 25 °C, 220 nm, tR 
(minor, syn) = 9.0 min, (minor, anti) = 12.1 min, tR (major, anti) = 15.2 min, tR (major, syn) = 18.3 
min; e.r. 94:6 (syn), e.r. = 98.5:1.5 (anti), d.r. (syn/anti) = 38:62. 
 
A racemic mixture of diastereomers 5d (syn) and 5e (anti) was separated by preparative HPLC and 
pure single diastereomers were characterized as follows: 
 
syn-diastereomer (5d): 
1
H NMR (500 MHz, CDCl3) δ 7.40 – 7.34 (m, 2H), 7.31 – 7.25 (m, 3H), 
7.25 – 7.19 (m, 2H), 7.19 – 7.14 (m, 1H), 7.04 – 6.98 (m, 2H), 3.55 (s, 3H), 3.52 (s, 3H), 3.47 (td, J 
= 9.9, 5.3 Hz, 1H), 2.96 (ddd, J = 11.2, 10.1, 3.9 Hz, 1H), 2.78 – 2.65 (m, 3H), 2.55 (dd, J = 13.7, 
3.9 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 174.7, 171.8, 141.1, 139.1, 128.9, 128.6, 128.4, 128.1, 
127.4, 126.5, 54.0, 51.6, 51.6, 44.8, 39.4, 37.2; HRMS (ESI) calculated for C20H22O4Na (M+Na)
+
: 
349.1410; found 349.1410. 
 
anti-diastereomer (5e): 
1
H NMR (500 MHz, CDCl3) δ 7.45 – 7.40 (m, 2H), 7.40 – 7.35 (m, 3H), 
7.35 – 7.29 (m, 3H), 7.28 – 7.23 (m, 2H), 3.70 (s, 3H), 3.69 – 3.65 (m, 1H), 3.46 (s, 3H), 3.19 (ddd, 
S-26 
 
J = 10.0, 7.5, 5.2 Hz, 1H), 3.11 (dd, J = 15.9, 5.8 Hz, 1H), 3.05 (dd, J = 13.5, 10.1 Hz, 1H), 3.00 
(dd, J = 13.6, 5.2 Hz, 1H), 2.92 (dd, J = 15.8, 9.2 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 173.8, 
172.3, 140.8, 139.1, 128.9, 128.5, 128.5, 128.1, 127.2, 126.5, 53.3, 51.8, 51.3, 44.2, 37.8, 35.9; 
HRMS (ESI) calculated for C20H22O4Na (M+Na)
+
: 349.1410; found 349.1411. 
 
Different silyl ketene acetals (E)-2e, (Z)-2e and 2f have been compared with respect to 
diastereoselectivity in the Mukaiyama–Michael reaction with 1a. Reactions with HNTf2 were 
conducted at –78 °C in DCM (entries 1-3). The reactions with 2f were performed under the 
conditions specified in the general procedure. The product was obtained after methylation with 
K2CO3 and MeI. 
 
entry silyl ketene acetal catalyst (loading) d.r. (syn/anti) e.r. (syn) e.r. (anti) 
1 (E)-2e HNTf2 (5 mol%) 69:31 / / 
2 (Z)-2e HNTf2 (5 mol%) 76:24 / / 
3 2f HNTf2 (5 mol%) 69:31 / / 
4 (E)-2e (S,S)-4e (1 mol%) 92:8 99:1 94:6 
5 (Z)-2e (S,S)-4e (5 mol%) 38:62 94:6 98.5:1.5 
6 2f (S,S)-4e (1 mol%) 33:67 80.5:19.5 90:10 
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Product Derivatizations & Assignment of Absolute and Relative 
Stereochemistry 
 
Product Derivatizations 
 
(R)-3-heptyl-2,2-dimethylpentanedioic acid: To a solution of diester 3o (42 mg, 0.15 mmol) in 
methanol (0.3 mL) in a vial, aq. NaOH (50%, 10 equiv., 0.12 mL) was 
added and the resulting reaction mixture was heated under stirring to 80 °C 
overnight. Aq. HCl (10%) was added after cooling to r.t. and the reaction 
mixture was extracted with DCM. The organic phase was washed with 
brine, drying over MgSO4, filtering and concentration gave the pure 
dicarboxylic acid as a colorless oil (37 mg, quant.). 
1
H NMR (500 MHz, 
CDCl3) δ 2.43 – 2.32 (m, 2H), 2.24 (dddd, J = 10.8, 8.6, 4.1, 2.2 Hz, 1H), 
1.51 (ddq, J = 12.8, 7.9, 2.6 Hz, 1H), 1.42 (ddt, J = 17.9, 10.3, 5.2 Hz, 
1H), 1.37 – 1.25 (m, 10H), 1.25 (s, 3H), 1.09 (s, 3H), 0.88 (t, J = 6.9 Hz, 
3H);
 13
C NMR (126 MHz, CDCl3) δ 185.1, 180.5, 44.7, 42.1, 35.4, 32.0, 29.7, 29.4, 29.3, 28.2, 
24.8, 22.8, 18.2, 14.2.; HRMS (ESI) calculated for C14H25O4 (M-H)
-
: 257.1758; found 257.1760; 
[α]D
25
 = –28.2° (c=0.44, CHCl3). GC column: IVADEX 1/PS086 G 662, 25.0 m, temperature: 230 
80 1/MIN 220 10 MIN ISO 350, gas: 0.50 bar H2, sample size: 1.0 μL, tR (major) = 136.34 min, tR 
(minor) = 136.61 min, e.r. = 95:5 
 
rac-(3R,4S)-4-benzyl-5-methoxy-5-oxo-3-phenylpentanoic acid (7): To a solution of diester rac-
5d (21 mg, 0.06 mmol, d.r. >20:1) in 2:1 methanol/THF 
(0.24 mL+0.12mL) at 0 °C, aq. NaOH (50%, 5 equiv., 30 μL) was added 
dropwiese, subsequently allowed to warm up to r.t. and stirred for 1 h in 
total. After full conversion was indicated by TLC, aq. HCl (10%) was 
added and the reaction mixture was extracted with DCM. The organic 
phase was washed with brine, drying over MgSO4, filtering and 
concentration gave the pure monocarboxylic acid as a colorless solid (20 mg, quant., d.r. >20:1). 
1
H NMR (500 MHz, CDCl3) δ 7.38 – 7.30 (m, 2H), 7.28 – 7.17 (m, 5H), 7.17 – 7.12 (m, 1H), 7.01 
– 6.95 (m, 2H), 3.50 (s, 3H), 3.40 (td, J = 9.6, 5.6 Hz, 1H), 2.92 (ddd, J = 11.2, 10.1, 4.0 Hz, 1H), 
2.77 – 2.64 (m, 3H), 2.51 (dd, J = 13.6, 4.0 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 177.0, 174.7, 
140.9, 139.0, 128.9, 128.7, 128.5, 128.1, 127.5, 126.5, 54.0, 51.7, 44.4, 39.1, 37.2; HRMS (ESI) 
calculated for C19H20O4Na (M+Na)
+
: 335.1254; found 335.1254. 
rac-5-methoxy-4,4-dimethyl-5-oxo-3-phenylpentanoic acid (6): Prepared according to a 
modified previous procedure (4 h reaction time, extraction with EtOAc 
instead of DCM) from rac-3a (56 mg, 0.21 mmol) to give the title 
compound as a colorless oil (53 mg, quant.). 
1
H NMR (500 MHz, 
CDCl3) δ 7.30 – 7.18 (m, 3H), 7.17 – 7.10 (m, 2H), 3.61 (s, 3H), 3.47 
(dd, J = 11.0, 4.1 Hz, 1H), 2.83 (dd, J = 16.1, 11.0 Hz, 1H), 2.67 (dd, J = 16.2, 4.1 Hz, 1H), 1.12 (s, 
3H), 1.06 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 177.9, 177.4, 139.2, 129.4, 128.1, 127.3, 52.0, 
48.6, 46.2, 35.8, 24.4, 21.6; HRMS (ESI) calculated for C14H18O4Na (M+Na)
+
: 273.1097; found 
273.1099. 
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(4S)-5,5-dimethyl-4-phenyltetrahydro-2H-pyran-2-ol (8): According to the general procedure 
for the asymmetric Mukaiyama–Michael reaction, (E)-methyl cinnamate (1a, 
0.20 mmol, 32 mg) was reacted at 0 °C for 14 hours. Then, LiAlH4 (1 M in Et2O, 
0.3 mL, 0.3 mmol) was added to the reaction mixture and the resulting 
suspension was stirred for 3 h at 0 °C. A sat. solution of Rochelle’s salt (1 mL) 
was added at 0 °C and the mixture stirred for 1 h at r.t.. The mixture was 
extracted with EtOAc, the organic layer washed with brine, dried over MgSO4 
and concentrated. Purification by column chromatography on silica gel 
(90:10→80:20→65:35→50:50 hexane/MTBE) gave the title compound as mixture of 
diastereomers (31 mg, 75% yield, d.r. 1:1, colorless solid). 
1
H NMR (500 MHz, CDCl3) δ 7.33 – 
7.27 (m, 4H), 7.26 – 7.21 (m, 2H), 7.19 – 7.12 (m, 4H), 5.46 (t, J = 2.8 Hz, 1H), 4.85 (ddd, J = 9.4, 
6.0, 2.4 Hz, 1H), 3.96 (d, J = 11.0 Hz, 1H), 3.65 (d, J = 6.1 Hz, 1H), 3.61 (d, J = 11.5 Hz, 1H), 3.41 
(d, J = 11.5 Hz, 1H), 3.20 (d, J = 11.0 Hz, 1H), 3.08 (dd, J = 13.6, 3.8 Hz, 1H), 2.99 (t, J = 2.4 Hz, 
1H), 2.64 (dd, J = 13.4, 3.6 Hz, 1H), 2.32 (tdd, J = 13.7, 3.7, 1.9 Hz, 1H), 2.08 (td, J = 13.2, 9.4 
Hz, 1H), 1.88 (ddd, J = 13.0, 3.7, 2.4 Hz, 1H), 1.73 (ddd, J = 13.7, 3.7, 1.1 Hz, 1H), 0.93 (s, 3H), 
0.92 (s, 3H), 0.72 (s, 3H), 0.72 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 141.1, 140.7, 129.4, 129.2, 
127.9, 127.8, 126.8, 126.6, 97.3, 92.1, 77.7, 71.0, 49.9, 44.2, 34.8, 34.3, 34.0, 31.7, 25.1, 24.4, 
19.0, 18.3; [α]D
25
 = +102.9° (c=0.49, CHCl3); HRMS (ESI) calculated for C13H18O2Na (M+Na)
+
: 
229.1199; found 229.1201. 
 
Assignment of Absolute Stereochemistry 
 
(S)-2,2-dimethyl-3-phenylpentane-1,5-diol:  
An ice-cooled solution of (S)-3a (407 mg, 1.54 mmol) in THF (15 mL) 
under argon was treated with LiAlH4 (1 M in Et2O, 2.3 mL, 2.3 mmol). 
The ice-bath was removed and the reaction was stirred for 2 h at r.t.. A 
sat. solution of Rochelle’s salt (20 mL) was added at 0 °C and the mixture 
stirred for 1 h at r.t.. Extraction with EtOAc, drying of the organic layer 
over MgSO4 and concentration gave the title compound as a colorless, 
crystalline solid (310 mg, 99% yield) without further purification. 
1
H NMR (500 MHz, CDCl3) δ 7.31 – 7.26 (m, 2H), 7.24 – 7.18 (m, 3H), 3.51 (ddd, J = 10.9, 6.9, 
4.3 Hz, 1H), 3.42 (d, J = 10.9 Hz, 1H), 3.35 (ddd, J = 10.3, 8.6, 6.0 Hz, 1H), 3.21 (d, J = 10.9 Hz, 
1H), 2.83 (dd, J = 11.8, 3.0 Hz, 1H), 2.04 (dddd, J = 13.7, 8.6, 6.9, 3.0 Hz, 1H), 1.95 (dddd, J = 
13.7, 11.7, 6.0, 4.3 Hz, 1H), 1.71 (s, 2H), 0.94 (s, 3H), 0.81 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 
141.9, 129.7, 128.2, 126.5, 71.0, 61.9, 47.4, 38.6, 32.3, 22.6, 22.2; [α]D
25
 = +1.0° (c=0.21, CHCl3); 
HRMS (ESI) calculated for C13H20O2Na (M+Na)
+
: 231.1355; found 231.1357. 
 
(S)-3-(4-bromophenyl)-2,2-dimethylpentane-1,5-diol: Prepared according to previous procedure 
from (S)-3g (137 mg, 1.54 mmol) to give the title compound as a 
colorless solid (113 mg, 98% yield). 
1
H NMR (500 MHz, acetone-d6) δ 
7.51 – 7.39 (m, 2H), 7.23 – 7.17 (m, 2H), 3.65 (t, J = 5.3 Hz, 1H), 3.39 (t, 
J = 5.1 Hz, 1H), 3.33 (ddt, J = 10.4, 8.0, 4.5 Hz, 1H), 3.28 (dd, J = 10.5, 
5.1 Hz, 1H), 3.19 (dddd, J = 10.2, 8.2, 6.9, 5.4 Hz, 1H), 3.13 (dd, J = 
10.5, 5.6 Hz, 1H), 2.89 (dd, J = 12.1, 3.0 Hz, 1H), 2.04 – 1.98 (m, 1H), 
1.91 (dddd, J = 13.4, 12.0, 7.0, 4.1 Hz, 1H), 0.91 (s, 3H), 0.75 (s, 3H);
 13
C 
NMR (126 MHz, acetone-d6) δ 142.9, 132.7, 131.4, 120.1, 70.4, 61.4, 
47.6, 38.9, 33.0, 22.8, 22.7; [α]D
25
 = +9.2° (c=0.45, CHCl3); HRMS (ESI) 
calculated for C13H19O2BrNa (M+Na)
+
: 309.0461; found 309.0461. 
Both 1,5-diols were crystallized from DCM/hexane to afford single-crystals suitable for X-ray 
structure analysis (see below). All other products were assigned by analogy. 
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(S)-3,3-dimethyl-4-phenyltetrahydro-2H-pyran (9): A seal-cap vial was charged with (S)-2,2-
dimethyl-3-phenylpentane-1,5-diol (42 mg, 0.2 mmol), p-toluenesulfonic acid 
(8 mg, 0.04 mmol) and MgSO4 (40 mg). The reactants were dissolved in toluene 
(2 mL), the vial was sealed and the suspension was heated to 120 °C overnight. 
Purification by column chromatography on silica gel (10:1 hexane/EtOAc) gave 
the title compound as a colorless solid (37 mg, 97% yield). 
1
H NMR (500 MHz, 
CDCl3) δ 7.33 – 7.28 (m, 2H), 7.25 – 7.21 (m, 1H), 7.20 – 7.14 (m, 2H), 4.13 (ddt, J = 11.3, 4.8, 
1.2 Hz, 1H), 3.56 (dd, J = 11.2, 0.9 Hz, 1H), 3.50 (ddd, J = 12.2, 11.3, 2.5 Hz, 1H), 3.26 (dd, J = 
11.1, 1.0 Hz, 1H), 2.58 (dd, J = 13.0, 3.6 Hz, 1H), 2.30 (tdd, J = 13.2, 12.4, 4.8 Hz, 1H), 1.49 
(dddd, J = 13.5, 3.9, 2.4, 1.5 Hz, 1H), 0.93 (s, 3H), 0.70 (s, 3H);
 13
C NMR (126 MHz, CDCl3) δ 
141.8, 129.3, 127.8, 126.5, 80.3, 69.3, 51.5, 34.8, 28.2, 25.1, 19.0; [α]D
25
 = +57.9° (c=0.76, 
CHCl3); HRMS (GC-EI) calculated for C13H18O: 191.1430; found 191.1431. 
 
Assignment of Relative Stereochemistry 
 
A racemic mixture of diastereomers 5d (syn) and 5e (anti) was separated by preparative HPLC and 
the single diastereomers were subsequently derivatized to tetrahydropyrans 11 and 13, respectively. 
 
rac-(2S,3R)-2-benzyl-3-phenylpentane-1,5-diol (10): Prepared according to previous procedure 
from rac-5d (48 mg, 0.15 mmol) to give the title compound as a colorless 
solid (40 mg, quant.). 
1
H NMR (500 MHz, CDCl3) δ 7.31 – 7.22 (m, 2H), 
7.21 – 7.11 (m, 5H), 7.11 – 7.03 (m, 1H), 7.02 – 6.96 (m, 2H), 3.64 (dd, J 
= 11.3, 3.5 Hz, 1H), 3.49 (ddd, J = 10.9, 6.4, 4.7 Hz, 1H), 3.41 – 3.30 (m, 
2H), 2.94 (ddd, J = 10.7, 8.2, 3.9 Hz, 1H), 2.47 (dd, J = 13.7, 3.8 Hz, 1H), 
2.28 (dd, J = 13.7, 10.8 Hz, 1H), 2.17 – 2.05 (m, 3H), 1.92 (ddq, J = 12.0, 
8.1, 3.9 Hz, 1H), 1.83 (ddt, J = 13.7, 10.5, 5.1 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 143.3, 
141.3, 129.1, 128.7, 128.7, 128.4, 126.6, 126.0, 61.2, 61.0, 48.1, 42.7, 35.7, 35.0; HRMS (ESI) 
calculated for C18H22O2Na (M+Na)
+
: 293.1512; found 293.1513. 
rac-(2R,3R)-2-benzyl-3-phenylpentane-1,5-diol (12): Prepared according to the previous 
procedure from rac-5e (46 mg, 0.14 mmol) to give the title compound as a 
colorless solid (38 mg, quant.). 
1
H NMR (500 MHz, CDCl3) δ 7.36 – 7.28 
(m, 2H), 7.30 – 7.20 (m, 5H), 7.20 – 7.16 (m, 1H), 7.16 – 7.11 (m, 2H), 
3.54 (ddd, J = 11.0, 6.9, 4.5 Hz, 1H), 3.46 – 3.36 (m, 2H), 3.27 (dd, J = 
11.2, 4.4 Hz, 1H), 2.99 (ddd, J = 11.0, 6.9, 3.7 Hz, 1H), 2.85 (dd, J = 
13.7, 4.6 Hz, 1H), 2.54 (dd, J = 13.7, 9.9 Hz, 1H), 2.24 – 2.14 (m, 1H), 
2.03 (dq, J = 6.7, 4.9 Hz, 1H), 1.96 (h, J = 6.7, 5.9 Hz, 3H);
 13
C NMR (126 MHz, CDCl3) δ 142.9, 
140.8, 129.2, 128.7, 128.5, 128.5, 126.6, 126.1, 62.0, 61.3, 48.2, 42.6, 34.6, 34.5; HRMS (ESI) 
calculated for C18H22O2Na (M+Na)
+
: 293.1512; found 293.1512. 
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rac-(3S,4R)-3-benzyl-4-phenyltetrahydro-2H-pyran (11): Prepared analogously to (S)-9 from 
diol rac-10 (40 mg, 0.15 mmol) to give the pure title compound as a colorless 
solid (35 mg, 94% yield). For 
1
H NMR and 
13
C NMR, see below; HRMS (GC-
EI) calculated for C18H20O: 252.1509; found 252.1510. 
 
 
 
 
 
rac-(3R,4R)-3-benzyl-4-phenyltetrahydro-2H-pyran (13): Prepared according to the previous 
procedure from diol rac-12 (38 mg, 0.14 mmol) to give the pure title compound 
as a colorless solid (34 mg, 96% yield). For 
1
H NMR and 
13
C NMR, see below; 
HRMS (GC-EI) calculated for C18H20O: 252.1509; found 252.1510. 
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Table S6. Peak table compound 11. 
1
H NMR (500 MHz, CDCl3), 
13
C NMR (126 MHz, CDCl3). 
 
Atom δ J COSY HSQC HMQC NOESY
1 C 72,63 1ax, 1eq 5ax, 5eq, 1ax, 1eq, 6a, 6b, 2, 3
Hax 3,168 11.5(1eq), 10.6(2) 1eq, 2, 6a, 6b 1 1, 5, 3, 2, 6 8, 1eq, 5ax, 6b, 3
Heq 3,917 11.5(1ax), 0.9(5eq), 4.2(2) 5eq, 2, 1ax, 6b 1 11, 1, 5, 3, 2 8, 6b, 1ax, 2
2 C 43,20 2 1ax, 1eq, 6a, 6b, 2, 3, 4ax, 4eq
H 2,192 10.6(1ax), 4.2(1eq), 10.5(6b), 11.0(3), 3.2(6a) 1eq, 3, 6a, 1ax, 6b 2 7, 1, 3, 2, 6 8, 12, 1eq, 4ax, 6a
3 C 48,51 3 12, 5ax, 5eq, 1ax, 1eq, 6a, 6b, 3, 2, 4ax, 4eq
H 2,491 11.0(2), 12.0(4ax), 4.0(4eq) 4eq, 2, 4ax, 12, 6b 3 11, 12, 1, 5, 3, 2, 6, 4 12, 5ax, 1ax, 4eq, 6b, 6a
4 C 35,48 4ax, 4eq 5eq, 3, 4ax, 4eq
Hax 1,892 12.0(3), 4.6(5eq), 13.7(4eq), 12.3(5ax) 5eq, 5ax, 3, 4eq 4 11, 5, 3, 2, 4 12, 5eq, 2
Heq 1,765 4.0(3), 13.7(4ax), 1.7(5eq), 2.3(5ax) 5eq, 5ax, 3, 4ax 4 3, 2, 4 12, 5eq, 5ax, 3
5 C 68,69 5ax, 5eq 5ax, 5eq, 1ax, 1eq, 3, 4ax
Hax 3,498 12.3(4ax), 2.3(4eq), 11.4(5eq) 5eq, 4eq, 4ax 5 1, 5, 3 5eq, 1ax, 4eq, 3
Heq 4,043 0.9(1eq), 4.6(4ax), 1.7(4eq), 11.4(5ax) 4eq, 1eq, 5ax, 4ax 5 1, 5, 3, 4 4ax, 5ax, 4eq
6 C 36,68 6a, 6b 8, 1ax, 6a, 6b, 2, 3
Ha 2,597 3.2(2), 13.9(6b) 2, 8, 9, 10, 1ax, 6b 6 7, 12, 8, 1, 3, 2, 6 8, 12, 6b, 2, 3
Hb 2,050 10.5(2), 13.9(6a) 3, 2, 8, 6a, 1ax, 1eq 6 7, 8, 1, 3, 2, 6 8, 12, 1eq, 1ax, 3, 6a
7 C 139,91 9, 6a, 6b, 2
8 C 128,87 8 8, 10, 6a, 6b
H 6,986 m 9, 10, 6a, 6b 8 10, 8, 6 6b, 12, 1eq, 1ax, 2, 6a
9 C 128,33 9 9
H 7,219 m 10, 8, 6a 9 7, 9
10 C 126,03 10 8
H 7,148 m 9, 8, 6a 10 8
11 C 144,41 13, 3, 4ax, 1eq
12 C 127,80 12 12, 14, 3, 6a
H 7,297 m 13, 14, 3 12 14, 12, 3 6b, 4ax, 8, 4eq, 3, 2, 6a
13 C 128,84 13 13
H 7,375 m 14, 12 13 11, 13
14 C 126,70 14 12
H 7,263 m 13, 12 14 12  
 
Assignment of stereochemistry: 
The relative stereochemistry was determined to be anti based on coupling constants of adjacent 
hydrogen atoms of 11 as shown below, and NOESY signals. 
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Table S7. Peak table compound 13. 
1
H NMR (500 MHz, CDCl3), 
13
C NMR (126 MHz, CDCl3). 
 
Atom δ J COSY HSQC HMQC NOESY
1 C 69,67 1ax, 1eq 5eq, 6a, 6b, 1eq
Hax 3,496 Ddd 11.5(1eq), 2.4/1.6(2; 6b) 1eq, 6b, 2 1 6 2, 3
Heq 3,817 Dt 11.5(1ax), 1.3(2; 5eq) 5eq, 1ax, 2 1 3, 2, 5, 1, 6 8, 2, 6a
2 C 43,61 2 6a, 6b, 1eq
H 2,025 Dm 11.8(6a) 1eq, 1ax, 3, 6a, 6b 2 8, 1ax, 1eq, 6b, 3, 12
3 C 43,98 3 12, 5eq, 3, 1eq, 4ax
H 3,211 Dt 12.9(4ax), 3.9(4eq; 2) 12, 4ax, 4eq, 2 3 11, 12, 3, 4, 6 4eq, 2, 5ax, 1ax, 12
4 C 25,63 4ax, 4eq 3, 4ax
Hax 2,303 DDDd 13.3(4eq), 12.9(3), 12.2(5ax), 4.7(5eq) 4eq, 5eq, 5ax, 3 4 3, 5, 4 5eq, 4eq, 6a, 12
Heq 1,704 Dm 13.3(4ax) 4ax, 5eq, 5ax, 3 4 5eq, 5ax, 4ax, 3, 12
5 C 68,85 5ax, 5eq 5eq, 1eq, 4ax
Hax 3,591 DDd  12.2(4ax), 11.3(5eq), 2.4(4eq) 5eq, 4ax, 4eq 5 5eq, 4eq, 3
Heq 4,222 Dddm 11.3(5ax), 4.7(4ax), 1.8(4eq) 4ax, 4eq, 1eq, 5ax 5 3, 5, 1 5ax, 4ax, 4eq
6 C 30,60 6a, 6b 8, 1ax, 1eq, 3, 6a, 6b
Ha 2,755 DD 13.3(6b), 11.8(2) 8, 6b, 2 6 7, 8, 9, 2, 1, 6 8, 4ax, 6b, 1eq, 12
Hb 2,249 Dm 13.3(6a) 8, 1ax, 6a, 2 6 7, 8, 2, 1, 6 8, 2, 6a
7 C 141,49 9, 6a, 6b
8 C 129,31 8 8, 10, 6a, 6b
H 6,995 m 9, 6b, 6a 8 10, 8, 6 1eq, 6b, 2, 6a
9 C 128,33 9 9, 6a
H 7,209 m 10, 8 9 7, 9
10 C 125,80 10 8
H 7,133 m 9 10 8
11 C 143,85 13, 3
12 C 127,37 12 12, 14, 3
H 7,294 m 13, 3 12 14, 12, 3 4ax, 4eq, 2, 3, 6a
13 C 128,60 13 13
H 7,398 m 14, 12 13 13, 11
14 C 126,43 14 12
H 7,273 m 13 14 12  
 
Assignment of stereochemistry: 
The relative stereochemistry was determined to be syn based on coupling constants of adjacent 
hydrogen atoms of 13 as shown below, and NOESY signals. 
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X-ray Crystallography Data 
 
Single-Crystal X-ray Structure Analysis of (S)-2,2-dimethyl-3-phenyl-pentane-1,5-diol 
 
Figure S1. The molecular structure of (S)-2,2-dimethyl-3-phenyl-pentane-1,5-diol. Phenyl, methyl 
and methylene H atoms are removed for clarity. 
 
Table S8. Crystal data and structure refinement. 
 
Identification code  GAT-GB-597 (10566) 
Empirical formula  C13 H20 O2 
Color  colourless 
Formula weight  208.29  g·mol-1  
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  monoclinic 
Space group  P 21,  (no. 4)  
Unit cell dimensions a = 6.2186(7) Å = 90°. 
 b = 7.6511(8) Å = 96.281(2)°. 
 c = 12.8993(14) Å  = 90°. 
Volume 610.05(11) Å3 
Z 2 
Density (calculated) 1.134  Mg·m-3 
Absorption coefficient 0.587 mm-1 
F(000) 228 e 
Crystal size 0.290 x 0.201 x 0.080 mm3 
 range for data collection 3.447 to 72.168°. 
Index ranges -7  h  7, -9 k  9, -15 l  15 
Reflections collected 14442 
Independent reflections 2371 [Rint = 0.0306] 
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Reflections with I>2(I) 2250 
Completeness to  = 67.679° 100.0 %  
Absorption correction Gaussian 
Max. and min. transmission 0.96413 and 0.89095 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2371 / 3 / 147 
Goodness-of-fit on F2 1.173 
Final R indices [I>2(I)] R1 = 0.0480 wR
2 = 0.1336 
R indices (all data) R1 = 0.0497 wR
2 = 0.1350 
Absolute structure parameter 0.035(132)  972 selected quotients (Parsons' 
method) 
Extinction coefficient 0.045(6) 
Largest diff. peak and hole 0.191 and -0.182 e·Å-3 
 
Table S9. Atomic coordinates and equivalent isotropic displacement parameters (Å2). 
 
Ueq is defined as one third of the trace of the orthogonalized Uij tensor. 
 x y z Ueq 
C(1) 0.7817(4) 0.4438(4) 0.2212(2) 0.030(1) 
C(2) 0.7684(5) 0.6048(4) 0.1500(2) 0.034(1) 
C(3) 0.9495(5) 0.7339(4) 0.1792(2) 0.037(1) 
C(4) 0.6230(4) 0.2929(4) 0.1836(2) 0.032(1) 
C(5) 0.6558(5) 0.2387(4) 0.0717(2) 0.035(1) 
C(6) 0.6700(5) 0.1337(4) 0.2544(2) 0.036(1) 
C(7) 0.3852(5) 0.3433(5) 0.1822(3) 0.044(1) 
C(8) 0.7696(4) 0.4914(4) 0.3350(2) 0.030(1) 
C(9) 0.6075(5) 0.5966(4) 0.3686(2) 0.036(1) 
C(10) 0.5942(5) 0.6251(5) 0.4742(2) 0.038(1) 
C(11) 0.7438(5) 0.5505(4) 0.5483(2) 0.039(1) 
C(12) 0.9105(5) 0.4512(4) 0.5167(2) 0.037(1) 
C(13) 0.9231(5) 0.4227(4) 0.4111(2) 0.033(1) 
O(1) 0.9636(4) 0.8644(3) 0.1008(2) 0.048(1) 
O(2) 0.8751(4) 0.2001(3) 0.0580(2) 0.035(1) 
 
The absolute structure determination of two further crystals was undertaken:  
 1st crystal 
 Flack parameter x = 0.005(553) by classical fit to all intensities 
                      0.013(255) from 1004 selected quotients (Parsons' method) 
 2nd crystal 
 Flack parameter x = 0.068(445) by classical fit to all intensities 
                      0.039(194) from 977 selected quotients (Parsons' method) 
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Table S10. Bond lengths [Å] and angles [°]. 
 
______________________________________________________________________   
C(1)-C(8) 1.521(4) C(1)-C(2) 1.533(4)
C(1)-C(4) 1.561(4) C(1)-H(1A) 1.0000
C(2)-C(3) 1.514(4) C(2)-H(2A) 0.9900
C(2)-H(2B) 0.9900 C(3)-O(1) 1.430(4)
C(3)-H(3A) 0.9900 C(3)-H(3B) 0.9900
C(4)-C(7) 1.527(4) C(4)-C(6) 1.531(4)
C(4)-C(5) 1.537(4) C(5)-O(2) 1.425(4)
C(5)-H(5A) 0.9900 C(5)-H(5B) 0.9900
C(6)-H(6A) 0.9800 C(6)-H(6B) 0.9800
C(6)-H(6C) 0.9800 C(7)-H(7A) 0.9800
C(7)-H(7B) 0.9800 C(7)-H(7C) 0.9800
C(8)-C(9) 1.395(4) C(8)-C(13) 1.395(4)
C(9)-C(10) 1.391(4) C(9)-H(9) 0.9500
C(10)-C(11) 1.383(5) C(10)-H(10) 0.9500
C(11)-C(12) 1.382(4) C(11)-H(11) 0.9500
C(12)-C(13) 1.389(4) C(12)-H(12) 0.9500
C(13)-H(13) 0.9500 O(1)-H(1) 0.90(3)
O(2)-H(2) 0.89(3) 
 
C(8)-C(1)-C(2) 112.4(2) C(8)-C(1)-C(4) 112.4(2)
C(2)-C(1)-C(4) 114.7(2) C(8)-C(1)-H(1A) 105.5
C(2)-C(1)-H(1A) 105.5 C(4)-C(1)-H(1A) 105.5
C(3)-C(2)-C(1) 112.7(2) C(3)-C(2)-H(2A) 109.1
C(1)-C(2)-H(2A) 109.1 C(3)-C(2)-H(2B) 109.1
C(1)-C(2)-H(2B) 109.1 H(2A)-C(2)-H(2B) 107.8
O(1)-C(3)-C(2) 112.4(2) O(1)-C(3)-H(3A) 109.1
C(2)-C(3)-H(3A) 109.1 O(1)-C(3)-H(3B) 109.1
C(2)-C(3)-H(3B) 109.1 H(3A)-C(3)-H(3B) 107.9
C(7)-C(4)-C(6) 109.2(3) C(7)-C(4)-C(5) 106.5(2)
C(6)-C(4)-C(5) 108.0(2) C(7)-C(4)-C(1) 113.3(3)
C(6)-C(4)-C(1) 109.3(2) C(5)-C(4)-C(1) 110.3(2)
O(2)-C(5)-C(4) 113.5(2) O(2)-C(5)-H(5A) 108.9
C(4)-C(5)-H(5A) 108.9 O(2)-C(5)-H(5B) 108.9
C(4)-C(5)-H(5B) 108.9 H(5A)-C(5)-H(5B) 107.7
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C(4)-C(6)-H(6A) 109.5 C(4)-C(6)-H(6B) 109.5
H(6A)-C(6)-H(6B) 109.5 C(4)-C(6)-H(6C) 109.5
H(6A)-C(6)-H(6C) 109.5 H(6B)-C(6)-H(6C) 109.5
C(4)-C(7)-H(7A) 109.5 C(4)-C(7)-H(7B) 109.5
H(7A)-C(7)-H(7B) 109.5 C(4)-C(7)-H(7C) 109.5
H(7A)-C(7)-H(7C) 109.5 H(7B)-C(7)-H(7C) 109.5
C(9)-C(8)-C(13) 117.4(3) C(9)-C(8)-C(1) 123.4(2)
C(13)-C(8)-C(1) 119.1(3) C(10)-C(9)-C(8) 121.1(3)
C(10)-C(9)-H(9) 119.4 C(8)-C(9)-H(9) 119.4
C(11)-C(10)-C(9) 120.3(3) C(11)-C(10)-H(10) 119.8
C(9)-C(10)-H(10) 119.8 C(12)-C(11)-C(10) 119.5(3)
C(12)-C(11)-H(11) 120.3 C(10)-C(11)-H(11) 120.3
C(11)-C(12)-C(13) 120.0(3) C(11)-C(12)-H(12) 120.0
C(13)-C(12)-H(12) 120.0 C(12)-C(13)-C(8) 121.6(3)
C(12)-C(13)-H(13) 119.2 C(8)-C(13)-H(13) 119.2
C(3)-O(1)-H(1) 109(4) C(5)-O(2)-H(2) 107(3)  
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Table S11. Anisotropic displacement parameters (Å2). 
 
The anisotropic displacement factor exponent takes the form:  
 -22[ h2a*2U11 + ... + 2 h k a* b* U12 ]. 
 U11 U22 U33 U23 U13 U12 
C(1) 0.030(1)  0.030(1) 0.029(1)  0.002(1) 0.003(1)  0.004(1) 
C(2) 0.041(2)  0.033(2) 0.028(1)  0.004(1) 0.004(1)  0.006(1) 
C(3) 0.051(2)  0.028(2) 0.034(2)  0.004(1) 0.010(1)  0.001(1) 
C(4) 0.028(1)  0.036(2) 0.031(1)  -0.003(1) 0.004(1)  0.000(1) 
C(5) 0.036(2)  0.037(2) 0.032(2)  -0.005(1) 0.000(1)  0.001(1) 
C(6) 0.043(2)  0.033(2) 0.033(2)  -0.002(1) 0.009(1)  -0.006(1) 
C(7) 0.030(2)  0.053(2) 0.049(2)  -0.007(2) 0.005(1)  0.000(1) 
C(8) 0.032(1)  0.029(2) 0.028(1)  -0.001(1) 0.005(1)  0.001(1) 
C(9) 0.038(2)  0.036(2) 0.034(1)  0.002(1) 0.006(1)  0.005(1) 
C(10) 0.043(2)  0.034(2) 0.039(2)  -0.003(1) 0.013(1)  0.002(1) 
C(11) 0.049(2)  0.038(2) 0.030(1)  -0.004(1) 0.009(1)  -0.006(1) 
C(12) 0.045(2)  0.037(2) 0.030(1)  0.001(1) 0.001(1)  -0.003(1) 
C(13) 0.036(1)  0.033(2) 0.030(1)  -0.001(1) 0.002(1)  0.002(1) 
O(1) 0.079(2)  0.029(1) 0.040(1)  0.005(1) 0.026(1)  0.004(1) 
O(2) 0.041(1)  0.031(1) 0.035(1)  0.001(1) 0.012(1)  0.001(1) 
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Table S12. Hydrogen coordinates and isotropic displacement parameters (Å2). 
 
 x  y  z  Ueq 
 
H(1A) 0.9301 0.3951 0.2184 0.035 
H(2A) 0.7740 0.5665 0.0770 0.041 
H(2B) 0.6278 0.6638 0.1538 0.041 
H(3A) 0.9254 0.7916 0.2456 0.045 
H(3B) 1.0885 0.6700 0.1904 0.045 
H(5A) 0.5659 0.1344 0.0525 0.042 
H(5B) 0.6043 0.3344 0.0236 0.042 
H(6A) 0.5766 0.0364 0.2285 0.054 
H(6B) 0.6415 0.1631 0.3256 0.054 
H(6C) 0.8219 0.0995 0.2545 0.054 
H(7A) 0.3537 0.4433 0.1355 0.066 
H(7B) 0.3553 0.3750 0.2528 0.066 
H(7C) 0.2940 0.2442 0.1574 0.066 
H(9) 0.5044 0.6496 0.3184 0.043 
H(10) 0.4818 0.6963 0.4955 0.046 
H(11) 0.7321 0.5673 0.6205 0.046 
H(12) 1.0164 0.4024 0.5671 0.045 
H(13) 1.0389 0.3549 0.3903 0.040 
H(1) 1.003(8) 0.814(7) 0.043(3) 0.083(16) 
H(2) 0.899(9) 0.090(4) 0.078(4) 0.097(19) 
 
INTENSITY STATISTICS FOR DATASET  
 
 Resolution   #Data #Theory %Complete Redundancy Mean I Mean I/s Rmerge  Rsigma 
 
  Inf - 3.28      36     36    100.0     8.33    231.93   82.46  0.0163  0.0102 
 3.28 - 2.24      83     84     98.8     7.10     91.97   73.12  0.0213  0.0123 
 2.24 - 1.77     125    125    100.0     5.31     62.43   60.85  0.0210  0.0155 
 1.77 - 1.52     118    118    100.0     5.24     22.95   50.67  0.0255  0.0168 
 1.52 - 1.40     114    114    100.0     6.45     23.18   53.18  0.0256  0.0155 
 1.40 - 1.29     120    120    100.0     6.47     21.96   53.90  0.0254  0.0161 
 1.29 - 1.22     116    116    100.0     5.87     19.63   45.08  0.0225  0.0174 
 1.22 - 1.16     123    123    100.0     5.73     22.25   46.05  0.0214  0.0177 
 1.16 - 1.10     128    128    100.0     5.45     18.00   44.59  0.0235  0.0188 
 1.10 - 1.06     111    111    100.0     4.81     11.60   36.05  0.0309  0.0235 
 1.06 - 1.02     142    142    100.0     5.85     11.16   35.63  0.0434  0.0234 
 1.02 - 0.99     101    101    100.0     8.38      9.45   31.63  0.0732  0.0257 
 0.99 - 0.96     141    141    100.0     8.94      6.83   23.35  0.0976  0.0354 
 0.96 - 0.94      99    100     99.0     8.16      4.13   16.13  0.1204  0.0541 
 0.94 - 0.91     149    149    100.0     6.56      4.57   13.68  0.1169  0.0627 
 0.91 - 0.89     101    101    100.0     6.21      3.06    9.95  0.1512  0.0894 
 0.89 - 0.87     133    133    100.0     6.14      3.81   11.27  0.1301  0.0692 
 0.87 - 0.85     150    152     98.7     5.44      3.01   10.55  0.1476  0.0816 
 0.85 - 0.84      71     71    100.0     5.25      2.42    8.92  0.1503  0.0898 
 0.84 - 0.82     155    157     98.7     4.17      2.56    8.97  0.1393  0.0886 
 0.82 - 0.81      64     91     70.3     1.56      2.14    6.99  0.0967  0.1214 
------------------------------------------------------------------------------ 
 0.91 - 0.81     674    705     95.6     4.88      2.93    9.73  0.1404  0.0845 
  Inf - 0.81    2380   2413     98.6     6.00     19.72   32.56  0.0306  0.0196 
-------------------------------------------------------------------------------  
 0.75 - 0.65    1502   1505     99.8     4.57       5.8   13.24  0.0855  0.0586 
  Inf - 0.65    4402   4412     99.8     6.19      18.7   28.84  0.0368  0.0226 
------------------------------------------------------------------------------- 
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The structure was solved by direct methods and refined by full-matrix least-squares
 
against F
2
 to R1 
= 0.048 [I > 2(I)], wR2 = 0.135, 147 parameters. The C-H H atoms were refined using a riding 
model with a UH = 1.2 x UC. The O-H H atoms were refined with isotropic atomic displacement 
parameters and the O-H bond distances were restrained to be 0.84 Å with an estimated standard 
deviation of 0.02. S = 1.175, residual electron density 0.19 (1.35 Å from C11)/ -0.18 (0.48 from 
H12) e Å
-3
. Three crystals were investigated and their absolute configurations determined. The 
respective Flack parameters (Parson's method) are 0.035(132) [972 quotients], 0.039(194) [977 
quotients] and 0.013(255) [1004 quotients]. In addition, the absolute configuration of two crystals 
of the 4-bromyl-phenyl derivative were determined (see below). CCDC-1550399. 
 
Single-Crystal X-ray Structure Analysis of (S)-2,2-dimethyl-3-(4-bromo-phenyl)-pentane-1,5-
diol 
 
Figure S2. The molecular structure of (S)-2,2-dimethyl-3-(4-bromo-phenyl)-pentane-1,5-diol. 
Phenyl, methyl and methylene H atoms are removed for clarity. 
 
Table S13. Crystal data and structure refinement. 
 
Identification code  GAT-GB-611-01 (10742) 
Empirical formula  C13 H19 Br O2 
Color  colourless 
Formula weight  287.19  g·mol-1  
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P 21 21 21,  (no. 19)  
Unit cell dimensions a = 7.6003(11) Å = 90°. 
 b = 10.0962(5) Å = 90°. 
 c = 17.0161(15) Å  = 90°. 
Volume 1305.7(2) Å3 
Z 4 
Density (calculated) 1.461  Mg·m-3 
Absorption coefficient 3.133 mm-1 
F(000) 592 e 
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Crystal size 0.33 x 0.09 x 0.08 mm3 
 range for data collection 3.563 to 33.071°. 
Index ranges -11  h  11, -15 k  15, -26 l  26 
Reflections collected 29594 
Independent reflections 4949 [Rint = 0.0396] 
Reflections with I>2(I) 4560 
Completeness to  = 25.242° 99.6 %  
Absorption correction Gaussian 
Max. and min. transmission 0.80490 and 0.44130 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4949 / 0 / 151 
Goodness-of-fit on F2 1.103 
Final R indices [I>2(I)] R1 = 0.0261 wR
2 = 0.0537 
R indices (all data) R1 = 0.0323 wR
2 = 0.0560 
Absolute structure parameter -0.009(4) [1826 quotients] 
Extinction coefficient 0 
Largest diff. peak and hole 0.378 and -0.424 e·Å-3 
 
Table S14. Atomic coordinates and equivalent isotropic displacement parameters (Å2). 
 
Ueq is defined as one third of the trace of the orthogonalized Uij tensor. 
 x y z Ueq 
C(1) 0.6271(3) 0.4764(2) 0.6021(1) 0.012(1) 
C(2) 0.7695(2) 0.5829(2) 0.5938(1) 0.014(1) 
C(3) 0.8997(3) 0.5496(2) 0.5295(1) 0.017(1) 
C(4) 0.4826(3) 0.5112(2) 0.6636(1) 0.014(1) 
C(5) 0.4054(3) 0.6481(2) 0.6446(1) 0.018(1) 
C(6) 0.3356(3) 0.4081(2) 0.6596(1) 0.021(1) 
C(7) 0.5527(3) 0.5183(2) 0.7479(1) 0.021(1) 
C(8) 0.7099(3) 0.3411(2) 0.6141(1) 0.012(1) 
C(9) 0.8440(3) 0.3205(2) 0.6687(1) 0.015(1) 
C(10) 0.9276(3) 0.1992(2) 0.6760(1) 0.016(1) 
C(11) 0.8748(2) 0.0962(2) 0.6282(1) 0.014(1) 
C(12) 0.7415(3) 0.1118(2) 0.5740(1) 0.015(1) 
C(13) 0.6603(3) 0.2342(2) 0.5673(1) 0.015(1) 
Br(1) 0.9879(1) -0.0706(1) 0.6354(1) 0.021(1) 
O(1) 1.0288(2) 0.6503(2) 0.5202(1) 0.020(1) 
O(2) 0.3636(2) 0.6629(2) 0.5636(1) 0.021(1) 
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Table S15. Bond lengths [Å] and angles [°]. 
______________________________________________________________________   
C(1)-C(8) 1.518(3) C(1)-C(2) 1.532(3)
C(1)-C(4) 1.557(3) C(1)-H(1A) 1.0000
C(2)-C(3) 1.514(3) C(2)-H(2A) 0.9900
C(2)-H(2B) 0.9900 C(3)-O(1) 1.421(2)
C(3)-H(3A) 0.9900 C(3)-H(3B) 0.9900
C(4)-C(6) 1.528(3) C(4)-C(7) 1.532(3)
C(4)-C(5) 1.535(3) C(5)-O(2) 1.422(3)
C(5)-H(5A) 0.9900 C(5)-H(5B) 0.9900
C(6)-H(6A) 0.9800 C(6)-H(6B) 0.9800
C(6)-H(6C) 0.9800 C(7)-H(7A) 0.9800
C(7)-H(7B) 0.9800 C(7)-H(7C) 0.9800
C(8)-C(13) 1.393(3) C(8)-C(9) 1.394(3)
C(9)-C(10) 1.386(3) C(9)-H(9) 0.9500
C(10)-C(11) 1.380(3) C(10)-H(10) 0.9500
C(11)-C(12) 1.380(3) C(11)-Br(1) 1.8947(19)
C(12)-C(13) 1.385(3) C(12)-H(12) 0.9500
C(13)-H(13) 0.9500 O(1)-H(1) 0.74(3)
O(2)-H(2) 0.74(3) 
 
C(8)-C(1)-C(2) 110.55(15) C(8)-C(1)-C(4) 113.92(16)
C(2)-C(1)-C(4) 113.68(16) C(8)-C(1)-H(1A) 106.0
C(2)-C(1)-H(1A) 106.0 C(4)-C(1)-H(1A) 106.0
C(3)-C(2)-C(1) 111.92(17) C(3)-C(2)-H(2A) 109.2
C(1)-C(2)-H(2A) 109.2 C(3)-C(2)-H(2B) 109.2
C(1)-C(2)-H(2B) 109.2 H(2A)-C(2)-H(2B) 107.9
O(1)-C(3)-C(2) 111.89(17) O(1)-C(3)-H(3A) 109.2
C(2)-C(3)-H(3A) 109.2 O(1)-C(3)-H(3B) 109.2
C(2)-C(3)-H(3B) 109.2 H(3A)-C(3)-H(3B) 107.9
C(6)-C(4)-C(7) 109.13(17) C(6)-C(4)-C(5) 108.91(17)
C(7)-C(4)-C(5) 106.70(16) C(6)-C(4)-C(1) 109.37(16)
C(7)-C(4)-C(1) 113.24(17) C(5)-C(4)-C(1) 109.39(16)
O(2)-C(5)-C(4) 112.54(17) O(2)-C(5)-H(5A) 109.1
C(4)-C(5)-H(5A) 109.1 O(2)-C(5)-H(5B) 109.1
C(4)-C(5)-H(5B) 109.1 H(5A)-C(5)-H(5B) 107.8
C(4)-C(6)-H(6A) 109.5 C(4)-C(6)-H(6B) 109.5
H(6A)-C(6)-H(6B) 109.5 C(4)-C(6)-H(6C) 109.5
H(6A)-C(6)-H(6C) 109.5 H(6B)-C(6)-H(6C) 109.5
C(4)-C(7)-H(7A) 109.5 C(4)-C(7)-H(7B) 109.5
H(7A)-C(7)-H(7B) 109.5 C(4)-C(7)-H(7C) 109.5
H(7A)-C(7)-H(7C) 109.5 H(7B)-C(7)-H(7C) 109.5
C(13)-C(8)-C(9) 117.59(18) C(13)-C(8)-C(1) 120.54(17)
C(9)-C(8)-C(1) 121.77(17) C(10)-C(9)-C(8) 121.79(18)
C(10)-C(9)-H(9) 119.1 C(8)-C(9)-H(9) 119.1
C(11)-C(10)-C(9) 118.65(18) C(11)-C(10)-H(10) 120.7
C(9)-C(10)-H(10) 120.7 C(12)-C(11)-C(10) 121.44(18)
C(12)-C(11)-Br(1) 118.57(15) C(10)-C(11)-Br(1) 119.98(15)
C(11)-C(12)-C(13) 118.94(18) C(11)-C(12)-H(12) 120.5
C(13)-C(12)-H(12) 120.5 C(12)-C(13)-C(8) 121.59(18)
C(12)-C(13)-H(13) 119.2 C(8)-C(13)-H(13) 119.2
C(3)-O(1)-H(1) 109.5 C(5)-O(2)-H(2) 109.5  
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Table S16. Anisotropic displacement parameters (Å2). 
 
The anisotropic displacement factor exponent takes the form:  
 -22[ h2a*2U11 + ... + 2 h k a* b* U12 ]. 
 U11 U22 U33 U23 U13 U12 
C(1) 0.011(1)  0.012(1) 0.013(1)  0.000(1) 0.000(1)  -0.001(1) 
C(2) 0.012(1)  0.012(1) 0.019(1)  -0.001(1) 0.002(1)  0.000(1) 
C(3) 0.014(1)  0.016(1) 0.022(1)  0.000(1) 0.005(1)  -0.002(1) 
C(4) 0.012(1)  0.016(1) 0.015(1)  0.000(1) 0.002(1)  0.001(1) 
C(5) 0.016(1)  0.018(1) 0.020(1)  0.000(1) 0.003(1)  0.004(1) 
C(6) 0.016(1)  0.022(1) 0.024(1)  0.003(1) 0.004(1)  -0.003(1) 
C(7) 0.020(1)  0.027(1) 0.014(1)  -0.001(1) 0.002(1)  0.004(1) 
C(8) 0.011(1)  0.013(1) 0.013(1)  0.001(1) 0.001(1)  -0.001(1) 
C(9) 0.016(1)  0.014(1) 0.015(1)  -0.002(1) -0.003(1)  -0.001(1) 
C(10) 0.016(1)  0.016(1) 0.015(1)  -0.001(1) -0.004(1)  0.000(1) 
C(11) 0.016(1)  0.013(1) 0.014(1)  0.002(1) 0.001(1)  0.002(1) 
C(12) 0.017(1)  0.013(1) 0.016(1)  -0.002(1) -0.003(1)  0.000(1) 
C(13) 0.014(1)  0.015(1) 0.015(1)  -0.001(1) -0.004(1)  0.001(1) 
Br(1) 0.027(1)  0.015(1) 0.019(1)  0.000(1) -0.004(1)  0.008(1) 
O(1) 0.013(1)  0.017(1) 0.030(1)  0.007(1) 0.003(1)  -0.001(1) 
O(2) 0.013(1)  0.025(1) 0.024(1)  0.008(1) 0.001(1)  0.004(1) 
 
Table S17. Hydrogen coordinates and isotropic displacement parameters (Å2). 
 
 x  y  z  Ueq 
H(1A) 0.5658 0.4723 0.5501 0.014 
H(2A) 0.7131 0.6689 0.5818 0.017 
H(2B) 0.8330 0.5920 0.6443 0.017 
H(3A) 0.9588 0.4649 0.5422 0.021 
H(3B) 0.8358 0.5377 0.4793 0.021 
H(5A) 0.2976 0.6617 0.6763 0.022 
H(5B) 0.4913 0.7172 0.6599 0.022 
H(6A) 0.2852 0.4072 0.6066 0.031 
H(6B) 0.2438 0.4307 0.6977 0.031 
H(6C) 0.3836 0.3205 0.6719 0.031 
H(7A) 0.5929 0.4304 0.7643 0.031 
H(7B) 0.4588 0.5484 0.7831 0.031 
H(7C) 0.6513 0.5808 0.7502 0.031 
H(9) 0.8790 0.3917 0.7017 0.018 
H(10) 1.0194 0.1871 0.7132 0.019 
H(12) 0.7059 0.0398 0.5417 0.019 
H(13) 0.5687 0.2455 0.5299 0.018 
H(1) 0.9893(19) 0.708(3) 0.4998(17) 0.030 
H(2) 0.268(5) 0.650(3) 0.5576(4) 0.031 
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INTENSITY STATISTICS FOR DATASET  
 
 Resolution   #Data #Theory %Complete Redundancy Mean I Mean I/s Rmerge  Rsigma 
 
  Inf - 2.64      75     80     93.8    11.36    144.63  101.41  0.0308  0.0101 
 2.64 - 1.77     176    176    100.0     9.49     85.24   76.37  0.0257  0.0102 
 1.77 - 1.40     253    253    100.0     8.58     53.40   67.36  0.0269  0.0122 
 1.40 - 1.22     261    261    100.0     8.02     42.27   54.21  0.0275  0.0139 
 1.22 - 1.11     245    245    100.0     7.67     34.87   50.74  0.0294  0.0157 
 1.11 - 1.03     258    258    100.0     7.28     23.99   41.46  0.0353  0.0194 
 1.03 - 0.97     241    241    100.0     7.03     21.90   38.07  0.0387  0.0215 
 0.97 - 0.92     258    258    100.0     6.60     18.12   30.63  0.0423  0.0254 
 0.92 - 0.88     269    269    100.0     6.26     14.17   26.27  0.0525  0.0306 
 0.88 - 0.84     276    276    100.0     5.97     15.09   25.44  0.0536  0.0320 
 0.84 - 0.82     189    189    100.0     5.68     12.30   21.53  0.0604  0.0375 
 0.82 - 0.79     287    287    100.0     5.40      9.92   18.36  0.0735  0.0457 
 0.79 - 0.77     221    221    100.0     5.24     10.02   17.63  0.0744  0.0474 
 0.77 - 0.75     255    255    100.0     4.86      8.45   14.88  0.0924  0.0576 
 0.75 - 0.73     263    263    100.0     4.87      7.64   13.72  0.1011  0.0631 
 0.73 - 0.71     304    304    100.0     4.56      6.09   10.92  0.1161  0.0785 
 0.71 - 0.70     177    177    100.0     4.44      5.50    9.81  0.1275  0.0861 
 0.70 - 0.68     368    368    100.0     4.25      5.81   10.10  0.1229  0.0872 
 0.68 - 0.67     183    183    100.0     3.97      4.90    8.36  0.1450  0.1062 
 0.67 - 0.66     202    202    100.0     3.94      5.24    8.68  0.1346  0.1019 
 0.66 - 0.65     216    217     99.5     3.75      4.26    7.15  0.1699  0.1254 
------------------------------------------------------------------------------ 
 0.75 - 0.65    1713   1714     99.9     4.29      5.75   10.05  0.1238  0.0874 
  Inf - 0.65    4977   4983     99.9     5.96     20.58   28.28  0.0393  0.0256 
------------------------------------------------------------------------------- 
 
The structure was solved by direct methods and refined by full-matrix least-squares
 
against F
2
 to R1 
= 0.026 [I > 2(I)], wR2 = 0.056, 151 parameters.  The H atoms were refined using a riding model 
with UH = 1.5 x Ux for the methyl and hydroxyl groups, otherwise UH = 1.2 x UC. S = 1.103, 
residual electron density 0.38 (0.75 Å from C3)/ -0.42 (0.60 from Br1) e Å
-3
. The Flack parameter 
(Parson's method) is -0.009(4) [1826 quotients]. The absolute structure of a second crystal was 
determined (Flack parameter -0.008(4) [1519 quotients]). CCDC-1550400. 
 
 
Figure S3. Superposition of the molecular structures of (S)-2,2-dimethyl-3-phenyl-pentane-1,5-diol 
(green) and (S)-2,2-dimethyl-3-(4-bromo-phenyl)-pentane-1,5-diol (pink).  
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Mechanistic NMR Studies 
 
Reaction Intermediate 
 
To identify the initial reaction product before protonolysis, Mukaiyama–Michael reactions of 
methyl cinnamate 1a (19.5 mg, 0.12 mmol) and SKA 2a (50 μL, 0.24 mmol) with (S,S)-4e (4.0 mg, 
2.4 μmol) or HNTf2 (24 μL, 0.2 M in DCE, 2.4 μmol) were conducted in an NMR tube in 
cyclohexane-d12 (0.6 mL) at r.t. for 7 h (>99% conversion). 
 
 
 
The initial reaction intermediates E/Z-D were characterized from the reaction mixture after full 
conversion. The E/Z rations were determined to be 4:96 (with 4e) and 10:90 (with HNTf2). We 
observed slow E/Z isomerization when the reaction mixture was kept at r.t. after completion. 
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Table S18. Peak table intermediate Z-D 
 
 
Atom
Chemical 
Shift
J COSY HSQC HMBC Si-HMQC NOESY
Si1 19,15 14
1 C 176,80 3, 7, 8, 6
2 C 47,48 3, 4, 7, 8
3 C 50,13 3 3, 4, 7, 8, 10
3 H 3,83 d 9.3(4 H) 4, 13 3 5, 9, 4, 2, 1, 7, 8, 3, 10 8, 7, 14, 10
4 C 76,16 4 3, 4
4 H 3,95 d 9.3(3 H) 13, 3 4 5, 9, 4, 2, 13, 3 8, 7, 14, 13, 10
5 C 158,27 4, 3, 13
6 C 50,96 6 6
6 H 3,45 s 6 6, 1 8, 7, 14, 10
7 C 23,76 7 3, 8
7 H 1,08 s 8 7 2, 1, 8, 3 3, 6, 13, 14, 4, 10
8 C 23,08 8 3, 7
8 H 1,10 s 7 8 2, 1, 7, 3 3, 6, 13, 14, 4, 10
9 C 143,99 3, 4
10 C 130,07 3
10 H 7.13 - 6.99 m 3 3, 8, 7, 4, 6
11 C 127,86
11 H 7.13 - 6.99 m
12 C 126,37
12 H 7.13 - 6.99 m
13 C 54,45 13 4
13 H 3,46 s 4, 3 13 5 8, 7, 14, 4
14 C 0,31 14 14
14 H 0,02 s 14 14 Si1 3, 6, 7, 8, 13, 4
 
 
Reaction intermediate Z-D was identified from the reaction mixture with catalyst (S,S)-4e (E/Z 
4:96). The geometry of the double bond was assigned due to characteristic NOESY correlation 
between 4-H and 13-H (red circle in Table S18). 
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Table S19. Peak table intermediate E-D 
 
 
Atom
Chemical 
Shift
J COSY HSQC HMBC Si-HMQC NOESY
Si1 19,43 14
1 C 176,73 3, 6, 7, 8
2 C 47,48 3, 4, 7, 8
3 C 49,72 3 3, 7, 8, 10
3 H 3,88 d 10.2(4 H) 4 3 1, 5, 9, 4, 2, 7, 8, 3, 10 10, 7, 8
4 C 84,58 4 3, 4
4 H 4,14 d 10.2(3 H) 3, 13 4 5, 9, 4, 2 10, 7, 8, 14
5 C 154,80 3, 4, 13
6 C 50,92 6 6
6 H 3,46 s 6 1, 6 7, 8
7 C 23,80 7 3, 8
7 H 1,06 s 8 7 1, 2, 8, 3 3, 4, 6, 13, 10
8 C 23,02 8 3, 7
8 H 1,08 s 7 8 1, 2, 7, 3 3, 4, 6, 13, 10
9 C 143,61 3, 4
10 C 129,80 3
10 H 7.13 - 6.99 m 3 3, 4, 7, 8
11 C 127,93
11 H 7.13 - 6.99 m
12 C 126,43
12 H 7.13 - 6.99 m
13 C 54,10 13
13 H 3,33 s 4 13 5 7, 8, 14
14 C -0,05 14 14
14 H 0,22 s 14 14 Si1 4, 13
 
Reaction intermediate E-D was identified from the reaction mixture with catalyst (S,S)-4e (E/Z 
4:96). 
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Preliminary Kinetic Study 
 
In order to follow the course of the reaction under standard conditions, we conducted the 
Mukaiyama–Michael reaction of methyl cinnamate 1a (19.5 mg, 0.12 mmol), SKA 2a (75 μL, 
0.36 mmol) and (S,S)-4e (2.0 mg, 1.2 μmol) in an NMR tube in cyclohexane-d12 (0.6 mL) at 0 °C. 
The integrals of olefinic protons of 1a (red) and Z-D (yellow) were plotted against time (graph 
below). After 8 h (480 min) reaction time, the starting material is converted to >99% of product. 
The Z/E ratio was determined to be >99:1. No other reaction intermediates could be detected in 
significant amounts: 
 
1
H NMR after 8 h reaction time:
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ABSTRACT: Despite tremendous advances in enantioselective 
catalysis of the Diels–Alder reaction, the use of simple α,β-
unsaturated esters as one of the most abundant and useful class of 
dienophiles is still severely limited in scope due to their low 
reactivity. We report here a catalytic asymmetric Diels–Alder 
methodology for a large variety of α,β-unsaturated methyl esters 
and different dienes based on extremyl reactive silylium imidodi-
phosphorimidate (IDPi) Lewis acids. Mechanistic insights from 
accurate domain-based local pair natural orbital coupled-cluster 
(DLPNO-CCSD(T)) calculations rationalize catalyst control and 
stereochemical outcome. 
The discovery of the Diels–Alder reaction by Kurt Alder and Otto 
Diels is regarded as one of the transforming events in organic 
chemistry.1 The power and efﬁciency to rapidly build up complex-
ity by forming up to four stereocenters at once was quickly real-
ized and led to many important and elegant applications in the 
chemical synthesis of complex natural products,2 agrochemicals, 
pharmaceuticals and fragrances.3 In the historical development of 
stereoselective synthesis, the Diels–Alder reaction has served as 
one of the most prominent platforms and α,β-unsaturated carbox-
ylic acid derivatives have been a widely applied class of dieno-
philes. In fact, a very early approach to asymmetric synthesis has 
been the Lewis acid-mediated Diels–Alder reaction of enantiopure 
acrylates with cyclopentadiene.4 Within the area of asymmetric 
Lewis acid catalysis, chiral complexes based on aluminum, titani-
um, copper, boron and others have emerged,5 which enabled high 
enantioselectivities with α,β-unsaturated N-acyl oxazolidinones, 
aldehydes, ketones, and triﬂuoroethyl esters as dienophiles. Also 
some simple, unactivated α,β-unsaturated esters, such as methyl 
or ethyl acrylate and crotonate, in combination with cyclopentadi-
ene can engage in highly enantioselective Diels–Alder reactions 
catalyzed either by chiral alkyldichloroboranes introduced by 
Hawkins6 or Corey’s cationic oxazaborolidines (CBS),5c,7 which 
undoubtedly represent the most versatile family of chiral Lewis 
acids to date. Also various organocatalytic approaches have been 
described for α,β-unsaturated aldehydes and ketones via asymmet-
ric iminium ion or Brønsted acid catalysis.8,9 Despite these exam-
ples, the application of simple α,β-unsaturated esters as a highly 
abundant and fundamental class of dienophiles is still severely 
limited in scope due to their particularly low reactivity.10 
   In our efforts to overcome existing challenges in asymmetric 
Lewis acid catalysis, we have recently proposed a new strategy to 
catalyze the Diels–Alder reaction of α,β-unsaturated esters with 
an achiral, cationic silylium ion and an enantiopure counteranion  
(Eq. 1).11 This asymmetric counteranion-directed silylium Lewis 
acid catalysis (silylium-ACDC)12 differs conceptually from 
 
conventional enantioselective Lewis acid catalysis, which typical-
ly utilizes metal(loid) complexes with chiral ligands or substitu-
ents.13 Rendering such complexes cationic and combining them 
with weakly coordinating, achiral counteranions is often a power-
ful measure to increase their activity. In contrast, the inversion of 
the chiral entities within the ion pair, as provided with silylium-
ACDC, allows for the unique feature in silylium catalysis of 
possessing a repair pathway upon hydrolytic deactivation:11,14 The 
source of chirality is hydrolytically stable, converts back to the 
Brønsted acidic state, and can be re-activated in the presence of a 
suitable silylating reagent. Providing a slight excess of the silylat-
ing reagent compared to the chiral Brønsted acid then allows for 
very low catalyst loadings of the chiral Brønsted acid precatalyst. 
In addition, the logic of designing more stabilized and weaker 
coordinating enantiopure anions also applies here and leads to 
higher activity of the corresponding cationic silylium species. 
   After demonstrating this concept for the catalytic asymmetric 
Diels–Alder reactions of 9-fluorenylmethyl cinnamate esters with 
a chiral C–H acid as Lewis acid precursor,11 we were recently able 
to utilize simple α,β-unsaturated methyl esters in highly enanti-
oselective Mukaiyama–Michael reactions with silyl ketene acetals 
(SKA) and highly acidic and confined imidodiphosphorimidate 
(IDPi) catalysts.15 We now report the development of a catalytic 
asymmetric Diels–Alder methodology for a large variety of α,β- 
unsaturated methyl esters and different dienes, including normally 
unreactive substrate combinations. 
 
 
Figure 1. Reaction Development and Catalyst Systems.  
 
Figure 2. Substrate and Diene Scope. Reactions of α,β-unsaturated methyl esters with cyclopentadiene 2a, 2,3-dimethylbutadiene 2b and 
isoprene 2c. awith catalyst 4a. bwith catalyst 4b. cwith catalyst 4c. dwith catalyst 4d (3 mol%). Yields refer to isolated material. d.r., dia-
stereomeric ratio; e.r., enantiomeric ratio. For details, see the supplementary material. 
 
   We chose the Diels–Alder reaction between only weakly reac-
tive methyl trans-cinnamate (1a) and cyclopentadiene (2a) as our 
model reaction (Fig. 1) and conducted an extensive catalyst eval-
uation. We found that our IDPi acids provided both sufficient 
activity and promising enantioselectivities compared to other 
chiral acids tested (for more details, see the supplementary mate-
rial). Gratifyingly, we could identify two distinct families of IDPi 
catalysts, which after optimization gave very high enantio- and 
diastereoselectivities in our model reaction. Catalysts 4a and 4b 
possess 3,5-trifluoromethylphenyl substituents, while IDPi 4c 
features cyclobutyl-derivatized 3-fluorenyl substituents on the 
BINOL backbone. In general, inner core modification toward 
longer perfluoroalkyl groups (e.g. R = C2F5)
15e-15h increased cata-
lytic activity, while the impact on enantioselectivity varied. The 
type of silylating reagent (5) suitable to activate the IDPi Brønsted 
acid precursors to the silylium-Lewis acids depends on catalyst 
acidity and activation temperature. We investigated silyl ketene 
acetals (SKA), methallylsilanes, and allylsilanes as activators and 
found that their silylating power decreased in this order. While the 
type of reagent had no effect on enantioselectivity, the impact of 
the silyl group on both reaction rate and stereoselectivity was 
quite significant. Independent reaction optimization for our two 
privileged catalyst lead structures revealed triethyl allylsilane 5a 
as the optimal activator of catalyst 4a (condition A), while catalyst 
4c performed best with triisopropylsilyl (TIPS) SKA 5b (condi-
tion B). Both catalyst systems gave equally high yields and enan-
tioselectivities (e.r. ≥ 97:3) in our model reaction using only 
1 mol% of IDPi and a sub-stoichiometric amount of silylating 
reagent at -40 °C. 
   With this flexibility and optional fine-tuning in hand, we pro-
ceeded to explore the scope of α,β-unsaturated esters as dieno-
philes with cyclopentadiene (2a) (Fig. 2). As condition A provided 
higher reactivity and increased diastereoselectivity, we tested 
methyl- and bromo-substituted cinnamates with catalyst 4a and 
found that ortho-, meta- or para-substitution is well tolerated, and 
the desired products (3b-g) were obtained in high yields, excellent 
enantioselectivities, and high diastereoselectivities. Similar results 
were achieved for para-fluoro- or trifluoromethyl-substituted 
products 3h and 3i under the same conditions. For stronger elec-
tron-deficient substrates such as cinnamate 1j and 3-heteroaryl-
substituted acrylates 1n and 1o, we used catalyst 4b to efficiently 
catalyze the reaction and achieved high enantioselectivities. When 
electron-rich substrates were tested to afford products 3k and 3i, 
increased catalyst loading (3 mol% of 4a) and temperature (–
20 °C) provided sufficient reactivity to obtain high yields and 
stereoselectivity. As 3-alkyl acrylates were empirically found to 
be more reactive than 3-aryl acrylates,5c both available catalyst 
systems were explored at decreased temperatures (–80 °C) and 
gave product 3p in comparably excellent yields and enantioselec-
tivities (for more details, see the supplementary material). Using 
catalyst 4a, we tested substrates with various alkyl substitutions 
and could isolate the corresponding products (3q-s, 3u-v) with 
consistently very high levels of stereocontrol, while the enantiose-
lectivities slightly decreased with shorter chains lengths. With γ-
branched methyl 4-methylpent-2-enoate (1t) and methyl crotonate 
(1w), however, only diminished enantioselectivities were obtained. 
Switching to catalyst 4c in combination with the triethylsilyl (TES) 
group under neat conditions instead gave excellent results for both 
Diels–Alder products (3t and 3w). In light of the extremely high 
activity of our silylium-Lewis acids, we proceeded to explore less 
reactive dienes. We selected 2,3-dimethylbutadiene (krel = 4.9) and 
isoprene (krel = 2.3) as representatives as these dienes have been 
determined to be orders of magnitude less reactive than cyclopen-
tadiene (krel = 1350) in reference to butadiene (krel = 1).
16 During 
optimization, we found that IDPi’s of the 3-fluorenyl substitution 
family were generally superior to the bistrifluoromethylphenyl 
derivatives (4a and 4b) in enantiodiscrimination, while the latter 
exhibited significantly higher activity. This issue could be solved 
by attaching a longer, linear perfluoroalkyl chain (R = C6F13) to 
the inner core sulfonyl groups, which led to the identification of 
cyclopentyl-derived 4d as the optimal catalyst in combination 
with TIPS methallylsilane 5d as the activator. With this catalyst 
system, Diels–Alder reactions of two representative dienophiles 
covering a broad range of reactivity (1a and 1p) with both
 
Figure 3. Scale-Up Experiments. Preparative scale reactions with reduced catalyst loadings. For details, see the supplementary material. 
 
2,3-dimethylbutadiene and isoprene were enabled highly enanti-
oselectively and with good yields, under neat conditions. Increas-
ing the reaction temperature to above 0 °C was found to be delete-
rious for the reaction rate as catalyst methylation was observed 
presumably due to a collapse of the chiral ion pair consisting of 
silylated methyl ester substrate and counteranion. 
   We wer also able to lower the catalyst loading of IDPi 4a to 
only 0.1 mol% and to conduct our model reaction on a gram-scale 
under neat conditions to furnish product 3a in nearly quantitative 
yield and with an e.r. of 95:5 (Fig. 3A). Importantly, only small 
amounts of cyclopentadiene polymerization products were formed 
and could be easily filtered off during workup. As our silylium 
Lewis acid strategy conveniently provides self-drying 
conditions,11,15g we could also run this gram-scale reaction with-
out inert gas atmosphere to give essentially identical results. In 
contrast, strictly anhydrous conditions in a Schlenk flask allowed 
us to lower the loading of silylating reagent to only 5 mol%. 
Further gram-scale experiments with methyl crotonate 1w and 
substituted cinnamates (1e and 1k, Fig. 3B-D) and with 0.1 mol% 
of catalyst gave equally high yields and enantioselectivities after 
prolonged reaction time. 
   In order to obtain deeper insight into reaction mechanism and 
the catalyst’s mode of action, we investigated the reaction profile 
for methyl cinnamate 1a, cyclopentadiene 2a and (S,S)-4a at the 
DLPNO-CCSD(T)/def2-TZVP + C-PCM(toluene) // PBE-D3 
(BJ)/def2-SVP level of theory (for details, see the supplementary 
material).17 Silylation of the IDPi acid with allylsilane 5a to give 
the active catalyst occurs instantaneously at r.t. as observed by 
NMR and propene formation was detected (Fig. 4A). Subsequent-
ly, the silyl group is transferred onto the carbonyl group of cin-
namate 1a to form a chiral ion pair (CIP, Fig. 4B) in an endother-
mal process (ΔG = 7.4 kcal/mol) with the s-trans conformation as 
the most stable intermediate. Interaction of cyclopentadiene with 
the CIP gives a reactant complex (RCs-trans) as a subsequent inter-
mediate towards the Diels–Alder transition states. The competing 
transition states for each of the endo-enantiomers (TSs-trans; 
marked in black and blue) are predicted to give an e.r. of 93:7 
(G‡=1.2 kcal/mol), which is in good agreement with the exper-
imental data (e.r. 97:3, G‡=1.6 kcal/mol). The most stable TS 
features two stabilizing non-classical C-H···O hydrogen bonds 
(between an oxygen atom of the SO2CF3 group of the catalyst and 
the C-H groups of the cyclopentadiene) that are missing in the 
other TS structures. Subsequently, de-silylation and release of the 
product is thermodynamically favored rendering the silylated IDPi 
as the resting state within the catalytic cycle. We further investi-
gated the CIP in greater detail to understand the origin of enanti-
oselectivity (Fig. 4C). The electrostatic potential maps revealed 
that the most favorable interaction mode (ΔG = –23.8 kcal/mol) 
for this structure orients the phenyl ring of ester 1a far from the 
counteranion, consistent with the high enantioselectivities ob-
served for various substitutions at the 3-position. In addition, the 
methyl group of the substrate is pointing inside the chiral pocket 
of the IDPi moiety, overall resulting in a striking geometrical 
match of the ion pair. In this context, we also tested ethyl and 
benzyl trans-cinnamate as substrates, but not only detected slug-
gishly reactivity with catalyst 4a, but also significantly diminished 
enantioselectivities (e.r. 75:25 with ethyl cinnamate; e.r. 57.5:42.5 
with benzyl cinnamate, which can be rationalized by an improper 
fit with such bulkier groups. 
 
Figure 4. Computational Studies. A Catalyst activation. B Diels–Alder reaction profiles. C Interaction within the chiral ion pair (CIP); 
Geometry optimizations with PBE-D3(BJ)/def2-SVP; single-point energies with DLPNO-CCSD(T)/def2-TZVP+C-PCM(toluene). For 
more details, see the supplementary material. 
   In summary, we report the development of a catalytic asymmet-
ric Diels–Alder methodology for a large variety of poorly reactive 
α,β-unsaturated methyl esters and different dienes to give the 
cycloaddition products in excellent yields, enantio- and diastere-
oselectivities. Many of the products have previously been inacces-
sible with known chiral Lewis acids, while the corresponding 
Diels–Alder reactions can now be accomplished with very low 
catalyst loadings of only 0.1-3 mol%. Future work will focus on 
overcoming remaining challenges in catalytic asymmetric Diels–
Alder reactions and on synthetic applications towards important 
target structures. 
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General Information and Instrumentation 
Unless otherwise stated, all reagents were purchased from commercial suppliers and used without 
further purification. For all reactions under argon, dried and degassed solvents were used. Dry 
argon was purchased from Air Liquide with >99.5% purity. All reported yields, unless otherwise 
specified, refer to spectroscopically and chromatographically pure compounds. Nomenclature 
follows the suggestions proposed by the computer program ChemBioDraw of CBD/Cambridgesoft. 
The enantiomeric ratios were determined by HPLC or GC analysis employing a chiral stationary 
phase column specified in the individual experiment, by comparing the samples with the 
appropriate racemic mixtures. The diastereomeric ratios were determined by HPLC analysis or 
1
H 
NMR analysis and specified in the individual experiment. The absolute configurations were 
determined by comparing the optical rotations with reported values available in literature. All other 
products were assigned by analogy. 
 
Thin-layer chromatography (TLC) was performed using silica gel pre-coated plastic sheets 
(Polygram SIL G/UV254, 0.2 mm, with fluorescent indicator; Macherey-Nagel), which were 
visualized with a UV lamp (254 or 366 nm) and/or phosphomolybdic acid (PMA) stain and/or 
permanganate stain. Preparative thin-layer chromatography (PrepTLC) was performed on silica gel 
pre-coated glass plates SIL G-25 UV254 and SIL G-100 UV254 with 0.25 mm and 1.0 mm SiO2 
layers (Macherey-Nagel). Flash column chromatography was performed on Merck silica gel (60, 
particle size 0.040-0.063 mm). 
1
H, 
13
C, 
19
F, 
31
P nuclear magnetic resonance (NMR) spectra were 
recorded on a Bruker AV-500, AV-400 or DPX-300 spectrometer in a suitable deuterated solvent. 
The solvents employed and respective measuring frequencies are indicated for each experiment. 
The resonance multiplicity is described as s (singlet), d (doublet), t (triplet), q (quadruplet), p 
(pentet), hept (heptet), m (multiplet), and br (broad). All spectra were recorded at 298 K unless 
otherwise noted, processed with Bruker TOPSPIN or MestReNova suits of programs, and coupling 
constants are reported as observed. The residual deuterated solvent signal relative to 
tetramethylsilane was used as the internal reference in 
1
H and 
13
C NMR spectra (e.g. CDCl3 = 7.26 
ppm for 
1
H, 77.160 ppm for 
13
C), and are reported as follows: chemical shift in ppm (multiplicity, 
coupling constant J in Hz, number of protons). All spectra are broadband decoupled unless 
otherwise noted. Electron impact (EI) mass spectrometry (MS) was performed on a Finnigan MAT 
8200 (70 eV) or MAT 8400 (70 eV) spectrometer. Electrospray ionization (ESI) mass spectrometry 
was conducted on a Bruker ESQ 3000 spectrometer. High resolution mass spectrometry (HRMS) 
was performed on a Finnigan MAT 95 (EI) or Bruker APEX III FTMS (7T magnet, ESI). The 
ionization method and mode of detection employed is indicated for the respective experiment. High 
performance liquid chromatography (HPLC) was performed on Shimadzu LC-20AD liquid 
chromatograph (SIL-20AC auto sampler, CMB-20A communication bus module, DGU-20A5 
degasser, CTO-20AC column oven, SPD-M20A diode array detector), Shimadzu LC-20AB liquid 
chromatograph (SIL-20ACHT auto sampler, DGU-20A5 degasser, CTO-20AC column oven, SPD-
M20A diode array detector), or Shimadzu LC-20AB liquid chromatograph (reversed phase, SIL-
20ACHT auto sampler, CTOS3 20AC column oven, SPD-M20A diode array detector) using Daicel 
columns with a chiral stationary phase. All solvents used were HPLC-grade solvents purchased 
from Sigma-Aldrich. The column employed and the respective solvent mixture is indicated for each 
experiment. Optical rotations were measured on an Autopol IV automatic polarimeter (Rudolph 
Research Analytical) at 589 nm (sodium D line), 25 °C. Data are reported as: [α]D
t
, concentration (c 
in g/100 mL), and in the corresponding solvent. 
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If available, α,β-unsaturated methyl esters have been purchased from commercial sources and the 
E/Z ratios were >99:1, unless stated otherwise. Other α,β-unsaturated methyl esters have been 
prepared as described previously with E/Z ratios of >99:1.
1
 
 
Purification and storage of dienes 
 
1,3-Cyclopentadiene was prepared by pyrolysis of dicyclopentadiene
2
 and was stored in a Schlenk 
flask under argon at ‒78 °C. Other commercial dienes were washed several times with 1M NaOH, 
water and brine to remove the inhibitor (mostly BHT = 3,5-di-tert-butyl-4-hydroxytoluol). The 
dienes were then dried over MgSO4, subsequently distilled under argon from NaBH4 and stored in 
a Schlenk flask under argon at ‒20 °C. In some initial screening experiments, unpurified dienes 
were used as specified.  
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Synthesis and Characterization of Silylating Reagents 
 
The following silylating reagents have been tested during the reaction development. Reagents 5a-d 
were found optimal for individual combinations of substrate and catalyst. 
 
 
 
Allylsilanes 5e, 5a, 5f and 5g were purchased from commercial sources and used without further 
purification. Silyl ketene acetals (SKA) 5h, 5c, 5l, 5b were synthesized and purified as described 
previously.
1
 Methallylsilane 5j was purchased from commercial sources and used without further 
purification. Methallylsilane 5k, 5d, 5l, 5m were synthesized and purified according to a slightly 
modified literature procedure
3
 and stored in Schlenk flasks under argon in a fridge at 5 °C.  
 
 
 
triethyl(2-methylallyl)silane (5k): To a 50 mL two-neck Schlenk-flask under argon equipped with 
a magnetic stirring bar and a reflux condenser was added magnesium (705 mg, 
29.0 mmol). The apparatus was evacuated and purged with argon three times. Then, 
THF (2.00 mL) was added and to the resulting suspension was added one grain of 
iodine to initiate the reaction. A solution of 3-chloro-2-methylpropene (1.97 mL, 1.81 g, 
20.0 mmol) and triethylsilyl chloride (2.52 mL, 2.26 g, 15.0 mmol) in THF (13.0 mL) was added 
dropwise using a syringe pump over 35 min (total volume 17.5 mL, 20 mL syringe, diameter 
20 mm, pump rate: 0.50 mL ⋅ min–1) to the reaction mixture under reflux (NOTE: a color change 
from yellow to a cloudy/turbid colorless suspension was immediately visible upon addition of the 
methallylchloride/silyl chloride solution). After the addition was complete, the reaction mixture 
was heated under reflux for an additional 33 h at 75 °C (oil bath temperature). The formed colorless 
precipitate was filtrated off and the residue was extracted with hexane (2 × 50 mL). The combined 
filtrate and extracts were concentrated under reduced pressure and triethyl(2-methylallyl)silane 5k 
was obtained by distillation under reduced pressure (bp 48–52 °C at 3.3–5.3 mbar) as a colorless oil 
(1.80 g, 10.6 mmol, 71%). 
1
H NMR (500 MHz, CDCl3) δ 4.61–4.56 (m, 1H), 4.53–4.48 (m, 1H), 
1.73 (s, 3H), 1.56 (s, 2H), 0.96 (t, J = 7.9 Hz, 9H), 0.56 (q, J = 7.9 Hz, 6H); 
13
C NMR (126 MHz, 
CDCl3) δ (mixture of rotamers) 144.2, 144.1, 108.3, 108.3, 25.4, 25.4, 23.3, 23.3, 7.5, 7.5, 3.7, 3.7; 
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29
Si NMR (99 MHz, CDCl3) δ 5.4; HRMS (CI, ammonia) calculated for C10H26NSi
+
 [M+NH4]
+
: 
188.1829; found: 188.1828. 
 
triisopropyl(2-methylallyl)silane (5d): Magnesium (705 mg, 29.0 mmol) was transferred to a 
50 mL two neck round-bottom flask under argon equipped with a magnetic stirring 
bar and a reflux condenser. THF (2 m L) and a small amount of iodine were added 
to initiate the reaction and the light-brown solution was heated to 70 °C (oil bath 
temperature). A solution of 3-chloro-2-methylpropene (1.97 mL, 1.81 g, 20.0 mmol) and 
triisopropylsilyl chloride (3.21 mL, 2.89 g, 15 mmol) in THF (13.0 mL) was dropwise added over 
30 min to the reaction mixture at reflux (NOTE: a color change from yellow to colorless was 
observed; formation of a colorless off-white precipitate was also observed during the addition). The 
reaction mixture was heated under reflux for an additional 15 h when the addition was complete. 
The precipitate was filtered off and the residue was extracted with hexane (2 × 50 mL). The 
combined filtrate and extracts were first distilled in a Vigreux column (7 cm) under atmospheric 
pressure to remove the excess of organic solvents. Triisopropyl(2-methylallyl)silane 5d was 
obtained by distillation (Vigreux column, 7 cm) under reduced pressure (bp 85–87 °C at 12.6 mbar) 
as a colorless oil (2.15 g, 10.1 mmol, 50%). 
1
H NMR (500 MHz, CDCl3) δ 4.63–4.59 (m, 2H), 
1.79 (app t, J = 1.1 Hz, 3H), 1.67–1.62 (m, 2H), 1.11–1.02 (m, 21H); 13C NMR (126 MHz, CDCl3) 
δ 144.6, 109.5, 25.8, 20.9, 18.9, 11.7; 29Si NMR (99 MHz, CDCl3) δ 4.6; HRMS (CI, ammonia) 
calculated for C13H29Si
+
 [M+H]
+
: 213.2033; found: 213.2032. 
 
tributyl(2-methylallyl)silane (5l): To a 50 mL two-neck Schlenk-flask under argon equipped with 
a magnetic stirring bar and a reflux condenser was added magnesium (705 mg, 
29.0 mmol). The apparatus was evacuated and purged with argon three times. 
Then, THF (2.00 mL) was added and to the resulting suspension was added one 
crystal of iodine to initiate the reaction. A solution of 3-chloro-2-methylpropene (1.97 mL, 1.81 g, 
20.0 mmol) and triethylsilyl chloride (2.52 mL, 2.26 g, 15.0 mmol) in THF (13.0 mL) was added 
dropwise using a syringe pump over 35 min (total volume 17.5 mL, 20 mL syringe, diameter 
20 mm, pump rate: 0.50 mL min
–1
) to the reaction mixture under reflux (NOTE: a color change 
from yellow to a cloudy/turbid colorless suspension was immediately visible upon addition of the 
methallylchloride/silyl chloride solution). After the addition was complete, the reaction mixture 
was heated under reflux for an additional 33 h at 75 °C (oil bath temperature). The formed colorless 
precipitate was filtered off and the residue was extracted with iso-hexane (2 × 50 mL). The 
combined filtrate and extracts were concentrated under reduced pressure and tributylsilyl(2-
methallyl)silane 5l was obtained by distillation under reduced pressure (bp 104–107 °C at 
3.3 mbar) as a colorless oil (2.73 g, 10.7 mmol, 71%). 
1
H NMR (500 MHz, CDCl3) δ 4.58 (dq, J = 
2.8, 1.4 Hz, 1H), 4.49 (dq, J = 2.0, 0.9 Hz, 1H), 1.73 (t, J = 1.1 Hz, 3H), 1.55 (d, J = 1.0 Hz, 2H), 
1.37–1.24 (m, 12H), 0.89 (t, J = 7.1 Hz, 9H), 0.61–0.48 (m, 6H); ); 13C NMR (126 MHz, CDCl3) δ 
144.2, 108.4, 27.0, 26.2, 25.5, 24.3, 13.9, 12.5; 
29
Si NMR (99 MHz, CDCl3) δ 1.7; HRMS (EI) 
calculated for C16H34Si: 254.2430; found: 254.2428. 
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Tris(trimethylsilyl)silylmethallylsilane 5m was prepared according to a slightly modified procedure 
reported in the literature.
4
 
 
 
 
1,1,1,3,3,3-hexamethyl-2-(2-methylallyl)-2-(trimethylsilyl)trisilane (5m): 
Tetrakis(trimethylsilyl)silane (160 mg, 0.50 mmol, 1.0 equiv.) was transferred to 
a 10 mL Schlenk-tube under argon and KOtBu (1.0 M solution in THF, 58.2 mg, 
0.52 mL, 0.52 mmol, 1.04 equiv.) was added at r.t.. The solution was stirred for 
24 h at r.t. (NOTE: slow color change from colorless to yellow-orange was observed), then the 
solution of tris(trimethylsilyl)potassium was cooled to 0 °C and 3-chloro-2-methyl-1-propene 
(2.4 mL, 24 mmol) was added. The mixture was stirred for 1 h at 0° C, the ice bath was removed 
and the reaction was further stirred at r.t. (2 d), then treated at 0 °C with sat. aq. NH4Cl (0.5 mL). 
The organic layer was separated and the aqueous layer was extracted with Et2O (2 × 5 mL). The 
combined extracts were dried over MgSO4 and concentrated under reduced pressure. The crude 
product was filtered through a short pad of silica (using pentane as eluent), to afford the 5m as a 
white waxy solid (134.2 mg, 0.44 mmol, 89%). 
1
H NMR (500 MHz, CDCl3) δ 4.60 (s, 1H), 4.56 
(s, 1H), 1.79 (s, 2H), 1.76 (s, 3H), 0.19 (s, 27H) ); 
13
C NMR (126 MHz, CDCl3) δ 146.2, 109.0, 
25.0, 18.6, 1.3; HRMS (EI) calculated for C13H34Si4: 302.1732; found: 302.1727. The analytical 
data was in agreement with the data reported in the literature.
4
 
 
 
 
S-7 
 
Synthesis and Characterization of Catalysts 
 
Synthesis of BINOL derivatives 
 
 
 
3,3’-zincated MOM-protected BINOL (S)-B: 
To a solution of MOM-protected BINOL (S)-A (5.92 g, 15.8 mmol) in 
THF (40 mL) under argon at –5 °C, n-BuLi in hexane (2.45 M, 22.6 mL, 
55.3 mmol, 3.5 equiv.) was added over a period of 5 min (NOTE: The 
temperature was kept between –10 °C and –5 °C during the addition. 
The color changed from light yellow to deep red). The reaction was 
stirred between -10 °C and -5 °C for 4 h, during which the color 
changed from deep red to red-brownish. Then, the reaction mixture was 
cooled to –78 °C and a solution of ZnCl2 in THF (0.96 M, 34.7 mL, 33.2 mmol, 2.1 equiv.) was 
added over a period of 20 min. The dry-ice bath was removed and the reaction was allowed to 
warm up to r.t. and stirred for additional 45 min, during which the color changed from red-
brownish to light yellow. Then, the solvent was removed from the reaction vessel under reduced 
pressure by using a cooling trap with liquid nitrogen (NOTE: A voluminous foam results). Upon 
dryness, the organozinc compound was afforded as a pale yellow solid and dried on high vaccum 
overnight. A stock solution (0.27 M) in THF under argon was prepared (54 mL total volume) and 
stored in a fridge at –20 °C. The concentration was determined through deuterium incorporation 
after treatment with D2O as analyzed by 
1
H-NMR (~93%) with respect to the total volume and the 
initial molarity of (S)-A (15.8 mmol). 
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Representative procedure for derivatization of 2-bromo-9H-fluorene: 
 
 
 
2'-bromospiro[cyclopentane-1,9'-fluorene]: Following a reported procedure,
5
 aq. NaOH (50%, 
8.8 mL, 110 mmol, 5.5 equiv.) was added dropwise to the mixture of 2-
bromo-9H-fluorene (4.90 g, 20.0 mmol, 1.0 equiv.) and benzyl-
triethylammonium chloride (91.1 g, 0.4 mmol, 2 mol%) in DMSO (20 mL) 
under argon at r.t. (NOTE: rapid color change from yellow to red). After the 
subsequent addition of 1,4-dibromobutane (2.4 mL, 20.0 mmol, 1.0 equiv.) 
(NOTE: color change from red to beige), the reaction was stirred for 5 hours 
at r.t.. Then, water (100 mL) and toluene (100 mL) were added and the organic layer was separated, 
dried over MgSO4 and concentrated under reduced pressure. The crude product was purified by 
column chromatography (hexanes) to yield 2'-bromospiro[cyclopentane-1,9'-fluorene] as a light 
yellow solid (3.70 g, 12.4 mmol, 62%). 
1
H NMR (500 MHz, CDCl3) δ 7.69 – 7.63 (m, 1H), 7.59 – 
7.52 (m, 2H), 7.47 – 7.39 (m, 2H), 7.35 – 7.29 (m, 2H), 2.19 – 2.04 (m, 8H); 13C NMR (126 MHz, 
CDCl3) δ 156.51, 154.07, 138.65, 138.58, 129.91, 128.01, 127.04, 126.43, 123.02, 121.25, 121.06, 
119.77, 57.94, 39.83, 27.07; HRMS (GC-EI) calculated for C15H11Br: 298.0357; found: 298.0356. 
 
2'-bromospiro[cyclobutane-1,9'-fluorene]: Prepared according to the representative procedure on 
a 30 mmol scale for to give the title compound as a colorless viscous oil 
(3.0 g, 10.6 mmol, 35%). 
1
H NMR (500 MHz, CDCl3) δ 7.90 (d, J = 1.7 Hz, 
1H), 7.76 (dt, J = 7.7, 0.9 Hz, 1H), 7.64 (dt, J = 7.2, 1.0 Hz, 1H), 7.53 (d, J = 
8.1 Hz, 1H), 7.46 (dd, J = 8.0, 1.8 Hz, 1H), 7.39 (td, J = 7.4, 1.3 Hz, 1H), 7.34 
(td, J = 7.4, 1.2 Hz, 1H), 2.72 – 2.57 (m, 4H), 2.48 – 2.34 (m, 2H); 13C NMR 
(126 MHz, CDCl3) δ 154.5, 152.0, 138.5, 138.4, 130.2, 128.1, 127.3, 126.3, 
122.9, 121.4, 121.0, 119.7, 52.1, 33.3, 17.1; HRMS (GC-EI): calculated for C16H13Br: 284.0195; 
found: 284.0193. 
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Representative procedure for Negishi cross-coupling reactions and subsequent MOM-
deprotections: (S)-3,3'-bis(9,9-dimethyl-9H-fluoren-2-yl)-[1,1'-binaphthalene]-2,2'-diol 
In a 2-neck flask under argon, 2-bromo-9,9-dimethyl-9H-fluorene 
(2.46 g, 9.0 mmol) and Pd(
t
Bu3P)2 (77 mg, 0.15 mmol) were 
dissolved in THF (60 mL). Then, a solution of organozinc BINOL 
(S)-B in THF (0.27 M, 11.1 mL, 3.0 mmol) was added at r.t. under 
stirring and the resulting reaction mixture was refluxed under argon 
for 18 h. The cooled reaction mixture was treated with sat. aq. 
NH4Cl (30 mL) and extracted with MTBE (3 × 50 mL). The 
combined organic layers were washed with brine, dried over MgSO4 
and concentrated under reduced pressure. The crude product was 
dissolved in MeOH or dioxane (30 mL), HCl in MeOH (12 mL, 
1.25 M, 15 mmol) was added and the reaction solution was refluxed 
overnight. After evaporation of the solvent, the crude product was 
purified by column chromatography on silica gel (Hex/EtOAc 
20:1→10:1) to give the title compound as an off-white solid (1.46 g, 
72% over two steps). 
1
H NMR (500 MHz, CDCl3) δ 8.10 (s, 2H), 
7.96 (d, J = 8.1 Hz, 2H), 7.84 (d, J = 7.9 Hz, 2H), 7.82 (d, J = 1.4 Hz, 2H), 7.79 – 7.76 (m, 2H), 
7.73 (dd, J = 7.8, 1.6 Hz, 2H), 7.48 – 7.44 (m, 2H), 7.41 (ddd, J = 8.1, 6.8, 1.3 Hz, 2H), 7.38 – 7.32 
(m, 6H), 7.28 (d, J = 8.5 Hz, 2H), 5.47 (s, 2H), 1.55 (s, 12H);
 13
C NMR (126 MHz, CDCl3) δ 
154.1, 154.0, 150.3, 139.1, 139.0, 136.5, 133.2, 131.4, 131.2, 129.7, 128.7, 128.6, 127.6, 127.4, 
127.2, 124.5, 124.5, 124.1, 122.8, 120.3, 120.2, 112.8, 47.2, 27.4; HRMS (ESI) calculated for 
C50H37O2 (M-H)
-
: 669.2799; found 669.2805. 
 
(S)-3,3'-di(9H-fluoren-2-yl)-[1,1'-binaphthalene]-2,2'-diol: Prepared according to the 
representative procedure on a 3 mmol scale for (S)-B with 2-bromo-
9H-fluorene (2.57 g, 10.5 mmol) to give the title compound as an 
off-white solid (1.10 g, 59% over two steps). 
1
H NMR (500 MHz, 
CDCl3) δ 8.10 (s, 2H), 7.98 – 7.93 (m, 4H), 7.91 (d, J = 7.9 Hz, 2H), 
7.85 (dt, J = 7.6, 0.9 Hz, 2H), 7.77 (dd, J = 7.9, 1.6 Hz, 2H), 7.58 
(dt, J = 7.4, 1.0 Hz, 2H), 7.42 (ddt, J = 8.5, 7.4, 1.5 Hz, 4H), 7.38 – 
7.32 (m, 4H), 7.29 (dd, J = 8.5, 1.2 Hz, 2H), 5.46 (s, 2H), 3.99 (s, 
4H).; 
13
C NMR (126 MHz, CDCl3) δ 150.3, 143.7, 141.5, 141.5, 
136.0, 133.1, 131.4, 131.1, 129.7, 128.6, 128.5, 127.4, 127.0, 127.0, 
126.4, 125.2, 124.5, 124.5, 120.2, 120.0, 112.7, 37.2; HRMS (ESI) 
calculated for C46H29O2 [M-H]
−
: 613.2173; found: 613.2170. 
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(S)-3,3'-di(spiro[cyclobutane-1,9'-fluoren]-2'-yl)-[1,1'-binaphthalene]-2,2'-diol: Prepared 
according to the representative procedure on a 3 mmol scale for (S)-
B with 2'-bromospiro[cyclobutane-1,9'-fluorene] (3.0 g, 10.6 mmol) 
to give the title compound as an off-white solid (1.66 g, 80% over 
two steps). 
1
H NMR (500 MHz, CDCl3) δ 8.22 – 8.13 (m, 4H), 8.00 
(d, J = 8.0 Hz, 2H), 7.88 – 7.80 (m, 4H), 7.79 – 7.72 (m, 4H), 7.48 – 
7.42 (m, 2H), 7.42 – 7.36 (m, 6H), 7.34 (d, J = 8.4 Hz, 2H), 5.55 (s, 
2H), 2.83 – 2.72 (m, 4H), 2.73 – 2.64 (m, 4H), 2.45 (p, J = 9.0, 8.5 
Hz, 4H); 
13
C NMR (126 MHz, CDCl3) δ 152.8, 152.7, 150.3, 139.2, 
139.1, 136.8, 133.2, 131.4, 131.2, 129.7, 128.7, 128.6, 127.9, 127.4, 
127.2, 124.6, 124.5, 124.2, 122.8, 119.8, 119.7, 112.8, 77.4, 52.2, 
33.4, 33.4, 17.2.; HRMS (ESI) calculated for C52H37O2 [M-H]
−
: 
693.2799; found: 693.2800. 
 
 
 
 
(S)-3,3'-di(spiro[cyclopentane-1,9'-fluoren]-2'-yl)-[1,1'-binaphthalene]-2,2'-diol: Prepared 
according to the representative procedure on a 3.5 mmol scale for 
(S)-B with 2'-bromospiro[cyclopentane-1,9'-fluorene] (3.1 g, 
10.4 mmol) to give the title compound as an off-white solid (2.11 g, 
84% over two steps). 
1
H NMR (500 MHz, CDCl3) δ 8.16 (s, 2H), 
8.04 – 7.98 (m, 2H), 7.89 (d, J = 1.5 Hz, 2H), 7.86 (d, J = 7.8 Hz, 
2H), 7.79 (dd, J = 6.6, 1.8 Hz, 2H), 7.76 (dd, J = 7.8, 1.6 Hz, 2H), 
7.52 (dd, J = 6.7, 1.8 Hz, 2H), 7.45 (ddd, J = 8.1, 6.7, 1.3 Hz, 2H), 
7.41 – 7.34 (m, 6H), 7.30 (d, J = 8.4 Hz, 2H), 5.61 (s, 2H), 2.24 – 
2.14 (m, 16H); 
13
C NMR (126 MHz, CDCl3) δ 154.69, 154.63, 
150.34, 139.18, 139.06, 136.73, 133.14, 131.22, 129.64, 128.48, 
128.37, 127.72, 127.18, 126.83, 124.33, 124.31, 124.29, 123.01, 
119.75, 119.56, 112.87, 57.89, 39.91, 39.87, 26.96; HRMS (ESI) 
calculated for C52H37O2 [M-H]
−
: 693.2799; found: 693.2800.  
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Synthesis of phosphorimidoyl trichlorides 
 
 
 
The syntheses of ((trifluormethyl)sulfonyl)phosphorimidoyl trichloride
6
 C1, 
((perfluoroethyl)sulfonyl)phosphorimidoyl trichloride
7
 C2 have been described previously. 
1,1,2,2,3,3,4,4,4 nonafluoro-n-butanesulfonamide was synthesized as reported in the literature
8
 and 
purified by recrystallization from toluene. 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluorohexane-1-
sulfonamide and 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonamide were 
purchased from commercial sources and recrystallized twice from toluene to removed impurities of 
branched perfluoroalkylsulfonamides. 
 
Representative procedure: ((Perfluoro-n-butyl)sulfonyl)phosphorimidoyl trichloride (C3)  
In a Schlenk flask under Argon equipped with a magnetic stirring bar connected to 
a two-neck flask containing NaOH pellets and a vacuum pump in this order, a 
mixture of sulfonamide (2.50 g, 8.36 mmol, 1.0 equiv) and PCl5 (1.84 g, 
8.86 mmol, 1.06 equiv) was heated to 100 °C under Argon for 1 h. The reaction 
was monitored by 
1
H, 
19
F, and 
31
P NMR to ensure full consumption of sulfonamide. 
Removal of the excess amount of PCl5 by prolonged evacuation in vacuum afforded the title 
compound in quantitative yield as colorless oil, which was stored in a Schlenk flask under argon. 
19
F NMR (471 MHz, CD2Cl2) δ -81.1 (t, J = 10.1 Hz, 3F), -112.6 (t, J = 14.2 Hz, 2F), -120.7 – -
121.6 (m, 2F), -125.8 – -126.7 (m, 2F); 31P NMR (203 MHz, CD2Cl2) δ 17.0; HRMS (CI [DE] i-
butane) calculated for C4H1N1O2Cl3F9P1S1 [M+H]: 433.8387; found: 433.8390. 
 
((Perfluoro-n-hexyl)sulfonyl)phosphorimidoyl trichloride (C4): Obtained as a colorless oil, 
which became a solid upon storage in a fridge at 4 °C. 
19
F NMR (471 MHz, 
CDCl3) δ -80.7 (t, J = 9.9 Hz, 3F), -111.9 (tdt, J = 12.3, 6.7, 3.3 Hz, 2F), -120.0 
(ddt, J = 19.6, 14.2, 6.6 Hz, 2F), -121.7 (p, J = 13.9 Hz, 2F), -122.4 – -122.9 (m, 
2F), -126.1 (ttd, J = 13.1, 6.7, 6.1, 3.0 Hz, 2F); 
31
P NMR (203 MHz, CDCl3) δ 
15.3; HRMS (CI [DE] i-butane) calculated for C6H1N1O2Cl3F13P1S1 [M+H]: 533.8318; found: 
533.8321. 
 
((Perfluoro-n-octyl)sulfonyl)phosphorimidoyl trichloride (C5): Obtained as a colorless solid.
 
19
F NMR (471 MHz, CDCl3) δ -80.7 (t, J = 9.8 Hz, 3F), -111.9 (t, J = 15.4 Hz, 
2F), -119.6 – -120.4 (m, 2F), -121.3 – -121.5 (m, 2F), -121.5 – -121.7 (m, 2F), -
121.7 – -122.0 (m, 2F), -122.4 – -122.9 (m, 2F), -125.8 – -126.3 (m, 2F); 31P 
NMR (203 MHz, CDCl3) δ 15.3; HRMS (CI [DE] i-butane) calculated for 
C8H1N1O2Cl3F17P1S1 [M+H]: 633.8260; found: 633.8255. 
 
NOTE: 
13
C spectra could not be obtained due to very low signal intensity. 
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General Procedure for IDPi Synthesis 
 
 
 
An improved protocol for the synthesis of imidodiphosphorimidate Brønsted acids was applied.
6
 In 
a Schlenk tube under argon, a suspension of 3,3’-substituted (S,S)-BINOL (1.05 mmol, 2.1 equiv.) 
in toluene (2.5 mL) was treated with phosphorimidoyl trichloride C1-5 (1.05 mmol, 2.1 equiv.) and 
then NEt3 (1.12 mL, 8.0 mmol, 16 equiv.). The reaction mixture was stirred for 15 min at r.t., until 
neat hexamethyldisilazane (HMDS, 104 μL, 0.5 mmol, 1 equiv.) was added dropwise. The reaction 
mixture was stirred for additional 15 min at r.t., the Schlenk tube was subsequently sealed and 
heated to 120 °C for 3 days. After cooling to r.t., aq. HCl (10%) was added and the mixture was 
extracted with DCM or Et2O. The combined organic layers were washed with brine, dried over 
MgSO4 and concentrated under reduced pressure. The crude material was purified by column 
chromatography on silica gel (hexane/MTBE 90:10→80:20→70:30→60:40→50:50 and/or 0.5−5% 
EtOAc in DCM) to afford the desired product as a salt. The corresponding IDPi Brønsted acids 
(S,S)-4a-r were obtained after acidification in DCM or Et2O with aq. HCl (6 M) and evaporation of 
the solvent followed by drying under high vacuum as typically off-white solids. 
 
The following IDPi catalysts have been prepared during the course of this work: 
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(S,S)-4a: 
Prepared according to the general procedure on a 
1.0 mmol scale (with respect to HMDS) and purified 
by column chromatography (first: hexane/Et2O 80:20 
→ 70:30 → 60:40 → 50:50; second: DCM/EtOAc 
99:1 → 98:2 → 97:3 → 96:4 → 95:5). Off-white 
solid (914 mg, 0.51 mmol, 51%). 
1
H NMR (500 
MHz, CDCl3): δ 8.19 – 8.04 (m, 4H), 7.98 – 7.89 (m, 
4H), 7.86 (s, 4H), 7.82 – 7.70 (m, 4H), 7.68 – 7.57 
(m, 6H), 7.38 (ddd, J = 8.3, 6.8, 1.3 Hz, 2H), 7.33 (s, 
4H), 7.15 (d, J = 8.6 Hz, 2H), 6.66 (s, 2H); 
13
C NMR 
(126 MHz, CDCl3) δ 143.7 (t, J = 5.6 Hz), 141.6 (t, J = 4.9 Hz), 138.0, 137.7, 133.3, 132.5, 132.3, 
132.2, 132.2, 132.1, 132.1, 132.0, 132.0, 131.9, 131.8, 131.7, 131.5, 131.3, 130.8, 130.5, 130.0, 
129.9, 129.9, 129.5, 129.3, 128.8, 128.1, 127.4, 127.3, 126.7, 126.4, 126.3, 124.2, 124.1, 123.7, 
122.1, 121.9, 121.3, 120.1, 119.9, 119.8, 117.5 (other signals not detected or observed); 
19
F NMR 
(280 MHz, CDCl3) δ -62.5 (s, 12F), -63.1 (s, 12F), -79.0 (s, 6F); 
31
P NMR (200 MHz, CDCl3) δ -
15.4; HRMS (ESI) calculated for C74H32N3O8F30P2S2 (M-H)
-
: 1786.0633; found: 1786.0641. 
 
(S,S)-4b: 
Prepared according to the general procedure on a 
0.33 mmol scale (with respect to HMDS) and purified 
by column chromatography (first: hexane/Et2O 80:20 
→ 70:30 → 60:40 → 50:50; second: DCM/EtOAc 
99:1 → 98:2 → 97:3 → 96:4 → 95:5). Off-white 
solid (329 mg, 0.174 mmol, 52%). 
1
H NMR (500 
MHz, CDCl3) δ 8.07 (t, J = 4.0 Hz, 4H), 7.96 – 7.88 
(m, 4H), 7.86 (s, 2H), 7.83 (s, 2H), 7.79 (d, J = 8.5 
Hz, 2H), 7.73 (ddd, J = 8.3, 5.9, 2.0 Hz, 2H), 7.64 (s, 
4H), 7.63 – 7.59 (m, 2H), 7.38 (ddd, J = 8.4, 6.8, 1.3 
Hz, 2H), 7.32 (s, 4H), 7.17 (d, J = 8.6 Hz, 2H), 6.64 (s, 2H); 
13
C NMR (126 MHz, CDCl3) δ 143.7 
(t, J = 5.3 Hz), 141.9 (t, J = 5.1 Hz), 138.2, 137.9, 133.3, 132.3, 132.2, 132.1, 132.0, 132.0, 131.9, 
131.8, 131.8, 131.7, 131.5, 131.4, 131.2, 130.9, 130.7, 129.9, 129.9, 129.5, 129.3, 128.7, 128.0, 
127.3, 127.2, 126.8, 126.4, 126.3, 124.3, 124.1, 123.7, 122.1, 122.0, 122.0, 121.9, 121.9, 121.6, 
119.9, 119.8, 118.5, 118.3, 118.0, 116.2, 116.0, 115.7, 111.5, 111.1 (other signals not detected or 
observed); 
19
F NMR (470 MHz, CDCl3) δ -62.5 (s, 12F), -63.1 (s, 12F), -79.1 (s, 6F), -117.0 (s, 
4F); 
31
P NMR (200 MHz, CDCl3) δ -14.7; HRMS (ESI) calculated for C76H32N3O8P2S2F34 (M-H)
-
: 
1886.0569; found: 1886.0573. 
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(S,S)-4e: 
Prepared according to the general procedure on a 
0.255 mmol scale (with respect to HMDS) and 
purified by column chromatography (first: 
hexane/MTBE 90:10 → 80:20 → 70:30 → 60:40 → 
50:50 → 40:60 → 30:70; second: DCM/EtOAc 99:1 
→ 98:2 → 97:3). Off-white solid (369 mg, 
0.177 mmol, 69%). 
1
H NMR (500 MHz, CDCl3) δ 
8.15 (s, 2H), 8.10 (d, J = 8.2 Hz, 2H), 7.96 – 7.89 (m, 
4H), 7.86 (s, 2H), 7.83 – 7.77 (m, 4H), 7.73 (ddd, J = 
8.4, 5.3, 2.7 Hz, 2H), 7.67 – 7.59 (m, 6H), 7.39 (ddd, 
J = 8.2, 6.9, 1.0 Hz, 2H), 7.33 (s, 4H), 7.17 (d, J = 8.6 Hz, 2H), 6.65 (s, 2H); 
13
C NMR (126 MHz, 
CDCl3) δ 143.4 (t, J = 5.3 Hz), 141.7 (t, J = 5.0 Hz), 138.2, 137.4, 133.3, 132.5, 132.4, 132.2, 
132.2, 132.2, 132.1, 132.0, 132.0, 132.0, 131.9, 131.7, 131.6, 131.2, 130.7, 130.5, 129.9, 129.4, 
129.4, 129.4, 128.8, 128.1, 127.4, 127.3, 127.3, 126.7, 126.4, 126.2, 124.2, 124.1, 123.8, 122.2, 
122.2, 122.2, 122.1, 121.9, 121.9, 121.7, 119.9, 119.7, 116.0 (other signals not detected or 
observed); 
19
F NMR (470 MHz, CDCl3) δ -62.5 (s, 12F), -63.35 (s, 12F), -80.98 (t, J = 10.1 Hz, 
6F), -112.47 (d, J = 261.2 Hz, 2F), -113.30 (d, J = 264.6 Hz, 2F), -120.91 (s, 4F), -125.87 (d, J = 
296.8 Hz, 2F), -126.71 (d, J = 297.4 Hz, 2F); 
31
P NMR (200 MHz, CDCl3) δ -15.1; HRMS (ESI) 
calculated for C80H32F42N3O8P2S2 (M-H)
-
: 2086.0441; found: 2086.0427. 
 
(S,S)-4f: 
Prepared according to the general procedure on a 
0.174 mmol scale (with respect to HMDS), purified 
by column chromatography (first: hexane/MTBE 
90:10 → 80:20 → 70:30 → 60:40 → 50:50 → 40:60 
→ 30:70; second: DCM/EtOAc 99:1 → 98:2) and 
acidified in Et2O instead of DCM. Off-white solid 
(237 mg, 0.104 mmol, 60%). 
1
H NMR (500 MHz, 
CDCl3) δ 8.15 (s, 2H), 8.10 (d, J = 8.2 Hz, 2H), 7.96 
– 7.88 (m, 4H), 7.86 (s, 2H), 7.82 – 7.76 (m, 4H), 
7.73 (ddd, J = 8.4, 5.4, 2.5 Hz, 2H), 7.66 – 7.58 (m, 
6H), 7.39 (ddd, J = 8.3, 6.8, 1.3 Hz, 2H), 7.33 (s, 4H), 7.17 (d, J = 8.5 Hz, 2H), 6.65 (s, 2H); 
13
C NMR (126 MHz, CDCl3) δ 143.4 (t, J = 5.6 Hz), 141.7 (t, J = 4.6 Hz), 138.2, 137.4, 133.3, 
132.5, 132.4, 132.2, 132.2, 132.2, 132.1, 132.0, 132.0, 132.0, 131.9, 131.7, 131.6, 131.2, 130.7, 
130.5, 129.9, 129.4, 129.4, 128.8, 128.1, 127.3, 127.3, 126.7, 126.4, 126.2, 124.2, 124.1, 123.8, 
122.3, 122.2, 122.2, 122.2, 122.2, 122.0, 121.9, 121.9, 121.8, 121.8, 121.8, 121.7, 119.9, 119.7 
(other signals not detected or observed); 
19
F NMR (470 MHz, CDCl3) δ -62.6 (s, 12F), -63.4 (s, 
12F), -81.0 (t, J = 9.6 Hz, 6F), -112.3 (d, J = 256.1 Hz, 2F), -113.2 (d, J = 259.1 Hz, 2F), -120.1 (d, 
J = 61.2 Hz, 4F), -122.1 (s, 4F), -123.0 (s, 4F), -126.4 (d, J = 13.6 Hz, 4F); 
31
P NMR (200 MHz, 
CDCl3) δ -15.1; HRMS (ESI) calculated for C84H32F50N3O8P2S2 (M-H)
-
: 2286.0313; found: 
2286.0296. 
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(S,S)-4g: 
Prepared according to the general procedure on a 
0.236 mmol scale (with respect to HMDS), purified 
by column chromatography (first: hexane/MTBE 
90:10 → 80:20 → 70:30 → 60:40 → 50:50 → 40:60 
→ 30:70; second: DCM/EtOAc 99.5:0.5 → 99:1 → 
98:2) and acidified in Et2O instead of DCM. Off-
white solid (85 mg, 0.034 mmol, 15%). 
1
H NMR 
(500 MHz, CDCl3) δ 8.15 (s, 2H), 8.10 (d, J = 8.2 Hz, 
2H), 7.96 – 7.88 (m, 4H), 7.85 (s, 2H), 7.82 – 7.76 
(m, 4H), 7.73 (ddd, J = 8.3, 5.8, 2.1 Hz, 2H), 7.67 – 
7.59 (m, 6H), 7.39 (ddd, J = 8.4, 6.9, 1.3 Hz, 2H), 7.33 (s, 4H), 7.17 (d, J = 8.6 Hz, 2H), 6.65 (s, 
2H); 
13
C NMR (126 MHz, CDCl3) δ 143.5 (t, J = 5.0 Hz), 141.8 (t, J = 5.3 Hz), 138.2, 137.5, 
133.3, 132.5, 132.4, 132.2, 132.2, 132.2, 132.1, 132.0, 131.9, 131.9, 131.8, 131.7, 131.6, 131.2, 
130.7, 130.5, 129.9, 129.9, 129.9, 129.4, 129.3, 128.8, 128.1, 127.3, 126.7, 126.4, 126.3, 124.2, 
124.1, 123.8, 122.2, 122.2, 122.1, 122.1, 121.9, 121.8, 121.8, 121.8, 119.9, 119.8 (other signals not 
detected or observed); 
19
F NMR (470 MHz, CDCl3) δ -62.6 (s, 12F), -63.4 (s, 12F), -80.9 (t, J = 
10.0 Hz, 6F), -112.3 (d, J = 258.7 Hz, 2F), -113.2 (d, J = 260.5 Hz, 2F), -120.0 (d, J = 51.2 Hz, 
4F), -121.1 – -122.8 (m, 12F), -122.9 (s, 4F), -126.3 (s, 4F); 31P NMR (200 MHz, CDCl3) δ -14.8; 
HRMS (ESI) calculated for C88H32F58N3O8P2S2 (M-H)
-
: 2486.0186; found: 2486.0164. 
 
(S,S)-4h: 
Prepared according to the general procedure on a 
0.15 mmol scale (with respect to HMDS) and 
purified by column chromatography (hexane/MTBE 
20:1 → 9:1 → 4:1 → 2:1). Off-white solid (112 mg, 
0.064 mmol, 43%). 
1
H NMR (500 MHz, CDCl3): δ 
8.14 – 8.05 (m, 6H), 7.93 – 7.82 (m, 4H), 7.82 – 7.79 
(m, 4H), 7.70 (ddd, J = 8.3, 6.8, 1.3 Hz, 2H), 7.66 – 
7.62 (m, 2H), 7.62 – 7.58 (m, 4H), 7.50 (dd, J = 8.1, 
5.7 Hz, 4H), 7.41 (ddd, J = 8.4, 6.7, 1.3 Hz, 2H), 
7.33 (dd, J = 7.2, 1.4 Hz, 2H), 7.30 (td, J = 7.5, 1.1 
Hz, 2H), 7.26 – 7.15 (m, 10H), 6.55 (d, J = 8.0 Hz, 
2H), 6.44 (dd, J = 7.9, 1.6 Hz, 2H), 6.09 (dd, J = 7.9, 1.6 Hz, 2H), 2.84 – 2.76 (m, 2H), 2.68 – 2.53 
(m, 8H), 2.42 – 2.33 (m, 8H), 2.29 – 2.15 (m, 6H); 13C NMR (126 MHz, CDCl3) δ 153.0, 152.9, 
152.5, 151.9, 144.0 (t, J = 5.0 Hz), 143.1 (t, J = 5.0 Hz), 139.5, 139.0, 138.8, 138.6, 135.1, 135.0, 
134.5, 134.4, 132.3, 132.0, 132.0, 131.9, 131.8, 131.4, 129.1, 128.9, 128.9, 128.7, 128.1, 127.6, 
127.4, 127.3, 127.1, 127.0, 126.9, 126.7, 126.6, 124.1, 123.6, 122.6, 122.5, 121.9, 120.1, 119.8, 
119.2, 118.7, 118.3, 117.5, 52.1, 52.1, 33.7, 33.1, 32.8, 32.7, 17.1 (other signals not detected or 
observed); 
19
F NMR (470 MHz, CDCl3) δ -78.3 (s, 6F); 
31
P NMR (200 MHz, CDCl3) δ -16.6; 
HRMS (ESI) calculated for C106H72N3O8F6P2S2 (M-H)
-
: 1754.4146; found: 1754.4158. 
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(S,S)-4c: 
Prepared according to the general procedure on a 
0.071 mmol scale (with respect to HMDS) and 
purified by column chromatography (hexane/MTBE 
10:1 → 4:1 → 2:1 → 1:1). Off-white solid (95 mg, 
0.051 mmol, 72%). 
1
H NMR (500 MHz, CDCl3): δ 
8.09 (s, 2H), 8.06 (dd, J = 8.4, 5.8 Hz, 4H), 7.92 – 
7.84 (m, 4H), 7.83 – 7.77 (m, 4H), 7.71 (ddd, J = 8.3, 
6.9, 1.3 Hz, 2H), 7.66 – 7.63 (m, 2H), 7.59 (ddd, J = 
8.2, 6.6, 1.3 Hz, 2H), 7.56 (d, J = 1.6 Hz, 2H), 7.53 
(dt, J = 7.6, 0.9 Hz, 2H), 7.47 – 7.43 (m, 2H), 7.40 
(ddd, J = 8.5, 6.7, 1.3 Hz, 2H), 7.35 (d, J = 7.9 Hz, 
2H), 7.31 – 7.27 (m, 4H), 7.25 – 7.19 (m, 4H), 7.19 – 7.16 (m, 2H), 7.09 (s, 2H), 6.49 (d, J = 8.0 
Hz, 2H), 6.38 (dd, J = 8.0, 1.6 Hz, 2H), 6.33 (dd, J = 7.9, 1.6 Hz, 2H), 2.84 – 2.76 (m, 2H), 2.67 – 
2.52 (m, 8H), 2.41 – 2.23 (m, 13H), 2.18 – 2.11 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 153.1, 
153.0, 152.4, 151.9, 144.1 (t, J = 5.0 Hz), 143.0 t, J = 5.0 Hz), 139.7, 139.1, 138.8, 138.6, 135.1, 
135.1, 134.5, 134.2, 132.3, 132.1, 131.9, 131.8, 131.7, 131.5, 129.3, 129.0, 128.9, 128.9, 128.1, 
127.5, 127.3, 127.1, 127.0, 126.9, 126.8, 126.7, 126.5, 124.0, 123.6, 122.5, 122.4, 121.8, 119.9, 
119.2, 118.7, 118.3, 52.1, 52.1, 33.5, 33.0, 32.8, 17.1, 17.0 (other signals not detected or observed); 
19
F NMR (470 MHz, CDCl3) δ -79.0 (s, 6F), -114.8 – -116.8 (m, 4F); 
31
P NMR (200 MHz, CDCl3) 
δ -17.5; HRMS (ESI) calculated for C108H72N3O8F10P2S2 (M-H)
-
: 1854.4082; found: 1854.4089. 
 
(S,S)-4i: 
Prepared according to the general procedure on a 
0.076 mmol scale (with respect to HMDS) and 
purified by column chromatography (first: 
hexane/MTBE 9:1 → 4:1 → 2:1 → 1:1). Off-white 
solid (99 mg, 0.048 mmol, 67%). 
1
H NMR (500 
MHz, CDCl3): δ 8.08 (s, 2H), 8.06 (d, J = 8.3 Hz, 
2H), 8.03 (dd, J = 8.6, 1.3 Hz, 2H), 7.88 (td, J = 5.9, 
5.2, 1.4 Hz, 4H), 7.81 (d, J = 1.6 Hz, 2H), 7.77 (d, J 
= 7.5 Hz, 2H), 7.72 (ddd, J = 8.3, 6.8, 1.3 Hz, 2H), 
7.67 – 7.64 (m, 2H), 7.60 – 7.54 (m, 6H), 7.41 (d, J = 
8.0 Hz, 2H), 7.40 – 7.35 (m, 4H), 7.32 – 7.27 (m, 
4H), 7.24 (dd, J = 7.4, 1.3 Hz, 2H), 7.20 (td, J = 7.5, 1.2 Hz, 4H), 7.05 (s, 2H), 6.60 (dd, J = 7.9, 
1.6 Hz, 2H), 6.55 (d, J = 8.0 Hz, 2H), 6.34 (dd, J = 7.9, 1.6 Hz, 2H), 2.81 – 2.74 (m, 2H), 2.69 – 
2.54 (m, 8H), 2.38 – 2.21 (m, 12H), 2.17 – 2.08 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 153.1, 
152.9, 152.3, 152.1, 144.2 (t, J = 5.0 Hz), 143.1 (t, J = 5.0 Hz), 139.7, 139.1, 138.9, 138.6, 135.1, 
135.0, 134.4, 133.9, 132.3, 132.1, 131.8, 131.7, 131.3, 129.5, 129.1, 128.9, 128.7, 128.1, 127.4, 
127.3, 127.3, 127.1, 127.0, 126.8, 126.6, 126.5, 123.8, 123.7, 123.6, 122.4, 121.8, 119.8, 119.3, 
118.7, 118.3, 52.1, 52.0, 33.2, 33.1, 32.7, 17.1, 17.0 (other signals not detected or observed); 
19
F NMR (470 MHz, CDCl3) δ -81.0 (t, J = 10.1 Hz, 3F), -111.0 – -112.6 (m, 2F), -121.1 (q, J = 
11.1 Hz, 2F), -125.1 – -126.9 (m, 2F); 31P NMR (200 MHz, CDCl3) δ -16.8; HRMS (ESI) 
calculated for C112H72N3O8F18P2S2 (M-H)
-
: 2054.3954; found: 2054.3944. 
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(S,S)-4j: 
Prepared according to the general procedure on a 
0.5 mmol scale (with respect to HMDS) and purified 
by column chromatography (first: hexane/MTBE 9:1 
→ 4:1 → 2:1 → 1:1). Off-white solid (205 mg, 
0.091 mmol, 64%). 
1
H NMR (500 MHz, CDCl3): δ 
8.10 (s, 2H), 8.07 (d, J = 8.3 Hz, 2H), 8.04 – 8.00 
(m, 2H), 7.91 – 7.84 (m, 4H), 7.81 (d, J = 1.6 Hz, 
2H), 7.76 (d, J = 7.5 Hz, 2H), 7.72 (ddd, J = 8.2, 6.8, 
1.3 Hz, 2H), 7.63 (d, J = 7.5 Hz, 2H), 7.58 (ddd, J = 
8.2, 5.9, 2.1 Hz, 2H), 7.56 – 7.51 (m, 4H), 7.42 – 
7.37 (m, 6H), 7.30 (d, J = 7.4 Hz, 2H), 7.28 (d, J = 
8.0 Hz, 2H), 7.23 (td, J = 7.4, 1.2 Hz, 2H), 7.21 – 7.18 (m, 2H), 7.18 – 7.15 (m, 2H), 7.07 (s, 2H), 
6.60 (d, J = 8.0 Hz, 4H), 6.37 (dd, J = 7.9, 1.6 Hz, 2H), 2.83 – 2.73 (m, 2H), 2.68 – 2.52 (m, 8H), 
2.38 – 2.22 (m, 12H), 2.18 – 2.08 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 153.1, 152.9, 152.3, 
152.1, 144.2 (t, J = 5.0 Hz), 143.1 (t, J = 5.0 Hz), 139.7, 139.1, 139.0, 138.6, 135.1, 134.9, 134.3, 
134.0, 132.3, 132.1, 131.8, 131.7, 131.3, 129.4, 129.1, 128.9, 128.7, 128.1, 127.4, 127.3, 127.1, 
127.0, 126.8, 126.6, 126.5, 126.5, 123.8, 123.7, 123.6, 122.4, 122.4, 122.0, 119.7, 119.2, 118.7, 
118.4, 52.1, 52.0, 33.2, 33.1, 33.1, 32.6, 17.1, 17.0 (other signals not detected or observed); 
19
F NMR (470 MHz, CDCl3) δ -80.8 (t, J = 9.7 Hz, 6F), -110.4 – -112.6 (m, 4F), -120.1 (dt, J = 
32.4, 14.4 Hz, 4F), -121.8 (p, J = 13.1 Hz, 4F), -122.6 – -123.2 (m, 4F), -126.2 (t, J = 14.6 Hz, 4F); 
31
P NMR (200 MHz, CDCl3) δ -16.8; HRMS (ESI) calculated for C116H72N3O8F26P2S2 (M-H)
-
: 
2254.3827; found: 2254.3809. 
 
(S,S)-4k: 
Prepared according to the general procedure on a 
0.22 mmol scale (with respect to HMDS) and 
purified by column chromatography (first: 
hexane/MTBE 9:1 → 4:1 → 2:1 → 1:1; second: 
DCM/EtOAc 99.5:0.5 → 99:1 → 98:2). Off-white 
solid (50 mg, 0.02 mmol, 9%). 
1
H NMR (500 MHz, 
CDCl3): δ 8.11 (s, 2H), 8.05 (dd, J = 20.2, 8.3 Hz, 
4H), 7.88 (d, J = 8.1 Hz, 4H), 7.82 (s, 2H), 7.80 – 
7.69 (m, 4H), 7.64 (d, J = 7.5 Hz, 2H), 7.61 – 7.51 
(m, 6H), 7.39 (q, J = 8.3 Hz, 6H), 7.30 (dd, J = 17.3, 
7.4 Hz, 4H), 7.24 – 7.14 (m, 6H), 7.08 (s, 2H), 6.61 
(dd, J = 8.2, 3.0 Hz, 4H), 6.39 (d, J = 7.9 Hz, 2H), 2.85 – 2.75 (m, 2H), 2.71 – 2.51 (m, 8H), 2.40 – 
2.23 (m, 12H), 2.19 – 2.10 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 153.1, 152.9, 152.3, 152.1, 
144.2 (t, J = 5.0 Hz), 143.1 (t, J = 5.0 Hz), 139.7, 139.1, 139.0, 138.6, 135.1, 134.8, 134.3, 134.0, 
132.3, 132.1, 131.9, 131.8, 131.7, 131.3, 129.5, 129.1, 128.9, 128.7, 128.1, 127.4, 127.3, 127.1, 
127.0, 126.8, 126.6, 126.5, 126.5, 123.8, 123.7, 122.4, 122.4, 122.0, 119.7, 119.3, 118.7, 118.4, 
52.1, 52.0, 33.3, 33.1, 33.1, 32.6, 17.1, 17.0 (other signals not detected or observed); 
19
F NMR 
(470 MHz, CDCl3) δ -80.8 (t, J = 9.8 Hz, 6F), -110.5 – -112.8 (m, 4F), -120.1 (p, J = 12.8, 11.4 Hz, 
4F), -121.6 (m, 4F), -121.8 – -122.3 (m, 8F), -122.8 (dd, J = 22.3, 11.9 Hz, 4F), -126.1 (t, J = 14.2 
Hz, 4F); 
31
P NMR (200 MHz, CDCl3) δ -16.7; HRMS (ESI) calculated for C120H72N3O8F34P2S2 
(M-H)
-
: 2454.3699; found: 2454.3676. 
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(S,S)-4l: 
Prepared according to the general procedure on a 
0.066 mmol scale (with respect to HMDS) and 
purified by column chromatography (5% EtOAc, 
20% DCM, 75% hexanes). Off-white solid (106 mg, 
0.058 mmol, 88%). 
1
H NMR (500 MHz, CD2Cl2): δ 
8.12 (s, 2H), 8.08 (t, J = 8.1 Hz, 4H), 7.86 (t, J = 7.5 
Hz, 2H), 7.80 (d, J = 8.5 Hz, 2H), 7.69 (dd, J = 8.5, 
6.9 Hz, 2H), 7.61 (ddd, J = 8.1, 6.3, 1.5 Hz, 2H), 
7.58 – 7.52 (m, 4H), 7.47 – 7.43 (m, 4H), 7.43 – 7.36 
(m, 6H), 7.34 (dt, J = 7.0, 3.0 Hz, 2H), 7.28 – 7.23 
(m, 4H), 7.23 – 7.17 (m, 6H), 7.16 (s, 2H), 6.68 (d, J 
= 7.9 Hz, 2H), 6.51 (dd, J = 7.9, 1.6 Hz, 2H), 6.30 – 
6.22 (m, 2H), 2.22 (qd, J = 10.6, 9.1, 5.4 Hz, 2H), 2.17 – 1.91 (m, 22H), 1.88 – 1.60 (m, 8H); 
13
C NMR (126 MHz, CD2Cl2) δ 154.82, 154.75, 154.47, 153.79, 139.53, 138.85, 138.82, 138.64, 
134.96, 134.52, 134.39, 133.87, 132.15, 131.78, 131.56, 131.36, 129.13, 128.67, 128.54, 128.43, 
127.76, 127.48, 127.30, 126.84, 126.81, 126.77, 126.54, 126.41, 123.85, 123.65, 123.27, 122.85, 
122.72, 121.87, 119.66, 119.11, 118.69, 118.24, 57.89, 57.77, 39.94, 39.84, 39.04, 38.87, 26.94, 
26.73, 26.57, 26.41 (other signals not detected or observed); 
19
F NMR (470 MHz, CD2Cl2) δ -78.7 
(s, 6F); 
31
P NMR (200 MHz, CD2Cl2) δ -16.9; HRMS (ESI) calculated for C110H80N3O8F6P2S2 
(M-H)
-
: 1810.4772; found: 1810.4779. 
 
(S,S)-4m: 
Prepared according to the general procedure on a 
0.25 mmol scale (with respect to HMDS) and 
purified by column chromatography (hexane/MTBE 
20:1 → 9:1 → 4:1 → 2:1). Off-white solid (238 mg, 
0.124 mmol, 50%). 
1
H NMR (500 MHz, CDCl3): δ 
8.03 (q, J = 8.3 Hz, 6H), 7.86 – 7.81 (m, 4H), 7.68 
(ddd, J = 8.3, 6.8, 1.3 Hz, 2H), 7.58 (ddd, J = 8.2, 
6.4, 1.5 Hz, 2H), 7.54 (d, J = 7.5 Hz, 2H), 7.51 (d, J 
= 1.6 Hz, 2H), 7.43 – 7.37 (m, 8H), 7.31 (ddd, J = 
7.9, 4.9, 2.1 Hz, 4H), 7.25 – 7.14 (m, 10H), 7.02 (s, 
2H), 6.59 (d, J = 8.0 Hz, 2H), 6.47 (dd, J = 8.0, 1.6 
Hz, 2H), 6.30 (dd, J = 7.9, 1.7 Hz, 2H), 2.29 – 2.19 
(m, 2H), 2.13 – 1.95 (m, 22H), 1.86 – 1.69 (m, 8H); 13C NMR (126 MHz, CDCl3) δ 155.3, 155.2, 
154.6, 154.2, 144.3 (t, J = 5.0 Hz), 143.3 (t, J = 5.0 Hz), 140.2, 139.5, 139.3, 138.9, 135.3, 134.7, 
134.5, 132.5, 132.3, 132.2, 132.0, 132.0, 131.8, 129.5, 129.1, 128.9, 128.2, 127.7, 127.5, 127.4, 
127.3, 127.3, 127.1, 127.0, 126.7, 126.7, 124.1, 124.0, 123.8, 123.1, 123.0, 122.0, 120.3, 119.6, 
119.0, 118.7, 58.2, 58.2, 40.4, 40.0, 39.3, 27.3, 27.1, 26.9 (other signals not detected or observed); 
19
F NMR (470 MHz, CDCl3) δ -78.9 (s, 6F), -114.8 – -116.5 (m, 4F); 
31
P NMR (200 MHz, CDCl3) 
δ -17.3; HRMS (ESI) calculated for C112H80N3O8F10P2S2 (M-H)
-
: 1910.4708; found: 1910.4713. 
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(S,S)-4n: 
Prepared according to the general procedure on a 
0.086 mmol scale (with respect to HMDS) and 
purified by column chromatography (hexane/MTBE 
20:1 → 9:1 → 4:1 → 2:1). Off-white solid (57 mg, 
0.027 mmol, 32%). 
1
H NMR (500 MHz, CDCl3): δ 
7.98 – 7.92 (m, 4H), 7.89 (d, J = 8.2 Hz, 2H), 7.77 (t, 
J = 7.5 Hz, 2H), 7.71 (d, J = 8.6 Hz, 2H), 7.60 (ddd, 
J = 8.3, 6.7, 1.3 Hz, 2H), 7.49 (ddd, J = 7.7, 6.1, 2.0 
Hz, 4H), 7.43 (d, J = 1.6 Hz, 2H), 7.37 (d, J = 7.9 
Hz, 2H), 7.32 (d, J = 7.4 Hz, 2H), 7.30 – 7.25 (m, 
4H), 7.25 – 7.21 (m, 4H), 7.17 – 7.12 (m, 4H), 7.12 – 
7.07 (m, 6H), 6.88 (s, 2H), 6.50 (t, J = 7.8 Hz, 4H), 
6.33 (dd, J = 7.9, 1.6 Hz, 2H), 2.07 – 1.86 (m, 24H), 1.75 – 1.68 (m, 2H), 1.66 – 1.48 (m, 6H); 
13
C NMR (126 MHz, CDCl3) δ 155.0, 154.8, 154.4, 153.9, 144.3 (t, J = 5.0 Hz), 143.1 (t, J = 5.0 
Hz), 140.0, 139.3, 139.1, 138.7, 135.1, 135.0, 134.3, 133.9, 132.3, 132.1, 131.8, 131.7, 131.7, 
131.3, 129.5, 128.8, 128.6, 127.8, 127.3, 127.1, 127.0, 126.7, 126.5, 126.4, 126.3, 124.0, 123.6, 
123.4, 122.9, 122.6, 121.7, 120.0, 119.3, 118.7, 118.4, 58.1, 57.9, 39.7, 39.6, 39.3, 39.0, 27.1, 26.8, 
26.6, 26.5 (other signals not detected or observed); 
19
F NMR (470 MHz, CDCl3) δ -80.9 (t, J = 
10.1 Hz, 6F), -110.9 – -112.7 (m, 4F), -121.0 (q, J = 10.7 Hz, 4F), -125.2 – -126.9 (m, 4F); 
31
P NMR (200 MHz, CDCl3) δ -16.7; HRMS (ESI) calculated for C116H80N3O8F18P2S2 (M-H)
-
: 
2110.4580; found: 2110.4574. 
 
(S,S)-4d: 
Prepared according to the general procedure on a 
0.12 mmol scale (with respect to HMDS) and 
purified by column chromatography (hexane/MTBE 
10:1 → 5:1 → 2:1 → 1:1). Off-white solid (141 mg, 
0.061 mmol, 50%). 
1
H NMR (500 MHz, CDCl3): δ 
8.04 (d, J = 7.2 Hz, 4H), 7.98 (d, J = 8.2 Hz, 2H), 
7.84 (t, J = 7.5 Hz, 2H), 7.79 (d, J = 8.5 Hz, 2H), 
7.70 – 7.64 (m, 2H), 7.56 (ddd, J = 15.3, 6.4, 1.9 Hz, 
4H), 7.51 (d, J = 1.6 Hz, 2H), 7.41 (dd, J = 11.6, 7.7 
Hz, 4H), 7.37 – 7.34 (m, 4H), 7.32 – 7.29 (m, 4H), 
7.23 (d, J = 1.5 Hz, 2H), 7.22 – 7.13 (m, 8H), 6.99 
(s, 2H), 6.64 (d, J = 8.0 Hz, 2H), 6.56 (d, J = 7.9 Hz, 
2H), 6.45 (dd, J = 8.0, 1.6 Hz, 2H), 2.16 – 1.93 (m, 24H), 1.82 – 1.75 (m, 2H), 1.73 – 1.63 (m, 6H); 
13
C NMR (126 MHz, CDCl3) δ 155.0, 154.8, 154.4, 153.9, 144.2 (t, J = 5.0 Hz), 143.1 (t, J = 5.0 
Hz), 139.9, 139.3, 139.1, 138.7, 135.0, 134.3, 134.0, 132.3, 132.1, 131.8, 131.7, 131.7, 131.3, 
129.4, 128.9, 128.5, 127.8, 127.3, 127.1, 127.1, 127.0, 126.7, 126.5, 126.4, 126.3, 124.0, 123.6, 
123.4, 122.9, 122.6, 121.8, 119.9, 119.3, 118.7, 118.4, 58.1, 57.9, 39.7, 39.7, 39.3, 39.0, 27.1, 26.7, 
26.6, 26.5 (other signals not detected or observed); 
19
F NMR (470 MHz, CDCl3) δ -80.8 (t, J = 
10.0 Hz, 6F), -110.5 – -113.0 (m, 4F), -120.0 (dt, J = 48.6, 14.6 Hz, 4F), -121.4 – -122.1 (m, 4F), -
122.6 – -123.2 (m, 4F), -125.9 – -126.5 (m, 4F); 31P NMR (200 MHz, CDCl3) δ -16.6; HRMS 
(ESI) calculated for C120H80N3O8F26P2S2 (M-H)
-
: 2310.4452; found: 2310.4438. 
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(S,S)-4o: 
Prepared according to the general procedure on a 
0.5 mmol scale (with respect to HMDS) and purified 
by column chromatography (hexane/MTBE 9:1 → 
4:1 → 2:1 → 1:1). Off-white solid (557 mg, 
0.325 mmol, 65%). 
1
H NMR (500 MHz, CDCl3): δ 
8.09 – 8.02 (m, 6H), 7.89 – 7.82 (m, 4H), 7.70 (ddd, 
J = 8.2, 6.8, 1.2 Hz, 2H), 7.62 – 7.56 (m, 4H), 7.50 
(d, J = 1.4 Hz, 2H), 7.45 – 7.41 (m, 4H), 7.41 – 7.37 
(m, 6H), 7.31 – 7.27 (m, 4H), 7.24 – 7.23 (m, 2H), 
7.23 – 7.18 (m, 6H), 7.08 (s, 2H), 6.73 (d, J = 7.9 
Hz, 2H), 6.62 (dd, J = 8.0, 1.6 Hz, 2H), 6.25 (dd, J = 
7.9, 1.7 Hz, 2H), 1.50 (s, 6H), 1.42 (s, 6H), 1.26 (s, 
6H), 1.22 (s, 6H); 
13
C NMR (126 MHz, CDCl3) δ 154.3, 154.2, 153.9, 153.7, 144.1 (t, J = 5.0 Hz), 
142.9 (t, J = 5.0 Hz), 139.4, 138.8, 138.8, 138.6, 134.9, 134.8, 134.3, 134.2, 132.2, 132.2, 131.9, 
131.8, 131.5, 129.2, 129.0, 128.8, 128.7, 127.7, 127.6, 127.3, 127.2, 127.1, 127.0, 126.9, 126.8, 
126.7, 126.6, 123.8, 123.6, 123.5, 122.6, 122.5, 121.8, 120.4, 119.8, 119.2, 119.1, 47.1, 47.1, 27.6, 
27.1, 27.0, 26.6 (other signals not detected or observed); 
19
F NMR (470 MHz, CDCl3) δ -78.2 (s, 
6F); 
31
P NMR (200 MHz, CDCl3) δ -16.8; HRMS (ESI) calculated for C102H72N3O8F6P2S2 (M–H)
-
: 
1706.4146; found: 1706.4162. 
 
(S,S)-4p: 
Prepared according to the general procedure on a 
0.10 mmol scale (with respect to HMDS) and 
purified by column chromatography (hexane/MTBE 
20:1 → 9:1 → 4:1 → 2:1). Off-white solid (62 mg, 
0.034 mmol, 34%). 
1
H NMR (500 MHz, CDCl3): δ 
8.06 – 8.01 (m, 6H), 7.89 – 7.83 (m, 4H), 7.71 (ddd, 
J = 8.4, 6.8, 1.3 Hz, 2H), 7.61 – 7.56 (m, 4H), 7.50 
(d, J = 1.6 Hz, 2H), 7.45 (d, J = 7.9 Hz, 2H), 7.42 – 
7.37 (m, 6H), 7.33 (ddd, J = 20.0, 5.8, 3.3 Hz, 4H), 
7.28 – 7.26 (m, 1H), 7.25 (d, J = 1.2 Hz, 1H), 7.24 – 
7.18 (m, 8H), 6.99 (s, 2H), 6.69 (d, J = 8.0 Hz, 2H), 
6.57 (dd, J = 7.9, 1.6 Hz, 2H), 6.43 (dd, J = 7.9, 1.6 
Hz, 2H), 1.51 (s, 6H), 1.45 (s, 6H), 1.26 (s, 6H), 1.18 (s, 6H); 
13
C NMR (126 MHz, CDCl3) δ 
154.3, 154.2, 153.9, 153.8, 144.2 (t, J = 5.0 Hz), 143.2 (t, J = 5.0 Hz), 139.5, 138.9, 138.8, 138.5, 
134.9, 134.3, 134.1, 132.3, 132.2, 131.9, 131.8, 131.7, 131.6, 129.3, 128.9, 127.7, 127.5, 127.3, 
127.3, 127.1, 127.0, 126.9, 126.7, 126.5, 123.7, 123.7, 123.6, 122.5, 122.4, 121.8, 120.4, 119.8, 
119.2, 119.0, 47.2, 47.1, 29.9, 27.6, 27.1, 26.6, 22.6 (other signals not detected or observed); 
19
F NMR (470 MHz, CDCl3) δ -78.9 (s, 6F), -114.9 – -116.4 (m, 4F); 
31
P NMR (200 MHz, CDCl3) 
δ -17.3; HRMS (ESI) calculated for C104H72N3O8F10P2S2 (M-H)
-
: 1806.4082; found: 1806.4084. 
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(S,S)-4q: 
Prepared according to the general procedure on a 
0.076 mmol scale (with respect to HMDS) and 
purified by column chromatography (hexane/MTBE 
9:1 → 4:1 → 2:1 → 1:1). Off-white solid (42 mg, 
0.026 mmol, 34%). 
1
H NMR (500 MHz, CDCl3): δ 
8.11 (d, J = 8.1 Hz, 2H), 8.03 (d, J = 8.5 Hz, 2H), 
8.00 (s, 2H), 7.94 – 7.84 (m, 4H), 7.78 – 7.68 (m, 
4H), 7.62 – 7.55 (m, 4H), 7.53 (d, J = 7.9 Hz, 2H), 
7.50 – 7.43 (m, 4H), 7.42 – 7.36 (m, 4H), 7.31 – 7.26 
(m, 2H), 7.25 – 7.22 (m, 4H), 7.21 – 7.17 (m, 2H), 
7.14 (d, J = 7.9 Hz, 2H), 7.09 (d, J = 13.9 Hz, 4H), 
6.95 (s, 2H), 6.73 (d, J = 7.8 Hz, 2H), 6.55 (d, J = 7.9 Hz, 2H), 3.75 (d, J = 21.9 Hz, 2H), 3.53 – 
3.33 (m, 6H); 
13
C NMR (126 MHz, CDCl3) δ 143.8, 143.6, 143.1, 142.9, 141.7, 141.2, 141.2, 
134.8, 134.0, 133.9, 133.6, 132.1, 131.9, 131.9, 131.8, 130.9, 129.1, 128.9, 128.6, 128.5, 127.5, 
127.4, 127.3, 127.2, 127.1, 127.0, 126.9, 126.6, 126.5, 126.4, 126.2, 125.1, 124.8, 123.5, 121.6, 
120.2, 119.9, 119.0, 118.9, 36.9, 36.3 (other signals not detected or observed); 
19
F NMR (470 
MHz, CDCl3) δ -78.6 (s, 6F); 
31
P NMR (200 MHz, CDCl3) δ -16.8; HRMS (ESI) calculated for 
C94H56N3O8F6P2S2 (M–H)
-
: 1594.2894; found: 1594.2910. 
 
(S,S)-4r: 
Prepared according to the general procedure on a 
0.048 mmol scale (with respect to HMDS) and 
purified by column chromatography (hexane/MTBE 
9:1 → 4:1 → 2:1 → 1:1). Off-white solid (47 mg, 
0.028 mmol, 58%). 
1
H NMR (500 MHz, CDCl3): δ 
8.09 (d, J = 8.4 Hz, 2H), 8.03 (d, J = 8.2 Hz, 2H), 
7.99 (s, 2H), 7.93 – 7.86 (m, 4H), 7.80 – 7.72 (m, 
4H), 7.59 (ddd, J = 8.1, 6.6, 1.3 Hz, 2H), 7.55 (dd, J 
= 7.8, 5.3 Hz, 4H), 7.52 (d, J = 7.3 Hz, 2H), 7.44 (d, 
J = 8.4 Hz, 2H), 7.42 – 7.39 (m, 2H), 7.37 (d, J = 7.3 
Hz, 2H), 7.30 (td, J = 7.4, 1.2 Hz, 2H), 7.26 – 7.24 
(m, 2H), 7.20 (td, J = 7.4, 1.2 Hz, 2H), 7.15 (s, 2H), 7.08 – 7.03 (m, 4H), 7.00 (s, 2H), 6.72 (d, J = 
7.8 Hz, 2H), 6.59 (d, J = 7.9 Hz, 2H), 3.76 (d, J = 21.9 Hz, 2H), 3.54 – 3.36 (m, 6H); 13C NMR 
(126 MHz, CDCl3) δ 144.2 (t, J = 5.0 Hz), 143.8, 143.6, 143.1, 142.9, 141.7, 141.3, 141.2, 134.8, 
133.9, 133.7, 132.1, 132.1, 131.9, 131.7, 131.0, 129.2, 128.9, 128.6, 128.4, 127.5, 127.4, 127.3, 
127.2, 127.1, 126.9, 126.8, 126.6, 126.5, 126.4, 126.4, 126.1, 125.1, 124.8, 123.5, 121.5, 120.3, 
119.8, 119.0, 118.9, 36.8, 36.4 (other signals not detected or observed); 
19
F NMR (470 MHz, 
CDCl3) δ -79.3 (s, 6F), -116.3 (d, J = 50.1 Hz, 4F).; 
31
P NMR (200 MHz, CDCl3) δ -17.1; HRMS 
(ESI) calculated for C96H56N3O8F10P2S2 (M–H)
-
: 1694.2830; found: 1694.2849. 
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Reaction Development 
Optimization for Dienophiles 
Table S1 Initial Catalyst screening 
 
Initial catalyst screening experiments were performed on an analytical scale (0.02 mmol) in 
argonated GC-vial at r.t. with commercial SKA 5h (1 equiv.) as the silylating reagent for the 
specified period of time. The reaction mixtures were analyzed by 
1
H NMR and the desired product 
was isolated by preparative TLC. Chiral DSIs (D1 and D2) and C−H acids (D3-5) gave either 
insufficient reactivity or no enantioselectivity. IDPi catalyst 4a and 4o, however, both catalyzed the 
reaction with high efficiency and promising enantioselectivity. Further, the reaction conditions 
were optimized independently with 4a and 3-fluorenyl-substituted IDPis, such as 4o. 
 
entry CATALYST conv.(%)a e.r.endo
b d.r. (endo/exo)b 
1 D1 traces / / 
2 D2 
60% 
(traces of product)c 
50:50 1:1 
3d D3 >99% 52.5:47.5 26:1 
4 D4 82% 51:49 9:1 
5 D5 
71% 
(traces of product)c 
n.d. n.d. 
6 4s >99% 70:30 14:1 
7 4a >99% 85:15 11:1 
8 4t >99% 26.5:73.5 10:1 
9 4u >99% 25:75 6:1 
10 4v >99% 54:46 8:1 
11 4w >99% 73:27 11:1 
12 4q >99% 74:26 7:1 
13 4o >99% 85:15 8:1 
aDetermined by 1H NMR analysis. bDetermined by HPLC on a chiral stationary phase. cMukaiyama-Michael adduct was 
the major product. d -40 °C.  
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Table S2 Screening of silyl groups with 4a.
a 
 
The influence of the silyl group on conversion and stereoselectivity was tested by employing 
various silyl ketene acetal (SKA) reagents. The triethylsilyl (TES) group gave the best result. 
 
 
entry SiR3 conv.(%)
b e.r.endo
c e.r.exo
c 
d.r. 
(endo/exo)c 
1 TMS (5h) 90% 86.5:13.5 82:18 11:1 
2 TES (5c) >99% 88:12 86.5:13.5 9:1 
3 TBS (5i) >95% 87.5:12.5 83.5:16.5 11:1 
4 TIPS (5b) >99% 87:13 87:13 6:1 
aReactions were performed on a 0.02 mmol scale and 5 equiv. of CP 2a. bDetermined by 1H NMR analysis. cDetermined 
by HPLC on a chiral stationary phase. 
 
Table S3 Screening of solvents with 4a.
a 
 
The influence of the solvent was evaluated and many non-protic, apolar solvents were found to 
give equally good results. Toluene was chosen due to good solubility of reactants and substrates. 
 
entry SOLVENT conv.(%)b e.r.endo
c e.r.exo
c 
d.r. 
(endo/exo)c 
1 Et2O >99% 86.75:13.25 84.5:15.5 9:1 
2 MTBE 38% 79.5:20.5 n.d. 2.6:1 
3 1,4-dioxane >95% 85.5:14.5 82.75:17.25 9:1 
4 TMS2O >99% 89.75:10.25 87.5:12.5 8:1 
5 CH2Cl2 >95% 72:28 69:31 8.5:1 
6 CHCl3 90% 81.25:18.75 77.5:22.5 7:1 
7 CCl4 >95% 89.75:10.25 87.5:12.5 8:1 
8 EtOAc 70% 82.25:17.75 75.5:24.4 7:1 
9 MeCN 36% 52.5:47.5 50:50 1:1 
10 benzene >95% 87.25:12.75 84.75:15.25 8:1 
11 toluene >95% 88:12 86:14 8:1 
12 o-xylene >95% 88.5:11.5 86.75:13.25 9:1 
13 m-xylene >95% 87.75:12.25 86.75:13.25 9:1 
14 p-xylene >95% 88.5:11.5 87.25:12.75 9:1 
15 mesitylene >95% 87.75:12.25 87:13 9:1 
16 n-hexane >99% 90:10 89:11 9:1 
17 cyclohexane >99% 89.75:10.25 89:11 10:1 
aReactions were performed on a 0.02 mmol scale and 5 equiv. of CP 2a. bDetermined by 1H NMR analysis. cDetermined 
by HPLC on a chiral stationary phase. 
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Table S4 Evaluation of other silylating reagent with 4a.
a
 
We found that lowering the temperature to −40°C gave excellent enantio- and diastereoselectivity 
for product 3a, however, the use of SKA 5c in high quantities caused the formation of 
Mukaiyama−Michael side products. Thus, allylsilane 5a was tested as an alternative reagent to 
silylate the catalyst. Reagent loadings of as low as 10 mol% of 5a were found to be sufficient to 
activate the catalyst and fully prevent side product formation. However, the reaction time for 
reaching full converstion of 1a was very long (6 days). 
 
 
entry silylating reagent conv.(%)b e.r.endo
c e.r.exo
c 
d.r. 
(endo/exo)c 
1 5c (100 mol%) >99%d 96.75:3.25 n.d. 22:1 
2 5a (100 mol%) >99%e 97:3 94.5:5.5 22:1 
3 5a (50 mol%) >95%e 97:3 n.d. 20:1 
4 5a (30 mol%) >99%e 96.75:3.25 95.5:4.5 21:1 
5 5a (20 mol%) >99%e 97:3 95.5:4.5 19:1 
6 5a (10 mol%) >99%e 96.75:3.25 94.25:5.75 21:1 
aReactions were performed on a 0.02 mmol scale and 5 equiv. of CP 2a. bDetermined by 1H NMR analysis. cDetermined 
by HPLC on a chiral stationary phase. d24 h reaction time, Mukaiyama−Michael adduct is the major product. e6d reaction 
time. 
 
Table S5 Evaluation of concentration effects at r.t. with 4a.
a
 
We tested the effect of concentration on the reaction at r.t. and detected only small deviations in 
stereoselectivities, but a strong deceleration with dilution. 
 
 
entry concentration conv.(%)b e.r.endo
c e.r.exo
c 
d.r. 
(endo/exo)c 
1 1M >99% 86.5:13.5 85.25:14.75 8:1 
2 0.5M >99% 87:13 85.25:14.75 8:1 
3 0.2M >95% 87.5:12.5 85:15 8:1 
4 0.1M 93% 87.5:12.5 84.25:15.75 8:1 
5 0.05M 78% 87.75:12.25 82:18 7:1 
6 0.025M 47% 87.5:12.5 74.5:25.5 6:1 
7 0.01M 10% 88.75:11.25 n.d. 3:1 
aReactions were performed on a 0.02 mmol scale and 5 equiv. of CP 2a. bDetermined by 1H NMR analysis. cDetermined 
by HPLC on a chiral stationary phase. 
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Table S6 Evaluation of concentration effects at low temperature with 4a.
a
 
A study on concentration effects was repeated with silylating agent 5a at decreased temperature 
(−40°C) and the reaction time to achieve full conversion was evaluated. At 1M concentration, the 
reaction completed within 24 h using 1 mol% catalyst. For these optimal conditions, we derived a 
corresponding general procedure for the catalytic, asymmetric Diels−Alder reaction (vide infra). 
 
 
entry concentration reaction timeb e.r.endo
c e.r.exo
c 
d.r. 
(endo/exo)c 
1 0.2M 6d 97:3 93.25:6.75 21:1 
2 0.4M 2d 96.75:3.25 96:4 20:1 
3 1M <24h 96.5:3.5 95.5:4.5 19:1 
4 2M <24h 95.5:4.5 95.25:4.75 17:1 
aReactions were performed on a 0.02 mmol scale and 10 equiv. of CP 2a. bfor the reaction to reach full conversion. 
cDetermined by HPLC on a chiral stationary phase. 
 
 
Table S7 Screening of silyl groups with 4o.
a 
 
For the second catalyst lead structure 4o, the influence of the silyl group on conversion and 
stereoselectivity was re-evaluated. In this case, the triisopropylsilyl (TIPS) group was found 
optimal. In addition, only small amounts of Mukaiyama-Michael side products were detected with SKA 
5b. 
 
 
entry SiR3 conv.(%)
b e.r.endo
c e.r.exo
c 
d.r. 
(endo/exo)c 
1 TMS (5h) 83% 85.75:14.25 86.5:13.5 7.5:1 
2 TES (5c) >99% 87.5:12.5 86.75:13.25 7.5:1 
3 TBS (5i) 76% 86.25:13.75 85:15 9:1 
4 TIPS (5b) >99% 88.25:11.75 88.25:11.75 5.5:1 
aReactions were performed on a 0.02 mmol scale and 10 equiv. of CP 2a. bDetermined by 1H NMR analysis. cDetermined 
by HPLC on a chiral stationary phase. 
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Table S8 Screening of other 3-fluorenyl-derived IDPi catalysts.
a
 
 
Although promising results were obtained with 4o, reactivity was significantly lower than with 4a. 
Thus, we tested more 3-fluorenyl-derived IDPi catalysts including the corresponding inner-core 
modified derivatives (X = SO2CF3, SO2C2F5) to achieve higher reactivity and/or enantioselectivity. 
We found that using corresponding cyclobutyl-derivatives 4h and 4c resulted in increased 
stereoinduction, while the latter was significantly more active due to the inner-core modification 
(X = SO2C2F5). Product 3a was isolated in 90% yield after 12 h of reaction time (entry 3). These 
conditions were used in a corresponding general procedure for the catalytic, asymmetric 
Diels−Alder reaction (vide infra). 
 
 
entry CATALYST conv.(%)b e.r.endo
c e.r.exo
c 
d.r. 
(endo/exo)c 
1 4o 84% (64h) 94.75:5.25 95.5:4.5 7:1 
2 4h 92% (64h) 97:3 92:8 12:1 
3d 4c >99% (<12h) 97.5:2.5 91.5:8.5 16:1 
4 4l 89% (64h) 95:5 95.75:4.25 7:1 
5 4m >99% (64h) 97:3 94.75:5.25 12.5:1 
aReactions were performed on a 0.02 mmol scale and 10 equiv. of CP 2a. bDetermined by 1H NMR analysis after the 
specified reaction time. cDetermined by HPLC on a chiral stationary phase. dat 1M concentration using 5 equiv. of CP 2a. 
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Optimization for Dienes 
 
General procedure for the screening experiments: 
The experiments were conducted on a 0.08 mmol or 0.1 mmol scale. An oven-dried 2.0 mL screw-
cap glass vial was charged with the corresponding (S,S)-IDPi catalyst (0.8 µmol or 1.0 µmol, 
1 mol%) and the appropriate α,β-unsaturated methyl ester (0.08 mmol or 0.1 mmol). A Teflon-
coated magnetic stirring bar was added, the vial was closed with a screw-cap containing a 
PTFE/rubber septum and sealed with parafilm. The reaction vial was evacuated and purged with 
argon (3 ×). The silyl donor (30–50 mol%) was transferred to the reaction mixture and the reaction 
mixture was stirred for 5 min at r.t.. Then, the diene was transferred to the reaction vial and the 
colorless solution was stirred at the indicated temperature for the specified reaction time until 
sufficient conversion was observed. The reaction was monitored by TLC and 
1
H NMR 
spectroscopy and treated with triethylamine. The desired Diels–Alder product was obtained by 
preparative TLC. 
 
Table S9. Catalyst screening
a 
 
aReactions were performed on a 0.08 mmol scale with 50 mol% of 5a or 30 mol% of 5b and 1 mol% of catalyst for 
1.75 d and quenched with 1.1 equiv. of NEt3. 
bDetermined by 1H NMR analysis; n.a.: not applicable. cDetermined by 
HPLC on a chiral stationary phase. 
 
An initial catalyst screening (Table S9) of representative examples of both catalyst families used 
for the dienophile scope indicated that 3-fluorenyl-derived IDPi (4c) provided the Diels–Alder 
products with higher enantiomeric ratios for both dienes compared to the more acidic 
trifluoromethylphenyl derivative (4a). Therefore, further IDPi catalyst derivatives of the 3-
fluorenyl substitution family with different core modifications and substituents in the 3,3’-position 
of the BINOL backbone were investigated (Table S10). 
  
entry catalyst 
silyl 
donor 
conversion(%)
b
 ratio
b
 3:[MM] e.r.
c
 3x or 3z 
diene substrate: isoprene (2c) 
1 4a 5a 24 n.a. 67.4:32.6 
2 4c 5b 34 15:85 95.3:4.7 
diene substrate: 2,3-dimethylbuta-1,3-diene (2b) 
3 4a 5a 16 n.a. 51.4:48.6 
4 4c 5b 34 10:90 78.3:21.7 
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Table S10. Catalyst screening with isoprene
a 
 
aReactions were performed on a 0.08 mmol scale with 30 mol% of SKA and 1 mol% of catalyst for 1.5 d and quenched 
with 1.1 equiv. of NEt3. 
bDetermined by 1H NMR analysis. cDetermined by HPLC on a chiral stationary phase. d3.5 days 
reaction time. e50 mol% TIPS-SKA (5b) were used. 
 
 
 
 
diene substrate: isoprene (2c) 
entry catalyst conversion (%)
b
 ratio
b
 3z:[MM] e.r.
c
 3z 
1 4r 35 18:82 54.6:45.4 
2 4p 28 6:94 91.9:8.1 
3 4c 34 21:79 94.3:5.7 
4 4m 34 40:60 96.7:3.3 
5
d 
4h 34 4:96 94.4:5.6 
6
e
 4c 43 17:83 95.1:4.9 
7
e
 4i 61 21:79 95.2:4.8 
8
e
 4j 63 27:73 95.5:4.5 
9
e
 4k 64 21:79 96.8:3.2 
10
d 
4l 34 25:75 95.3:4.7 
11
e
 4m 34 40:60 96.7:3.3 
12 4n 37 42:58 97.2:2.8 
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Table S11. Catalyst screening with 2,3-dimethylbutadiene
a 
 
aReactions were performed on a 0.08 mmol scale with 30 mol% of SKA and 1 mol% of catalyst for 1.5 d and quenched 
with 1.1 equiv. of NEt3. 
bDetermined by 1H NMR analysis. cDetermined by HPLC on a chiral stationary phase. d3.5 days 
reaction time. e50 mol% TIPS-SKA (5b) were used. 
 
 
 
  
diene substrate: 2,3-dimethylbuta-1,3-diene (2b) 
entry catalyst conversion (%)
b
 ratio
b
 3x:[MM] e.r.
c
 3x 
1 4r 56 31:69 55.4:44.6 
2 4p 37 2:98 84.3:15.7 
3 4c 44 22:78 78.3:21.7 
4 4m 52 24:76 93.6:6.4 
5
d 
4h 32 5:95 89.4:10.6 
6
e
 4c 35 10:90 75.6:24.4 
7
e
 4i 57 20:80 92.7:7.3 
8
e
 4j 55 22:78 92.7:7.3 
9
e
 4k 62 18:82 92.3:7.7 
10
d 
4l 36 18:82 92.7:7.3 
11 4m 52 24:76 93.6:6.4 
12 4n 50 14:86 95.2:4.8 
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Increasing the size of the 3-fluorenyl substituent from 9H-fluorenyl to 3-cyclopentylfluorenyl 
proved to be beneficial for the enantiomeric ratio with both tested dienes (2b and 2c, see Table 
S10, entries 1–4, and Table S11, entries 1–4). Inner-core modifications bearing longer 
perfluoroalkyl substituents provided an improvement in both reactivity and selectivity towards the 
desired Diels–Alder product, while maintaining or slightly improving the enantiomeric ratio 
(Tables S10 and S11, entries 5–12). The IDPi catalysts bearing 3-cyclopentylfluorenyl substituents 
were identified as the best catalyst system for both dienes. With this catalyst subgroup in hand, the 
effect of the silyl group on both enantioselectivity and conversion was investigated. Changing the 
silyl group from the initially used TIPS group to TMS, TES or TBS was found to be deleterious for 
conversion, chemo- and enantioselectivity (Table S12). 
 
Screening of silyl ketene acetals (SKA) as silyl donors 
Table S12. Screening silyl groups with silyl ketene acetals
a
 
 
aReactions were performed on a 0.08 mmol scale with 50 mol% of SKA and 1 mol% of catalyst for 1.5 d and quenched 
with 1.1 equiv. of NEt3. 
bDetermined by 1H NMR analysis. cDetermined by HPLC on a chiral stationary phase. 
  
entry SKA 5 conversion (%)
b
 ratio
b
 3:[MM] e.r.
c
 3x or 3z 
diene substrate: isoprene (2c) 
1 TMS-SKA (5h) 37 5:95 90.3:9.7 
2 TES-SKA (5c) 51 7:93 94.4:5.6 
3 TBS-SKA (5i) 28 3:97 94.3:5.7 
4 TIPS-SKA (5b) 53 15:85 96.7:3.3 
diene substrate: 2,3-dimethylbuta-1,3-diene (2b) 
5 TMS-SKA (5h) 49 4:96 78.8:21.2 
6 TES-SKA (5c) 49 5:96 86.4:13.6 
7 TBS-SKA (5i) 44 1:99 91.4:6.6 
8 TIPS-SKA (5b) 56 11:89 94.4:5.6 
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In contrast to Diels–Alder reactions with cyclopentadiene, using SKAs as silylating reagents with 
less reactive dienes is the competing Mukaiyama–Michael reaction and the corresponding product 
is usually observed as the major product species in the crude reaction mixture. In addition, 
incomplete conversion was observed, even after prolonged reaction times suggesting deactivation 
of the catalyst. In order to clarify this issue, a mixture of 1a (0.08 mmol), 2b (0.8 mmol, 10 equiv.), 
SKA 5b (24 μmol, 30 mol%) and IDPi catalyst 4c (0.8 μmol, 1 mol%) was dissolved in 0.5 mL 
C6D6 and transferred to a 5 mm NMR tube under argon. 
1
H and 
31
P NMR spectra were collected 
periodically until full consumption of SKA 5b was observed. 
 
The 
31
P NMR spectra indicate complete silylation long as 5b is present in the reaction mixture. 
However, as the sub-stoichiometric amount of silylating reagent 5b is gradually consumed in the 
competing Mukaiyama–Michael reaction, deactivation of the catalyst due to slow hydrolysis 
occures. Consequently, the formed silylated Mukaiyama–Michael product does not silylate (or 
significantly slower than silyl ketene acetal 5b) the IDPi catalyst as suggested by the 
31
P NMR 
spectrum of the reaction mixture after 6 days (Figure S1). 
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Figure S1: Stacked 
31
P NMR spectra of the reaction mixture after 24 h reaction time and 6 days 
reaction time using 30 mol% of 5b as silylating reagent. 
Representative 
1
H NMR spectrum for the analysis of the reaction mixture: 
 
Figure S2. Representative stacked 
1
H NMR spectra of the reaction mixture described above (upper 
spectrum), the purified Mukaiyama–Michael product (middle spectrum) and the purified Diels–
Alder product. The proton signals chosen for integration to determine the conversion are 
highlighted in the dashed boxes. 
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Screening of methallylsilanes as silyl donors 
Due to the observed competing Mukaiyama–Michael reaction with silyl ketene acetals as silylating 
reagents, allylsilanes and (2-methallyl)silanes were tested as alternative silyl donors for the 
activation of 3-fluorenyl-derived IDPi’s. 
 
Table S13. Screening of (2-methallyl)silanes as silylating reagents.
a
 
 
aReactions were performed on a 0.1 mmol scale with 50 mol% of (2-methallyl)silanes 5 and 1 mol% of catalyst (S,S)-4d 
for 3 d and quenched with 1.1 equiv. of NEt3. 
bDetermined by 1H NMR analysis. cDetermined by HPLC on a chiral 
stationary phase. 
 
Table S14. Screening of allylsilanes and (2-methallyl)silanes as silylating reagents.
a
 
 
aReactions were performed on a 0.1 mmol scale with 50 mol% of silylating reagent and 1 mol% of IDPi catalyst for 3 d 
and quenched with 1.1 equiv. of NEt3. 
bDetermined by 1H NMR analysis. cDetermined by HPLC on a chiral stationary 
phase; n.d.: not determined.d3.75 d reaction time using 50 mol% 5g. 
  
entry Si-(2-methallyl)silane conversion (%)
b
 
remaining silyl  Si-
(2-methallyl)silane 
e.r.
c
 
1 TMS (5j) 8 14 75:25 
2 TES (5k) 16 20 86:14 
3 SiBu3 (5l) 24 19 76:24 
4 TIPS (5d) 22 20 96:4 
5 Si(TMS)3 (5m) 8 36 94:6 
entry catalyst silylating reagent conversion (%)
b
 e.r.
c
 
1 4n 5g ~ 5 n.d. 
2 4d 5g ~ 5 n.d. 
3
d
 4n 5g 8 93.9:6.1 
4 4n 5d 12 94.1:5.9 
5 4d 5d 13 94.5:5.5 
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Several (2-methallyl)silanes bearing different silyl groups were prepared and used in the 
enantioselective Diels–Alder reactions in order to investigate the effect of the silyl group on 
conversion and enantioselectivity. In consistency with the results obtained with silyl ketene acetals, 
the TIPS group delivered the desired Diels–Alder product with an excellent enantiomeric ratio 
(96:4; Table S13, entry 4). A direct comparison between allylsilanes and (2-methallyl)silanes 
indicated an accelerated silylation of the catalyst with (2-methallyl)silanes, thus resulting in a 
shorter induction/dormant period of the catalytic system (Table S14). 
 
Screening of concentration effects 
 
As the reaction was conducted under neat conditions, we expected a concentration on effect 
stereoselectivity and conversion with different equivalents of diene. In general, lower 
concentrations resulted in an increased enantiomeric ratio of Diels–Alder product 3x, whereas 
higher conversion was observed at 0.02 M concentration (corresponding to 4 equiv. of diene, see 
Table S15). Thus, in the preparative scale experiments, either 4 or 5 equivalents of the diene were 
used to achieve an acceptable balance of conversion and enantioselectivity. 
 
Table S15. Screening of different concentrations.
a 
 
 
aReactions were performed on a 0.1 mmol scale with 50 mol% of 5d and 1 mol% of catalyst (S,S)-4d for 2.5 d and 
quenched with 1.1 equiv. of NEt3. 
bDetermined by 1H NMR analysis. cDetermined by HPLC on a chiral stationary phase. 
  
entry 2b/equiv. concentration (M) conversion (%)
b
 e.r.
c
 
1 2 0.044 7 92.4:7.6 
2 3 0.029 19 93.5:6.5 
3 4 0.022 24 94.7:5.3 
4 5 0.018 17 95.3:4.7 
5 10 0.009 14 95.9:4.1 
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Temperature screening 
Table S16. Screening of different reaction temperatures.
a 
 
aReactions were performed on a 0.1 mmol scale with 50 mol% of 5d and 1 mol% of catalyst (S,S)-4n for 1.75 d and 
quenched with 1.1 equiv. of NEt3. 
bDetermined by 1H NMR analysis. cDetermined by HPLC on a chiral stationary phase. 
d8.5 d reaction time. 
 
We tested if increasing the temperature (40 °C and 60 °C) would improve the conversion of the 
Diels–Alder reaction with catalyst (S,S)-4n, however surprisingly found that this proved to be 
detrimental for both conversion and enantioselectivity (Table S16). In contrast, for the preparation 
of racemates using HNTf2 as catalyst this effect was not observed and increasing temperatures 
usually provided full conversion of the starting materials. 
 
Preliminary kinetic studies 
A possible explanation accounting for these results could involve a deactivation pathway with IDPi 
catalysts at increased temperatures. Therefore, we followed the course of the catalytic 
enantioselective Diels–Alder reaction at r.t. over time with substrates 1a and 1y and 2,3-
dimethylbutadiene 2b (see below). One member of each catalyst family was chosen to compare 
both electronic and steric effects. 
 
 
  
entry diene silyl donor temperature(°C) conversion(%)
b
 e.r.
c
 
1 2b 5b 40 6 92:8 
2
d
 2b 5d 60 12 62:38 
3 2c 5b 40 5 95:5 
4
d
 2c 5d 60 10 79:21 
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To an oven dried 2 mL screw-cap glass vial were added the IDPi catalyst (1.43 mg, 0.80 μmol, 
1.0 equiv.) and the appropriate α,β-unsaturated methyl ester (80 μmol, 1.0 equiv.). A Teflon-coated 
magnetic stirring bar was added, the vial was sealed, evacuated and purged with argon (3 ×). 
Allyltriethylsilane (16 μL, 80 μmol, 1.0 equiv.) and 2,3-dimethyl-1,3-butadiene (91 μL, 0.8 mmol, 
10 equiv.) were transferred to the reaction vial and the resulting pale yellow solution was stirred at 
25 °C. At the indicated time, a 5 μL aliquot was taken, quenched with triethylamine (12 μL, 
1 equiv.), dissolved in 0.5 mL CDCl3 and the conversion of the reaction was determined by 
1
H NMR spectroscopy (integration of the methoxy groups of starting material and product; see 
Figure S3 with representative stacked 
1
H NMR spectra depicted below). 
 
Figure S3. Stacked 
1
H NMR spectra of starting materials, the kinetic study (
1
H NMR spectra from 
each collected data point) and the Diels–Alder product 3y.  
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With (S,S)-4a, higher conversions were observed then with (S,S)-4c for both substrates, however 
full conversion was only obtained with substrate 1y (see plots in Figure S4a-d). In all other cases, 
the reaction stopped after a certain amount of time and only partial conversion was obtained. These 
preliminary kinetic data suggests that catalyst inhibition or deactivation for certain substrates and 
catalyst combinations is indeed an inhibitory pathway. 
 
 
Figure S4. a) Preliminary kinetic data obtained for the reaction of dienophile 1a with catalyst 
(S,S)-4a. b) Reaction of dienophile 1a with catalyst (S,S)-4c. c) Reaction of dienophile 1y with 
catalyst (S,S)-4a. d) Reaction of dienophile 1y with catalyst (S,S)-4c. 
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Methylation of the catalyst 
In consequence to these preliminary kinetic studies, we carefully re-examined reactions at higher 
temperature than r.t. (Table S16). Upon isolation of the Diels–Alder product by preparative TLC, 
we detected a less polar IDPi derivative in significant amounts (Figure S5B). This compound was 
identified as the methylated IDPi (methyl-[S,S]-4n) by HRMS (ESI): calculated for 
C117H83N3O8F18P2S2Na (M+Na)
+
: 2148.4702; found: 2148.4717. In further studies at various 
temperatures, we qualitatively observed increasing catalyst methylation with higher temperatures. 
We reason that this inhibitory pathway accounts for the observed partial conversions at r.t. and 
rationalize it via collapse of the chiral ion pair (CIP) consisting of silylated substrate and chiral 
counteranion (Figure S5A). Thus, methyl cinnamate 1a acts as a methyl group donor to give a silyl 
ester side product. For catalyst derivatives with longer perfluoroalkyl groups as inner-
modifications, we qualitatively observed less catalyst methylation. For IDPi 4d (X = SO2C6F13) 
essentially no methylation was detected ≤0 °C. We therefore reason that the stability of the chiral 
ion pair depends not only on the reaction temperature, but also on the nucleophilicity of the chiral 
counteranion and on methyl ester substrate. For the optimized conditions, we selected 3 mol% of 
IDPi 4d (X = SO2C6F13), 0 °C as reaction temperature and 3 equiv. of diene (see general 
procedures), for which we obtained full conversion with both substrates after 3.5 to 5.5 days. 
 
 
Figure S5. A Proposed methylation pathway of IDPi catalysts; B Qualitative analysis of a 
representative preparative TLC plate (silica gel; hexane/EtOAc 19:1, one elution, 254 nm) 
indicating catalyst methylation at 40 °C. 
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General Procedures 
 
Catalytic, Asymmetric Diels-Alder Reactions 
 
Procedure A: Catalyst activation with allylsilanes 
 
A 4 mL vial with a septum lid was charged with a magnetic stirrer bar, the appropriate α,β-
unsaturated ester (0.2 mmol) and (S,S)-4a (2 μmol, 3.6 mg, 1 mol%) under argon. The reagents 
were dissolved in dry toluene (0.2 mL) and triethylallylsilane 5a (40 μmol, 8 μL, 20 mol%) was 
added. The reaction mixture was stirred at r.t. for 5 min, subsequently cooled to the appropriate 
temperature and cyclopentadiene was added (1 mmol, 84 μL, 5 equiv.). Some parafilm was 
wrapped around the lid to seal the vial and the reaction was stirred at the appropriate temperature 
until TLC or NMR analysis indicated full consumption of the starting material. The reaction was 
then treated with a mixture of methanol/triethylamine (5:1, 50 μL) and diluted with hexanes, which 
caused precipitation of eventual cyclopentadiene polymers. The reaction mixture was filtered 
through cotton directly onto an equilibrated silica flash column and elution with the specified 
solvent mixture afforded the pure Diels-Alder products. 
 
Procedure B: Catalyst activation with silyl ketene acetals 
 
A 4 mL vial with a septum lid was charged with a magnetic stirrer bar, the appropriate α,β-
unsaturated ester (0.2 mmol) and (S,S)-4c (2 μmol, 3.7 mg, 1 mol%) under argon. The reagents 
were dissolved in dry toluene (0.2 mL) and the reaction mixture was cooled to the appropriate 
temperature. Then, silyl ketene acetal 5b (40 μmol, 12 μL, 20 mol%) and cyclopentadiene (1 mmol, 
84 μL, 5 equiv.) were added in this order. The following steps were identical to those described in 
procedure A. 
 
Procedure C: Neat reaction conditions 
A 4 mL vial with a septum lid was charged with a magnetic stirrer bar, the appropriate α,β-
unsaturated ester (0.2 mmol) and (S,S)-4a-c (2 μmol, 1 mol%) under argon. The sealed vial was 
cooled to the appropriate temperature and cyclopentadiene (2 mmol, 180 μL, 10 equiv.) was added. 
The reaction was stirred for 10 min to correctly adjust the temperature, before silylating agent 5a-d 
(40 μmol, 20 mol%) was added. The following steps were identical to those described in procedure 
A. 
 
NOTE: We found that catalysts with highly fluorinated 3,3’-substituents, such as 4a and 4b, 
generally tend to be more active, however also cause a certain level of cyclopentadiene 
polymerization. These catalysts can be activated with both, silyl ketene acetals or allyl silanes with 
the exception of triisopropylallylsilane reacting very sluggishly with these IDPi acids. With 
catalysts possessing 3-fluorene-derivated 3,3’-substituents, such as 4c, cyclopentadiene 
polymerization is significantly suppressed or not detected at all depending on the reaction 
temperature. These IDPi derivatives are conveniently activated with silyl ketene acetals, while they 
generally react only slowly with allyl silanes. 
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Procedure D: Reactions with alternative dienes at 0 °C 
An oven-dried 2.0 mL screw-cap glass vial was charged with (S,S)-4d (13.9 mg, 6 µmol, 3 mol%) 
and the appropriate α,β-unsaturated methyl ester (0.2 mmol). A Teflon-coated magnetic stirring bar 
was added, the vial was closed with a screw-cap containing a PTFE/rubber septum and sealed with 
parafilm. The reaction vial was evacuated, purged with argon (3 ×) and subsequently placed into an 
aluminum block submerged in an ice/acetone bath at −10 °C. The diene was transferred to the 
reaction vial and the colorless solution was kept at this temperature for 5 min. After the elapsed 
time, triisopropyl(2-methallyl)silane (5d, 23 µL, 0.1 mmol, 50 mol%) was added to the reaction 
mixture to initiate the reaction. Then, the vial was placed into an aluminum block in a cryostat at 
0 °C and stirred at this temperature for the indicated time. The reaction was monitored by TLC and 
1
H NMR spectroscopy and quenched with triethylamine (5 µL, 0.2 equiv.). 
 
Procedure E: Reactions with alternative dienes at −20 °C and −40 °C 
An oven-dried 2.0 mL screw-cap glass vial was charged with (S,S)-4d (13.9 mg, 6 µmol, 3 mol%) 
and the appropriate α,β-unsaturated methyl ester (0.2 mmol). A Teflon-coated magnetic stirring bar 
was added, the vial was closed with a screw-cap containing a PTFE/rubber septum and sealed with 
parafilm. Then, the reaction vial was evacuated, purged with argon (3 ×) and subsequently placed 
into an aluminum block submerged in a dry-ice/isopropanol bath at −77 °C. The diene was 
transferred to the reaction vial and the colorless solution was kept at this temperature for 5 min. 
After the elapsed time, triisopropyl(2-methallyl)silane (5d, 23 µL, 0.1 mmol, 50 mol%) was added 
to the reaction mixture to initiate the reaction. Then, the vial was placed into an aluminum block in 
a cryostat at 0 °C and stirred at this temperature for the indicated time.  
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Preparation of racemic Diels-Alder Products 
 
Procedure A: with HNTf2 as catalyst using Schlenk technique 
 
In a flame-dried Schlenk flask, appropriate α,β-unsaturated ester (8 mmol) and trimethylallylsilane 
(0.8 mmol, 0.13 mL, 10 mol%) were dissolved in dry DCM (8 mL) under argon. The reaction 
solution was cooled to -78 °C and a stock solution of HNTf2 (0.2 M in DCM, 40 μL, 8 μmol, 
0.1 mol%) was added. Then, cyclopentadiene (40 mmol, 3.4 mL, 5 equiv.) was added and the 
reaction mixture was warmed up to 0 °C. Upon completion of the reaction indicated by TLC 
(typically within a few hours), the reaction was quenched with triethylamine (0.5 mL) and diluted 
with hexanes. Precipitated cyclopentadiene polymers were removed by filtration through celite and 
subsequent column chromatography on silica gel gave the racemic Diels-Alder products. 
 
NOTE: This procedure was used for sensitive substrates such as methyl acrylate and methyl 
crotonate, which are prone to decomposition or polymerization. Higher amounts of silylating 
reagent were necessary in some cases to prevent extensive cyclopentadiene polymerization. 
 
Procedure B: with HNTf2 as catalyst in a vial 
 
In a 4 mL vial with a septum lid with a magnetic stirrer bar, the appropriate α,β-unsaturated ester 
(0.2 mmol) was dissolved in dry toluene (0.2 mL) under argon. Trimethylallylsilane (0.1 mmol, 
15 μL, 50 mol%) and a stock solution of HNTf2 (0.2 M in DCM, 10 μL, 2 μmol, 1 mol%) was 
added in this order at r.t.. Then, cyclopentadiene (1 mmol, 84 μL, 5 equiv.) was added and the 
reaction mixture was stirred at r.t. until TLC indicated complete reaction (typically within a few 
hours). Triethylamine (10 μL) was added and the solvent was removed under reduced pressure. The 
residue oil was diluted with methanol and the precipitated cyclopentadiene polymers were filtered 
off through cotton. Concentration under reduced pressure gave the crude racemic Diels-Alder 
product, which were used for analytics without further purification. 
 
Procedure C: thermal Diels-Alder reaction 
 
A microwave reaction vial was charged with the appropriate unsaturated ester (0.2 mmol) and 
cyclopentadiene (2.4 mmol, 0.2 mL). The vial was sealed and heated to 120 °C overnight. Racemic 
Diels-Alder products were obtained after purification of the crude material by preparative TLC. 
 
NOTE: Under these conditions, the exo-cycloadduct is typically the major diastereomer. 
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Characterization of Products 
 
methyl (1R,2S,3S,4S)-3-phenylbicyclo[2.2.1]hept-5-ene-2-carboxylate (3a): Prepared according 
to procedure A with catalyst (S,S)-4a (2 μmol, 3.6 mg, 1 mol%), (E)-methyl 
cinnamate (1a, 0.20 mmol, 32 mg) and cyclopentadiene (1 mmol, 90 μL) at 
−40 °C for 12 hours. The product was obtained as a diastereomeric mixture after 
column chromatography (hexane/DCM 4:1→2:1→1:1) as a colorless oil (42 mg, 
92%). The enantiomeric and diastereomeric ratios were determined by HPLC on 
a chiral stationary phase. [α]D
25
 = +127.1 (c 0.65, CHCl3); HPLC Daicel Chiralcel OJ-3R, 
MeOH/H2O = 90/10, 1 mL/min, 25 °C, 220 nm, tR (major, endo) = 7.6 min, tR (major, exo) = 8.8 
min, tR (minor, exo) = 9.5 min, tR (minor, endo) = 11.9 min; e.r.endo = 97:3, e.r.exo = 96.5:3.5, d.r. 
(endo/exo) = 26:1. 
 
The performance of catalysts 4a-c was compared at a reaction temperature of −40 °C and a reaction 
time of 12 hours following the appropriate procedure A or B respectively: 
 
entry catalyst silyl group procedure yield (%) e.r.endo e.r.exo 
d.r. 
(endo/exo) 
1 4a TES A 92 97:3 96.5:3.5 26:1 
2 4b TES A 90 95.5:4.5 95:5 19:1 
3 4c TIPS B 90 97.5:2.5 91.5:8.5 16:1 
 
 
An enantioenriched mixture of endo/exo diastereomers (d.r. 9:1, e.r.endo = 95.5:4.5, e.r.exo = 95:5) 
was separated by preparative HPLC and the pure diastereomers were characterized as followed: 
 
endo-diastereomer: methyl (1R,2S,3S,4S)-3-phenylbicyclo[2.2.1]hept-5-ene-2-carboxylate 
(3aendo): 
1
H NMR (500 MHz, CDCl3) δ 7.22 – 7.18 (m, 1H), 6.42 
(dd, J = 5.6, 3.1 Hz, 1H), 6.12 (dd, J = 5.6, 2.8 Hz, 1H), 
3.67 (s, 3H), 3.32 – 3.25 (m, 1H), 3.11 (dd, J = 5.0, 1.8 
Hz, 1H), 3.07 – 3.03 (m, 1H), 3.01 (dd, J = 5.0, 3.6 Hz, 
1H), 1.81 – 1.76 (dm, J = 8.7 Hz, 1H), 1.61 – 1.55 (dm, J = 8.7 Hz, 1H); 13C NMR (126 MHz, 
CDCl3) δ 175.0, 144.4, 139.2, 134.7, 128.6, 127.6, 126.2, 77.4, 77.2, 76.9, 52.2, 51.9, 48.5, 47.6, 
47.3, 46.4; [α]D
25
 = +114.8 (c 0.77, CHCl3); Lit.:
9
 [α]D
20
 = +126.8 (c 0.401, CHCl3) for e.r.endo = 
98.5:1.5, d.r. (endo/exo) = 99:1; HRMS (ESI) calculated for C15H16O2Na (M+Na)
+
: 251.1042; 
found 251.1044. 
 
exo-diastereomer: methyl (1S,2S,3S,4R)-3-phenylbicyclo[2.2.1]hept-5-ene-2-carboxylate (3aexo): 
1
H NMR (500 MHz, CDCl3) δ 7.28 – 7.23 (m, 2H), 
7.21 – 7.15 (m, 3H), 6.31 (dd, J = 5.7, 3.2 Hz, 1H), 
6.03 (dd, J = 5.7, 2.9 Hz, 1H), 3.72 (s, 3H), 3.70 (dd, J 
= 5.3, 3.5 Hz, 1H), 3.20 – 3.13 (m, 2H), 2.52 (dd, J = 
5.3, 1.8 Hz, 1H), 1.90 (dm, J = 8.6 Hz, 1H), 1.56 (dm, 
J = 8.6 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 176.2, 
143.2, 136.7, 136.1, 128.2, 128.0, 127.9, 126.3, 77.4, 77.2, 76.9, 52.1, 50.6, 48.8, 48.4, 48.2, 48.1; 
[α]D
25
 = +247.5 (c 0.54, CHCl3); HRMS (ESI) calculated for C15H16O2Na (M+Na)
+
: 251.1042; 
found 251.1043. 
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Table S17. Peak table for methyl (1R,2S,3S,4S)-3-phenylbicyclo[2.2.1]hept-5-ene-2-carboxylate 
(3aendo). Red arrows and circles indicate the characteristic NOESY signals for the assignment of 
stereochemistry. 
 
Atom δ J COSY HSQC HMBC NOESY
C1 46,40 1 1, 2, 4, 5, 6, 7', 7''
H1 3,289 m 6, 7', 7'' 1 1, 4, 5 2, 6, 7', 7''
C2 52,15 2 2, 4, 7''
H2 3,005 dd 3.6(H1), 5.0(H3) 3, 4 2 1, 2, 3, 6, 8, 10 1, 7', 9, 11
C3 47,65 3 2, 3, 7'', 11
H3 3,113 dd 5.0(H2), 1.8(H7'' anti) 2, 7'', 11 3 3, 4, 5, 7, 8, 10, 11 5, 9, 11
C4 48,49 4 1, 3, 4, 5, 6, 7', 7''
H4 3,042 m 2, 5, 7', 7'' 4 1, 2, 4, 6 5, 7', 7'', 11
C5 139,24 5 1, 3, 5, 6, 7'
H5 6,424 dd 3.1(H4), 5.6(H6) 4, 6 5 1, 4, 5, 6, 7 3, 4, H7''
C6 134,70 6 2, 4, 5, 6, 7'
H6 6,122 dd 2.8(H1), 5.6(H5) 1, 5 6 1, 4, 5, 6, 7 1, 9, H7''
C7 47,32 7', 7'' 3, 5, 6, 7', 7''
H7' syn 1,786 dm 8.7(H7'' anti) 1, 4, 7'' 7 1, 4, 5, 6, 7 1, 2, 4, 11
H7'' anti 1,579 dm 8.7(H7' syn) 1, 3, 4, 7' 7 1, 2, 3, 4, 7, 8 1, 4, 5, 6
C8 174,96 2, 3, 7'', 9
C9 51,87 9 9
H9 3,672 s 9 8, 9 2, 3, 6
C10 144,38 2, 3, 12
C11 127,61 11 3, 11, 13
H11 7,328 m 3 11 3, 11, 13 2, 3, 4, 7'
C12 128,60 12 12
H12 7,308 m 12 10, 12
C13 126,19 13 11
H13 7,200 m 13 11
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Table S18. Peak table for methyl (1S,2S,3S,4R)-3-phenylbicyclo[2.2.1]hept-5-ene-2-carboxylate 
(3aexo). Red arrows and circles indicate the characteristic NOESY signals for the assignment of 
stereochemistry. 
 
Atom δ J COSY HSQC HMBC NOESY
C1 48,24 1 1, 2, 4, 5, 6, 7'
H1 3,149 m 6, 7', 7'' 1 1, 3, 4, 5 2, 6, 7', 7''
C2 50,57 2 2, 3, 4, 5, 7''
H2 2,520 dd 5.3(3), 1.8(7''anti) 3, 7'' 2 1, 2, 3, 6, 7, 8, 10 1, 6, 11
C3 48,85 3 1, 2, 3, 6, 7', 7'', 11
H3 3,702 dd 3.5(4), 5.3(2) 2, 4, 11 3 2, 3, 4, 5, 8, 10, 11 4, 7', 11
C4 48,41 4 1, 3, 4, 5, 6, 7'
H4 3,180 m 3, 5, 7', 7'' 4 1, 2, 4, 6 3, 5, 7', 7'', 11
C5 136,06 5 1, 3, 5, 6, 7', 7''
H5 6,026 dd 2.9(4), 5.6(6) 4, 6, 7' 5 1, 2, 4, 5, 6, 7 4, 7'', 11
C6 136,73 6 2, 4, 5, 6, 7', 7''
H6 6,314 dd 3.2(1), 5.6(5) 1, 5, 7' 6 1, 3, 4, 5, 6, 7 1, 2, 7''
C7 48,11 7', 7'' 2, 5, 6, 7', 7''
H7' syn 1,897 dm 8.6(7''anti) 1, 4, 5, 6, 7'' 7 1, 3, 4, 5, 6, 7 1, 3, 4
H7'' anti 1,557 dm 8.6(7'syn) 1, 2, 4, 7' 7 2, 3, 5, 6, 7, 10 1, 4, 5, 6
C8 176,21 2, 3, 9
C9 52,05 9 9
H9 3,716 s 9 8, 9
C10 143,17 2, 3, 7'', 12
C11 127,97 11 3, 11, 13
H11 7,178 m 3 11 3, 11, 13 2, 3, 4, 5
C12 128,18 12 12
H12 7,255 m 12 10, 12
C13 126,29 13 11
H13 7,176 m 13 11
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methyl (1R,2S,3S,4S)-3-(p-tolyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3b): Prepared 
according to procedure A with catalyst (S,S)-4a (2 μmol, 3.6 mg, 1 mol%), 
methyl (E)-3-(p-tolyl)acrylate (1b, 0.20 mmol, 35.4 mg) and cyclopentadiene 
(1 mmol, 90 μL) at −40 °C for 48 hours. The product was obtained as a 
diastereomeric mixture after column chromatography (hexane/DCM 
4:1→2:1→1:1) as a colorless oil (48 mg, 99%). The enantiomeric ratios 
were determined by HPLC on a chiral stationary phase. The diastereomeric ratio was determined 
by 
1
H NMR. 
1
H NMR (500 MHz, CDCl3) δ 7.22 (d, J = 8.1 Hz, 2H), 7.12 (d, J = 7.9 Hz, 2H), 6.42 
(dd, J = 5.7, 3.2 Hz, 1H), 6.12 (dd, J = 5.7, 2.8 Hz, 1H), 3.67 (s, 3H), 3.28 (dtq, J = 4.1, 2.2, 1.1 Hz, 
1H), 3.07 (dd, J = 5.1, 1.7 Hz, 1H), 3.03 – 2.97 (m, 2H), 2.33 (s, 3H), 1.78 (dt, J = 8.6, 1.5 Hz, 1H), 
1.56 (dq, J = 8.7, 1.8 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 175.0, 141.3, 139.2, 135.7, 134.6, 
129.3, 127.5, 52.1, 51.8, 48.7, 47.4, 47.3, 46.3, 21.1; HRMS (EI) calculated for C16H18O2: 
242.1301; found 242.1301; [α]D
25
 = +118.5 (c 0.53, CHCl3); HPLC (Heartcut) 1. 50 mm Zorbax 
Eclipse PAH, 4.6 mm, methanol/water – gradient 50 % B - 5` - 80 % B -5` - 80% - 1` - 100% B, 
1.0 mL/min, 38.5 MPa, 308 K, 220 nm; 2. 150mm Chiralcel OJ-3R, 4.6 mm, methanol, 1.0 
mL/min, 298 K, 17.7 MPa, 220 nm; tR (major, exo) = 5.3 min, tR (major, endo) = 5.5 min, tR 
(minor, exo) = 7.0 min, tR (minor, endo) = 9.5 min; e.r.endo = 97:3, e.r.exo = 96:4, d.r. (endo/exo) = 
20:1. 
 
methyl (1R,2S,3S,4S)-3-(m-tolyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3c): Prepared 
according to procedure A with catalyst (S,S)-4a (2 μmol, 3.6 mg, 1 mol%), 
methyl (E)-3-(m-tolyl)acrylate (1c, 0.20 mmol, 35.9 mg) and cyclopentadiene 
(1 mmol, 90 μL) at −40 °C for 48 hours. The product was obtained as a 
diastereomeric mixture after column chromatography (hexane/DCM 4:1→2:1) as 
a colorless oil (44 mg, 89%). The enantiomeric and diastereomeric ratios were 
determined by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 
7.20 (t, J = 7.5 Hz, 1H), 7.16 – 7.10 (m, 2H), 7.02 (d, J = 7.4 Hz, 1H), 6.42 (dd, J 
= 5.7, 3.2 Hz, 1H), 6.12 (dd, J = 5.7, 2.8 Hz, 1H), 3.67 (s, 3H), 3.32 – 3.25 (m, 1H), 3.08 (dd, J = 
5.1, 1.8 Hz, 1H), 3.05 – 2.98 (m, 2H), 2.35 (s, 3H), 1.79 (dt, J = 8.8, 1.5 Hz, 1H), 1.57 (dq, J = 8.7, 
1.8 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 175.0, 144.3, 139.3, 138.1, 134.6, 128.5, 128.5, 126.9, 
124.5, 52.0, 51.8, 48.6, 47.6, 47.4, 46.4, 21.7; HRMS (EI) calculated for C16H18O2: 242.1301; 
found 242.1302; [α]D
25
 = +128.1 (c 0.51, CHCl3); HPLC Daicel Chiralcel OJ-3R, MeOH/H2O = 
90/10, 1 mL/min, 25 °C, 220 nm, tR (major, endo) = 7.7 min, tR (minor, exo) = 9.5 min, tR (major, 
exo) = 10.6 min, tR (minor, endo) = 11.8 min; e.r.endo = 97.5:2.5, e.r.exo = 98:2, d.r. (endo/exo) = 
17:1. 
 
methyl (1R,2S,3S,4S)-3-(o-tolyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3d): Prepared 
according to procedure A with catalyst (S,S)-4a (2 μmol, 3.6 mg, 1 mol%), 
methyl (E)-3-(o-tolyl)acrylate (1d, 0.20 mmol, 36.0 mg) and cyclopentadiene 
(1 mmol, 90 μL) at −40 °C for 48 hours. The product was obtained as a 
diastereomeric mixture after column chromatography (hexane/DCM 
4:1→2:1→1:1) as a colorless oil (43 mg, 87%). The enantiomeric and 
diastereomeric ratios were determined by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, 
CDCl3) δ 7.31 – 7.27 (m, 1H), 7.21 – 7.16 (m, 2H), 7.18 – 7.09 (m, 2H), 6.47 (dd, J = 5.7, 3.2 Hz, 
1H), 6.10 (dd, J = 5.6, 2.8 Hz, 1H), 3.64 (s, 3H), 3.30 (dddt, J = 4.0, 3.2, 2.3, 1.1 Hz, 1H), 3.20 (dd, 
J = 5.2, 1.7 Hz, 1H), 3.12 (dd, J = 5.1, 3.6 Hz, 1H), 2.84 (dq, J = 3.2, 1.6 Hz, 1H), 2.32 (s, 3H), 
1.85 (dt, J = 8.7, 1.5 Hz, 1H), 1.55 (dd, J = 8.8, 1.8 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 175.1, 
142.0, 139.1, 137.2, 134.2, 130.7, 126.2, 126.1, 125.5, 51.8, 49.6, 49.5, 47.2, 46.8, 44.6, 20.4; 
HRMS (EI) calculated for C16H18O2: 242.1301; found 242.1302; [α]D
25
 = +150.3 (c 0.64, CHCl3); 
HPLC (Heartcut) 1. 50 mm Eclipse Plus C18, 3.0 mm, methanol/water – gradient 50% B - 5` - 70 
% B - 5` - 70 % B - 1`- 100% B, 0.5 mL/min, 34.8 MPa, 308 K, 220 nm; 2. 150 mm Chiralcel 
OJ3R, 4.6 mm, methanol/water = 90:10, 1.0 mL/min, 25.6 MPa, 308 K, 220 nm; tR (minor, exo) = 
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4.2 min, tR (major, exo) = 4.9 min, tR (minor, endo) = 5.7 min, tR (major, endo) = 6.1 min; e.r.endo = 
97:3, e.r.exo = not given due to weak signal, d.r. (endo/exo) = >50:1. 
 
methyl (1R,2S,3S,4S)-3-(4-bromophenyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3e): Prepared 
according to procedure A with catalyst (S,S)-4a (2 μmol, 3.6 mg, 1 mol%), 
methyl (E)-3-(4-bromophenyl)acrylate (1e, 0.20 mmol, 48.5 mg) and 
cyclopentadiene (2 mmol, 180 μL) at −40 °C for 24 hours. The product was 
obtained as a diastereomeric mixture after column chromatography 
(hexane/DCM 4:1→2:1→1:1) as a colorless oil (60 mg, 97%). The 
enantiomeric and diastereomeric ratios were determined by HPLC on a chiral stationary phase. 
HPLC Daicel Chiralcel OJ-3R, MeCN/H2O = 60/40, 1 mL/min, 25 °C, 220 nm, tR (major, exo) = 
8.9 min, tR (major, endo) = 9.7 min, tR (minor, exo) = 10.5 min, tR (minor, endo) = 12.3 min; e.r.endo 
= 97.5:2.5, e.r.exo = 97.5:2.5, d.r. (endo/exo) = 16:1; [α]D
25
 = +102.2 (c 0.64, CHCl3). 
 
An enantioenriched mixture of endo/exo diastereomers (d.r. 17:1, e.r.endo = 95.5:4.5, e.r.exo = 91:9) 
was separated by preparative HPLC on a chiral stationary phase to give optically pure 
diastereomers, which were characterized as followed: 
 
endo-diastereomer: methyl (1R,2S,3S,4S)-3-(4-bromophenyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (3eendo): 
1
H NMR (500 MHz, CDCl3) δ 
7.44 – 7.39 (m, 2H), 7.22 – 7.17 (m, 2H), 6.40 (dd, 
J = 5.7, 3.2 Hz, 1H), 6.12 (dd, J = 5.7, 2.8 Hz, 1H), 
3.67 (s, 3H), 3.33 – 3.26 (m, 1H), 3.05 (dd, J = 5.0, 
1.8 Hz, 1H), 3.03 – 2.96 (m, 1H), 2.92 (dd, J = 5.0, 
3.6 Hz, 1H), 1.72 (d, J = 8.8 Hz, 1H), 1.58 (d, J = 
8.8 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 174.7, 143.5, 139.1, 134.9, 131.6, 129.4, 120.0, 52.4, 
52.0, 48.2, 47.3, 47.2, 46.3; [α]D
25
 = +101.1 (c 0.73, CHCl3); HRMS (ESI) calculated for 
C15H15O2BrNa (M+Na)
+
: 329.0148; found 329.0151. 
 
exo-diastereomer: methyl (1S,2S,3S,4R)-3-(4-bromophenyl)bicyclo[2.2.1]hept-5-ene-2-
carboxylate (3eexo): 
1
H NMR (500 MHz, CDCl3) δ 
7.39 – 7.33 (m, 1H), 7.07 – 7.01 (m, 1H), 6.31 (dd, J = 
5.7, 3.1 Hz, 1H), 5.99 (dd, J = 5.7, 2.9 Hz, 1H), 3.71 
(s, 2H), 3.64 (dd, J = 5.3, 3.4 Hz, 1H), 3.16 – 3.14 (m, 
1H), 3.14 – 3.11 (m, 0H), 2.44 (dd, J = 5.3, 1.7 Hz, 
1H), 1.86 (dtt, J = 8.7, 1.6, 0.7 Hz, 1H), 1.56 (dq, J = 
8.7, 1.7 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 
175.9, 142.2, 137.0, 135.8, 131.2, 129.7, 120.1, 52.1, 50.7, 48.4, 48.2, 48.2; [α]D
25
 = +260.2 
(c 0.625, CHCl3); HRMS (ESI) calculated for C15H15O2BrNa (M+Na)
+
: 329.0148; found 329.0151. 
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methyl (1R,2S,3S,4S)-3-(3-bromophenyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3f): Prepared 
according to procedure A with catalyst (S,S)-4a (2 μmol, 3.6 mg, 1 mol%), 
methyl (E)-3-(3-bromophenyl)acrylate (1f, 0.20 mmol, 48.4 mg) and 
cyclopentadiene (1 mmol, 90 μL) at −40 °C for 48 hours. The product was 
obtained as a diastereomeric mixture after column chromatography 
(hexane/DCM 4:1→2:1) as a colorless oil (57 mg, 92%). The enantiomeric and 
diastereomeric ratios were determined by HPLC on a chiral stationary phase. 
1
H 
NMR (500 MHz, CDCl3) δ 7.46 (d, J = 2.0 Hz, 1H), 7.33 (dt, J = 8.0, 1.4 Hz, 
1H), 7.27 – 7.23 (m, 1H), 7.17 (t, J = 7.8 Hz, 1H), 6.40 (dd, J = 5.7, 3.2 Hz, 1H), 6.12 (dd, J = 5.6, 
2.8 Hz, 1H), 3.68 (s, 3H), 3.33 – 3.26 (m, 1H), 3.07 (dd, J = 5.1, 1.8 Hz, 1H), 3.02 (dq, J = 3.2, 1.5 
Hz, 1H), 2.95 (dd, J = 5.0, 3.6 Hz, 1H), 1.74 (dt, J = 8.8, 1.5 Hz, 1H), 1.59 (dq, J = 8.8, 1.8 Hz, 
1H);
 13
C NMR (126 MHz, CDCl3) δ 174.6, 146.9, 139.0, 134.9, 130.6, 130.1, 129.3, 126.4, 122.8, 
52.3, 52.0, 48.2, 47.3, 47.3, 46.4; HRMS (EI) calculated for C15H15O2Br: 306.0250; found 
306.0245; [α]D
25
 = +104.1 (c 0.58, CHCl3); HPLC Daicel Chiralpak AD-3R, MeOH/H2O = 80/20, 
1 mL/min, 25 °C, 220 nm, tR (minor, exo) = 14.6 min, tR (minor, endo) = 15.8 min, tR (major, endo) 
= 18.3 min, tR (major, exo) = 20.6 min; e.r.endo = 97.5:2.5, e.r.exo = 97.5:2.5, d.r. (endo/exo) = 15:1. 
 
methyl (1R,2S,3S,4S)-3-(2-bromophenyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3g): Prepared 
according to procedure A with catalyst (S,S)-4a (2 μmol, 3.6 mg, 1 mol%), 
methyl (E)-3-(2-bromophenyl)acrylate (1g, 0.20 mmol, 48.2 mg) and 
cyclopentadiene (2 mmol, 180 μL) at −40 °C for 24 hours. The product was 
obtained as a diastereomeric mixture after column chromatography 
(hexane/DCM 4:1→2:1→1:1) as a colorless oil (43 mg, 70%). The enantiomeric 
and diastereomeric ratios were determined by HPLC on a chiral stationary phase. 
1
H NMR (500 
MHz, CDCl3) δ 7.60 (dd, J = 7.9, 1.3 Hz, 1H), 7.32 (dd, J = 7.9, 1.7 Hz, 1H), 7.28 (td, J = 7.7, 1.2 
Hz, 1H), 7.08 (td, J = 7.7, 1.8 Hz, 1H), 6.49 (dd, J = 5.7, 3.2 Hz, 1H), 6.14 (dd, J = 5.6, 2.8 Hz, 
1H), 3.64 (s, 3H), 3.38 (dd, J = 5.2, 1.7 Hz, 1H), 3.31 (dddt, J = 4.1, 3.3, 2.4, 1.1 Hz, 1H), 3.14 (dd, 
J = 5.2, 3.6 Hz, 1H), 2.93 – 2.88 (m, 1H), 1.71 (dddd, J = 8.8, 2.2, 1.4, 0.6 Hz, 1H), 1.52 (dq, J = 
8.8, 1.8 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 174.6, 142.6, 138.8, 134.6, 133.5, 127.8, 127.5, 
127.4, 126.4, 51.9, 50.0, 49.1, 48.3, 46.7, 46.6; HRMS (ESI) calculated for C15H16O2Br (M+H)
+
: 
307.0328; found 307.0329; [α]D
25
 = +95.6 (c 0.55, CHCl3); HPLC (2D-Separation) 1. 50 mm 
Eclipse PAH 1.8 μm, 3.0 mm, methanol/water – gradient 60% - 5' - 90% B, 0.5 mL/min, 38.5 MPa, 
308 K; 2. 150 mm 3-CelluCoat RP, 4.6 mm, methanol/water – gradient 70% - 5' - 90% B, 1.0 
ml/min, 35.3 MPa, 298 K; tR (major, endo) = 10.4 min, tR (minor, endo) = 10.7 min, tR (exo) = 
39.6 min, tR (exo) = 39.8 min; e.r.endo = 97.5:2.5, e.r.exo = not given due to weak signal, d.r. 
(endo/exo) = 47:1. 
 
methyl (1R,2S,3S,4S)-3-(4-fluorophenyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3h): Prepared 
according to procedure A with catalyst (S,S)-4a (2 μmol, 3.6 mg, 1 mol%), 
methyl (E)-3-(4-fluorophenyl)acrylate (1h, 0.20 mmol, 36.5 mg) and 
cyclopentadiene (2 mmol, 180 μL) at −40 °C for 24 hours. The product was 
obtained as a diastereomeric mixture after column chromatography 
(hexane/DCM 4:1→2:1) as a colorless oil (49 mg, 98%). The enantiomeric 
and diastereomeric ratios were determined by HPLC on a chiral stationary phase. 
1
H NMR (500 
MHz, CDCl3) δ 7.32 – 7.23 (m, 2H), 7.04 – 6.95 (m, 2H), 6.41 (dd, J = 5.7, 3.2 Hz, 1H), 6.12 (dd, J 
= 5.7, 2.8 Hz, 1H), 3.67 (s, 3H), 3.32 – 3.26 (m, 1H), 3.07 (d, J = 4.7 Hz, 1H), 3.00 (dq, J = 3.3, 1.7 
Hz, 1H), 2.93 (dd, J = 5.1, 3.5 Hz, 1H), 1.74 (dt, J = 8.7, 1.5 Hz, 1H), 1.59 (dq, J = 8.7, 1.8 Hz, 
1H);
 13
C NMR (126 MHz, CDCl3) δ 174.8, 162.4, 160.4, 140.1, 140.0, 139.1, 134.8, 129.0, 128.9, 
115.4, 115.2, 52.5, 51.9, 48.4, 47.2, 47.0, 46.3; HRMS (ESI) calculated for C15H15O2F1Na 
(M+Na)
+
: 269.0948; found 269.0948; [α]D
25
 = +103.3 (c 0.79, CHCl3); HPLC Daicel Chiralcel OJ-
3R, MeOH/H2O = 90/10, 1 mL/min, 25 °C, 220 nm, tR (major, endo) = 6.1 min, tR (major, exo) = 
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6.9 min, tR (minor, exo) = 7.3 min, tR (minor, endo) = 8.9 min; e.r.endo = 97:3, e.r.exo = 95.5:4.5, d.r. 
(endo/exo) = 18:1. 
 
methyl (1R,2S,3S,4S)-3-(4-(trifluoromethyl)phenyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate 
(3i): Prepared according to procedure A with catalyst (S,S)-4a (2 μmol, 
3.6 mg, 1 mol%), methyl (E)-3-(4-(trifluoromethyl)phenyl)acrylate (1i, 
0.20 mmol, 45.9 mg) and cyclopentadiene (1 mmol, 90 μL) at −40 °C for 
48 hours. The product was obtained as a diastereomeric mixture after 
column chromatography (hexane/DCM 4:1→2:1→1:1) as a colorless oil 
(58 mg, 98%). The enantiomeric and diastereomeric ratios were determined 
by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 8.1 Hz, 2H), 7.44 
(d, J = 8.1 Hz, 2H), 6.43 (dd, J = 5.7, 3.2 Hz, 1H), 6.14 (dd, J = 5.6, 2.8 Hz, 1H), 3.68 (s, 3H), 3.32 
(s, 1H), 3.16 (d, J = 4.8 Hz, 1H), 3.06 (dt, J = 3.3, 1.7 Hz, 1H), 2.96 (dd, J = 5.1, 3.6 Hz, 1H), 1.74 
(dt, J = 8.8, 1.5 Hz, 1H), 1.62 (dq, J = 8.8, 1.8 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 174.5, 
148.6, 139.0, 135.0, 127.9, 125.5 (q, J = 3.7 Hz), 52.4, 52.0, 48.1, 47.6, 47.3, 46.4; 
19
F NMR (471 
MHz, CDCl3) δ -62.4; HRMS (ESI) calculated for C16H15O2F3Na (M+Na)
+
: 319.0916; found 
319.0919; [α]D
25
 = +93.1 (c 0.64, CHCl3); HPLC Daicel Chiralcel OJ-3R, MeOH/H2O = 75/25, 
1 mL/min, 25 °C, 220 nm, tR (major, exo) = 20.7 min, tR (major, endo) = 21.9 min, tR (minor, exo) 
= 24.0 min, tR (minor, endo) = 29.6 min; e.r.endo = 97.5:2.5, e.r.exo = 98.5:1.5, d.r. (endo/exo) = 12:1. 
 
methyl (1R,2S,3S,4S)-3-(4-cyanophenyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3j): Prepared 
according to procedure A with catalyst (S,S)-4b (6 μmol, 11.3 mg, 3 mol%), 
methyl (E)-3-(4-cyanophenyl)acrylate (1j, 0.20 mmol, 37.8 mg) and 
cyclopentadiene (1 mmol, 90 μL) at −40 °C for 3 days. The product was 
obtained as a diastereomeric mixture after column chromatography 
(hexane/DCM 2:1→1:1→1:2→1:4) as a colorless wax (48 mg, 94%). The 
enantiomeric and diastereomeric ratios were determined by HPLC on a chiral stationary phase. 
1
H 
NMR (500 MHz, CDCl3) δ 7.62 – 7.57 (m, 2H), 7.46 – 7.41 (m, 2H), 6.41 (dd, J = 5.7, 3.2 Hz, 
1H), 6.14 (dd, J = 5.7, 2.8 Hz, 1H), 3.68 (s, 3H), 3.32 (dddd, J = 4.6, 2.7, 2.0, 1.1 Hz, 1H), 3.15 
(dd, J = 5.2, 1.9 Hz, 1H), 3.06 (dq, J = 3.1, 1.5 Hz, 1H), 2.92 (dd, J = 5.1, 3.6 Hz, 1H), 1.70 (dddd, 
J = 8.8, 2.2, 1.4, 0.6 Hz, 1H), 1.62 (dq, J = 8.9, 1.8 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 174.3, 
150.2, 138.9, 135.1, 132.4, 128.4, 119.1, 110.1, 52.5, 52.1, 47.9, 47.8, 47.3, 46.4; HRMS (ESI) 
calculated for C16H15NO2Na (M+Na)
+
: 276.0995; found 276.0997; [α]D
25
 = +125.8 (c 0.48, CHCl3); 
HPLC (2D-Separation) 1. 50 mm Eclipse PAH 1.8 μm, 3.0 mm, methanol/water – gradient 40% - 
5' - 60% B, 0.5 mL/min, 308 K, 32.7 MPa; 2. 150 mm AmyCoat RP, 4.6 mm, methanol/water = 
90:10, 1.0 mL/min, 298 K, 21.0 MPa, 220 nm; tR (major, exo) = 12.5 min, tR (minor, exo) = 
13.5 min, tR (minor, endo) = 36.2 min, tR (major, endo) = 24.8 min; e.r.endo = 95:5, e.r.exo = 
64.5:35.5, d.r. (endo/exo) = 13:1. 
 
methyl (1R,2S,3S,4S)-3-(4-methoxyphenyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3k): 
Prepared according to procedure A with catalyst (S,S)-4a (6 μmol, 
10.8 mg, 3 mol%), methyl (E)-3-(4-methoxyphenyl)acrylate (1k, 
0.20 mmol, 38.3 mg), triethylallylsilane (0.1 mmol, 20 μL, 50 mol%) and 
cyclopentadiene (2 mmol, 180 μL) at −20 °C for 2 days. The product was 
obtained as a diastereomeric mixture after column chromatography 
(hexane/DCM 2:1→1:1) as a colorless oil (50 mg, 97%). The enantiomeric and diastereomeric 
ratios were determined by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 7.26 
– 7.21 (m, 2H), 6.88 – 6.83 (m, 2H), 6.41 (dd, J = 5.7, 3.2 Hz, 1H), 6.11 (dd, J = 5.7, 2.8 Hz, 1H), 
3.79 (s, 3H), 3.66 (s, 3H), 3.27 (dddt, J = 4.0, 3.1, 2.2, 1.1 Hz, 1H), 3.04 (dd, J = 5.1, 1.8 Hz, 1H), 
2.98 (dq, J = 3.3, 1.7 Hz, 1H), 2.95 (dd, J = 5.0, 3.6 Hz, 1H), 1.80 – 1.73 (m, 1H), 1.56 (dq, J = 8.7, 
1.8 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 175.0, 158.0, 139.2, 136.4, 134.6, 128.5, 114.0, 55.4, 
52.3, 51.8, 48.7, 47.3, 47.0, 46.3; HRMS (ESI) calculated for C16H19O3 (M+H)
+
: 259.1329; found 
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259.1333; [α]D
25
 = +112.6 (c 0.57, CHCl3); HPLC Daicel Chiralcel OJ-3R, MeCN/H2O = 70/30, 
1 mL/min, 25 °C, 220 nm, tR (major, exo) = 4.4 min, tR (major, endo) = 4.9 min, tR (minor, exo) = 
5.4 min, tR (major, endo) = 6.6 min; e.r.endo = 95:5, e.r.exo = n.d., d.r. (endo/exo) = 12:1. 
 
methyl (1R,2S,3S,4S)-3-(benzo[d][1,3]dioxol-5-yl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3l): 
Prepared according to procedure A with catalyst (S,S)-4a (6 μmol, 10.8 mg, 
3 mol%), methyl (E)-3-(benzo[d][1,3]dioxol-5-yl)acrylate (1l, 0.20 mmol, 
41.6 mg), triethylallylsilane (0.1 mmol, 20 μL, 50 mol%) and 
cyclopentadiene (2 mmol, 180 μL) at −20 °C for 2 days. The product was 
obtained as a diastereomeric mixture after column chromatography 
(hexane/DCM 2:1→1:1) as a colorless oil (51 mg, 94%). The enantiomeric and diastereomeric 
ratios were determined by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 6.84 
(d, J = 1.6 Hz, 1H), 6.77 (ddd, J = 8.1, 1.7, 0.7 Hz, 1H), 6.74 (d, J = 8.0 Hz, 1H), 6.39 (dd, J = 5.7, 
3.2 Hz, 1H), 6.10 (dd, J = 5.7, 2.8 Hz, 1H), 5.92 (s, 2H), 3.67 (s, 3H), 3.26 (dddt, J = 4.2, 3.2, 2.4, 
1.2 Hz, 1H), 3.02 (dd, J = 5.0, 1.8 Hz, 1H), 2.97 (dq, J = 3.2, 1.6 Hz, 1H), 2.91 (dd, J = 5.0, 3.5 Hz, 
1H), 1.75 (ddd, J = 9.5, 1.9, 1.2 Hz, 1H), 1.60 – 1.55 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 
174.9, 147.8, 145.9, 139.2, 138.4, 134.7, 120.2, 108.3, 101.0, 52.6, 51.9, 48.6, 47.5, 47.3, 46.3; 
HRMS (ESI) calculated for C16H16O4Na (M+Na)
+
: 295.0941; found 295.0940; [α]D
25
 = +102.3 
(c 0.58, CHCl3); HPLC Kromasil AmyCoat RP, MeOH/H2O = 85/15, 1 mL/min, 25 °C, 254 nm, tR 
(minor, exo) = 11.6 min, tR (minor, endo) = 13.2 min, tR (major, endo) = 18.8 min, tR (minor, exo) = 
22.2 min; e.r.endo = 96:4, e.r.exo = 91:9, d.r. (endo/exo) = 15:1. 
 
methyl (1R,2S,3S,4S)-3-(naphthalen-1-yl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3m): 
Prepared according to procedure A with catalyst (S,S)-4a (2 μmol, 3.6 mg, 
1 mol%), methyl (E)-3-(naphthalen-1-yl)acrylate (1m, 0.20 mmol, 42.4 mg) and 
cyclopentadiene (1 mmol, 90 μL) at −40 °C for 48 hours. The product was 
obtained as a diastereomeric mixture after column chromatography 
(hexane/DCM 4:1→2:1) as a colorless oil (55 mg, 99%). The enantiomeric and 
diastereomeric ratios were determined by HPLC on a chiral stationary phase. 
1
H 
NMR (500 MHz, CDCl3) δ 8.16 (d, J = 8.4 Hz, 1H), 7.86 (dd, J = 7.9, 1.7 Hz, 
1H), 7.74 (d, J = 7.5 Hz, 1H), 7.51 (dddd, J = 17.8, 8.0, 6.8, 1.4 Hz, 2H), 7.47 – 7.42 (m, 2H), 6.60 
(dd, J = 5.7, 3.1 Hz, 1H), 6.19 (dd, J = 5.6, 2.8 Hz, 1H), 3.80 (dd, J = 5.1, 1.1 Hz, 1H), 3.66 (s, 
3H), 3.34 (dtd, J = 3.6, 1.8, 0.9 Hz, 1H), 3.21 (dd, J = 5.1, 3.6 Hz, 1H), 3.08 (dt, J = 3.3, 1.7 Hz, 
1H), 1.88 (d, J = 8.7 Hz, 1H), 1.63 (dq, J = 8.7, 1.8 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 175.2, 
139.9, 138.9, 134.6, 134.1, 132.7, 128.9, 127.1, 126.1, 125.7, 125.4, 124.2, 122.8, 51.9, 49.8, 49.8, 
47.8, 47.0, 43.9; HRMS (ESI) calculated for C19H18O2Na (M+Na)
+
: 301.1199; found 301.1200; 
[α]D
25
 = +89.8 (c 0.53, CHCl3); HPLC (2D-Separation) 1. 50 mm Eclipse PAH 1.8 μm, 3.0 mm, 
methanol/water – gradient 60% - 5' - 90% B, 0.5 mL/min, 37.0 MPa, 308 K; 2. 150 mm 3-
AmyCoat RP, 4.6 mm, acetonitrile/water = 50:50, 1.0 ml/min, 18.6 MPa, 298 K, 220 nm; tR (exo) = 
15.0 min, tR (exo) = 16.1 min, tR (major, endo) = 36.2 min, tR (minor, endo) = 37.5 min; e.r.endo = 
97.5:2.5, e.r.exo = not given due to weak signal, d.r. (endo/exo) = >50:1. 
 
methyl (1R,2S,3S,4S)-3-(furan-2-yl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3n): Prepared 
according to procedure A with catalyst (S,S)-4b (6 μmol, 11.3 mg, 3 mol%), 
methyl (E)-3-(furan-2-yl)acrylate (1n, 0.20 mmol, 30.4 mg) and cyclopentadiene 
(2 mmol, 180 μL) at −40 °C for 14 hours. The product was obtained as a 
diastereomeric mixture after column chromatography (hexane/DCM 
4:1→2:1→1:1) as an orange oil (39 mg, 89%). The enantiomeric and 
diastereomeric ratios were determined by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, 
CDCl3) δ 7.33 – 7.30 (m, 1H), 6.34 (dd, J = 5.7, 3.2 Hz, 1H), 6.29 (dd, J = 3.2, 1.8 Hz, 1H), 6.10 – 
6.05 (m, 2H), 3.65 (s, 3H), 3.29 – 3.26 (m, 1H), 3.11 (dd, J = 4.8, 3.6 Hz, 1H), 3.06 (dd, J = 5.0, 
1.8 Hz, 1H), 3.01 – 2.98 (m, 1H), 1.74 (dt, J = 8.6, 1.6 Hz, 1H), 1.51 (dq, J = 8.7, 1.8 Hz, 1H); 13C 
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NMR (126 MHz, CDCl3) δ 174.3, 157.7, 141.3, 138.3, 134.4, 110.3, 105.0, 51.9, 49.8, 48.6, 47.7, 
46.0, 41.9; HRMS (EI) calculated for C13H14O3 (M): 218.0937; found 218.0937; [α]D
25
 = +120.0 
(c 0.42, CHCl3); HPLC (Heartcut) 1. 50 mm YMC Triart C18 ExRS, 3.0 mm, methanol/water – 
gradient 50 % B - 5` - 70 % B -5` - 70% - 1` - 100% B, 0.5 mL/min, 58.7 MPa, 308 K, 220 nm; 2. 
150mm Chiralcel OJ-3R, 4.6 mm, methanol/water = 90:10, 1.0 mL/min, 298 K, 26.5 MPa, 220 nm; 
tR (major, exo) = 4.7 min, tR (minor, exo) = 5.0 min, tR (major, endo) = 5.0 min, tR (minor, endo) = 
6.6 min; e.r.endo = 94:6, e.r.exo = not given due to weak signal, d.r. (endo/exo) = >50:1. 
 
methyl (1R,2S,3S,4S)-3-(thiophen-2-yl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3o): Prepared 
according to procedure A with catalyst (S,S)-4b (6 μmol, 11.3 mg, 3 mol%), 
methyl (E)-3-(thiophen-2-yl)acrylate (1o, 0.20 mmol, 34.3 mg) and 
cyclopentadiene (1 mmol, 90 μL) at −40 °C for 3 days. The product was obtained 
as a diastereomeric mixture after column chromatography (hexane/DCM 
2:1→1:1→1:2) as a colorless oil (43 mg, 90%). The enantiomeric and 
diastereomeric ratios were determined by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, 
CDCl3) δ 7.14 (dd, J = 5.1, 1.2 Hz, 1H), 6.94 (dd, J = 5.1, 3.5 Hz, 1H), 6.90 (dt, J = 3.5, 1.1 Hz, 
1H), 6.38 (dd, J = 5.7, 3.2 Hz, 1H), 6.11 (dd, J = 5.7, 2.8 Hz, 1H), 3.67 (s, 3H), 3.33 – 3.25 (m, 
2H), 3.07 (dd, J = 4.8, 3.6 Hz, 1H), 3.01 (ddq, J = 3.2, 1.6, 0.8 Hz, 1H), 1.83 (dtt, J = 9.0, 1.5, 0.7 
Hz, 1H), 1.60 (dq, J = 8.9, 1.8 Hz, 1H);
 13
C NMR (126 MHz, CDCl3) δ 174.3, 148.7, 138.5, 134.5, 
126.9, 123.8, 123.3, 53.6, 51.9, 50.7, 47.6, 46.1, 43.9; HRMS (ESI) calculated for C13H14O2SNa 
(M+Na)
+
: 257.0607; found 257.0606; [α]D
25
 = +117.7 (c 0.53, CHCl3); HPLC Daicel Chiralcel OJ-
3R, MeCN/H2O = 40/60, 1 mL/min, 25 °C, 220 nm, tR (minor, exo) = 35.6 min, tR (major, endo) = 
38.2 min, tR (minor, endo) = 42.9 min, tR (minor, exo) = 45.1 min; e.r.endo = 94:6, e.r.exo = 90:10, d.r. 
(endo/exo) = >50:1. 
 
ethyl (1R,2S,3S,4S)-3-phenylbicyclo[2.2.1]hept-5-ene-2-carboxylate: Prepared according to 
procedure B with catalyst (S,S)-4d (2 μmol, 3.7 mg, 1 mol%), silyl ketene acetal 
5b (0.04 mmol, 12 μL, 20 mol%), ethyl (E)-cinnamate (0.20 mmol, 35.7 mg) and 
cyclopentadiene (1 mmol, 90 μL) at −40 °C for 7 days. The product was obtained 
as a diastereomeric mixture after column chromatography (hexane/DCM 
4:1→2:1) as a colorless oil (49 mg, 99%). The enantiomeric and diastereomeric 
ratios were determined by HPLC on a chiral stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 7.37 
– 7.28 (m, 4H), 7.23 – 7.18 (m, 1H), 6.43 (dd, J = 5.7, 3.2 Hz, 1H), 6.12 (dd, J = 5.7, 2.8 Hz, 1H), 
4.13 (p, J = 7.1 Hz, 2H), 3.29 (tdq, J = 3.1, 2.2, 1.1 Hz, 1H), 3.12 (dd, J = 5.2, 1.8 Hz, 1H), 3.05 
(dt, J = 3.3, 1.7 Hz, 1H), 2.99 (dd, J = 5.0, 3.6 Hz, 1H), 1.79 (dt, J = 8.6, 1.5 Hz, 1H), 1.60 – 1.56 
(m, 1H), 1.26 (t, J = 7.1 Hz, 3H);
 13
C NMR (126 MHz, CDCl3) δ 174.4, 144.5, 139.2, 134.6, 128.6, 
127.6, 126.1, 60.5, 52.4, 48.4, 47.5, 47.3, 46.4, 14.5; HRMS (ESI) calculated for C16H19O2 
(M+H)
+
: 243.1380; found 243.1384; [α]D
25
 = +89.0 (c 0.54, CHCl3); HPLC Daicel Chiralcel OJ-
3R, MeOH/H2O = 90/10, 1 mL/min, 25 °C, 220 nm, tR (major, endo) = 8.7 min, tR (minor, exo) = 
10.2 min, tR (major, exo) = 10.8 min, tR (minor, endo) = 12.0 min; e.r.endo = 88:12, e.r.exo = 82:18, 
d.r. (endo/exo) = 14:1. 
 
The performance of catalysts 4a and 4c was compared at a reaction temperature of −40 °C and a 
reaction time of 7 days following the appropriate procedure A or B respectively: 
 
entry catalyst procedure yield (%) 
d.r. 
(endo:exo) 
e.r. (endo) e.r. (exo) 
1 4a A 99 15:1 73.5:26.5 75:25 
2 4c B 99 14:1 88:12 82:18 
 
 
S-51 
 
benzyl (1R,2S,3S,4S)-3-phenylbicyclo[2.2.1]hept-5-ene-2-carboxylate: Prepared according to 
procedure B with catalyst (S,S)-4d (2 μmol, 3.7 mg, 1 mol%), silyl ketene acetal 
5b (0.04 mmol, 12 μL, 20 mol%), benzyl (E)-cinnamate (0.20 mmol, 47.7 mg) 
and cyclopentadiene (1 mmol, 90 μL) at −40 °C for 3 weeks. The conversion was 
determined by 
1
H-NMR to be approx. 10% and isolation of the product for 
stereochemical analysis was performed by preparative TLC. The enantiomeric 
and diastereomeric ratios were determined by HPLC on a chiral stationary phase. 
1
H NMR (300 
MHz, CDCl3): δ = 7.42–7.13 (m, 10H), 6.42 (dd, J = 5.6, 3.2 Hz, 1H), 6.06 (dd, J = 5.6, 3.2 Hz, 
1H), 5.11 (q, J = 12.4, 6.9 Hz, 2H), 3.32 (s, 1H), 3.15 (dd, J = 7.3, 2.0 Hz, 2H), 3.05 (dd, J = 4.9, 
3.6 Hz, 2H), 1.89 (d, J = 8.6 Hz, 1H), 1.80 (d, J = 8.7 Hz, 2H), 1.61–1.55 (m, 2H); 13C NMR (75 
MHz, CDCl3) δ 174.2, 144.4, 139.3, 136.8, 134.6, 128.7, 128.6, 128.2, 128.0, 127.6, 126.2, 66.6, 
52.4, 48.5, 47.7, 47.4, 46.6; HRMS (ESI) calculated for C21H20O2Na (M+Na)
+
: 327.1354; found 
327.1355; HPLC Daicel Chiralcel OJ-3R, MeOH/MeCN/H2O = 45/45/10, 1 mL/min, 25 °C, 
220 nm, tR (major, endo) = 6.2 min, tR (major, exo) = 6.5 min, tR (minor, endo) = 8.3 min, tR 
(minor, exo) = 14.5 min; e.r.endo = 84:16, e.r.exo = 80:20, d.r. (endo/exo) = 32:1. 
 
The performance of catalysts 4a and 4c was compared at a reaction temperature of −40 °C and a 
reaction time of 3 weeks following the appropriate procedure A or B respectively: 
 
entry catalyst procedure conversion (%) 
d.r. 
(endo:exo) 
e.r. (endo) e.r. (exo) 
1 4a A <5 21:1 58.5:41.5 57.5:42.5 
2 4c B 10 32:1 84:16 80:20 
 
 
methyl (1R,2S,3S,4S)-3-phenethylbicyclo[2.2.1]hept-5-ene-2-carboxylate (3p): Prepared 
according to procedure B with catalyst (S,S)-4a (2 μmol, 3.6 mg, 1 mol%), 
silyl ketene acetal 5c (0.04 mmol, 10 μL, 20 mol%), methyl (E)-5-phenylpent-
2-enoate 1p (0.20 mmol, 38.4 mg) and cyclopentadiene (1 mmol, 90 μL) at 
−80 °C for 30 h. The product was obtained as a diastereomeric mixture after 
column chromatography (hexane/DCM 4:1→2:1) as a colorless oil (46 mg, 
89%). The enantiomeric and diastereomeric ratios were determined by HPLC 
on a chiral stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 7.32 – 7.26 (m, 
2H), 7.22 – 7.16 (m, 3H), 6.26 (dd, J = 5.7, 3.1 Hz, 1H), 6.01 (dd, J = 5.7, 2.8 Hz, 1H), 3.64 (s, 
3H), 3.15 – 3.12 (m, 1H), 2.77 – 2.67 (m, 2H), 2.67 – 2.63 (m, 1H), 2.49 (t, J = 3.8 Hz, 1H), 1.89 – 
1.80 (m, 2H), 1.80 – 1.73 (m, 1H), 1.56 – 1.52 (m, 1H), 1.46 (dq, J = 8.8, 1.7 Hz, 1H); 13C NMR 
(126 MHz, CDCl3) δ 175.2, 142.6, 138.6, 133.7, 128.4, 128.4, 125.9, 51.6, 51.4, 47.2, 46.6, 46.0, 
43.7, 38.2, 35.2; HRMS (EI) calculated for C17H20O2: 256.1458; found 256.1457; [α]D
25
 = +83.2 
(c 0.62, CHCl3); HPLC Daicel Chiralcel OJ-3R, MeOH/H2O = 90/10, 1 mL/min, 25 °C, 220 nm, tR 
(major, endo) = 6.7 min, tR (major, exo) = 7.2 min, tR (minor, exo) = 7.7 min, tR (minor, endo) = 8.5 
min; e.r.endo = 96.5:3.5, e.r.exo = 97:3, d.r. (endo/exo) = 10:1. 
 
The performance of catalysts 4a and 4c was compared at a reaction temperature of −80 °C and a 
reaction time of 24 hours following procedure B: 
 
entry catalyst silyl group yield (%) 
d.r. 
(endo:exo) 
e.r. (endo) e.r. (exo) 
1 4a TES 89 10:1 96.5:3.5 97:3 
2 4c TIPS (46% conv.) 5:1 98:2 92:8 
 
  
S-52 
 
methyl (1R,2S,3S,4S)-3-heptylbicyclo[2.2.1]hept-5-ene-2-carboxylate (3q): Prepared according 
to procedure B with catalyst (S,S)-4a (4 μmol, 7.2 mg, 1 mol%), silyl 
ketene acetal 5c (0.08 mmol, 20 μL, 20 mol%), methyl (E)-dec-2-enoate 
1q (0.40 mmol, 77.5 mg) and cyclopentadiene (2 mmol, 180 μL) at 
−80 °C for 30 h. The product was obtained as a diastereomeric mixture 
after column chromatography (hexane/DCM 4:1→2:1) as a colorless oil 
(84 mg, 80%). The enantiomeric and diastereomeric ratios were determined by GC on a chiral 
stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 6.24 (dd, J = 5.7, 3.1 Hz, 1H), 5.97 (dd, J = 5.7, 
2.8 Hz, 1H), 3.61 (s, 3H), 3.09 (tdd, J = 3.9, 2.7, 1.6 Hz, 1H), 2.58 (h, J = 1.6 Hz, 1H), 2.40 (dd, J 
= 4.5, 3.5 Hz, 1H), 1.74 – 1.69 (m, 1H), 1.52 – 1.19 (m, 14H), 0.89 – 0.85 (m, 3H); 13C NMR (126 
MHz, CDCl3) δ 175.4, 138.7, 133.5, 51.6, 51.3, 47.0, 46.6, 45.9, 43.8, 36.2, 32.0, 29.9, 29.4, 28.8, 
22.8, 14.2; HRMS (EI) calculated for C16H26O2: 250.1927; found 250.1925; [α]D
25
 = +68.8 (c 0.63, 
CHCl3); GC column: BGB 176/BGB 15 G 618, 30.0 m, temperature: 230 140 60 MIN ISO 9/MIN 
220 2 MIN ISO 350, gas: 0.50 bar H2, sample size: 1.0 μL, tR (minor, exo) = 53.63 min, tR (major, 
exo) = 56.83 min, tR (minor, endo) = 58.37 min, tR (major, endo) = 59.78 min; e.r.endo = 97.5:2.5, 
e.r.exo = 98.5:1.5, d.r. (endo/exo) = 19:1. 
 
methyl (1R,2S,3S,4S)-3-isobutylbicyclo[2.2.1]hept-5-ene-2-carboxylate (3r): Prepared 
according to procedure B with catalyst (S,S)-4a (4 μmol, 7.2 mg, 1 mol%), silyl 
ketene acetal 5c (0.08 mmol, 20 μL, 20 mol%), methyl (E)-5-methylhex-2-
enoate 1r (0.44 mmol, 64.1 mg, E/Z 96:4) and cyclopentadiene (2 mmol, 
180 μL) at −80 °C for 30 h. The product was obtained as a diastereomeric 
mixture after column chromatography (hexane/DCM 4:1→2:1) as a colorless oil 
(77 mg, 85%). The enantiomeric and diastereomeric ratios were determined by 
GC on a chiral stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 6.25 (dd, J = 5.7, 3.2 Hz, 1H), 5.97 
(dd, J = 5.7, 2.8 Hz, 1H), 3.61 (s, 3H), 3.12 – 3.05 (m, 1H), 2.54 (dq, J = 3.4, 1.7 Hz, 1H), 2.40 (dd, 
J = 4.5, 3.5 Hz, 1H), 1.83 (tdd, J = 7.8, 4.5, 1.7 Hz, 1H), 1.63 (dp, J = 13.2, 6.5 Hz, 1H), 1.51 (dt, J 
= 8.7, 1.5 Hz, 1H), 1.41 (dq, J = 8.7, 1.7 Hz, 1H), 1.38 – 1.21 (m, 2H), 0.91 (d, J = 3.1 Hz, 3H), 
0.89 (d, J = 3.0 Hz, 3H);
 13
C NMR (126 MHz, CDCl3) δ 175.4, 138.7, 133.5, 51.6, 51.4, 47.4, 46.6, 
46.1, 45.7, 41.4, 27.0, 23.2, 22.8; HRMS (EI) calculated for C13H20O2: 208.1458; found 208.1457; 
[α]D
25
 = +69.5 (c 0.57, CHCl3); GC column: BGB 176/BGB 15 G 618, 30.0 m, temperature: 230 
110 50 MIN ISO 9/MIN 220 3 MIN ISO 350, gas: 0.60 bar H2, sample size: 1.0 μL, tR (minor, exo) 
= 25.49 min, tR (major, exo) = 28.01 min, tR (major, endo) = 28.79 min, tR (minor, endo) = 
29.38 min; e.r.endo = 97:3, e.r.exo = n.d., d.r. (endo/exo) = 23:1. 
 
methyl (1R,2S,3S,4S)-3-propylbicyclo[2.2.1]hept-5-ene-2-carboxylate (3s): Prepared according 
to procedure B with catalyst (S,S)-4a (4 μmol, 7.2 mg, 1 mol%), silyl ketene 
acetal 5c (0.08 mmol, 20 μL, 20 mol%), methyl (E)-hex-2-enoate 1s (0.44 mmol, 
57 mg, E/Z 98:2) and cyclopentadiene (2 mmol, 180 μL) at −80 °C for 30 h. The 
product was obtained as a diastereomeric mixture after column chromatography 
(hexane/DCM 4:1→2:1) as a colorless oil (64 mg, 76%). The enantiomeric and 
diastereomeric ratios were determined by GC on a chiral stationary phase. 
1
H 
NMR (500 MHz, CDCl3) δ 6.24 (dd, J = 5.7, 3.2 Hz, 1H), 5.97 (dd, J = 5.7, 2.8 Hz, 1H), 3.61 (s, 
3H), 3.11 – 3.06 (m, 1H), 2.57 (dq, J = 3.3, 1.6 Hz, 1H), 2.40 (dd, J = 4.5, 3.5 Hz, 1H), 1.73 (tdd, J 
= 6.7, 4.6, 1.8 Hz, 1H), 1.53 – 1.30 (m, 6H), 0.93 – 0.88 (m, 3H); 13C NMR (126 MHz, CDCl3) δ 
175.5, 138.7, 133.5, 51.6, 51.2, 47.0, 46.6, 45.9, 43.5, 38.5, 21.9, 14.4; HRMS (EI) calculated for 
C12H18O2: 194.1301; found 194.1302; [α]D
25
 = +79.7 (c 0.65, CHCl3); GC column: G-TA 0.25 
G/448, 30.0 m, temperature: 230 80 30 MIN ISO 9/MIN 170 2 MIN ISO 350, gas: 0.90 bar H2, 
sample size: 1.0 μL, tR (minor, exo) = 23.89 min, tR (major, exo) = 24.68 min, tR (major, endo) = 
26.09 min, tR (minor, endo) = 28.72 min; e.r.endo = 96.5:3.5, e.r.exo = 99:1, d.r. (endo/exo) = 21:1. 
 
S-53 
 
methyl (1R,2S,3S,4S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate (3t): Prepared 
according to procedure C with catalyst (S,S)-4c (4 μmol, 7.4 mg, 1 mol%), silyl 
ketene acetal 5c (0.16 mmol, 40 μL, 40 mol%), methyl (E)-4-methylpent-2-
enoate 1t (0.42 mmol, 56 mg, E/Z 97:3) and cyclopentadiene (4 mmol, 340 μL) 
at −60 °C for 48 h. The product was obtained as a diastereomeric mixture after 
column chromatography (hexane/DCM 4:1→2:1) as a colorless oil (80 mg, 
98%). The enantiomeric and diastereomeric ratios were determined by GC on a chiral stationary 
phase. 
1
H NMR (500 MHz, CDCl3) δ 6.27 (dd, J = 5.7, 3.2 Hz, 1H), 5.94 (dd, J = 5.7, 2.8 Hz, 1H), 
3.62 (s, 3H), 3.11 (dddt, J = 4.1, 3.3, 2.4, 1.2 Hz, 1H), 2.77 (dq, J = 3.4, 1.7 Hz, 1H), 2.52 (t, J = 
3.8 Hz, 1H), 1.49 – 1.36 (m, 4H), 0.99 (d, J = 6.0 Hz, 3H), 0.94 (d, J = 6.2 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 175.5, 139.2, 133.4, 51.6, 51.4, 49.7, 46.8, 46.4, 45.2, 33.1, 22.3, 22.0; HRMS 
(ESI) calculated for C12H19O2 (M+H)
+
: 195.1380; found 195.1381; [α]D
25
 = +48.9 (c 0.56, CHCl3); 
GC column: G-TA 0.25 G/448, 30.0 m, temperature: 230 80 25 MIN ISO g/MIN 170 3 MIN ISO 
350, gas: 0.90 bar H2, sample size: 1.0 μL, tR (major, exo) = 19.59 min, tR (minor, exo) = 
20.12 min, tR (major, endo) = 21.25 min, tR (minor, endo) = 22.63 min; e.r.endo = 95.5:4.5, e.r.exo = 
92:8, d.r. (endo/exo) = 9:1. 
 
The stereoselectivity for 3t was optimized by comparing catalysts and reactions conditions: 
 
entry catalyst temp. silyl group yield 
d.r. 
(endo:exo) 
e.r.endo e.r.exo 
1 4a −20°C TES (19% conv.)
a,b
 3.7:1 84:16 89:11 
2 4c −20°C TIPS (93% conv.)
b
 1.3:1 92.5:7.5 92:8 
3 4c −40°C TES (70% conv.)
c,d
 3.1:1 94.5:5.5 90:10 
4 4c −60°C TES 98%
d,e
 9:1 95.5:4.5 92:8 
aextensive cyclopentadiene polymerization was observed. b18 h reaction time. c12 h reaction time. dThe reaction was 
performed neat with 10 eq. of cyclopentadiene. e48 h reaction time. 
 
methyl (1R,2S,3S,4S)-3-ethylbicyclo[2.2.1]hept-5-ene-2-carboxylate (3u): Prepared according to 
procedure B with catalyst (S,S)-4a (4 μmol, 7.2 mg, 1 mol%), silyl ketene acetal 
5c (0.08 mmol, 20 μL, 20 mol%), methyl (E)-pent-2-enoate 1u (0.41 mmol, 
49 mg, E/Z 98:2) and cyclopentadiene (2 mmol, 180 μL) at −80 °C for 30 h. The 
product was obtained as a diastereomeric mixture after column chromatography 
(pentane/DCM 4:1→2:1) as a colorless oil (56 mg, 76%). The enantiomeric and 
diastereomeric ratios were determined by GC on a chiral stationary phase. 
1
H NMR (500 MHz, 
CDCl3) δ 6.24 (dd, J = 5.7, 3.1 Hz, 1H), 5.97 (dd, J = 5.7, 2.8 Hz, 1H), 3.61 (s, 3H), 3.09 (dp, J = 
5.1, 1.7 Hz, 1H), 2.60 (h, J = 1.6 Hz, 1H), 2.40 (dd, J = 4.5, 3.5 Hz, 1H), 1.64 (tdd, J = 7.6, 4.5, 1.7 
Hz, 1H), 1.57 – 1.39 (m, 4H), 0.96 (t, J = 7.4 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 175.4, 
138.7, 133.6, 51.6, 51.1, 46.6, 46.5, 45.9, 45.7, 28.9, 13.2; HRMS (EI) calculated for C11H16O2: 
180.1145; found 180.1146; [α]D
25
 = +75.5 (c 0.54, CHCl3); GC column: BGB 176/BGB 15 G 618, 
30.0 m, temperature: 230 100 40 MIN ISO 9/MIN 220 3 MIN ISO 350, gas: 0.50 bar H2, sample 
size: 1.0 μL, tR (minor, exo) = 24.70 min, tR (major, exo) = 27.41 min, tR (minor, endo) = 
27.90 min, tR (major, endo) = 28.34 min; e.r.endo = 95.5:4.5, e.r.exo = 97.5:2.5, d.r. (endo/exo) = 16:1. 
 
methyl (1R,2S,3S,4S)-3-(bromomethyl)bicyclo[2.2.1]hept-5-ene-2-carboxylate (3v): Prepared 
according to procedure B with catalyst (S,S)-4a (4 μmol, 7.2 mg, 1 mol%), silyl 
ketene acetal 5c (0.08 mmol, 20 μL, 20 mol%), methyl (E)-4-bromobut-2-enoate 
1v (0.40 mmol, 84 mg, E/Z 96:4, >80% purity, freshly distilled) and 
cyclopentadiene (2 mmol, 180 μL) at −80 °C for 30 h. NOTE: After full 
conversion, the reaction was treated with a mixture of hexane/triethylamine(5:1, 
50 μL) and a drop of water. The standard treatment resulted in product decomposition. The product 
was obtained as a diastereomeric mixture after column chromatography (hexane/DCM 4:1→2:1) as 
S-54 
 
a colorless oil (81 mg, 88%). The enantiomeric and diastereomeric ratios were determined by GC 
on a chiral stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 6.28 (dd, J = 5.7, 3.2 Hz, 1H), 6.04 (dd, 
J = 5.7, 2.8 Hz, 1H), 3.64 (s, 3H), 3.56 (dd, J = 9.9, 7.2 Hz, 1H), 3.40 (dd, J = 9.9, 8.8 Hz, 1H), 
3.21 – 3.18 (m, 1H), 2.86 (dt, J = 3.4, 1.7 Hz, 1H), 2.54 (dd, J = 4.7, 3.6 Hz, 1H), 2.26 (dddd, J = 
8.7, 7.1, 4.7, 1.4 Hz, 1H), 1.53 – 1.46 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 173.9, 138.3, 134.4, 
51.9, 51.0, 46.5, 46.5, 46.3, 46.2, 37.2; HRMS (ESI) calculated for C10H13O2BrNa (M+Na)
+
: 
266.9991; found 266.9994; [α]D
25
 = +36.1 (c 0.62, CHCl3); GC column: LIPODEX E G644, 25.0 
m, temperature: 230 110 45 MIN ISO 8/MIN 220 3 MIN ISO350, gas: 0.40 bar H2, sample size: 
1.0 μL, tR (minor, exo) = 24.35 min, tR (major, exo) = 25.52 min, tR (major, endo) = 30.81 min, tR 
(minor, endo) = 31.89 min; e.r.endo = 87:13, e.r.exo = 90:10, d.r. (endo/exo) = 48:1. 
 
The stereoselectivity for 3v with catalysts 4a and 4c was compared following procedure B: 
 
entry catalyst temp. silyl group yield 
d.r. 
(endo:exo) 
e.r.endo e.r.exo 
1 4a −80°C TES 98%
a
 48:1 87:13 90:10 
2 4c 
−80°C → 
−60°C 
TES (66% conv.)
b,c
 1.2:1 95:5 74:26 
a30 h reaction time. bThe reaction was performed neat with 10 eq. of cyclopentadiene. cThe reaction was set up at −80 °C, 
warmed up to −60 °C after 18 h due to insufficient conversion, and stopped after 5d at −60 °C. 
 
methyl (1R,2R,3S,4S)-3-methylbicyclo[2.2.1]hept-5-ene-2-carboxylate (3w): Prepared 
according to procedure C with catalyst (S,S)-4c (2 μmol, 3.7 mg, 0.5 mol%), silyl 
ketene acetal 5c (0.08 mmol, 20 μL, 20 mol%), methyl crotonate 1w (0.41 mmol, 
41.5 mg) and cyclopentadiene (4 mmol, 340 μL) at −80 °C for 18 h. The product 
was obtained as a diastereomeric mixture after column chromatography 
(hexane/DCM 4:1→2:1) as a colorless oil (52 mg, 78%). The enantiomeric and diastereomeric 
ratios were determined by GC on a chiral stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 6.26 (dd, 
J = 5.7, 3.2 Hz, 1H), 5.98 (dd, J = 5.7, 2.8 Hz, 1H), 3.61 (s, 3H), 3.10 (dh, J = 3.4, 1.6 Hz, 1H), 
2.46 (td, J = 3.3, 1.6 Hz, 1H), 2.36 (dd, J = 4.5, 3.5 Hz, 1H), 1.82 (qdd, J = 6.8, 4.5, 1.7 Hz, 1H), 
1.57 – 1.49 (m, 1H), 1.42 (dq, J = 8.7, 1.8 Hz, 1H), 1.17 (d, J = 7.0 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 175.3, 138.8, 133.4, 52.5, 51.6, 49.0, 46.1, 46.0, 38.0, 21.1; HRMS (EI) calculated for 
C10H14O2: 166.0988; found 166.0986; [α]D
25
 = +112.4 (c 0.64, CHCl3); GC column: BGB 
176/BGB 15 G 618, 30.0 m, temperature: 230 85 60 MIN ISO 9/MIN 220 3 MIN ISO 350, gas: 
0.50 bar H2, sample size: 1.0 μL, tR (minor, exo) = 28.93 min, tR (major, exo) = 31.23 min, tR 
(minor, endo) = 32.42 min, tR (major, endo) = 34.90 min; e.r.endo = 97:3, e.r.exo = 95:5, d.r. 
(endo/exo) = >50:1. 
 
The stereoselectivity for 3w was optimized by comparing catalysts and reactions conditions 
following procedure B: 
 
entry catalyst temp. silyl group yield 
d.r. 
(endo:exo) 
e.r.endo e.r.exo 
1 4a −80°C TES (full conv.)
a
 26:1 85.5:14.5 92.5:7.5 
2 4a −100°C TES (>95% conv.)
a
 38:1 88.5:12.5 93.75:6.25 
3 4c −80°C TIPS (18% conv.)
a
 5:1 96.5:3.5 95:5 
4 4c −100°C TIPS (<5%)
a
 n.d. n.d. n.d. 
5 4c −80°C TMS (>95% conv.)
a,b
 5:1 93.5:6.5 94.5:5.5 
6 4c −80°C TES (full conv.)
a,b
 21:1 97:3 95:5 
7 4c −80°C TBS (full conv.)
a,b
 26:1 95:5 94.5:5.5 
8 4c −80°C TIPS (59% conv.)
a,b
 6:1 96:4 95:5 
9 4c −80°C TES 78%
b,c
 >50:1 97:3 95:5 
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a24 h reaction time. bThe reaction was performed neat with 10 eq. of cyclopentadiene. c18 h reaction time and 0.5 mol% 
of 4d.  
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methyl (1S,6S)-3,4,6-trimethylcyclohex-3-ene-1-carboxylate (3x): Prepared according to 
procedure D with catalyst (S,S)-4d (6 µmol, 13.9 mg, 3 mol%), 
triisopropylmethallylsilane 5d (0.1 mmol, 23.4 µL, 50 mol%), methyl (E)-
cinnamate 1a (0.2 mmol, 32.4 mg) and 2,3-dimethyl-1,3-butadiene 2b (1 
mmol, 113 µL, 5 equiv.) at 0 °C for 5.5 days. Purification by column 
chromatography on silica gel (hexane→hexane/EtOAc 19:1) afforded the title compound as a 
colorless oil (26.8 mg, 0.11 mmol, 55% yield). The enantiomeric ratio was determined by HPLC on 
a chiral stationary phase. 
1
H NMR (500 MHz, CDCl3) δ 7.29–7.26 (m, 2H), 7.23–7.15 (m, 3H), 
3.39 (s, 3H), 3.02 (ddd, J = 11.6, 9.8, 6.8 Hz, 1H), 2.86 (ddd, J = 11.5, 10.7, 5.2 Hz, 1H), 2.46–2.38 
(m, 1H), 2.25–2.21 (m, 1H), 2.21–2.15 (m, 2H), 1.69–1.66 (m, 3H), 1.66–1.63 (m, 3H); 13C NMR 
(126 MHz, CDCl3) δ 175.8, 144.2, 128.5, 127.5, 126.6, 125.4, 123.8, 51.4, 47.0, 43.7, 40.2, 35.6, 
18.8, 18.7; HRMS (EI) calculated for C16H20O2: 244.1458; found: 244.1457; [α]D
25
 = +77.4 
(c 0.78, CHCl3); HPLC Daicel Chiralcel OD-3R, MeOH/H2O = 80:20, 1 mL/min, 25 °C, 220 nm, 
tR (major) = 10.7 min, tR (minor) = 12.2 min; e.r. = 96:4. 
 
methyl (1S,6S)-3,4-dimethyl-6-phenethylcyclohex-3-ene-1-carboxylate (3y): Prepared 
according to procedure E with catalyst (S,S)-4d (6 µmol, 13.9 mg, 3 mol%), 
triisopropyl(2-methallyl)silane 5d (0.1 mmol, 23 µL, 50 mol%), methyl 
(E)-5-phenylpent-2-enoate 1p (0.2 mmol, 38.0 mg) and 2,3-dimethyl-1,3-
butadiene 2b (0.8 mmol, 91 µL, 4 equiv.) at −20 °C for 3.5 days. 
Purification by column chromatography on silica gel (hexane → hexane/ 
EtOAc 19:1) afforded the title compound as a colorless oil (44.8 mg, 
0.17 mmol, 82% yield). The enantiomeric ratio was determined by HPLC on a chiral stationary 
phase. 
1
H NMR (500 MHz, CDCl3) δ 7.30–7.26 (m, 2H), 7.22–7.14 (m, 3H), 3.67 (s, 3H), 2.73 
(ddd, J = 13.6, 11.0, 5.1 Hz, 1H), 2.53 (ddd, J = 13.7, 10.9, 6.0 Hz, 1H), 2.39 (td, J = 10.3, 5.2 Hz, 
1H), 2.32–2.25 (m, 1H), 2.18 (dd, J = 17.1, 5.3 Hz, 1H), 2.10 (dd, J = 17.0, 5.2 Hz, 1H), 1.96–1.88 
(m, 1H), 1.83–1.77 (m, 1H), 1.73 (dddd, J = 13.4, 11.0, 6.0, 3.8 Hz, 1H), 1.63 (s, 3H), 1.62 (s, 3H), 
1.47 (dddd, J = 13.4, 10.9, 9.1, 5.1 Hz, 1H); 
13
C NMR (126 MHz, CDCl3) δ 176.7, 142.6, 128.4, 
128.4, 125.8, 124.6, 123.7, 51.6, 46.5, 36.9, 36.2, 35.9, 35.0, 33.0, 19.1, 18.7; HRMS (EI) 
calculated for C18H24O2: 272.1771; found: 272.1771; [α]D
25
 = +82.0 (c 0.49, CHCl3); HPLC Daicel 
Chiralcel IC-3R, MeOH/H2O = 80:20, 1 mL/min, 25 °C, 220 nm, tR (major) = 12.1 min, tR (minor) 
= 14.3 min; e.r. = 92:8.  
 
methyl (1S,2S)-5-methyl-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate (3z): Prepared 
according to procedure D with catalyst (S,S)-4d (6 µmol, 13.9 mg, 
3 mol%), triisopropyl(2-methallyl)silane 5d (0.1 mmol, 23 µL, 50 mol%), 
methyl (E)-cinnamate 1a (0.2 mmol, 32.7 mg) and isoprene 2c (1 mmol, 
100 µL, 5 equiv.) at 0 °C for 5.5 days. Purification by column 
chromatography on silica gel (hexane → hexane/EtOAc 19:1) afforded the title compound as a 
colorless oil (32.4 mg, 0.14 mmol, 71% yield). The enantiomeric ratio was determined by HPLC on 
a chiral stationary phase. The regioisomeric ratio was determined by 
1
H NMR spectroscopy. 
1
H 
NMR (500 MHz, CDCl3) δ 7.32–7.24 (m, 2H), 7.24–7.15 (m, 3H), 5.45 (ddq, J = 5.9, 3.3, 1.6 Hz, 
1H), 3.39 (s, 3H), 3.07 (ddd, J = 11.2, 9.1, 7.3 Hz, 1H), 2.81 (ddd, J = 11.1, 10.3, 5.6 Hz, 1H), 
2.45–2.37 (m, 1H), 2.33 (dddd, J = 15.6, 6.9, 3.6, 1.7 Hz, 1H), 2.20 (d, J = 8.0 Hz, 2H), 1.70 (dt, J 
= 2.7, 1.3 Hz, 3H).
13
C NMR (126 MHz, CDCl3) δ 175.9, 144.2, 133.8, 128.5, 127.5, 126.6, 119.0, 
51.4, 46.2, 43.3, 38.4, 29.5, 23.3; HRMS (EI) calculated for C15H18O2: 230.1301; found: 230.1303; 
[α]D
25
 = +74.1 (c 0.95, CHCl3); HPLC Daicel Chiralcel OD-3R, MeOH/H2O = 75:25, 1 mL/min, 
25 °C, 220 nm, tR (major) = 13.7 min, tR (minor) = 15.4 min; e.r. = 98:2; r.r. (para/meta) > 50:1.  
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methyl (1S,6S)-4-methyl-6-phenethylcyclohex-3-ene-1-carboxylate (3aa): Prepared according to 
procedure E with catalyst (S,S)-4d (6 µmol, 13.9 mg, 3 mol%), 
triisopropyl(2-methallyl)silane 5d (0.1 mmol, 23 µL, 50 mol%), methyl 
(E)-5-phenylpent-2-enoate 1p (0.2 mmol, 38.0 mg) and isoprene 2c 
(0.8 mmol, 80 µL, 4 equiv.) at −20 °C for 3.5 days. Purification by column 
chromatography on silica gel (iso-hexane → iso-hexane/ethyl acetate 19:1) 
afforded the title compound as a colorless oil (51.6 mg, 0.20 mmol, 
99% yield). The enantiomeric ratio was determined by HPLC on a chiral stationary phase. The 
regioisomeric ratio was determined by 
1
H NMR spectroscopy.
 1
H NMR (500 MHz, CDCl3) δ 7.33–
7.26 (m, 2H), 7.22–7.13 (m, 3H), 5.37 (ddq, J = 4.1, 2.9, 1.5 Hz, 1H), 3.68 (s, 3H), 2.74 (ddd, J = 
13.6, 11.0, 5.1 Hz, 1H), 2.55 (ddd, J = 13.6, 10.8, 6.0 Hz, 1H), 2.36 (td, J = 9.7, 5.3 Hz, 1H), 2.32–
2.25 (m, 1H), 2.24–2.15 (m, 2H), 1.98 (qdd, J = 9.6, 5.4, 3.9 Hz, 1H), 1.80–1.71 (m, 2H), 1.70–
1.65 (m, 3H), 1.50 (dddd, J = 13.4, 10.9, 9.1, 5.1 Hz, 1H); 
13
C NMR (126 MHz, CDCl3) δ 176.7, 
142.5, 133.0, 128.5, 128.4, 125.9, 118.9, 51.6, 45.5, 36.2, 35.5, 35.1, 32.9, 28.7, 23.6; HRMS (EI) 
calculated for C17H22O2: 258.1614; found: 258.1616; [α]D
25
 = +86.1 (c 0.60, CHCl3); HPLC Daicel 
Chiralcel IC-3R, MeOH/H2O = 70:30, 1 mL/min, 25 °C, 220 nm, tR (major) = 31.8 min, tR (minor) 
= 36.2 min; e.r. = 97:3; r.r. (para/meta) > 50:1. 
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Scale-Up Experiments 
 
Following a modified procedure C, a 15 mL vial was charged with (E)-methyl cinnamate (1a, 
8 mmol, 1.3 g), (S,S)-4a (8 μmol, 14.3 mg, 0.1 mol%) and a magnetic stirrer bar. The vial was 
sealed with a screw-cap containing a PTFE/rubber septum and was either evacuated by purged with 
argon (3 ×) or left under air. After addition of triethylallylsilane 5a (320 μmol, 20 mol%) at r.t., the 
vial was cooled in a cryostat at −40 °C under stirring for 10 min. Then, neat cyclopentadiene 
(80 mmol, 6.6 mL) was added via a syringe, the cap sealed with parafilm. After 48 h, TLC 
indicated full conversion. Work-up and purification was performed as described before. In case of 
entry 3, a flame-dried Schlenk flask under argon was used in combination with 5 mol% 
triethylallylsilane 5a (80 μL). 
 
 
 
entry container atmosphere loading 5a yield (%) e.r.endo 
d.r. 
(endo/exo) 
1 vial argon 20 mol% 97 96.25:3.75 21:1 
2 vial air 20 mol% 99 96:4 22:1 
3 Schlenk argon 5 mol% 94 96:4 21:1 
 
Following a modified procedure A, a 15 mL vial was charged with methyl (E)-3-(4-
bromophenyl)acrylate (1e, 8 mmol, 48.5 mg), (S,S)-4b (8 μmol, 15.1 mg, 0.1 mol%) and a 
magnetic stirrer bar. The vial was sealed with a screw-cap containing a PTFE/rubber septum and 
was either evacuated by purged with argon (3 ×). Dry toluene (4 mL) and triethylallylsilane 5a 
(320 μmol, 20 mol%) were added at r.t. and the reaction was cooled to −40 °C. Then, neat 
cyclopentadiene (40 mmol, 3.3 mL) was added via a syringe, the cap sealed with parafilm. After 
7 days, TLC indicated full conversion. Work-up and purification was performed as described 
before. Product 3e was isolated in 92% yield (2.70 g, e.r.endo = 95:5, d.r. [endo/exo] = 21:1). 
 
 
 
NOTE: Attempts to perform this example under neat conditions at −40 °C or −20 °C resulted in 
extensive polymerization of cyclopentadiene and consequently very low conversion, presumably 
due to the very low solubility of 1e in cyclopentadiene. 
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Following a modified procedure C, a 15 mL vial was charged with methyl (E)-3-(4-
methoxyphenyl)acrylate (1k, 8 mmol, 1.54 g), (S,S)-4a (8 μmol, 14.3 mg, 0.1 mol%) and a 
magnetic stirrer bar. The vial was sealed with a screw-cap containing a PTFE/rubber septum and 
was either evacuated by purged with argon (3 ×). After addition of triethylallylsilane 5a (320 μmol, 
20 mol%) at r.t., the vial was cooled in a cryostat at −20 °C under stirring for 10 min. Then, neat 
cyclopentadiene (80 mmol, 6.6 mL) was added via a syringe, the cap sealed with parafilm. After 
6 days, TLC indicated full conversion. Work-up and purification was performed as described 
before. Product 3k was isolated in 94% yield (1.94 g, e.r.endo = 94.5:5.5, d.r. [endo/exo] = 18:1). 
 
 
 
Following a modified procedure C, a 15 mL vial was charged with S,S)-4c (8 μmol, 14.9 mg, 
0.1 mol%) and a magnetic stirrer bar. The vial was sealed with a screw-cap containing a 
PTFE/rubber septum and was either evacuated by purged with argon (3 ×). The vial was cooled in a 
cryostat at −60 °C. Then, neat cyclopentadiene (24 mmol, 2.0 mL) was added via a syringe 
followed by silyl ketene acetal 5c (400 μL, 20 mol%) and methyl crotonate 1w (8 mmol, 0.87 mL) 
in this order. The cap was sealed with parafilm and the reaction mixture was stirred at −60 °C for 
18 days, after which 
1
H NMR analysis indicated full conversion. Work-up and purification was 
performed as described before. Product 3w was isolated in 86% yield (1.44 g, e.r.endo = 95:5, d.r. 
[endo/exo] = 16:1). 
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Computational Studies 
 
Computational Details 
All calculations presented in this paper were carried out with the development version of the 
ORCA suite of programs base on version 4.0.
10 
All molecular geometries were optimized in the 
gas-phase using the PBE functional
11
 in conjunction with the D3 version of Grimme's dispersion 
correction with Becke-Johnson damping function,
12 
using the resolution of identity approximation. 
The def2-SVP basis set was used for all atoms with matching auxiliary basis.
13
 In all cases, a fine 
integration grid (grid7) was used. Analytic frequency calculations were performed to verify the 
nature of all stationary points (minima and transition states) and to calculate free energies and 
enthalpies at 233 K by using the rigid-rotor harmonic oscillator (RRHO) approximation, as 
implemented in ORCA, combined with B3LYP-D3(BJ)/def2-TZVP single-point energies.
14
 Single-
point energies taking into account solvation effects (toluene) were also carried out via the 
conductor like polarizable continuum model (C-PCM)
15
 at B3LYP-D3(BJ)/def2-TZVP level. The 
gas phase electronic energies were also refined using single-point DLPNO-CCSD(T)/def2-TZVP
16
 
calculations with NormalPNO settings and tighten TCutPairs threshold (10
-5
). Solvation, entropy 
and thermal corrections were kept at DFT level. This protocol is denoted as (DLPNO-CCSD(T) + 
C-PCM(toluene))//PBE-D3(BJ)/def2-SVP. 
 
Conformational sampling 
Due to the conformational flexibility of the substrate and the catalyst, two different strategies were 
used to localize the most stable transition states (TS) for both enantiomers. First, the conformers of 
the silylated methyl cinnamate 1a (Figure S6) together with different conformers of the (S,S)-4a 
counteranion (18 different conformers located by scanning the rotation of the SO2CF3 and 3,5-
trifluoromethylphenyl substituents) were used to explore several structures for the chiral ion pair 
(CIP). Although, this particular type of catalyst has a highly delocalized negative charge, the 
electrostatic potential map (see Fig. 4 in the manuscript) evidenced that the negative region is 
confined into a chiral pocket adopted by the anion. Consequently, the electrostatic interaction with 
the cationic substrate can be highly directional. In total, 9 CIP were found and used as a starting 
point for the endo-attack of cyclopentadiene on both faces of the silylated-1a. 16 different 
transition states were located: 9 for the favoured and 7 for the disfavoured enantiomer. 
 
 
Figure S6. Conformational possibilities for the silylated methyl cinnamate silylated-1a: the 
carbonyl group can be placed either s-trans or s-cis to the olefin, while the silyl group is bonded 
syn or anti to the ester fragment. The anti s-trans conformation is often most stable.
17
 
 
The two lowest-lying TS leading to both enantiomers of the endo-cycloadduct have s-trans 
conformation of silylated-1a (Figure S7). Both transition states originate from the same CIP and 
have different non-classical C-H···O and C-H···F hydrogen bonds assisting the cyclopentadiene 
addition. As visualized in Fig S7, the TSs-trans structure leading to the favoured enantiomer has two 
stabilizing C-H···O hydrogen bonds between an oxygen atom of the SO2CF3 group of the catalyst 
and the C-H groups of the cyclopentadiene (2.506 Å and 2.651 Å), that are lacked in the other TS. 
Thus, these interactions allow the discrimination of both TSs, guiding to the high 
enantioselectivity.  
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Figure S7. Close-up of the non-classical C-H···O (dotted red lines) and C-H···F (dotted green 
lines) hydrogen bonds assisting the cyclopentadiene attack for both enantiodetermining TS 
structures. Distances shorter than 3 Å are shown. 
 
Cartesian coordinates and electronic energies 
 
Cartesian coordinates (in Å) and electronic energies (in a. u.) of all the stationary points discussed 
in the text. Calculations reported at PBE-D3(BJ)/def2-SVP level. 
 
1a (methyl cinnamate) 
 
E = -536.508893432386  
  
 C      3.167405   -2.240044    0.596801 
 C      1.981376   -1.605171    0.411591 
 C      1.843926   -0.192442    0.004229 
 O      0.773230    0.371700   -0.162589 
 H      1.013776   -2.109466    0.554478 
 H      4.083181   -1.648838    0.428754 
 O      3.045638    0.428984   -0.173839 
 C      2.964095    1.798471   -0.571692 
 H      2.424154    2.402321    0.186271 
 H      4.005626    2.152713   -0.673705 
 H      2.425539    1.902030   -1.536002 
 C      3.372916   -3.632402    0.997605 
 C      4.697031   -4.113447    1.138768 
 C      2.305867   -4.529262    1.252985 
 C      4.949780   -5.437448    1.519809 
 H      5.535935   -3.427079    0.943362 
 C      2.557912   -5.850591    1.633261 
 H      1.266415   -4.183954    1.151328 
 C      3.880339   -6.311482    1.768626 
 H      5.987215   -5.789774    1.623366 
 H      1.715883   -6.532261    1.827227 
 H      4.074148   -7.352569    2.068202 
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Cyclopentadiene 
 
E = -193.710286707175  
 
 C      0.448150   -0.593955   -0.134747 
 C      1.810381   -0.544452   -0.134769 
 C      2.244175    0.858213   -0.134861 
 C      1.147724    1.668099   -0.134886 
 H     -0.179379   -1.495363   -0.134688 
 H      2.490591   -1.408233   -0.134730 
 H      3.293261    1.187182   -0.134898 
 H      1.138630    2.766391   -0.134948 
 C     -0.087365    0.810865   -0.134813 
 H     -0.735921    1.011391   -1.019477 
 H     -0.735864    1.011480    0.749872 
 
Catalyst [Si-X*] 
 
E = -8593.59563547091  
 
 P      0.960999   -1.153585   -0.218729 
 O      2.458345   -0.776130    0.366389 
 O      0.583893   -2.472576    0.715302 
 C      3.375817   -1.743024    0.750989 
 C      4.535292   -1.916061   -0.064318 
 C      5.486628   -2.832886    0.362922 
 C      5.301909   -3.618123    1.533549 
 C      6.274197   -4.582263    1.931894 
 C      6.065303   -5.392145    3.036687 
 C      4.859477   -5.277100    3.776507 
 C      3.898746   -4.340146    3.422743 
 C      4.097982   -3.465583    2.314043 
 C      3.141968   -2.459398    1.923828 
 C      1.905467   -2.202303    2.712819 
 C      1.951955   -1.856939    4.112918 
 C      3.175318   -1.604085    4.803244 
 C      3.180796   -1.281385    6.153111 
 C      1.966669   -1.217223    6.886564 
 C      0.759661   -1.434582    6.240498 
 C      0.716471   -1.725455    4.844990 
 C     -0.521905   -1.902372    4.170273 
 C     -0.581243   -2.179291    2.807902 
 C      0.653748   -2.286936    2.093911 
 C      4.680057   -1.183472   -1.344010 
 H      6.406311   -2.968982   -0.226017 
 H      7.191815   -4.678589    1.331211 
 H      6.822275   -6.134549    3.330658 
 H      4.680038   -5.941988    4.634738 
 H      2.965805   -4.273308    3.998277 
 H      4.121223   -1.659438    4.251449 
 H      4.137798   -1.083453    6.658928 
 H      1.986759   -0.990129    7.963326 
S-63 
 
 H     -0.191344   -1.374921    6.789627 
 H     -1.455085   -1.838636    4.750690 
 C     -1.890134   -2.462489    2.163660 
 C      4.391989    0.189173   -1.438837 
 C      4.510261    0.860259   -2.664708 
 C      4.924778    0.179613   -3.814654 
 C      5.194152   -1.196663   -3.729957 
 C      5.071476   -1.873466   -2.511608 
 C     -3.008529   -1.639854    2.417661 
 C     -4.276880   -2.003065    1.941493 
 C     -4.455022   -3.194798    1.218381 
 C     -3.345523   -4.006435    0.950750 
 C     -2.068461   -3.634904    1.400626 
 H      4.060556    0.741526   -0.552676 
 H      5.016957    0.711339   -4.771158 
 H      5.229621   -2.959100   -2.474662 
 H     -2.881220   -0.710340    2.989636 
 H     -5.449837   -3.487915    0.859692 
 H     -1.208242   -4.285860    1.193021 
 N      0.097042    0.092469    0.260552 
 P     -0.829657    1.271438   -0.144636 
 O     -0.580860    2.608007    0.787425 
 O     -2.356150    0.830150    0.282293 
 C     -0.654460    2.370508    2.164071 
 C      0.572597    2.258013    2.887748 
 C      0.485381    1.943248    4.240119 
 C     -0.765588    1.728497    4.881345 
 C     -0.829586    1.405488    6.268817 
 C     -2.043286    1.142835    6.884291 
 C     -3.243375    1.189434    6.127426 
 C     -3.220019    1.538770    4.784267 
 C     -1.990408    1.839792    4.126448 
 C     -1.917824    2.216850    2.735632 
 C     -3.136309    2.435766    1.903691 
 C     -4.135678    3.401562    2.289333 
 C     -3.973105    4.278611    3.402245 
 C     -4.963921    5.186647    3.747281 
 C     -6.167684    5.264243    2.999022 
 C     -6.345132    4.447124    1.894277 
 C     -5.338694    3.515848    1.502214 
 C     -5.492762    2.716887    0.337459 
 C     -4.502398    1.841085   -0.090123 
 C     -3.325096    1.731731    0.711294 
 C      1.885418    2.520886    2.243025 
 H      1.405628    1.865143    4.838750 
 H      0.111644    1.353710    6.835136 
 H     -2.078451    0.889590    7.954650 
 H     -4.204055    0.953731    6.609338 
 H     -4.156389    1.576052    4.215002 
 H     -3.043720    4.238664    3.985828 
 H     -4.811100    5.856800    4.606543 
 H     -6.948998    5.982707    3.288374 
S-64 
 
 H     -7.263228    4.512271    1.290290 
 H     -6.423917    2.800476   -0.243295 
 C     -4.675450    1.057798   -1.339522 
 C      2.073608    3.665647    1.442464 
 C      3.336343    3.966591    0.907898 
 C      4.427391    3.123748    1.152078 
 C      4.246066    1.978815    1.946807 
 C      2.988520    1.674327    2.487343 
 C     -5.130519    1.699282   -2.512637 
 C     -5.358112    0.965031   -3.683781 
 C     -5.148378   -0.423894   -3.710643 
 C     -4.665132   -1.055988   -2.559861 
 C     -4.420559   -0.325576   -1.385938 
 H      1.232596    4.347117    1.259430 
 H      5.411097    3.358310    0.724783 
 H      2.856643    0.765751    3.091381 
 H     -5.272658    2.788077   -2.514715 
 H     -5.320911   -1.000715   -4.629075 
 H     -4.028743   -0.841933   -0.501040 
 N      0.854198   -1.482464   -1.775686 
 N     -0.709511    1.800484   -1.685680 
 S      1.570587   -2.762279   -2.500459 
 O      1.982973   -2.392837   -3.867497 
 O      2.499871   -3.509621   -1.618159 
 S     -1.408206    3.042324   -2.336712 
 O     -1.442469    2.776837   -3.877576 
 O     -2.678859    3.572746   -1.822495 
 C     -0.185219    4.497751   -2.309296 
 C      0.084339   -3.913509   -2.715387 
 F      0.060166    4.811809   -1.036532 
 F      0.938843    4.157465   -2.930487 
 F     -0.757125    5.529011   -2.930925 
 F     -0.535481   -4.086301   -1.539035 
 F      0.515044   -5.096393   -3.165684 
 F     -0.782408   -3.396430   -3.599354 
 C      5.456834    1.123419    2.246431 
 C      3.509783    5.234484    0.097508 
 C      4.156439    2.324505   -2.699343 
 C      5.554345   -1.939910   -4.994875 
 F      6.167651    0.855366    1.122976 
 F      5.124873   -0.063928    2.807646 
 F      6.297792    1.751187    3.103652 
 F      2.943023    6.290446    0.734563 
 F      2.916395    5.151979   -1.118351 
 F      4.811276    5.529245   -0.107079 
 F      5.079852    3.086427   -2.053581 
 F      2.968338    2.541680   -2.073611 
 F      4.051255    2.808288   -3.958829 
 F      6.605110   -1.348376   -5.622626 
 F      5.893691   -3.225840   -4.757446 
 F      4.525959   -1.942103   -5.875789 
 C     -3.517957   -5.324570    0.221152 
S-65 
 
 C     -5.496642   -1.163381    2.242254 
 C     -4.356264   -2.534332   -2.557889 
 C     -5.742088    1.662053   -4.966677 
 F     -6.130398    2.938594   -4.765014 
 F     -4.685541    1.693632   -5.831812 
 F     -6.744250    1.017430   -5.606310 
 F     -5.227462   -3.225653   -1.776527 
 F     -4.418625   -3.077217   -3.795755 
 F     -3.114888   -2.756025   -2.068326 
 F     -5.172477    0.076660    2.690550 
 F     -6.272067   -0.998616    1.140533 
 F     -6.275027   -1.738578    3.189125 
 F     -2.994396   -5.299506   -1.024267 
 F     -4.821886   -5.666328    0.107287 
 F     -2.889929   -6.322961    0.891602 
 Si    -0.759352    1.392062   -4.852283 
 C     -1.647022   -0.162653   -4.286425 
 H     -2.540062    0.156444   -3.710948 
 H     -0.984306   -0.684976   -3.564362 
 C     -1.281334    2.037692   -6.540429 
 H     -2.387951    2.129365   -6.532592 
 H     -1.049037    1.244204   -7.284325 
 C      1.099560    1.333158   -4.629228 
 H      1.323213    1.009218   -3.592211 
 H      1.537719    2.343736   -4.755993 
 C      1.691800    0.334067   -5.640994 
 H      2.793223    0.275661   -5.550066 
 H      1.327691   -0.695864   -5.457373 
 H      1.461526    0.613737   -6.690323 
 C     -2.058774   -1.095614   -5.436201 
 H     -2.549791   -2.009715   -5.051078 
 H     -2.768408   -0.599505   -6.129626 
 H     -1.183021   -1.428909   -6.029796 
 C     -0.619062    3.366932   -6.929831 
 H     -0.973144    3.728257   -7.916696 
 H     -0.841191    4.160157   -6.186930 
 H      0.484837    3.273205   -6.990262 
 
CIP (s-trans) 
 
E = -9130.13585176186  
 
  P      0.953790   -0.466206   -0.632019 
  O      2.438547   -0.291037    0.072043 
  O      0.534429   -1.990269   -0.104793 
  C      3.335325   -1.350123    0.045352 
  C      4.435593   -1.283402   -0.862139 
  C      5.332463   -2.343742   -0.856387 
  C      5.161869   -3.467388   -0.000530 
  C      6.079222   -4.558947   -0.026588 
  C      5.887256   -5.672636    0.775826 
  C      4.756887   -5.740664    1.631771 
S-66 
 
  C      3.850021   -4.691743    1.689317 
  C      4.031032   -3.521605    0.895438 
  C      3.119495   -2.407910    0.923994 
  C      1.925846   -2.377332    1.814361 
  C      2.038091   -2.442258    3.247827 
  C      3.297514   -2.395406    3.915409 
  C      3.369346   -2.417632    5.300878 
  C      2.188505   -2.519054    6.083391 
  C      0.948227   -2.558290    5.463899 
  C      0.836000   -2.491231    4.043612 
  C     -0.432915   -2.475252    3.400615 
  C     -0.553105   -2.355220    2.019094 
  C      0.651282   -2.248843    1.254498 
  C      4.565428   -0.133446   -1.787681 
  H      6.200989   -2.320140   -1.532141 
  H      6.941841   -4.502318   -0.708441 
  H      6.601472   -6.508955    0.742320 
  H      4.594388   -6.635280    2.251710 
  H      2.974093   -4.760481    2.348726 
  H      4.214334   -2.309570    3.317263 
  H      4.350675   -2.352030    5.793714 
  H      2.260219   -2.559081    7.180781 
  H      0.024781   -2.629145    6.058007 
  H     -1.339783   -2.569413    4.017176 
  C     -1.887003   -2.438614    1.367156 
  C      4.356689    1.181497   -1.328481 
  C      4.400018    2.262513   -2.218312 
  C      4.701208    2.063386   -3.571208 
  C      4.926855    0.756604   -4.032115 
  C      4.845068   -0.336088   -3.154804 
  C     -2.988036   -1.727716    1.883363 
  C     -4.274732   -1.929877    1.354049 
  C     -4.483252   -2.835176    0.304980 
  C     -3.387365   -3.535631   -0.222362 
  C     -2.099062   -3.331614    0.292262 
  H      4.128377    1.360294   -0.270484 
  H      4.731183    2.914783   -4.262756 
  H      4.936062   -1.360025   -3.541561 
  H     -2.837606   -1.012855    2.705516 
  H     -5.489340   -2.990768   -0.103012 
  H     -1.250900   -3.890926   -0.124737 
  N      0.074164    0.629742    0.074132 
  P     -0.741223    1.969700   -0.113011 
  O     -0.500846    2.943549    1.206246 
  O     -2.324543    1.490833    0.101919 
  C     -0.698060    2.328355    2.438069 
  C      0.454280    1.929501    3.186091 
  C      0.238927    1.215784    4.361572 
  C     -1.068564    0.879401    4.807824 
  C     -1.268858    0.107505    5.990246 
  C     -2.542629   -0.267205    6.390274 
  C     -3.669713    0.126106    5.621382 
S-67 
 
  C     -3.511940    0.913666    4.489580 
  C     -2.216241    1.320855    4.054064 
  C     -2.007662    2.102651    2.861548 
  C     -3.145325    2.632177    2.059822 
  C     -4.118864    3.521735    2.641030 
  C     -3.991862    4.042919    3.962701 
  C     -4.947323    4.901057    4.488163 
  C     -6.078134    5.281983    3.719628 
  C     -6.220865    4.810046    2.424150 
  C     -5.251686    3.936099    1.850911 
  C     -5.379048    3.468231    0.513116 
  C     -4.417553    2.655495   -0.066068 
  C     -3.282389    2.282440    0.715309 
  C      1.829904    2.316069    2.780704 
  H      1.099809    0.906744    4.973644 
  H     -0.384324   -0.195613    6.570012 
  H     -2.682357   -0.872497    7.298742 
  H     -4.678205   -0.196633    5.919320 
  H     -4.389417    1.209410    3.900811 
  H     -3.115132    3.767000    4.564319 
  H     -4.822051    5.295313    5.507929 
  H     -6.830886    5.960183    4.148636 
  H     -7.083540    5.111434    1.809913 
  H     -6.262700    3.761957   -0.073839 
  C     -4.577695    2.139989   -1.453960 
  C      2.116151    3.632692    2.358280 
  C      3.440148    4.037887    2.135144 
  C      4.498651    3.132559    2.294033 
  C      4.218615    1.815484    2.686985 
  C      2.896826    1.406063    2.926482 
  C     -4.502117    3.001261   -2.567382 
  C     -4.671058    2.490430   -3.863168 
  C     -4.935874    1.127211   -4.070126 
  C     -4.998586    0.269846   -2.964843 
  C     -4.816144    0.769194   -1.664502 
  H      1.298834    4.355957    2.235341 
  H      5.532561    3.455609    2.121889 
  H      2.690290    0.370174    3.232384 
  H     -4.258796    4.060490   -2.413064 
  H     -5.070414    0.731566   -5.085703 
  H     -4.859429    0.091860   -0.801064 
  N      0.958025   -0.492981   -2.229455 
  N     -0.449358    2.800952   -1.450698 
  S      1.320082   -1.656487   -3.279211 
  O      1.083084   -1.113169   -4.639601 
  O      2.555369   -2.421427   -3.002648 
  S     -1.198521    4.175969   -1.880458 
  O     -1.397636    4.200215   -3.348503 
  O     -2.326467    4.564438   -0.992954 
  C      0.124668    5.480617   -1.532711 
  C     -0.084963   -2.934581   -3.072288 
  F      0.554826    5.359529   -0.270902 
S-68 
 
  F      1.159066    5.353272   -2.372267 
  F     -0.425323    6.690547   -1.697733 
  F      0.257820   -3.887263   -2.199021 
  F     -0.329521   -3.508415   -4.262290 
  F     -1.205703   -2.323014   -2.648404 
  C      5.343546    0.825418    2.874939 
  C      3.718305    5.488754    1.799501 
  C      4.070551    3.632667   -1.678784 
  C      5.273193    0.518630   -5.482105 
  F      6.558745    1.412083    2.823544 
  F      5.327926   -0.143882    1.916858 
  F      5.248357    0.185576    4.068799 
  F      3.261798    6.298540    2.790546 
  F      3.102979    5.881509    0.662388 
  F      5.040656    5.732391    1.656765 
  F      5.027203    4.069944   -0.815623 
  F      2.903724    3.600372   -0.989877 
  F      3.953893    4.559025   -2.655128 
  F      6.609749    0.383038   -5.662321 
  F      4.694752   -0.610408   -5.960939 
  F      4.871142    1.548566   -6.275222 
  C     -3.618174   -4.605616   -1.267558 
  C     -5.443862   -1.173889    1.941068 
  C     -5.177654   -1.215066   -3.152714 
  C     -4.459618    3.371836   -5.071534 
  F     -4.514079    4.681633   -4.779617 
  F     -3.237998    3.124864   -5.635114 
  F     -5.377861    3.119001   -6.039448 
  F     -6.148722   -1.715370   -2.352491 
  F     -5.482509   -1.550441   -4.427980 
  F     -4.027805   -1.882680   -2.836149 
  F     -5.527515   -1.343969    3.282929 
  F     -5.328338    0.168335    1.724803 
  F     -6.623783   -1.557413    1.406599 
  F     -3.592713   -5.839898   -0.705495 
  F     -2.667985   -4.602409   -2.237579 
  F     -4.817188   -4.474093   -1.884823 
  C     -1.521960   -0.067702   -5.543297 
  H     -1.473223   -1.085878   -7.462713 
  O     -2.046453   -0.100212   -4.351374 
  O     -0.797169    0.935559   -5.851610 
  C     -1.640928    0.911169   -3.387854 
  H     -0.564481    0.787717   -3.177625 
  H     -2.235994    0.689419   -2.489133 
  H     -1.850933    1.921746   -3.776959 
  Si     0.297774    1.635333   -7.072209 
  C      0.622874    3.299514   -6.271321 
  H     -0.360985    3.749006   -6.013700 
  H      1.076527    3.963367   -7.041202 
  C      1.807754    0.528670   -7.161570 
  H      2.171166    0.418425   -6.119493 
  H      2.582841    1.124739   -7.694140 
S-69 
 
  C     -0.705936    1.704544   -8.670264 
  H     -0.755706    0.679548   -9.100199 
  H     -0.076518    2.280933   -9.386393 
  C      1.510863    3.222889   -5.018777 
  H      1.046921    2.604020   -4.225287 
  H      1.675853    4.224892   -4.579823 
  H      2.501427    2.783982   -5.249565 
  C      1.651382   -0.861867   -7.787353 
  H      2.634621   -1.370837   -7.844748 
  H      1.232963   -0.827739   -8.815339 
  H      1.003179   -1.502974   -7.158008 
  C     -2.107065    2.322660   -8.565299 
  H     -2.599522    2.385781   -9.556876 
  H     -2.077512    3.345871   -8.141138 
  H     -2.769874    1.729713   -7.903828 
  H     -2.785885   -2.235117   -4.886893 
  C     -2.879327   -3.468214   -6.658040 
  C     -3.506630   -4.500022   -5.913168 
  C     -2.635933   -3.672344   -8.040025 
  C     -3.877099   -5.698903   -6.531504 
  H     -3.687190   -4.349675   -4.837815 
  C     -3.009566   -4.869855   -8.653480 
  H     -2.150212   -2.884236   -8.634582 
  C     -3.630846   -5.885491   -7.901490 
  H     -4.359126   -6.493338   -5.942777 
  H     -2.817045   -5.020112   -9.726232 
  H     -3.922263   -6.827852   -8.389641 
  C     -1.842160   -1.163882   -6.430919 
  C     -2.510768   -2.256397   -5.952276 
 
RC (s-trans, major) 
 
E = -9323.86539073144 
 
  P      0.849311   -0.815285   -0.739578 
  O      2.354885   -0.317630   -0.247771 
  O      0.698099   -2.250175    0.074271 
  C      3.400110   -1.208667   -0.034261 
  C      4.559891   -1.078804   -0.863338 
  C      5.590062   -1.992190   -0.677848 
  C      5.514900   -3.029708    0.290433 
  C      6.562425   -3.986606    0.431770 
  C      6.475082   -5.006475    1.366096 
  C      5.324088   -5.111378    2.190090 
  C      4.293196   -4.188206    2.085605 
  C      4.361111   -3.113558    1.150548 
  C      3.311891   -2.134740    1.010029 
  C      2.153558   -2.120064    1.948492 
  C      2.324664   -1.978769    3.371711 
  C      3.588810   -1.700726    3.970061 
  C      3.708504   -1.547492    5.344030 
  C      2.577301   -1.702239    6.188381 
S-70 
 
  C      1.332493   -1.963981    5.635928 
  C      1.163807   -2.072885    4.223469 
  C     -0.125006   -2.252957    3.648244 
  C     -0.314326   -2.314473    2.269990 
  C      0.856912   -2.228295    1.449012 
  C      4.692122    0.020059   -1.851322 
  H      6.502291   -1.902734   -1.287247 
  H      7.441367   -3.902331   -0.225889 
  H      7.288693   -5.740870    1.462506 
  H      5.244540   -5.935539    2.914996 
  H      3.403279   -4.289376    2.721407 
  H      4.469736   -1.582826    3.326024 
  H      4.689537   -1.303090    5.777478 
  H      2.689596   -1.605858    7.278861 
  H      0.445444   -2.075519    6.277217 
  H     -0.990638   -2.339179    4.322168 
  C     -1.664734   -2.480479    1.672320 
  C      4.354855    1.342877   -1.511354 
  C      4.501535    2.377694   -2.448756 
  C      4.973084    2.113936   -3.739663 
  C      5.298884    0.792873   -4.086066 
  C      5.173458   -0.241651   -3.150856 
  C     -2.795107   -1.874651    2.262084 
  C     -4.076671   -2.069445    1.720523 
  C     -4.258348   -2.845922    0.566632 
  C     -3.137639   -3.441566   -0.027923 
  C     -1.859663   -3.277932    0.522463 
  H      3.960491    1.568148   -0.512015 
  H      5.055728    2.922739   -4.477584 
  H      5.391110   -1.274513   -3.450358 
  H     -2.674424   -1.234069    3.147390 
  H     -5.258988   -2.991534    0.140046 
  H     -1.008416   -3.779956    0.048734 
  N     -0.156034    0.227889   -0.119098 
  P     -0.975339    1.555320   -0.364734 
  O     -0.637133    2.671871    0.816041 
  O     -2.540524    1.114450   -0.005936 
  C     -0.740899    2.227889    2.129080 
  C      0.464641    2.022226    2.870106 
  C      0.353210    1.467055    4.141664 
  C     -0.907022    1.119731    4.700870 
  C     -1.004610    0.526177    5.993972 
  C     -2.234368    0.159788    6.519576 
  C     -3.418972    0.383867    5.769328 
  C     -3.361412    0.999628    4.526991 
  C     -2.113194    1.391991    3.959769 
  C     -2.011326    2.008564    2.661108 
  C     -3.217773    2.430734    1.899484 
  C     -4.151464    3.364521    2.479009 
  C     -3.914208    4.024095    3.722019 
  C     -4.838341    4.915887    4.246798 
  C     -6.047871    5.194642    3.558314 
S-71 
 
  C     -6.298166    4.590198    2.336645 
  C     -5.361867    3.680201    1.764503 
  C     -5.592110    3.085207    0.494117 
  C     -4.661896    2.245746   -0.100213 
  C     -3.456311    1.956097    0.607136 
  C      1.783816    2.503506    2.385601 
  H      1.260139    1.313705    4.746039 
  H     -0.077184    0.357987    6.560850 
  H     -2.295056   -0.305866    7.514890 
  H     -4.392589    0.067076    6.171571 
  H     -4.282547    1.168570    3.955392 
  H     -2.977454    3.831176    4.261595 
  H     -4.626244    5.417678    5.202897 
  H     -6.774856    5.900076    3.987818 
  H     -7.221465    4.812486    1.779396 
  H     -6.529109    3.310392   -0.037841 
  C     -4.969433    1.649116   -1.433932 
  C      1.919139    3.816434    1.884352 
  C      3.189450    4.356208    1.637743 
  C      4.342806    3.583882    1.837120 
  C      4.211440    2.264585    2.293659 
  C      2.943754    1.725866    2.569846 
  C     -4.854410    2.421394   -2.606264 
  C     -5.250306    1.887798   -3.842398 
  C     -5.786970    0.596120   -3.923417 
  C     -5.887272   -0.181171   -2.760312 
  C     -5.475449    0.337258   -1.521517 
  H      1.024394    4.434874    1.728022 
  H      5.333872    4.009060    1.638512 
  H      2.852066    0.695869    2.942894 
  H     -4.439788    3.435534   -2.543725 
  H     -6.130745    0.202286   -4.889690 
  H     -5.574021   -0.265268   -0.608907 
  N      0.633861   -1.185907   -2.276126 
  N     -0.782772    2.242731   -1.799765 
  S      1.429609   -2.084431   -3.346803 
  O      0.651571   -2.074559   -4.608364 
  O      2.889826   -1.859620   -3.396408 
  S     -1.547594    3.579783   -2.296661 
  O     -1.919194    3.440036   -3.726714 
  O     -2.560659    4.109457   -1.345234 
  C     -0.163058    4.866257   -2.251236 
  C      1.274419   -3.866747   -2.711299 
  F      0.351231    4.921019   -1.017918 
  F      0.804531    4.561151   -3.127711 
  F     -0.680154    6.058677   -2.570831 
  F      2.094310   -4.060472   -1.670500 
  F      1.609897   -4.703574   -3.699274 
  F      0.009437   -4.130671   -2.329179 
  C      5.437435    1.415613    2.533356 
  C      3.301545    5.812978    1.237291 
  C      4.103390    3.774464   -2.043061 
S-72 
 
  C      5.645273    0.472284   -5.519211 
  F      6.583923    2.080246    2.278960 
  F      5.435894    0.300687    1.750200 
  F      5.494968    0.979466    3.819126 
  F      2.796364    6.609572    2.215935 
  F      2.607613    6.091775    0.112122 
  F      4.584055    6.188358    1.035089 
  F      5.014092    4.334880   -1.201487 
  F      2.918228    3.757517   -1.383550 
  F      3.973884    4.603520   -3.101404 
  F      6.344711    1.472916   -6.107048 
  F      6.374104   -0.660530   -5.630858 
  F      4.517305    0.294636   -6.265233 
  C     -3.282297   -4.223725   -1.311114 
  C     -5.275676   -1.416264    2.366882 
  C     -6.397680   -1.595205   -2.880213 
  C     -5.064939    2.669437   -5.121778 
  F     -4.821685    3.972608   -4.910307 
  F     -4.016848    2.167257   -5.844352 
  F     -6.155578    2.571295   -5.923674 
  F     -6.792920   -2.108198   -1.692783 
  F     -7.447780   -1.683559   -3.737124 
  F     -5.433754   -2.424848   -3.373279 
  F     -5.220716   -1.475785    3.717613 
  F     -5.364231   -0.093811    2.034353 
  F     -6.436980   -1.988806    1.977232 
  F     -4.553688   -4.630848   -1.528527 
  F     -2.488811   -5.315784   -1.335338 
  F     -2.926224   -3.450954   -2.378671 
  C     -2.416014   -0.391197   -5.579624 
  C     -3.118356   -0.738774   -6.792629 
  C     -4.356298   -1.322822   -6.750766 
  C     -3.691227   -4.236300   -6.848959 
  C     -2.004037   -3.705465   -5.366651 
  C     -3.399253   -4.108304   -5.516977 
  C     -1.433820   -3.583791   -6.602361 
  H     -2.132230   -4.849411   -8.226697 
  H     -0.389840   -3.308189   -6.797450 
  H     -1.498330   -3.521567   -4.412816 
  H     -4.091760   -4.265712   -4.679366 
  H     -4.652723   -4.532350   -7.289162 
  C     -2.451588   -3.950972   -7.647276 
  H     -2.607446   -3.159262   -8.415092 
  H     -2.643964   -0.430333   -7.733193 
  O     -2.963150   -0.767766   -4.454287 
  O     -1.343619    0.303658   -5.529996 
  C     -2.346528   -0.357760   -3.209175 
  H     -2.257780    0.742507   -3.186071 
  H     -3.019570   -0.726483   -2.420678 
  H     -1.341818   -0.810169   -3.116632 
  Si    -0.169607    1.155912   -6.593986 
  C      0.795223    2.177342   -5.368554 
S-73 
 
  H      1.479119    2.822535   -5.967006 
  H      0.061519    2.863675   -4.897658 
  C     -1.174611    2.231442   -7.785650 
  H     -0.595480    2.268626   -8.736333 
  H     -2.121556    1.709365   -8.042461 
  C      0.835682   -0.210781   -7.406817 
  H      1.819502    0.257499   -7.638614 
  H      1.048296   -0.953344   -6.606404 
  C      1.557183    1.396827   -4.295069 
  H      2.336070    0.733609   -4.719484 
  H      2.051351    2.086416   -3.585756 
  H      0.866872    0.775843   -3.698194 
  C     -1.474204    3.652137   -7.277673 
  H     -2.091979    4.214316   -8.007490 
  H     -2.017682    3.641261   -6.313619 
  H     -0.541925    4.230596   -7.118836 
  C      0.247642   -0.882112   -8.654130 
  H      0.947186   -1.629601   -9.081914 
  H     -0.691435   -1.424125   -8.421736 
  H      0.020247   -0.150361   -9.457420 
  H     -4.749571   -1.578550   -5.756143 
  C     -5.254846   -1.559391   -7.871695 
  C     -6.556957   -2.048285   -7.597359 
  C     -4.897648   -1.303396   -9.218942 
  C     -7.469922   -2.275324   -8.632869 
  H     -6.841268   -2.244390   -6.551413 
  C     -5.810034   -1.536241  -10.252243 
  H     -3.896277   -0.915273   -9.459087 
  C     -7.097729   -2.024488   -9.964157 
  H     -8.478303   -2.650041   -8.402707 
  H     -5.519365   -1.332610  -11.293882 
  H     -7.813033   -2.204738  -10.780716 
 
RC (s-trans, minor) 
 
E = -9323.86377638752 
 
  P      0.782125   -0.681975   -0.895618 
  O      2.283797   -0.463960   -0.227388 
  O      0.373791   -2.173283   -0.293596 
  C      3.189966   -1.514993   -0.137781 
  C      4.355473   -1.463892   -0.962403 
  C      5.254923   -2.517160   -0.875493 
  C      5.026254   -3.633507   -0.025589 
  C      5.935288   -4.731400    0.012572 
  C      5.681983   -5.840411    0.804397 
  C      4.496850   -5.894957    1.583353 
  C      3.599409   -4.836434    1.579919 
  C      3.841956   -3.670263    0.796154 
  C      2.936426   -2.549205    0.763165 
  C      1.734456   -2.501209    1.640644 
  C      1.844840   -2.576585    3.073823 
S-74 
 
  C      3.100926   -2.547197    3.749304 
  C      3.165286   -2.616280    5.133632 
  C      1.980588   -2.751167    5.905748 
  C      0.743788   -2.764442    5.278925 
  C      0.639314   -2.641254    3.861414 
  C     -0.625845   -2.562211    3.218399 
  C     -0.747907   -2.397713    1.839649 
  C      0.464146   -2.362763    1.077285 
  C      4.578368   -0.335904   -1.897348 
  H      6.169149   -2.495614   -1.487916 
  H      6.839892   -4.685250   -0.613328 
  H      6.388391   -6.683854    0.819565 
  H      4.282679   -6.787235    2.190841 
  H      2.680391   -4.898438    2.178228 
  H      4.022704   -2.449540    3.160795 
  H      4.144434   -2.567712    5.632796 
  H      2.046799   -2.834953    7.001002 
  H     -0.183180   -2.850136    5.865437 
  H     -1.531520   -2.626905    3.839909 
  C     -2.088781   -2.283110    1.207450 
  C      4.427002    0.996738   -1.471786 
  C      4.638015    2.055862   -2.366504 
  C      5.009846    1.809469   -3.693403 
  C      5.142862    0.481089   -4.128123 
  C      4.928962   -0.583963   -3.241187 
  C     -3.120492   -1.597016    1.882166 
  C     -4.421673   -1.558628    1.356353 
  C     -4.716230   -2.175318    0.133039 
  C     -3.689175   -2.838432   -0.557475 
  C     -2.391854   -2.902453   -0.027756 
  H      4.127420    1.208505   -0.437067 
  H      5.150203    2.644082   -4.392054 
  H      4.965986   -1.619748   -3.603500 
  H     -2.905396   -1.084943    2.830983 
  H     -5.736274   -2.152963   -0.271297 
  H     -1.615666   -3.456117   -0.568478 
  N     -0.137523    0.404711   -0.231064 
  P     -0.766763    1.851063   -0.323265 
  O     -0.291912    2.767795    0.977404 
  O     -2.378970    1.579247   -0.009356 
  C     -0.457363    2.182443    2.228438 
  C      0.703594    1.718437    2.923272 
  C      0.505708    1.034588    4.120327 
  C     -0.792927    0.799554    4.647602 
  C     -0.978672    0.069624    5.858657 
  C     -2.250516   -0.189617    6.346235 
  C     -3.388302    0.283231    5.640265 
  C     -3.238984    1.035685    4.483729 
  C     -1.944814    1.323655    3.958182 
  C     -1.748063    2.076116    2.744613 
  C     -2.885635    2.735322    2.050127 
  C     -3.702607    3.696425    2.748700 
S-75 
 
  C     -3.374481    4.187964    4.047423 
  C     -4.187234    5.111627    4.688836 
  C     -5.370497    5.589570    4.067289 
  C     -5.706449    5.148678    2.796976 
  C     -4.884874    4.210543    2.106821 
  C     -5.207794    3.766527    0.795250 
  C     -4.379612    2.906681    0.090214 
  C     -3.188185    2.436191    0.719314 
  C      2.083215    2.053531    2.489185 
  H      1.377574    0.684958    4.693790 
  H     -0.086724   -0.294775    6.389062 
  H     -2.381002   -0.763348    7.276394 
  H     -4.398907    0.052719    6.008443 
  H     -4.124914    1.396726    3.947088 
  H     -2.455328    3.838021    4.536556 
  H     -3.906389    5.482338    5.686272 
  H     -6.009443    6.317881    4.588789 
  H     -6.610615    5.524644    2.293654 
  H     -6.135288    4.125567    0.323803 
  C     -4.810139    2.426736   -1.257205 
  C      2.410229    3.366589    2.086774 
  C      3.749206    3.742202    1.904858 
  C      4.781920    2.807752    2.070752 
  C      4.458947    1.490407    2.429365 
  C      3.122600    1.113581    2.636973 
  C     -4.543207    3.158914   -2.427453 
  C     -5.074095    2.734455   -3.657626 
  C     -5.885539    1.593715   -3.736792 
  C     -6.149607    0.861387   -2.567732 
  C     -5.611562    1.270752   -1.338843 
  H      1.614273    4.112699    1.958384 
  H      5.827511    3.107536    1.929058 
  H      2.882599    0.081916    2.931482 
  H     -3.924886    4.063988   -2.365038 
  H     -6.328568    1.292852   -4.696482 
  H     -5.848207    0.716504   -0.422466 
  N      0.729142   -0.801064   -2.497208 
  N     -0.457770    2.647398   -1.678806 
  S      1.361355   -1.958692   -3.429891 
  O      1.214744   -1.534964   -4.841572 
  O      2.644665   -2.539954   -2.975409 
  S     -1.091821    4.088425   -2.064789 
  O     -1.367606    4.141360   -3.517998 
  O     -2.133379    4.568930   -1.114863 
  C      0.346405    5.284796   -1.763750 
  C      0.148383   -3.415424   -3.275848 
  F      0.867159    5.070008   -0.549435 
  F      1.302617    5.144238   -2.690870 
  F     -0.134042    6.532743   -1.824516 
  F      0.454315   -4.197873   -2.235224 
  F      0.207575   -4.147353   -4.398484 
  F     -1.108030   -2.956535   -3.121113 
S-76 
 
  C      5.546586    0.462654    2.635665 
  C      4.068281    5.198698    1.636197 
  C      4.414043    3.462472   -1.870137 
  C      5.506599    0.196385   -5.566006 
  F      6.783254    0.998423    2.559983 
  F      5.481327   -0.532489    1.709138 
  F      5.433709   -0.138227    3.849633 
  F      3.723032    5.958849    2.709263 
  F      3.385748    5.687332    0.577838 
  F      5.385530    5.400015    1.410597 
  F      5.377064    3.836654   -0.985616 
  F      3.226531    3.555998   -1.224131 
  F      4.412480    4.371515   -2.870389 
  F      6.842425    0.035435   -5.728357 
  F      4.913064   -0.934438   -6.021417 
  F      5.128009    1.210625   -6.389892 
  C     -4.003829   -3.460958   -1.899073 
  C     -5.512019   -0.843080    2.119289 
  C     -7.039979   -0.355454   -2.646543 
  C     -4.736891    3.500802   -4.915200 
  F     -4.534624    4.807652   -4.686350 
  F     -3.590803    3.006996   -5.485297 
  F     -5.706322    3.382469   -5.855306 
  F     -7.451850   -0.769584   -1.422833 
  F     -8.141406   -0.121602   -3.393812 
  F     -6.396630   -1.413209   -3.218134 
  F     -5.466344   -1.118613    3.443524 
  F     -5.401053    0.514093    1.998181 
  F     -6.745034   -1.169519    1.672527 
  F     -3.214481   -4.527977   -2.174241 
  F     -3.821290   -2.564579   -2.911998 
  F     -5.287231   -3.877390   -1.973429 
  C     -1.472828   -0.479695   -5.558949 
  C     -1.423750   -1.624994   -6.430490 
  C     -2.028869   -2.801052   -6.081653 
  C     -4.761551   -2.326394   -7.233837 
  C     -4.367840   -0.076981   -6.920868 
  C     -4.901166   -1.305565   -6.334076 
  C     -3.898673   -0.342033   -8.177530 
  H     -4.827984   -1.902509   -9.365357 
  H     -3.455720    0.382207   -8.874140 
  H     -4.336461    0.899963   -6.421165 
  H     -5.320432   -1.387534   -5.322394 
  H     -5.062666   -3.372684   -7.093211 
  C     -4.143508   -1.790352   -8.491987 
  H     -3.220363   -2.341790   -8.779489 
  H     -0.785719   -1.530024   -7.317560 
  O     -2.259135   -0.552203   -4.516100 
  O     -0.796145    0.593967   -5.727262 
  C     -2.212821    0.502231   -3.519967 
  H     -1.219125    0.483612   -3.037353 
  H     -3.009565    0.250108   -2.800522 
S-77 
 
  H     -2.384529    1.487857   -3.986758 
  Si     0.398547    1.340125   -6.837893 
  C      0.870394    2.822414   -5.800205 
  H     -0.055798    3.330490   -5.454697 
  H      1.399316    3.545255   -6.461343 
  C      1.886232    0.242150   -7.167654 
  H      2.312986   -0.037447   -6.184698 
  H      2.607236    0.965975   -7.615725 
  C     -0.590275    1.710725   -8.402237 
  H     -1.022581    0.752470   -8.767530 
  H      0.157981    2.003130   -9.173532 
  C      1.741755    2.440294   -4.593273 
  H      1.219476    1.735006   -3.916055 
  H      2.005246    3.329648   -3.992725 
  H      2.685520    1.957161   -4.911036 
  C      1.771509   -1.009476   -8.043849 
  H      2.777659   -1.383820   -8.323020 
  H      1.210579   -0.832646   -8.986563 
  H      1.278640   -1.828986   -7.484419 
  C     -1.676390    2.786646   -8.267483 
  H     -2.211702    2.952165   -9.225449 
  H     -1.245549    3.760686   -7.958613 
  H     -2.432019    2.520575   -7.503653 
  H     -2.598751   -2.812773   -5.142133 
  C     -1.897347   -4.081216   -6.759156 
  C     -2.426166   -5.230615   -6.121557 
  C     -1.221654   -4.239906   -7.994345 
  C     -2.288921   -6.496553   -6.701216 
  H     -2.925873   -5.113204   -5.147083 
  C     -1.091807   -5.504806   -8.574919 
  H     -0.784647   -3.363863   -8.496669 
  C     -1.625721   -6.636728   -7.931819 
  H     -2.695264   -7.380946   -6.188018 
  H     -0.562277   -5.614407   -9.533098 
  H     -1.516673   -7.631449   -8.389710 
  
S-78 
 
TS (s-trans, major) 
 
E = -9323.85434826665 
 
  P      0.852586   -0.809522   -0.742533 
  O      2.355070   -0.307852   -0.246114 
  O      0.699581   -2.239985    0.079168 
  C      3.400858   -1.199314   -0.035668 
  C      4.556977   -1.072828   -0.870230 
  C      5.584116   -1.991042   -0.690349 
  C      5.508819   -3.029854    0.276514 
  C      6.550846   -3.994110    0.409060 
  C      6.461935   -5.016194    1.340825 
  C      5.315539   -5.115312    2.171950 
  C      4.290662   -4.184500    2.076887 
  C      4.359824   -3.108429    1.143602 
  C      3.314629   -2.124759    1.009222 
  C      2.158958   -2.107100    1.950733 
  C      2.332458   -1.965767    3.373716 
  C      3.598762   -1.693929    3.970219 
  C      3.721144   -1.541906    5.344104 
  C      2.590247   -1.689840    6.190013 
  C      1.343268   -1.944817    5.639366 
  C      1.172364   -2.054603    4.227329 
  C     -0.117648   -2.233679    3.654391 
  C     -0.307735   -2.299955    2.276781 
  C      0.861639   -2.214551    1.453434 
  C      4.687477    0.025589   -1.858743 
  H      6.493679   -1.905083   -1.304133 
  H      7.426430   -3.914295   -0.253643 
  H      7.270715   -5.756835    1.429900 
  H      5.234646   -5.941186    2.894710 
  H      3.404162   -4.280970    2.718194 
  H      4.479388   -1.580218    3.324949 
  H      4.704223   -1.303761    5.776405 
  H      2.704657   -1.594147    7.280301 
  H      0.456533   -2.051882    6.281836 
  H     -0.982916   -2.317519    4.329061 
  C     -1.655994   -2.477804    1.679022 
  C      4.343838    1.347680   -1.521722 
  C      4.487145    2.381149   -2.460846 
  C      4.963037    2.117548   -3.750206 
  C      5.296680    0.797696   -4.093175 
  C      5.173313   -0.235758   -3.156556 
  C     -2.792126   -1.870251    2.254887 
  C     -4.070064   -2.080714    1.709908 
  C     -4.242094   -2.875234    0.566726 
  C     -3.114669   -3.473546   -0.012500 
  C     -1.840715   -3.293302    0.540767 
  H      3.947128    1.573731   -0.523544 
  H      5.042825    2.925456   -4.489422 
  H      5.396725   -1.267909   -3.454225 
S-79 
 
  H     -2.678842   -1.216292    3.131438 
  H     -5.239760   -3.031691    0.137117 
  H     -0.983927   -3.796354    0.078329 
  N     -0.157581    0.235640   -0.137049 
  P     -0.980774    1.560857   -0.388052 
  O     -0.646621    2.678998    0.792501 
  O     -2.544758    1.113621   -0.029739 
  C     -0.754013    2.237771    2.105852 
  C      0.449527    2.033077    2.850767 
  C      0.334059    1.479614    4.122682 
  C     -0.927981    1.133284    4.678393 
  C     -1.029110    0.539747    5.971242 
  C     -2.260327    0.173815    6.493761 
  C     -3.442912    0.398919    5.740613 
  C     -3.381895    1.014481    4.498316 
  C     -2.132055    1.405700    3.933819 
  C     -2.026176    2.019763    2.634165 
  C     -3.230853    2.437223    1.866592 
  C     -4.168022    3.371701    2.439030 
  C     -3.933604    4.040275    3.677726 
  C     -4.860502    4.933466    4.195380 
  C     -6.069975    5.204326    3.503581 
  C     -6.317843    4.590120    2.286264 
  C     -5.379017    3.678210    1.721621 
  C     -5.608587    3.069936    0.457344 
  C     -4.675606    2.229515   -0.130987 
  C     -3.466499    1.953687    0.576909 
  C      1.770243    2.513320    2.369413 
  H      1.238811    1.326696    4.730451 
  H     -0.103023    0.371350    6.540410 
  H     -2.323665   -0.291942    7.488874 
  H     -4.417727    0.082964    6.140510 
  H     -4.301393    1.183939    3.924309 
  H     -2.996626    3.853250    4.219207 
  H     -4.650657    5.442557    5.148180 
  H     -6.799110    5.911137    3.927142 
  H     -7.241293    4.805759    1.726772 
  H     -6.548026    3.284535   -0.074581 
  C     -4.987568    1.607171   -1.452579 
  C      1.906289    3.824249    1.863162 
  C      3.176961    4.364289    1.619185 
  C      4.330327    3.593807    1.825427 
  C      4.198522    2.276121    2.286631 
  C      2.930330    1.737510    2.560918 
  C     -4.857402    2.343374   -2.646911 
  C     -5.247636    1.774419   -3.869198 
  C     -5.789342    0.482968   -3.916528 
  C     -5.910117   -0.255333   -2.730912 
  C     -5.508168    0.299281   -1.504586 
  H      1.011654    4.441109    1.700282 
  H      5.321723    4.019157    1.628598 
  H      2.838455    0.708900    2.937731 
S-80 
 
  H     -4.434625    3.355618   -2.612946 
  H     -6.120397    0.059958   -4.875296 
  H     -5.622128   -0.273150   -0.574722 
  N      0.646700   -1.197153   -2.277101 
  N     -0.785035    2.244673   -1.822830 
  S      1.435527   -2.104129   -3.341294 
  O      0.627759   -2.152956   -4.584409 
  O      2.887391   -1.846507   -3.437975 
  S     -1.560670    3.573875   -2.326206 
  O     -1.928382    3.428856   -3.755801 
  O     -2.580708    4.095721   -1.377734 
  C     -0.184805    4.869576   -2.281698 
  C      1.338304   -3.875547   -2.665314 
  F      0.328041    4.931796   -1.047769 
  F      0.785656    4.567965   -3.155843 
  F     -0.709357    6.057678   -2.605260 
  F      2.160907   -4.025751   -1.620401 
  F      1.699784   -4.723306   -3.635945 
  F      0.079238   -4.171035   -2.281831 
  C      5.424559    1.428994    2.532600 
  C      3.288807    5.820068    1.214874 
  C      4.081673    3.776867   -2.058590 
  C      5.651112    0.475793   -5.524008 
  F      6.571336    2.094464    2.281778 
  F      5.427601    0.312742    1.750986 
  F      5.477542    0.994776    3.819197 
  F      2.788676    6.619094    2.194214 
  F      2.589995    6.096724    0.092326 
  F      4.570748    6.193992    1.006526 
  F      4.990643    4.343770   -1.219351 
  F      2.897273    3.755687   -1.398255 
  F      3.947389    4.602106   -3.119153 
  F      6.342613    1.481166   -6.112769 
  F      6.392265   -0.650111   -5.628309 
  F      4.528352    0.283169   -6.273655 
  C     -3.242790   -4.278733   -1.281686 
  C     -5.275114   -1.427248    2.345085 
  C     -6.426439   -1.669133   -2.811487 
  C     -5.059394    2.510116   -5.175479 
  F     -4.726067    3.800050   -5.010785 
  F     -4.074708    1.918280   -5.917893 
  F     -6.183667    2.462111   -5.933941 
  F     -6.836208   -2.143386   -1.612391 
  F     -7.466801   -1.781953   -3.675810 
  F     -5.459493   -2.519345   -3.265842 
  F     -5.234197   -1.491651    3.696028 
  F     -5.357839   -0.103600    2.016634 
  F     -6.433173   -1.996386    1.941024 
  F     -4.509694   -4.693969   -1.508996 
  F     -2.446111   -5.369699   -1.277360 
  F     -2.873458   -3.526306   -2.360228 
  C     -2.336006   -0.557484   -5.501664 
S-81 
 
  C     -2.911927   -1.082027   -6.694079 
  C     -4.200836   -1.691126   -6.680623 
  C     -3.842185   -3.703077   -6.757787 
  C     -2.021030   -3.625571   -5.342247 
  C     -3.390628   -3.949842   -5.433380 
  C     -1.566156   -3.246114   -6.608754 
  H     -2.371347   -4.683066   -7.955681 
  H     -0.535364   -2.942334   -6.832212 
  H     -1.427291   -3.578136   -4.423292 
  H     -4.033349   -4.214435   -4.583694 
  H     -4.803185   -4.080737   -7.137290 
  C     -2.599227   -3.642059   -7.621454 
  H     -2.666960   -3.023662   -8.535592 
  H     -2.454994   -0.746189   -7.632652 
  O     -2.917999   -0.896095   -4.371624 
  O     -1.321359    0.232696   -5.439835 
  C     -2.380055   -0.377657   -3.133043 
  H     -2.356235    0.725291   -3.170423 
  H     -3.062454   -0.738948   -2.348707 
  H     -1.355392   -0.762866   -2.974817 
  Si    -0.220841    1.073597   -6.571620 
  C      0.757319    2.153308   -5.406049 
  H      1.422970    2.784866   -6.038216 
  H      0.028015    2.845163   -4.937055 
  C     -1.306056    2.070797   -7.762150 
  H     -0.789465    2.073409   -8.748345 
  H     -2.255698    1.517479   -7.929708 
  C      0.836523   -0.259847   -7.391661 
  H      1.840011    0.209013   -7.508265 
  H      0.987262   -1.051206   -6.624630 
  C      1.548242    1.407897   -4.327434 
  H      2.320610    0.734632   -4.748727 
  H      2.055690    2.119589   -3.650039 
  H      0.874012    0.801747   -3.697054 
  C     -1.605379    3.508212   -7.304565 
  H     -2.281614    4.021934   -8.018017 
  H     -2.085680    3.534228   -6.307942 
  H     -0.677879    4.111558   -7.234793 
  C      0.371147   -0.838850   -8.733892 
  H      1.089120   -1.588856   -9.125226 
  H     -0.611760   -1.347768   -8.655677 
  H      0.265820   -0.054148   -9.511247 
  H     -4.690377   -1.684244   -5.696691 
  C     -5.158991   -1.527529   -7.804998 
  C     -6.537496   -1.709609   -7.546227 
  C     -4.762185   -1.195456   -9.119064 
  C     -7.487372   -1.565171   -8.565608 
  H     -6.861796   -1.964996   -6.524134 
  C     -5.712229   -1.055709  -10.139819 
  H     -3.699777   -1.025705   -9.350951 
  C     -7.077749   -1.240559   -9.868795 
  H     -8.555491   -1.703723   -8.339956 
S-82 
 
  H     -5.383374   -0.790873  -11.156114 
  H     -7.821639   -1.125207  -10.671215 
 
TS (s-trans, minor) 
 
E = -9323.85080394122 
 
 P      0.776751   -0.690212   -0.895570 
 O      2.281820   -0.480484   -0.232949 
 O      0.370059   -2.184837   -0.299919 
 C      3.183125   -1.535620   -0.149562 
 C      4.344127   -1.487824   -0.980268 
 C      5.242873   -2.541831   -0.895300 
 C      5.019447   -3.653604   -0.038139 
 C      5.932267   -4.748140    0.003659 
 C      5.687450   -5.851344    0.806093 
 C      4.506392   -5.903687    1.591402 
 C      3.604745   -4.848672    1.583519 
 C      3.839288   -3.687485    0.789887 
 C      2.932050   -2.567676    0.754872 
 C      1.730974   -2.516497    1.633708 
 C      1.841287   -2.587300    3.067142 
 C      3.097196   -2.553789    3.742826 
 C      3.161289   -2.614760    5.127599 
 C      1.976506   -2.746404    5.900190 
 C      0.739912   -2.764598    5.273055 
 C      0.635640   -2.648492    3.854893 
 C     -0.629421   -2.570110    3.211665 
 C     -0.751693   -2.406218    1.832786 
 C      0.460549   -2.375596    1.070405 
 C      4.570654   -0.357715   -1.911704 
 H      6.154632   -2.522082   -1.511472 
 H      6.833721   -4.702922   -0.626864 
 H      6.397876   -6.691337    0.825416 
 H      4.299311   -6.791255    2.208179 
 H      2.689451   -4.908876    2.187603 
 H      4.018940   -2.458100    3.153926 
 H      4.140201   -2.561616    5.626826 
 H      2.042440   -2.822981    6.996025 
 H     -0.187109   -2.847053    5.859931 
 H     -1.534806   -2.633172    3.833649 
 C     -2.092903   -2.284653    1.201900 
 C      4.431225    0.974266   -1.479991 
 C      4.655094    2.035616   -2.369113 
 C      5.027865    1.791647   -3.696068 
 C      5.147146    0.464007   -4.137192 
 C      4.920115   -0.602985   -3.256281 
 C     -3.122182   -1.602219    1.884552 
 C     -4.424687   -1.557175    1.362896 
 C     -4.723385   -2.162660    0.135334 
 C     -3.699082   -2.820243   -0.564107 
 C     -2.400132   -2.891687   -0.038930 
S-83 
 
 H      4.132032    1.184251   -0.444830 
 H      5.177052    2.627969   -4.390928 
 H      4.947101   -1.637136   -3.623980 
 H     -2.904409   -1.098298    2.837031 
 H     -5.744755   -2.136430   -0.265305 
 H     -1.626672   -3.441862   -0.587422 
 N     -0.135765    0.394235   -0.214546 
 P     -0.768511    1.837919   -0.320522 
 O     -0.298698    2.762056    0.977170 
 O     -2.382259    1.567440   -0.008938 
 C     -0.461338    2.177235    2.228662 
 C      0.700596    1.713920    2.922180 
 C      0.504662    1.030945    4.119941 
 C     -0.793073    0.796635    4.649661 
 C     -0.976450    0.069554    5.862711 
 C     -2.247268   -0.188251    6.353597 
 C     -3.386409    0.283036    5.648813 
 C     -3.239378    1.032458    4.489953 
 C     -1.946275    1.319081    3.961074 
 C     -1.751406    2.069348    2.745831 
 C     -2.889535    2.725954    2.049687 
 C     -3.706278    3.688857    2.745890 
 C     -3.377071    4.184362    4.042827 
 C     -4.188128    5.111610    4.681092 
 C     -5.370915    5.589162    4.058330 
 C     -5.708519    5.143566    2.790100 
 C     -4.888593    4.201670    2.103152 
 C     -5.212724    3.752949    0.793572 
 C     -4.384116    2.891978    0.090381 
 C     -3.191399    2.424177    0.719061 
 C      2.079412    2.047925    2.485059 
 H      1.377463    0.681446    4.692009 
 H     -0.083440   -0.293250    6.392295 
 H     -2.375819   -0.759344    7.285612 
 H     -4.396257    0.053928    6.020003 
 H     -4.126324    1.392680    3.954367 
 H     -2.458097    3.834982    4.532599 
 H     -3.906097    5.485748    5.676837 
 H     -6.008082    6.321003    4.577046 
 H     -6.612365    5.518936    2.285657 
 H     -6.141045    4.109724    0.321958 
 C     -4.818434    2.407792   -1.254272 
 C      2.406643    3.361398    2.084446 
 C      3.745476    3.735681    1.899039 
 C      4.777441    2.799578    2.059913 
 C      4.453992    1.481806    2.416395 
 C      3.117849    1.106193    2.627573 
 C     -4.540063    3.127438   -2.429683 
 C     -5.080170    2.704275   -3.656303 
 C     -5.911300    1.577105   -3.725243 
 C     -6.182496    0.853795   -2.552452 
 C     -5.636255    1.262573   -1.327161 
S-84 
 
 H      1.610941    4.108591    1.960468 
 H      5.822858    3.098376    1.915286 
 H      2.877168    0.074227    2.920455 
 H     -3.907372    4.023086   -2.373321 
 H     -6.368414    1.281239   -4.679848 
 H     -5.878951    0.717197   -0.407041 
 N      0.712529   -0.792370   -2.495200 
 N     -0.458887    2.629392   -1.678485 
 S      1.321738   -1.936654   -3.458726 
 O      1.164377   -1.482169   -4.858779 
 O      2.601733   -2.539457   -3.022942 
 S     -1.088269    4.068957   -2.073360 
 O     -1.364901    4.115069   -3.527316 
 O     -2.129455    4.559506   -1.127826 
 C      0.356063    5.260055   -1.782061 
 C      0.086657   -3.373759   -3.334731 
 F      0.879041    5.048802   -0.568158 
 F      1.308007    5.108520   -2.711507 
 F     -0.117885    6.510338   -1.847964 
 F      0.348668   -4.163100   -2.285829 
 F      0.165590   -4.102420   -4.455623 
 F     -1.165717   -2.891981   -3.213425 
 C      5.541127    0.452114    2.615400 
 C      4.065271    5.191929    1.630248 
 C      4.440828    3.442197   -1.868277 
 C      5.508547    0.184463   -5.576631 
 F      6.778154    0.986608    2.537030 
 F      5.471350   -0.539855    1.685812 
 F      5.432035   -0.152742    3.827796 
 F      3.716167    5.953183    2.701350 
 F      3.386456    5.679565    0.569018 
 F      5.383199    5.393247    1.408863 
 F      5.402942    3.806270   -0.978325 
 F      3.251384    3.543398   -1.226685 
 F      4.450425    4.354819   -2.865205 
 F      6.846370    0.045337   -5.744969 
 F      4.930840   -0.954846   -6.029382 
 F      5.110636    1.193302   -6.398144 
 C     -4.022000   -3.427697   -1.910255 
 C     -5.512837   -0.846049    2.132600 
 C     -7.094126   -0.347192   -2.625600 
 C     -4.737093    3.457232   -4.920499 
 F     -4.511317    4.761063   -4.703938 
 F     -3.605955    2.938355   -5.497874 
 F     -5.716471    3.347388   -5.854163 
 F     -7.483960   -0.772913   -1.400152 
 F     -8.208658   -0.085538   -3.344837 
 F     -6.482512   -1.407971   -3.229473 
 F     -5.459658   -1.121955    3.456154 
 F     -5.407950    0.511645    2.011027 
 F     -6.747355   -1.176536    1.691859 
 F     -3.225785   -4.481776   -2.209763 
S-85 
 
 F     -3.863393   -2.513834   -2.912709 
 F     -5.302757   -3.856052   -1.976289 
 C     -1.550087   -0.398458   -5.649526 
 C     -1.675189   -1.471038   -6.579202 
 C     -2.367855   -2.664176   -6.212267 
 C     -4.227224   -2.448928   -6.968283 
 C     -4.344960   -0.158086   -6.731940 
 C     -4.773823   -1.388284   -6.192334 
 C     -3.583572   -0.411027   -7.878401 
 H     -4.698975   -1.855406   -8.968666 
 H     -3.117755    0.355248   -8.512690 
 H     -4.480327    0.828618   -6.274636 
 H     -5.321654   -1.513235   -5.249123 
 H     -4.602305   -3.480664   -6.897011 
 C     -3.812513   -1.833202   -8.289625 
 H     -2.986530   -2.336642   -8.823885 
 H     -0.993024   -1.442713   -7.436415 
 O     -2.304867   -0.464974   -4.574107 
 O     -0.793431    0.633922   -5.780380 
 C     -2.155515    0.539860   -3.539470 
 H     -1.156131    0.424760   -3.081937 
 H     -2.951681    0.316623   -2.809455 
 H     -2.262446    1.556277   -3.956862 
 Si     0.424748    1.356095   -6.858698 
 C      0.939060    2.810437   -5.798329 
 H      0.024434    3.344664   -5.460938 
 H      1.502579    3.523670   -6.441061 
 C      1.867911    0.206272   -7.214914 
 H      2.322847   -0.055114   -6.239768 
 H      2.597290    0.882077   -7.720194 
 C     -0.515436    1.818703   -8.431571 
 H     -0.906862    0.883849   -8.891400 
 H      0.259428    2.181091   -9.144654 
 C      1.775943    2.384674   -4.582898 
 H      1.219490    1.687993   -3.925081 
 H      2.059558    3.257016   -3.966896 
 H      2.707460    1.874675   -4.893081 
 C      1.660613   -1.073740   -8.031381 
 H      2.635770   -1.517683   -8.318066 
 H      1.088133   -0.904489   -8.968657 
 H      1.134529   -1.836506   -7.424384 
 C     -1.624946    2.865384   -8.263446 
 H     -2.129853    3.091099   -9.225339 
 H     -1.222632    3.820595   -7.869987 
 H     -2.401394    2.539130   -7.544321 
 H     -2.666712   -2.707621   -5.156101 
 C     -1.972739   -3.991872   -6.754355 
 C     -2.349610   -5.148211   -6.033822 
 C     -1.229985   -4.155146   -7.943683 
 C     -2.007055   -6.425553   -6.493255 
 H     -2.897930   -5.032036   -5.085401 
 C     -0.887675   -5.434124   -8.404551 
S-86 
 
 H     -0.888402   -3.275840   -8.510523 
 C     -1.278495   -6.574237   -7.684744 
 H     -2.302966   -7.312130   -5.912344 
 H     -0.300852   -5.539935   -9.329472 
 H     -1.005819   -7.577076   -8.046247 
 
P (s-trans, major) 
 
E = -9323.89299227211 
 
  P      0.855760   -0.748004   -0.718468 
  O      2.367142   -0.277711   -0.224982 
  O      0.698538   -2.199059    0.063907 
  C      3.399922   -1.189886   -0.038819 
  C      4.544237   -1.077698   -0.890910 
  C      5.561180   -2.010927   -0.727900 
  C      5.485080   -3.050905    0.237600 
  C      6.517452   -4.027510    0.355321 
  C      6.427595   -5.051031    1.285303 
  C      5.290067   -5.139264    2.129927 
  C      4.274641   -4.196846    2.049288 
  C      4.345210   -3.119185    1.117882 
  C      3.310457   -2.123114    0.998020 
  C      2.156031   -2.102588    1.940456 
  C      2.329211   -1.970011    3.363889 
  C      3.596673   -1.708492    3.962139 
  C      3.718406   -1.561714    5.336644 
  C      2.585085   -1.703282    6.180495 
  C      1.336936   -1.948238    5.627781 
  C      1.167317   -2.054564    4.215324 
  C     -0.122279   -2.226977    3.639534 
  C     -0.311847   -2.284946    2.261313 
  C      0.858781   -2.197263    1.440411 
  C      4.670685    0.020253   -1.879807 
  H      6.463755   -1.935244   -1.353239 
  H      7.386223   -3.955593   -0.317132 
  H      7.228746   -5.801203    1.362686 
  H      5.208584   -5.966000    2.851650 
  H      3.394955   -4.284448    2.701144 
  H      4.478049   -1.597417    3.317341 
  H      4.702492   -1.331924    5.771181 
  H      2.698585   -1.610399    7.271113 
  H      0.448485   -2.050307    6.268738 
  H     -0.988618   -2.312133    4.312567 
  C     -1.660162   -2.457420    1.662670 
  C      4.331654    1.343324   -1.541071 
  C      4.460622    2.374372   -2.484462 
  C      4.921983    2.107822   -3.778655 
  C      5.252959    0.787482   -4.122656 
  C      5.140566   -0.243909   -3.182678 
  C     -2.797258   -1.865258    2.252208 
  C     -4.075963   -2.077780    1.710237 
S-87 
 
  C     -4.247619   -2.857312    0.556728 
  C     -3.118579   -3.435185   -0.040303 
  C     -1.844141   -3.254785    0.511108 
  H      3.948773    1.571854   -0.538251 
  H      4.992256    2.914038   -4.520778 
  H      5.359159   -1.276557   -3.482444 
  H     -2.685529   -1.223127    3.137625 
  H     -5.246369   -3.017786    0.131818 
  H     -0.986728   -3.744787    0.036436 
  N     -0.136790    0.292983   -0.073611 
  P     -0.983382    1.597196   -0.365949 
  O     -0.682959    2.734204    0.803036 
  O     -2.549651    1.137283   -0.030897 
  C     -0.788270    2.284656    2.115591 
  C      0.415286    2.071176    2.857618 
  C      0.298039    1.505144    4.123724 
  C     -0.964568    1.153662    4.674885 
  C     -1.065724    0.545671    5.961006 
  C     -2.297086    0.174570    6.479500 
  C     -3.479521    0.408079    5.728812 
  C     -3.418279    1.034284    4.491768 
  C     -2.168482    1.431265    3.931525 
  C     -2.060687    2.054292    2.636190 
  C     -3.263946    2.458258    1.858576 
  C     -4.214782    3.383875    2.421970 
  C     -3.992864    4.060969    3.658298 
  C     -4.931152    4.947645    4.166465 
  C     -6.140117    5.201990    3.467467 
  C     -6.377090    4.577185    2.253342 
  C     -5.426488    3.671686    1.698277 
  C     -5.646103    3.048634    0.439356 
  C     -4.700636    2.216787   -0.141422 
  C     -3.487184    1.965623    0.569625 
  C      1.737752    2.543957    2.374892 
  H      1.202176    1.343561    4.730110 
  H     -0.139700    0.370032    6.528194 
  H     -2.360695   -0.302355    7.469291 
  H     -4.454396    0.088680    6.125817 
  H     -4.337689    1.206860    3.918541 
  H     -3.056541    3.885808    4.205008 
  H     -4.731184    5.464337    5.117281 
  H     -6.878114    5.904063    3.883415 
  H     -7.300924    4.778938    1.689367 
  H     -6.589072    3.242913   -0.094135 
  C     -5.011761    1.563237   -1.449179 
  C      1.880383    3.850950    1.860587 
  C      3.153277    4.380916    1.606548 
  C      4.302581    3.604663    1.813246 
  C      4.164281    2.290976    2.284183 
  C      2.893844    1.761626    2.565978 
  C     -4.856552    2.254669   -2.667429 
  C     -5.234575    1.641654   -3.872973 
S-88 
 
  C     -5.786237    0.354337   -3.879745 
  C     -5.942546   -0.334752   -2.669438 
  C     -5.554829    0.262156   -1.459163 
  H      0.989106    4.472469    1.697247 
  H      5.295907    4.022373    1.609638 
  H      2.797230    0.734687    2.946585 
  H     -4.422220    3.262789   -2.664920 
  H     -6.098970   -0.101427   -4.829218 
  H     -5.693266   -0.270969   -0.509721 
  N      0.630712   -1.079497   -2.262100 
  N     -0.773719    2.251698   -1.812539 
  S      1.338108   -1.970719   -3.391089 
  O      0.428987   -2.013067   -4.564899 
  O      2.772394   -1.693368   -3.611228 
  S     -1.562811    3.553738   -2.361506 
  O     -1.909040    3.364091   -3.792103 
  O     -2.604598    4.083359   -1.441772 
  C     -0.206451    4.870597   -2.334606 
  C      1.316642   -3.749442   -2.732530 
  F      0.307701    4.954434   -1.103054 
  F      0.766161    4.571896   -3.207788 
  F     -0.748768    6.046627   -2.671780 
  F      2.198743   -3.886910   -1.734858 
  F      1.646671   -4.575967   -3.731568 
  F      0.088714   -4.078318   -2.287320 
  C      5.386456    1.438057    2.529537 
  C      3.271562    5.832286    1.188983 
  C      4.054352    3.769724   -2.080419 
  C      5.592080    0.465288   -5.557119 
  F      6.536399    2.101459    2.287859 
  F      5.389405    0.327254    1.739572 
  F      5.432490    0.994589    3.812889 
  F      2.785451    6.643434    2.165205 
  F      2.564071    6.102643    0.069965 
  F      4.553866    6.195711    0.965556 
  F      4.968908    4.341862   -1.251802 
  F      2.876080    3.746360   -1.409403 
  F      3.906266    4.591487   -3.142647 
  F      6.309815    1.454981   -6.141102 
  F      6.299296   -0.680548   -5.673105 
  F      4.461006    0.312188   -6.304257 
  C     -3.249948   -4.209563   -1.330124 
  C     -5.282100   -1.439751    2.358432 
  C     -6.503424   -1.734411   -2.718224 
  C     -5.020642    2.311439   -5.210161 
  F     -4.650713    3.597518   -5.105716 
  F     -4.042685    1.654126   -5.912821 
  F     -6.135876    2.257031   -5.977728 
  F     -6.843449   -2.200970   -1.493268 
  F     -7.607690   -1.803516   -3.503275 
  F     -5.601701   -2.607188   -3.246273 
  F     -5.227991   -1.504443    3.708749 
S-89 
 
  F     -5.382643   -0.115616    2.032312 
  F     -6.437503   -2.020370    1.964595 
  F     -4.500752   -4.687068   -1.520659 
  F     -2.397381   -5.257400   -1.385037 
  F     -2.960708   -3.409199   -2.394361 
  C     -2.158308   -0.749011   -5.395953 
  C     -2.525080   -1.610548   -6.552028 
  C     -4.018700   -2.060967   -6.586647 
  C     -3.879926   -3.625268   -6.855402 
  C     -2.095064   -3.807686   -5.394982 
  C     -3.380814   -4.198951   -5.543023 
  C     -1.727214   -2.996164   -6.618659 
  H     -2.257113   -4.713883   -7.903142 
  H     -0.650798   -2.854422   -6.809796 
  H     -1.456658   -3.917226   -4.511639 
  H     -4.011399   -4.688607   -4.788321 
  H     -4.801025   -4.063445   -7.280577 
  C     -2.593119   -3.678613   -7.701292 
  H     -2.655542   -3.113517   -8.654597 
  H     -2.258585   -1.041707   -7.461663 
  O     -2.738846   -1.033497   -4.274413 
  O     -1.335212    0.218296   -5.442189 
  C     -2.378103   -0.287210   -3.081353 
  H     -2.424902    0.794260   -3.291960 
  H     -3.109853   -0.593944   -2.319894 
  H     -1.348788   -0.571845   -2.792732 
  Si    -0.257542    1.032390   -6.652930 
  C      0.692361    2.194329   -5.547758 
  H      1.339672    2.801362   -6.222040 
  H     -0.046722    2.895396   -5.108303 
  C     -1.436834    1.908227   -7.844455 
  H     -0.968765    1.871800   -8.853553 
  H     -2.365380    1.302417   -7.929595 
  C      0.824739   -0.308197   -7.424355 
  H      1.833185    0.158980   -7.494286 
  H      0.944238   -1.101202   -6.654000 
  C      1.511488    1.524808   -4.439741 
  H      2.262274    0.810392   -4.829786 
  H      2.049254    2.282851   -3.841279 
  H      0.853211    0.980703   -3.738484 
  C     -1.778613    3.356482   -7.456838 
  H     -2.517417    3.792131   -8.159541 
  H     -2.205245    3.424532   -6.438106 
  H     -0.878482    4.003210   -7.478431 
  C      0.416340   -0.879380   -8.788187 
  H      1.141042   -1.641600   -9.139648 
  H     -0.577425   -1.372711   -8.765821 
  H      0.365841   -0.093375   -9.569225 
  H     -4.458627   -1.941536   -5.579912 
  C     -4.916326   -1.331962   -7.563613 
  C     -6.291165   -1.235712   -7.254762 
  C     -4.472320   -0.773109   -8.778873 
S-90 
 
  C     -7.186001   -0.581424   -8.112199 
  H     -6.661729   -1.688082   -6.320145 
  C     -5.365874   -0.121848   -9.643891 
  H     -3.411154   -0.833496   -9.065355 
  C     -6.724285   -0.016369   -9.311406 
  H     -8.249501   -0.507781   -7.838643 
  H     -4.991923    0.312821  -10.583250 
  H     -7.420663    0.505928   -9.984287 
 
P (s-trans, minor) 
 
E = -9323.89022570158 
 
  P      0.868969   -0.746806   -0.783113 
  O      2.409799   -0.535081   -0.210871 
  O      0.498982   -2.239353   -0.159551 
  C      3.299020   -1.597749   -0.104107 
  C      4.438578   -1.594533   -0.964334 
  C      5.321444   -2.661736   -0.875145 
  C      5.104428   -3.743009    0.022144 
  C      5.992938   -4.857259    0.064906 
  C      5.752471   -5.929427    0.909780 
  C      4.602186   -5.927857    1.741335 
  C      3.725863   -4.851843    1.733996 
  C      3.954882   -3.723589    0.892552 
  C      3.064817   -2.591033    0.846756 
  C      1.891020   -2.495132    1.757754 
  C      2.037782   -2.499290    3.189194 
  C      3.310364   -2.448785    3.830538 
  C      3.408247   -2.434736    5.214662 
  C      2.241399   -2.502879    6.021852 
  C      0.989185   -2.541322    5.427260 
  C      0.851023   -2.507381    4.007633 
  C     -0.428998   -2.466657    3.391368 
  C     -0.586790   -2.378944    2.008952 
  C      0.609265   -2.378167    1.218704 
  C      4.672153   -0.486279   -1.921315 
  H      6.214320   -2.676388   -1.518663 
  H      6.870551   -4.853231   -0.599993 
  H      6.442153   -6.786592    0.927951 
  H      4.397981   -6.790512    2.393468 
  H      2.833493   -4.870631    2.374090 
  H      4.217181   -2.395621    3.213876 
  H      4.399761   -2.369123    5.686818 
  H      2.334014   -2.516674    7.118410 
  H      0.076413   -2.580884    6.040288 
  H     -1.317264   -2.502812    4.039331 
  C     -1.940856   -2.322201    1.399756 
  C      4.628889    0.854925   -1.496978 
  C      4.889652    1.894357   -2.402893 
  C      5.195537    1.616862   -3.740186 
  C      5.213530    0.281216   -4.173621 
S-91 
 
  C      4.952578   -0.763290   -3.275887 
  C     -3.005177   -1.702618    2.090081 
  C     -4.309693   -1.728168    1.571282 
  C     -4.578095   -2.342522    0.341394 
  C     -3.519291   -2.928295   -0.367602 
  C     -2.220094   -2.934426    0.155499 
  H      4.383064    1.088352   -0.452578 
  H      5.370547    2.437247   -4.448158 
  H      4.903354   -1.800375   -3.633121 
  H     -2.816007   -1.189653    3.043485 
  H     -5.598863   -2.369840   -0.058633 
  H     -1.420903   -3.429375   -0.407185 
  N      0.005008    0.347201   -0.049965 
  P     -0.759022    1.716147   -0.243063 
  O     -0.397185    2.731532    1.015785 
  O     -2.352413    1.333834    0.055700 
  C     -0.540364    2.184371    2.286541 
  C      0.641427    1.809092    2.998712 
  C      0.477126    1.174007    4.226288 
  C     -0.808834    0.898862    4.764455 
  C     -0.955738    0.223081    6.011760 
  C     -2.211781   -0.079430    6.514755 
  C     -3.372230    0.291603    5.785473 
  C     -3.262709    0.984900    4.588114 
  C     -1.986393    1.317972    4.046083 
  C     -1.828741    2.015556    2.793756 
  C     -2.998158    2.549329    2.043067 
  C     -3.902217    3.481622    2.669955 
  C     -3.650433    4.058213    3.950892 
  C     -4.546551    4.949408    4.523136 
  C     -5.741872    5.309519    3.847378 
  C     -6.004765    4.787426    2.591043 
  C     -5.095799    3.881943    1.970014 
  C     -5.333636    3.378739    0.662286 
  C     -4.422834    2.553807    0.019719 
  C     -3.237650    2.171050    0.717542 
  C      2.006053    2.158545    2.528087 
  H      1.364871    0.890900    4.811739 
  H     -0.045505   -0.062237    6.559664 
  H     -2.311818   -0.608452    7.474631 
  H     -4.369291    0.027555    6.167763 
  H     -4.166797    1.265408    4.034097 
  H     -2.724003    3.801116    4.481757 
  H     -4.323055    5.387354    5.507618 
  H     -6.447041    6.013141    4.314514 
  H     -6.915647    5.074150    2.043005 
  H     -6.255196    3.672433    0.136976 
  C     -4.721032    2.087202   -1.367891 
  C      2.304239    3.463892    2.079980 
  C      3.632542    3.848512    1.842340 
  C      4.680374    2.931798    2.012280 
  C      4.385752    1.622811    2.419659 
S-92 
 
  C      3.060431    1.234733    2.673460 
  C     -4.462573    2.930908   -2.464666 
  C     -4.820331    2.527845   -3.760563 
  C     -5.462620    1.302166   -3.976461 
  C     -5.736812    0.466405   -2.883505 
  C     -5.357712    0.848042   -1.586073 
  H      1.494628    4.197041    1.962404 
  H      5.717794    3.240202    1.836816 
  H      2.841175    0.208343    3.001370 
  H     -3.964405    3.894433   -2.295531 
  H     -5.751641    1.000093   -4.991400 
  H     -5.578319    0.196964   -0.730142 
  N      0.710943   -0.826820   -2.376655 
  N     -0.502478    2.470956   -1.633856 
  S      1.345536   -1.888816   -3.414867 
  O      1.377234   -1.265038   -4.757830 
  O      2.518452   -2.647321   -2.923181 
  S     -1.107726    3.918141   -2.032526 
  O     -1.402022    3.948926   -3.486426 
  O     -2.122313    4.448105   -1.082679 
  C      0.378468    5.068253   -1.800491 
  C     -0.023155   -3.181321   -3.592845 
  F      0.950815    4.830374   -0.614518 
  F      1.279010    4.887018   -2.775397 
  F     -0.054917    6.333098   -1.838707 
  F     -0.100431   -3.953136   -2.500626 
  F      0.240888   -3.947562   -4.656876 
  F     -1.204684   -2.563089   -3.780048 
  C      5.497390    0.620503    2.622610 
  C      3.933152    5.292271    1.491686 
  C      4.753672    3.317268   -1.918641 
  C      5.496075   -0.021265   -5.625806 
  F      6.721221    1.180232    2.517071 
  F      5.437807   -0.388291    1.708205 
  F      5.419409    0.034051    3.845134 
  F      3.414682    6.123857    2.432461 
  F      3.397839    5.662365    0.307930 
  F      5.263130    5.530107    1.429534 
  F      5.631651    3.594989   -0.917907 
  F      3.510183    3.529869   -1.419022 
  F      4.961386    4.221519   -2.900041 
  F      6.824255   -0.132755   -5.871962 
  F      4.917294   -1.178992   -6.023420 
  F      5.026973    0.964571   -6.439009 
  C     -3.783987   -3.494945   -1.741423 
  C     -5.438501   -1.062486    2.322788 
  C     -6.522375   -0.796542   -3.145628 
  C     -4.459690    3.378100   -4.953951 
  F     -4.236501    4.660872   -4.640810 
  F     -3.329982    2.896710   -5.562299 
  F     -5.434172    3.343726   -5.905391 
  F     -6.628624   -1.583196   -2.049557 
S-93 
 
  F     -7.782226   -0.507142   -3.554872 
  F     -5.963415   -1.544824   -4.135517 
  F     -5.340848   -1.249918    3.659527 
  F     -5.448836    0.286796    2.111690 
  F     -6.648201   -1.522853    1.930906 
  F     -2.878444   -4.431261   -2.101231 
  F     -3.731651   -2.502098   -2.678622 
  F     -5.010460   -4.056787   -1.839690 
  C     -1.853889   -0.105892   -5.841302 
  C     -2.334282   -0.960490   -6.968430 
  C     -3.319473   -2.105569   -6.582790 
  C     -4.449567   -1.941724   -7.687796 
  C     -4.398646    0.370636   -7.549318 
  C     -5.206211   -0.685460   -7.298116 
  C     -3.107894   -0.184504   -8.127477 
  H     -4.284982   -1.126774   -9.744438 
  H     -2.464345    0.521494   -8.680283 
  H     -4.580082    1.426734   -7.311785 
  H     -6.182265   -0.679486   -6.793226 
  H     -5.047560   -2.859403   -7.826791 
  C     -3.641290   -1.417110   -8.891829 
  H     -2.848565   -2.108623   -9.240448 
  H     -1.409451   -1.367425   -7.422459 
  O     -2.524409   -0.158890   -4.735913 
  O     -0.838867    0.651406   -5.909275 
  C     -2.038811    0.579071   -3.571945 
  H     -1.049838    0.175743   -3.283134 
  H     -2.786812    0.382553   -2.788320 
  H     -1.964860    1.653735   -3.809819 
  Si     0.517972    1.430247   -6.813048 
  C      1.113894    2.661228   -5.537700 
  H      0.238876    3.258056   -5.197655 
  H      1.781734    3.372870   -6.075330 
  C      1.768220    0.125137   -7.323450 
  H      2.366240   -0.138683   -6.430963 
  H      2.454526    0.670005   -8.012075 
  C     -0.251613    2.243615   -8.331703 
  H     -0.564980    1.449946   -9.045595 
  H      0.621707    2.730850   -8.824603 
  C      1.828971    2.039760   -4.331055 
  H      1.158858    1.377522   -3.752678 
  H      2.188085    2.822281   -3.638409 
  H      2.699796    1.433241   -4.641036 
  C      1.245059   -1.162251   -7.972405 
  H      2.079748   -1.769814   -8.377022 
  H      0.542336   -0.972558   -8.812100 
  H      0.737481   -1.792118   -7.214664 
  C     -1.369462    3.266690   -8.100223 
  H     -1.659707    3.773269   -9.043003 
  H     -1.065277    4.051137   -7.378532 
  H     -2.279242    2.796704   -7.681527 
  H     -3.770375   -1.886742   -5.598758 
S-94 
 
  C     -2.724667   -3.496358   -6.501177 
  C     -3.199621   -4.362650   -5.494343 
  C     -1.744003   -3.982529   -7.389465 
  C     -2.706284   -5.667862   -5.369021 
  H     -3.956016   -3.990791   -4.787435 
  C     -1.253410   -5.292107   -7.272817 
  H     -1.335385   -3.336317   -8.182094 
  C     -1.730080   -6.138570   -6.260888 
  H     -3.077856   -6.313315   -4.558801 
  H     -0.483798   -5.648580   -7.974085 
  H     -1.335327   -7.161037   -6.163843 
 
P  
 
E = -730.258169480856 
 
  C     -0.929654    3.395982    1.217870 
  C      0.578645    3.494349    1.303629 
  C      1.228018    4.908886    1.304489 
  C      2.304380    4.775849    0.136735 
  C      0.873125    3.520456   -1.178612 
  C      1.494994    4.720624   -1.146817 
  C      1.280581    2.770200    0.079423 
  H      3.400117    2.970065   -0.539781 
  H      1.119246    1.676930    0.082838 
  H      0.117540    3.178728   -1.899864 
  H      1.346645    5.565710   -1.834327 
  H      3.098752    5.542070    0.193250 
  C      2.719469    3.296124    0.270936 
  H      3.162788    3.041050    1.254098 
  H      0.845834    2.925976    2.215585 
  O     -1.512454    4.525668    0.739598 
  O     -1.561117    2.393989    1.501954 
  C     -2.932990    4.455814    0.577391 
  H     -3.429526    4.230253    1.542552 
  H     -3.248830    5.444966    0.200806 
  H     -3.208805    3.660200   -0.144169 
  H      0.477544    5.658897    0.994400 
  C      1.829322    5.383142    2.612484 
  C      1.798796    6.763764    2.906469 
  C      2.470885    4.530515    3.535234 
  C      2.391120    7.277371    4.068420 
  H      1.294590    7.445983    2.203122 
  C      3.065521    5.038784    4.700643 
  H      2.504935    3.445554    3.354024 
  C      3.030591    6.414633    4.972453 
  H      2.348204    8.358408    4.272126 
  H      3.557124    4.349809    5.404546 
  H      3.494365    6.812245    5.887868 
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5. Summarizing Discussion 
During the course of this work, the activation and application of α,β-unsaturated esters in 
highly enantioselective transformations has been studied. While this fundamental substrate 
class is highly abundant, economical and displays diverse synthetic potential, α,β-
unsaturated esters, especially cinnamates, demonstrate particularly low reactivity as 
electrophiles in catalytic asymmetric reactions, despite recent successes in enantioselective 
catalysis with chiral Brønsted and Lewis acids. Gratifyingly, through the identification of 
novel and extremely active Lewis acid catalysts, we were able to overcome some of the 
major synthetic challenges associated with this class of compounds. 
Specifically, the design of catalysts with enhanced activity through a highly acidified C–H 
bond led to the synthesis of binaphthyl-allyl-tetrasulfones (BALT).56 Upon silylation, these 
chiral C–H acids become extremely active Lewis acid catalysts. With the appropriate catalyst 
derivative, we could affect a Diels–Alder reaction between typically unreactive cinnamates 
and cyclopentadiene with very high yields and excellent enantio- and diastereoselectivities 
using only 1 mol% catalyst loading and a catalytic amount of a silyl ketene acetal (Scheme 
5.1).57 This example represents the first highly enantioselective transformation involving an 
unambiguous chiral C–H acid as the catalyst. Mechanistic studies indicated the involvement 
of ionic species and a catalytic cycle based on the concept of asymmetric counteranion-
directed catalysis (ACDC). Conceptually, this strategy differs from conventional chiral Lewis 
acid catalysis typically involving a metal(loid) complex with chiral ligands or substituents 
(Scheme 5.2). Their activity can often be increased by rendering the complexes cationic and 
combining them with weakly coordinating, achiral counteranions. 
 
Scheme 5.1 Catalytic asymmetric Diels-Alder reactions of 9-fluorenylmethyl cinnamates 
catalyzed by a chiral C–H acid.  
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Scheme 5.2 Conventional approaches and silylium ion–ACDC in enantioselective Lewis acid 
catalysis. 
In contrast, an inversion of the chiral entities within the ion pair can be achieved by 
combining an achiral Lewis acidic silylium ion with a chiral counteranion. The important and 
unique feature of this silylium ion–ACDC approach arises from the possibility of a repair 
pathway upon hydrolytic deactivation of the Lewis acid catalyst, enabled by simply adjusting 
the amount of the silylating reagent. The valuable source of chirality is hydrolytically stable 
and can only switch between the anionic state (active Lewis acid) and the Brønsted acidic 
state, thus allowing extremely low catalyst loadings. A limitation of our studies involved the 
requirement of the 9-fluorenylmethyl ester group, which does not result in electrophilic 
activation, however was crucial to obtain high enantioselectivities. A subsequent 
computational study by Wheeler and coworkers concluded that the high stereoselectivities 
arise from stabilizing π–stacking interactions of the 9-fluorenylmethyl group with the 9-
phenanthrenyl substituent.58  
As we reasoned that such an achiral auxiliary group could ultimately be made obsolete with 
the right catalyst design, our subsequent efforts in catalyst and reaction development aimed 
for accessing simple and most readily available α,β-unsaturated methyl esters. These 
substrates, and cinnamates in particular, have been quantified among the very least 
electrophilic Michael acceptors by Mayr and coworkers,28 and very little precedence for their 
activation has been reported so far. We found that our recently developed confined 
imidodiphosphorimidate (IDPi) acids were exceptionally high performing catalysts for 
asymmetric Mukaiyama–Michael reactions of silyl ketene acetals (SKA) to α,β-unsaturated 
methyl esters.59 Very high enantio- and diastereoselectivities with only 1 mol% of 2a could 
be achieved with a large variety of substrates and different nucleophiles (Scheme 5.3). In 
addition, our chiral catalyst controls the diastereomeric outcome of the reaction depending 
on the geometry of the SKA applied: E-SKAs afford syn-products, whereas Z-SKAs pre-  
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Scheme 5.3 Catalytic asymmetric Mukaiyama–Michael reaction of silyl ketene acetals with 
α,β-unsaturated methyl esters. 
dominantly give the corresponding anti-products. Intriguingly, achiral triflimide (HNTf2) as 
catalyst failed to provide any increased diastereoselectivity with all SKA variants. Further 
catalyst optimization resulted in IDPi derivative 2b, which allowed us to obtain very high 
enantio- and diastereoselectivities for both the syn- and the anti-stereoisomer with methyl 
cinnamate as substrate (Scheme 5.4).60 From these results, we were able to derive a 
transition state model which rationalizes the stereochemical outcome of the reaction and 
predicts the stereochemistry for a desired product based on the configuration of the catalyst 
and the E/Z-geometry of the SKA. Through mechanistic and kinetic studies, we identified and 
characterized an open-chain silyl ketene acetal intermediate as the initial reaction product 
with Z/E ratio of >99:1 (Scheme 5.5). Direct utilization of this intermediate in a LAH 
reduction allowed selective differentiating the two ester groups, while treatment of the 
Mukaiyama–Michael product with aq. NaOH resulted in selective saponification of the less  
 
Scheme 5.4 Stereochemical model for the enantio- and diastereocontrol by the catalyst and 
the E/Z-geometry of the SKA. 
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sterically hindered ester group. Together with Master student Vanda Daskova, we further 
envisioned to employ the silyl ketene acetal intermediate as a nucleophile in a subsequent 
reaction with appropriate electrophiles. Indeed, we found that such tandem Mukaiyama–
Michael reactions could successfully be conducted with various halogenating agents and 
carbon electrophiles to afford α-functionalized products with excellent enantioselectivities 
and promising diastereoselectivities.60 
 
Scheme 5.5 Selective transformations of the silyl ketene acetal reaction intermediate and 
tandem α-functionalizations. 
Towards a general Diels–Alder methodology for simple α,β-unsaturated methyl esters as 
dienophiles, we could identify two distinct families of IDPi catalysts for very high enantio- 
and diastereoselectivities, each of which giving optimal results in combination with a 
different silyl group (Scheme 5.6).61 3,5-trifluoromethylphenyl substituted catalyst 
performed optimal with the triethylsilyl (TES) group, while 3-fluorene derivatives at the 3,3’-
position of the BINOL backbone interacted best with the triisopropylsilyl (TIPS) group. This 
flexibility in our catalytic system and the optional fine-tuning allowed us to employ an 
extraordinary broad scope of both 3-aryl- and 3-alkyl-substituted α,β-unsaturated methyl 
esters as substrates. Diels–Alder adducts with cyclopentadiene were isolated in excellent 
yields, enantio- and diastereoselectivities using only 0.5–3 mol% of catalyst. We also tested  
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Scheme 5.6 A general catalytic asymmetric Diels–Alder methodology of α,β-unsaturated 
methyl esters and different dienes. 
less reactive dienes in comparison to cyclopentadiene (krel = 1350), such as 2,3-
dimethylbutadiene (krel = 4.9) and isoprene (krel = 2.3), as referenced to butadiene (krel = 1) 
by Sauer et al..62 Under optimized conditions, high yield, regio- and enantioselectivities were 
obtained for the corresponding products. In order to demonstrate practical applicability, 
catalytic asymmetric Diels–Alder reactions with four different dienophiles were performed 
on a preparative scale and even reduced catalyst loadings of 0.1 mol% giving near 
quantitative yields and very high enantioselectivities (Scheme 5.7). We found that our 
catalytic system even tolerates neat reaction conditions with the diene acting as the solvent 
and observed only low levels of polymerization. Another practical aspect of this 
methodology arises from the self-drying properties of the reaction conditions, which allowed 
us to conduct the reaction in a standard vial without inert gas or dry solvents. The reaction 
profile was investigated in detail for methyl cinnamate and cyclopentadiene at the DLPNO-
CCSD(T)/def2-TZVP + C-PCM(toluene) // PBE-D3 (BJ)/def2-SVP level of theory in cooperation 
with the Neese research group. Transfer of the silyl group from the activated catalyst to the 
ester substrate as the first step was calculated to be endothermic (ΔG = 7.4 kcal/mol) and  
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Scheme 5.7 Gram-scale experiments with four different substrates and reduced catalyst 
loadings. 
the corresponding s-trans conformation was found to be more stable over the s-cis 
conformation. Detailed analysis of the resulting chiral ion pair (CIP) revealed a strong 
geometrical match between the chiral counteranion and silylated methyl cinnamate  
 
Scheme 5.8 Computational studies on the Diels–Alder reaction profile and the interaction 
within the chiral ion pair (CIP). 
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accounting for the obtained high enantioselectivities and the high tolerance at the 3-position 
of the substrate. Calculation of the transition states leading to both enantiomers featuring 
the structure of the chiral ion pair as the starting point resulted in a theoretical enantiomeric 
ratio (e.r. 93:7; ΔΔG‡ = 1.2 kcal/mol), which was in good agreement with the experimental 
data. 
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6. Summary & Outlook 
By addressing the first objective of the present work, silylium-ACDC enabled the activation of 
various α,β-unsaturated esters, among them unreactive cinnamates, in combination with 
appropriately strong chiral Brønsted pre-catalysts. Through the first example of highly 
enantioselective catalysis with a chiral C–H acid previously inaccessible Diels–Alder adducts 
derived from cinnamates could be obtained. The identification of 3-fluorenyl-derived IDPi’s 
as privileged catalyst family of catalysts for efficient enantiodiscrimination of α,β-
unsaturated methyl esters led to a highly enantio- and diastereoselective Mukaiyama–
Michael reaction with SKAs and a second-generation Diels–Alder methodology. 
The expansion of silylium-ACDC to non-silicon transfer reactions (catalytic in silicon) was 
successfully achieved for both developed Diels–Alder methodologies while the ability of self-
healing was maintained and side-reactions were excluded. 
The severe limitation of high catalyst loadings for asymmetric Diels–Alder reactions was fully 
overcome via self-healing and the extremely high activity of the employed acids. With 
catalyst loadings as low as 0.1 mol%, it can be argued that the most efficient catalyst system 
for asymmetric Diels–Alder reactions to date has been introduced. Intriguingly, the reaction 
conditions still tolerate a broad variety of functional groups and residual amounts of 
moisture. In addition, the scope of accessible Diels–Alder products has significantly been 
expanded for both dienophiles and dienes. Gram-scale experiments under neat conditions 
indicated the extraordinary potential for future large-scale applications. 
 
Scheme 6.1 Summary of the developed asymmetric catalytic methodology applying silylium-
ACDC with α,β-unsaturated esters.  
6. Summary & Outlook 
252 
Continued efforts in the development of catalytic asymmetric Diels–Alder methodology 
should comprise the expansion of the substrate scope to methyl acrylate and derivatives 
with different dienes, the expansion of the diene scope to silylated dienes, the investigation 
of high-pressure conditions on stereoselectivity and reaction rate, further scale-up (up to 
kilogram scale) and catalyst recycling to demonstrate industrial applicability, as well as the 
enantioselective synthesis of attractive target molecules, such as norbornene-derived 
pharmaceuticals63-68 and natural products of the dihydrochalcone family.69-72 
Further, efficient enantiodiscrimination of α,β-unsaturated methyl esters by silylated IDPi 
catalysts could be exploited for other catalytic asymmetric pericyclic reactions, such as 1,3-
dipolar cycloaddition reactions with substituted azides or diazomethane derivatives as 1,3-
dipols. Catalytic asymmetric conjugate addition reactions of silylated nucleophiles, such as 
silylazides and silylcyanides, hold great promise for the asymmetric synthesis of 
pharmaceutically relevant structures through the introduction of nitrogen-containing 
groups. In addition, the concept of silylium-ACDC catalytic in silicon could be expanded to 
other attractive, though rarely applied substrate classes, such as α,β-unsaturated nitriles, 
amides, ketones and propynoic esters for future catalytic asymmetric Diels–Alder reactions. 
 
Scheme 6.2 Outlook of further applications of silylium-ACDC with α,β-unsaturated methyl 
esters and other potential substrate classes.  
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